Study Notes BS Biochemistry At GCUF Faisalabad

Study Notes BS Biochemistry At GCUF Faisalabad

by

Looking for study notes to ace your BS Biochemistry program at GCUF Faisalabad? Check out our comprehensive guide for tips and key concepts.The BS Biochemistry program at GCUF is designed to equip students with a deep understanding of the biochemical processes that occur within living organisms. From molecular biology to enzymology, students will delve into the intricacies of biochemistry and its applications in various fields such as medicine, agriculture, and biotechnology.

Study Notes BS Biochemistry at GCUF Faisalabad.

Study Notes BS Biochemistry At GCUF Faisalabad

BCH- 301 Introductory Biochemistry 4 (3-1)

Study Notes: Foundations of Biochemistry

1. Biochemistry: Definition & Scope

Definition: Biochemistry is the study of the chemical substances, reactions, and processes that occur in living organisms. It bridges biology and chemistry, explaining life at the molecular level.

Scope: Encompasses:

  • Structural Biochemistry: The 3D architecture of biological molecules (proteins, nucleic acids, lipids, carbohydrates).
  • Metabolism: The network of chemical reactions that sustain life (catabolism for energy, anabolism for synthesis).
  • Molecular Genetics: The chemistry of genetic information storage (DNA), transmission (replication), and expression (transcription, translation).
  • Bioenergetics: How organisms acquire and utilize energy (ATP, electron transport chains).
  • Clinical & Medical Biochemistry: Understanding diseases (e.g., diabetes, cancer) at a molecular level and developing diagnostics/therapies.
  • Biotechnology & Genetic Engineering: Manipulating biomolecules for applications (insulin production, CRISPR).

2. Living Systems, Evolution, and Key Elements

Living Systems are characterized by: Complexity & Organization, Metabolism, Responsiveness, Homeostasis, Growth, Reproduction, and Evolution.

Evolution and the Rise of Living Systems: The prevailing theory is chemical evolution leading to abiogenesis:

  1. Formation of Primordial Soup: Simple molecules (H₂O, CH₄, NH₃, H₂) in the early Earth’s atmosphere formed organic precursors (amino acids, nucleotides) with energy input (lightning, UV).
  2. Polymerization: These monomers formed polymers (proteins, nucleic acids) on clay or mineral surfaces.
  3. Protocells: Self-assembling lipid membranes encapsulated these polymers, creating compartments with internal chemistry.
  4. RNA World Hypothesis: Self-replicating RNA molecules may have been the first genetic material and catalyst.
  5. Natural Selection: Systems with better replication and metabolism persisted, leading to the Last Universal Common Ancestor (LUCA) and the three domains of life (Bacteria, Archaea, Eukarya).

Important Elements of Living Systems:

  • Carbon (C): The backbone of life. Its tetravalency allows formation of stable single, double, and triple bonds, creating diverse, complex chains and rings (organic compounds).
  • Hydrogen (H): The most abundant element. Participates in bonds, energy transfers (H⁺ gradients), and determines acidity (pH).
  • Oxygen (O): Essential for aerobic respiration (final electron acceptor), a key component of water and most organic functional groups.
  • Nitrogen (N): Crucial component of amino acids (proteins), nucleotides (DNA/RNA), and chlorophyll.
  • Phosphorus (P): Found in the backbone of nucleic acids (phosphate groups), in ATP (energy currency), and in phospholipids (cell membranes).
  • Others: Sulfur (S) in proteins; Calcium (Ca) in signaling and structure; Magnesium (Mg) in chlorophyll and enzyme cofactors; Trace elements (Fe, Zn, Cu, I, etc.) as enzyme cofactors.

3. Foundations of Biochemistry

A multi-disciplinary foundation:

  • Physical Foundation: Principles of thermodynamics (ΔG, entropy, enthalpy), reaction kinetics, molecular interactions (H-bonds, van der Waals, ionic), and acid-base chemistry (pH, buffers).
  • Cellular Foundation: The cell is the fundamental unit of life. Compartmentalization (organelles) allows specialized metabolic pathways.
  • Chemical Foundation: Understanding covalent bonds, functional groups, stereochemistry, and the properties of water (the universal solvent).
  • Genetic Foundation: The central dogma of molecular biology: DNA → RNA → Protein. Genetic information directs all cellular processes.
  • Evolutionary Foundation: All life shares common biochemical pathways and molecules (universal genetic code, conserved metabolic cycles like glycolysis), indicating descent from a common ancestor.

4. Nature of Organic Matter, Isomerism, and Functional Groups

Nature of Organic Matter: Compounds based on carbon, typically containing C-C and C-H bonds. Biomolecules are often large polymers (macromolecules) made from smaller monomeric subunits.

Isomerism: Compounds with the same molecular formula but different structures.

  • Structural Isomers: Differ in the connectivity of atoms (e.g., glucose vs. fructose).
  • Stereoisomers: Same connectivity, different spatial arrangement.
    • Geometric (cis-trans): Differ around a double bond (e.g., unsaturated fatty acids).
    • Enantiomers: Non-superimposable mirror images (like left & right hands). Crucial in biology, as enzymes are stereospecific (e.g., L-amino acids, D-sugars).

General Reactions of Functional Groups:

  • Hydroxyl (-OH): Dehydration (ester/phosphoester formation), oxidation.
  • Carbonyl (C=O): Aldehydes/ketones undergo nucleophilic addition.
  • Carboxyl (-COOH): Acts as an acid (donates H⁺), forms esters and amides.
  • Amino (-NH₂): Acts as a base (accepts H⁺), forms amides.
  • Phosphate (-PO₄²⁻): High-energy bonds in ATP, forms stable esters (e.g., in DNA backbone).
  • Sulfhydryl (-SH): Forms disulfide bridges (-S-S-) in proteins (stabilizes structure).

5. Biologically Important Organic Compounds

1. Carbohydrates (Sugars & Saccharides)

  • Formula: ~(CH₂O)ₙ. Functions: Energy source (glucose), energy storage (starch, glycogen), structure (cellulose, chitin).
  • Monosaccharides: Simple sugars (e.g., glucose, fructose, ribose).
  • Disaccharides: Two linked monosaccharides (e.g., sucrose, lactose).
  • Polysaccharides: Long chains (e.g., starch, glycogen, cellulose). Glycosidic bonds link sugar units.

2. Proteins

  • Monomers: Amino acids (20 standard). Each has an amino group, carboxyl group, and a variable R-group (side chain).
  • Structure: Primary (sequence), Secondary (α-helix, β-sheet), Tertiary (3D fold), Quaternary (multi-subunit assembly).
  • Functions: Enzymes (catalysts), structure, transport, signaling, defense (antibodies), motion.
  • Bond: Peptide bond (amide linkage) forms between amino acids.

3. Lipids

  • Defining Feature: Hydrophobic (insoluble in water). Diverse group.
  • Types & Functions:
    • Fats & Oils (Triacylglycerols): Energy storage, insulation.
    • Phospholipids: Major component of all cell membranes (form bilayers).
    • Steroids: Cholesterol (membrane fluidity), hormones (estrogen, testosterone).
    • Waxes: Protection and waterproofing.

4. Nucleic Acids

  • Function: Storage, transmission, and expression of genetic information.
  • Monomers: Nucleotides. Each nucleotide = Phosphate + Pentose Sugar (ribose/deoxyribose) + Nitrogenous Base.
  • Types:
    • DNA (Deoxyribonucleic Acid): Double helix. Bases: A, T, G, C. Sugar: Deoxyribose. Stores genetic blueprint.
    • RNA (Ribonucleic Acid): Usually single-stranded. Bases: A, U, G, C. Sugar: Ribose. Involved in protein synthesis (mRNA, tRNA, rRNA).
  • Bonds: Phosphodiester bonds link nucleotides in the backbone. Hydrogen bonds between complementary bases (A-T/U, G-C) stabilize double helices.

Study Notes: Solution Preparation & Analytical Techniques in Biochemistry

1. PREPARATION OF SOLUTIONS

Molar Solutions (M)

Definition: Number of moles of solute per liter of solution (mol/L).
Formula: Molarity (M) = moles of solute / liters of solution

Preparation Steps:

  1. Calculate mass needed: Mass (g) = Molarity (M) × Volume (L) × Molar Mass (g/mol)
  2. Weigh the calculated mass accurately.
  3. Dissolve in a volumetric flask with solvent (usually distilled water).
  4. Add solvent to the calibration mark on the flask (final total volume).
    Example: 1 M NaCl (MW=58.44 g/mol) in 1 L → Dissolve 58.44 g NaCl in water and dilute to exactly 1 L total volume.

Normal/Equivalent Solutions (N)

Definition: Number of gram equivalents of solute per liter of solution.
Formula: Normality (N) = equivalents of solute / liters of solution

Gram Equivalent Weight (GEW) depends on:

  • Acid-Base Reactions: GEW = Molar Mass / n (n = # of H⁺ or OH⁻ donated/accept)
  • Redox Reactions: GEW = Molar Mass / n (n = # of electrons transferred)
  • Precipitation/Ion Exchange: GEW = Molar Mass / n (n = charge on ion)

Preparation: Similar to molar solutions but using GEW instead of molar mass.
Mass (g) = Normality (N) × Volume (L) × GEW (g/eq)
Example: 1 N H₂SO₄ (MW=98 g/mol, dibasic → n=2, GEW=49 g/eq) → Dissolve 49 g in water, dilute to 1 L.

Molal Solutions (m)

Definition: Number of moles of solute per kilogram of solvent (mol/kg).
Formula: Molality (m) = moles of solute / kg of solvent

Preparation:

  1. Calculate mass of solute: Mass (g) = Molality (m) × kg solvent × Molar Mass
  2. Weigh solute and solvent separately.
  3. Dissolve solute in measured mass of solvent.
    Key Point: Molality is temperature-independent (unlike molarity), important for colligative properties.
    Example: 1 m glucose (MW=180 g/mol) → Dissolve 180 g glucose in 1 kg (1000 g) water.

ppm and ppb Solutions

Definition:

  • ppm (parts per million): mg of solute per kg of solution (or mg/L for aqueous dilute solutions)
  • ppb (parts per billion): μg of solute per kg of solution (or μg/L)

Preparation:

  • For solids: Weigh in mg or μg, dissolve in 1 kg solvent → 1 ppm or 1 ppb.
  • For liquids: Often prepared by serial dilution from stock.
    Conversion: 1 ppm = 1 mg/L = 1000 ppb (for dilute aqueous solutions)
    Example: 100 ppm Cu²⁺ solution → Dissolve 100 mg CuSO₄·5H₂O in water, dilute to 1 L.

Dilution from Stock Solution

Formula: C₁V₁ = C₂V₂
Where: C₁ = concentration of stock, V₁ = volume of stock to use
C₂ = desired concentration, V₂ = desired final volume

Steps:

  1. Calculate V₁ = (C₂ × V₂) / C₁
  2. Measure V₁ mL of stock solution using pipette
  3. Transfer to volumetric flask
  4. Dilute to mark with solvent
    Example: Make 100 mL of 0.1 M NaCl from 1 M stock → V₁ = (0.1 × 100)/1 = 10 mL → Take 10 mL of 1 M NaCl, dilute to 100 mL.

2. STANDARDIZATION OF SOLUTIONS

Purpose: To determine exact concentration of a prepared solution (especially when solute isn’t primary standard).

Primary Standard Requirements:

  • High purity (>99.9%)
  • Stable (no decomposition/hygroscopy)
  • High equivalent weight (reduces weighing error)
  • Reacts stoichiometrically with analyte

Common Primary Standards:

  • Acid-Base: Sodium carbonate (Na₂CO₃), Potassium hydrogen phthalate (KHP)
  • Redox: Potassium dichromate (K₂Cr₂O₇), Sodium oxalate
  • Complexometric: Pure metals (Zn, Cu), EDTA disodium salt

Standardization Procedure (Titration):

  1. Prepare solution of approximate desired concentration
  2. Weigh accurate amount of primary standard
  3. Titrate unknown solution against primary standard
  4. Calculate exact concentration from titration data
    Calculation: M₁V₁ (unknown) = M₂V₂ (standard) for 1:1 stoichiometry

3. pH DETERMINATION

pH = -log[H⁺]
Scale: 0-14 (acidic <7, neutral =7, basic >7)

Methods:

  1. pH Paper/Indicator Strips: Qualitative/semi-quantitative, color comparison
  2. pH Meter: Most accurate method
    • Procedure: Calibrate with standard buffers (pH 4, 7, 10) → Rinse electrode → Immerse in sample → Record stable reading

Typical pH of Biological Samples:

  • Blood: 7.35-7.45 (tightly regulated)
  • Saliva: 6.2-7.6
  • Gastric juice: 1.5-3.5
  • Urine: 4.6-8.0 (varies with diet)
  • Intracellular fluid: ~7.2
  • Cerebrospinal fluid: 7.3-7.4

4. BUFFER PREPARATION

Definition: Solutions that resist pH change when small amounts of acid/base are added.
Components: Weak acid + its conjugate base OR weak base + its conjugate acid

Henderson-Hasselbalch Equation:
pH = pKa + log([A⁻]/[HA])
Where: [A⁻] = conjugate base concentration, [HA] = weak acid concentration

Buffer Capacity: Maximum amount of acid/base that can be neutralized before pH changes significantly. Maximum when pH = pKa.

Preparation Methods:

A. From Weak Acid and Its Salt:

  1. Choose buffer system with pKa close to desired pH (±1 unit)
  2. Use Henderson-Hasselbalch to calculate ratio [A⁻]/[HA]
  3. Prepare by mixing calculated amounts of acid and salt
    Example: Acetate buffer (pKa = 4.76) at pH 5.0:
    5.0 = 4.76 + log([acetate]/[acetic acid])
    [acetate]/[acetic acid] = 10^(0.24) = 1.74

B. By Partial Neutralization:

  1. Start with weak acid
  2. Add strong base to neutralize portion of acid, creating conjugate base
    Example: To make phosphate buffer pH 7.2:
    Start with NaH₂PO₄, add NaOH to convert some to Na₂HPO₄

C. From Stock Solutions:
Often prepare concentrated stock (e.g., 10×) and dilute before use

Common Biological Buffers:

  1. Phosphate Buffer (pKa 7.2): NaH₂PO₄/Na₂HPO₄, physiological pH, interferes with phosphate assays
  2. Tris Buffer (pKa 8.1): Tris-HCl/Tris-base, common in molecular biology, temperature-sensitive
  3. Acetate Buffer (pKa 4.76): Acetic acid/sodium acetate, acidic range
  4. HEPES (pKa 7.5): Good for cell culture, minimal metal binding
  5. Carbonate/Bicarbonate (pKa 6.1, 10.3): Blood buffer system

Buffer Preparation Protocol:

  1. Calculate amounts using Henderson-Hasselbalch
  2. Dissolve components in ~80% final volume
  3. Measure pH with calibrated pH meter
  4. Adjust pH with strong acid/base (HCl/NaOH)
  5. Dilute to final volume
  6. Recheck and adjust pH if needed
  7. Sterilize if required (autoclave or filter)

PRACTICAL TIPS & SAFETY

  • Always use volumetric glassware for accurate volume measurements
  • Label all solutions clearly (name, concentration, date, initials)
  • Store buffers properly (refrigeration for perishable components)
  • Check pH at working temperature (especially Tris)
  • Calibrate pH meter daily with fresh buffer standards
  • Handle concentrated acids/bases with proper PPE
  • Never add water to acid – always add acid to water

SUMMARY TABLE: Solution Types

Type Definition Unit Temperature Dependent? Key Use
Molarity moles solute/L solution M (mol/L) Yes (volume changes) Most common in biochemistry
Molality moles solute/kg solvent m (mol/kg) No Colligative properties
Normality equivalents/L solution N (eq/L) Yes Titrations, redox reactions
ppm mg solute/kg solution mg/kg or mg/L Yes (for mg/L) Trace analysis
ppb μg solute/kg solution μg/kg or μg/L Yes (for μg/L) Ultra-trace analysis

These techniques form the foundation of quantitative biochemical analysis and are essential for preparing reagents, conducting experiments, and analyzing biological samples accurately.

BCH 302 Biochemistry of Carbohydrates

Study Notes: Individual Carbohydrates – Structure, Function & Importance

I. MONOSACCHARIDES (Simple Sugars)

1. GLUCOSE (Dextrose, Blood Sugar)

Structure:

  • Aldohexose (6C aldehyde sugar)
  • Formula: C₆H₁₂O₆
  • Ring forms: Pyranose (6-membered) predominates
  • Anomers: α-D-glucopyranose and β-D-glucopyranose

Sources:

  • Fruits (grapes, dates), honey, corn syrup
  • Hydrolysis of starch, glycogen, maltose, sucrose
  • Blood glucose: 70-110 mg/dL (fasting)

Biochemical Functions & Importance:

  1. Primary energy source for most cells (especially brain, RBCs)
  2. Central metabolite in glycolysis, pentose phosphate pathway, gluconeogenesis
  3. Precursor for synthesis of:
    • Glycogen (storage)
    • Other monosaccharides (galactose, mannose)
    • Non-carbohydrate compounds (vitamin C, glucuronic acid)
  4. Regulation: Insulin/glucagon maintain blood glucose homeostasis
  5. Clinical significance: Diabetes mellitus (hyperglycemia), hypoglycemia

2. FRUCTOSE (Fruit Sugar)

Structure:

  • Ketohexose (6C ketone sugar)
  • Sweetest natural sugar (1.7× sweeter than sucrose)
  • Ring forms: Furanose (5-membered) predominates in free form

Sources:

  • Fruits, honey, high-fructose corn syrup (HFCS)
  • Hydrolysis of sucrose (glucose + fructose)

Biochemical Functions & Importance:

  1. Metabolized in liver via fructokinase → fructose-1-phosphate
  2. Alternative sweetener for diabetics (low glycemic index)
  3. Sperm energy source: High concentration in seminal fluid
  4. Pathology: Hereditary fructose intolerance (aldolase B deficiency)
  5. Excess consumption linked to non-alcoholic fatty liver disease

3. GALACTOSE

Structure:

  • Aldohexose epimer of glucose at C4
  • Rarely free in nature, usually combined

Sources:

  • Milk (as lactose: glucose + galactose)
  • Certain vegetables, legumes
  • Synthesized in mammary glands for lactose production

Biochemical Functions & Importance:

  1. Component of lactose (milk sugar)
  2. Glycolipid/Glycoprotein synthesis:
    • Brain glycolipids (cerebrosides)
    • Blood group antigens
    • Connective tissue proteoglycans
  3. Galactosemia: Genetic disorder (galactose-1-phosphate uridyltransferase deficiency) → toxic accumulation

4. MANNOSE

Structure:

  • Aldohexose epimer of glucose at C2

Sources:

  • Some fruits (cranberries, peaches)
  • Hydrolysis of plant mannans, gums
  • N-linked glycoproteins

Biochemical Functions & Importance:

  1. Protein glycosylation: N-linked oligosaccharide precursor
  2. Lectin recognition: Specific mannose receptors on macrophages
  3. Therapeutic use: D-mannose for UTI prevention (inhibits E. coli adhesion)
  4. Congenital disorders of glycosylation (CDG) involve mannose metabolism defects

5. RIBOSE & DEOXYRIBOSE

Ribose Structure:

  • Aldopentose (5C)
  • Formula: C₅H₁�O₅
  • OH at C2

Deoxyribose Structure:

  • 2-Deoxyribose (missing oxygen at C2)
  • Formula: C₅H₁₀O₄

Sources:

  • Synthesized via pentose phosphate pathway
  • Not typically dietary

Biochemical Functions & Importance:

  1. Ribose:
    • RNA backbone
    • ATP, NAD⁺, FAD, coenzyme A
    • PRPP (phosphoribosyl pyrophosphate) for nucleotide synthesis
  2. Deoxyribose:
    • DNA backbone
    • More stable than ribose (less prone to hydrolysis)

II. DISACCHARIDES

1. SUCROSE (Table Sugar)

Structure:

  • Glucose (α1→2) Fructose
  • Non-reducing sugar (both anomeric carbons involved)

Sources:

  • Sugar cane, sugar beets, maple syrup
  • Most common dietary disaccharide

Biochemical Functions & Importance:

  1. Transport sugar in plants (phloem)
  2. Storage in sugar cane/beets
  3. Hydrolyzed by sucrase (intestinal brush border)
  4. Dental caries primary substrate
  5. Invert sugar: Hydrolysis yields equimolar glucose+fructose (sweeter)

2. LACTOSE (Milk Sugar)

Structure:

  • Galactose (β1→4) Glucose
  • Reducing sugar

Sources:

  • Mammalian milk (4-5% in human, 4-5% in cow)

Biochemical Functions & Importance:

  1. Primary carbohydrate for nursing infants
  2. Hydrolyzed by lactase (intestinal brush border)
  3. Lactose intolerance: Lactase deficiency → bacterial fermentation → gas, diarrhea
  4. Regulation: Lactase expression decreases after weaning in most mammals (except some human populations)

3. MALTOSE (Malt Sugar)

Structure:

  • Glucose (α1→4) Glucose
  • Reducing sugar

Sources:

  • Germinating grains (barley malt)
  • Starch digestion by amylase
  • Beer production

Biochemical Functions & Importance:

  1. Intermediate in starch/glycogen digestion
  2. Hydrolyzed by maltase (intestinal brush border)
  3. Brewing industry: Maltose from barley malt fermentation

III. POLYSACCHARIDES

1. STARCH (Plant Storage)

Structure:

  • Amylose (20-30%): Linear α(1→4) glucose, helical
  • Amylopectin (70-80%): Branched α(1→4) with α(1→6) every 24-30 residues

Sources:

  • Grains (wheat, rice, corn), potatoes, legumes

Biochemical Functions & Importance:

  1. Main dietary carbohydrate worldwide
  2. Digestion: α-amylase (salivary, pancreatic) → maltose, maltotriose, α-limit dextrins
  3. Iodine test: Blue-black color (amylose helix traps I₂)
  4. Resistant starch: Escapes digestion, acts as dietary fiber

2. GLYCOGEN (Animal Storage)

Structure:

  • Highly branched α(1→4) glucose with α(1→6) every 8-12 residues
  • More branched than amylopectin
  • “Tree-like” structure with reducing and non-reducing ends

Sources:

  • Liver (100g, regulates blood glucose)
  • Muscle (400g, local energy)

Biochemical Functions & Importance:

  1. Rapid glucose mobilization (multiple non-reducing ends for phosphorylase)
  2. Liver glycogen: Maintains blood glucose
  3. Muscle glycogen: Fuels muscle contraction
  4. Glycogen storage diseases: Pompe’s, McArdle’s, von Gierke’s

3. CELLULOSE (Plant Structure)

Structure:

  • Linear β(1→4) glucose chains
  • H-bonds between chains → microfibrils → high tensile strength
  • Indigestible by humans (no cellulase)

Sources:

  • Plant cell walls, cotton (90% cellulose), wood (50%)

Biochemical Functions & Importance:

  1. Most abundant organic compound on Earth
  2. Dietary fiber: Promotes bowel movement, feeds gut microbiota
  3. Industrial: Paper, textiles, cellophane, biofuels
  4. Ruminants digest via symbiotic bacteria

4. CHITIN

Structure:

  • β(1→4) N-acetylglucosamine (GlcNAc)
  • Second most abundant polysaccharide

Sources:

  • Exoskeletons of arthropods (insects, crustaceans)
  • Fungal cell walls

Biochemical Functions & Importance:

  1. Structural polysaccharide (replaces cellulose in fungi, arthropods)
  2. Biomedical applications: Wound dressings, drug delivery (biocompatible, biodegradable)
  3. Chitosan: Deacetylated chitin, used in water purification

5. HYALURONIC ACID (Hyaluronan)

Structure:

  • Repeating disaccharide: Glucuronic acid β(1→3) N-acetylglucosamine β(1→4)
  • Unbranched, unsulfated GAG
  • Holds 1000× its weight in water

Sources:

  • Synovial fluid, vitreous humor, skin, umbilical cord

Biochemical Functions & Importance:

  1. Lubricant in joints (synovial fluid)
  2. Hydration of extracellular matrix
  3. Scaffold for cell migration during development/wound healing
  4. Cosmetic/medical: Dermal fillers, osteoarthritis treatment

IV. SPECIALIZED CARBOHYDRATES

1. INULIN

Structure:

  • Fructose β(2→1) polymers with terminal glucose
  • Fructan (fructose polymer)

Sources:

  • Jerusalem artichoke, chicory root, onions, garlic

Biochemical Functions & Importance:

  1. Plant storage in Asteraceae family
  2. Prebiotic: Selectively feeds beneficial gut bacteria (Bifidobacteria)
  3. Diagnostic: Renal clearance test (measures GFR)
  4. Low-calorie sweetener/fiber

2. PECTIN

Structure:

  • Complex polysaccharide with α(1→4) galacturonic acid backbone
  • “Plant jelly” – forms gels with sugar/acid

Sources:

  • Fruit skins (apples, citrus), plant cell walls

Biochemical Functions & Importance:

  1. Plant cell wall structure
  2. Gelling agent: Jams, jellies
  3. Dietary fiber: Lowers cholesterol, slows glucose absorption
  4. Food industry: Thickener, stabilizer

V. CLINICAL & METABOLIC CORRELATIONS

Disorder Defective Carbohydrate Enzyme Defect Symptoms
Diabetes Mellitus Glucose metabolism Insulin deficiency/resistance Hyperglycemia, polyuria, polydipsia
Galactosemia Galactose metabolism Galactose-1-P uridyltransferase Liver failure, cataracts, mental retardation
Lactose Intolerance Lactose digestion Lactase Bloating, diarrhea, cramps
Glycogen Storage Diseases Glycogen metabolism Various enzymes Hypoglycemia, hepatomegaly, muscle weakness
Fructose Intolerance Fructose metabolism Aldolase B Hypoglycemia, liver damage after fructose

SUMMARY: CARBOHYDRATE FUNCTIONS

  1. ENERGY: Glucose (immediate), Glycogen/Starch (storage)
  2. STRUCTURE: Cellulose (plants), Chitin (arthropods/fungi)
  3. RECOGNITION: Glycoproteins/glycolipids (cell signaling, immunity)
  4. LUBRICATION: Hyaluronic acid, mucopolysaccharides
  5. DIETARY FIBER: Cellulose, pectin, inulin (gut health)
  6. METABOLIC INTERMEDIATES: Pentoses, sugar phosphates
  7. OSMOREGULATION: Trehalose (insects), glycerol (algae)

Key Structural Features Determining Function:

  • Glycosidic linkage (α vs β, 1→4 vs 1→6)
  • Branching pattern (storage vs structural)
  • Presence of modifications (sulfation, acetylation)
  • Ability to form H-bonds (cellulose microfibrils)

Chemical and Structural Formulae of Aldoses and Ketoses

I. BASIC DEFINITIONS

Aldoses: Carbohydrates containing an aldehyde functional group (-CHO)
Ketoses: Carbohydrates containing a ketone functional group (>C=O)

General Chemical Formula: Cₙ(H₂O)ₙ (hydrates of carbon)
Empirical Formula: For most simple sugars: CH₂O

II. MONOSACCHARIDE CLASSIFICATION BY CARBON NUMBER

Carbon Atoms Aldose Name Ketose Name Examples
3 Triose Triulose Glyceraldehyde, Dihydroxyacetone
4 Tetrose Tetrulose Erythrose, Erythrulose
5 Pentose Pentulose Ribose, Arabinose, Xylose, Ribulose, Xylulose
6 Hexose Hexulose Glucose, Galactose, Mannose, Fructose, Sorbose
7 Heptose Heptulose Sedoheptulose
8 Octose Octulose –
9 Nonose Nonulose Sialic acid derivatives

III. SPECIFIC STRUCTURAL FORMULAE

A. TRIOSES (C₃H₆O₃)

1. Glyceraldehyde (Aldotriose)

    CHO
    |
  H-C-OH   (Fischer projection)
    |
  CH₂OH

Molecular Formula: C₃H₆O₃
Functional Group: Aldehyde at C1
Importance: Reference compound for D/L stereochemistry

2. Dihydroxyacetone (Ketotriose)

    CH₂OH
    |
  C=O        (No chiral center - achiral)
    |
  CH₂OH

Molecular Formula: C₃H₆O₃
Functional Group: Ketone at C2
Biological Role: Intermediate in glycolysis (glycerone phosphate)

B. TETROSES (C₄H₈O₄)

1. Aldotetroses (4 possible stereoisomers)
Erythrose (D- and L- forms)
Fischer Projection:

    CHO
    |
  H-C-OH
    |
  H-C-OH
    |
  CH₂OH

Molecular Formula: C₄H₈O₄
Biological Role: Intermediate in pentose phosphate pathway

2. Ketotetroses
Erythrulose (important in photosynthesis – Calvin cycle)

    CH₂OH
    |
    C=O
    |
  H-C-OH
    |
  CH₂OH

C. PENTOSES (C₅H₁₀O₅)

1. Aldopentoses (8 possible stereoisomers)
a. Ribose (RNA component)

    CHO
    |
  H-C-OH
    |
  H-C-OH
    |
  H-C-OH
    |
  CH₂OH

Molecular Formula: C₅H₁₀O₅
Ring Form: Furanose (5-membered)

b. Arabinose (plant polysaccharides)

    CHO
    |
  HO-C-H
    |
  H-C-OH
    |
  H-C-OH
    |
  CH₂OH

c. Xylose (wood sugar, hemicellulose)

    CHO
    |
  H-C-OH
    |
  HO-C-H
    |
  H-C-OH
    |
  CH₂OH

2. Ketopentoses
a. Ribulose (Calvin cycle intermediate)

    CH₂OH
    |
    C=O
    |
  HO-C-H
    |
  H-C-OH
    |
  CH₂OH

Molecular Formula: C₅H₁₀O₅
Importance: Ribulose-1,5-bisphosphate (RuBisCO substrate)

b. Xylulose (uronic acid pathway intermediate)

    CH₂OH
    |
    C=O
    |
  HO-C-H
    |
  H-C-OH
    |
  CH₂OH

D. HEXOSES (C₆H₁₂O₆)

1. Aldohexoses (16 possible stereoisomers)
a. D-Glucose (most abundant sugar)

    CHO
    |
  H-C-OH
    |
  HO-C-H
    |
  H-C-OH
    |
  H-C-OH
    |
  CH₂OH

Molecular Formula: C₆H₁₂O₆
Ring Form: Predominantly α- and β-D-glucopyranose (6-membered)

b. D-Galactose (C4 epimer of glucose)

    CHO
    |
  H-C-OH
    |
  HO-C-H
    |
  H-C-OH
    |
  H-C-OH
    |
  CH₂OH

Importance: Component of lactose, glycolipids, proteoglycans

c. D-Mannose (C2 epimer of glucose)

    CHO
    |
  H-C-OH
    |
  HO-C-H
    |
  H-C-OH
    |
  H-C-OH
    |
  CH₂OH

2. Ketohexoses
a. D-Fructose (fruit sugar, levulose)

    CH₂OH
    |
    C=O
    |
  H-C-OH
    |
  HO-C-H
    |
  H-C-OH
    |
  CH₂OH

Molecular Formula: C₆H₁₂O₆
Sweetness: ~1.7× sucrose

b. D-Sorbose (commercial sweetener)

    CH₂OH
    |
    C=O
    |
  H-C-OH
    |
  HO-C-H
    |
  H-C-OH
    |
  CH₂OH

E. HEPTOSES (C₇H₁₄O₇)

Sedoheptulose (7-carbon ketose sugar)
Importance: Central intermediate in pentose phosphate pathway

IV. STRUCTURAL FORMULAE

A. FISCHER PROJECTION

1. Aldose Series

  • Aldoses are polyhydroxy aldehydes
  • Allose has all stereocenters with OH on the right
  • Glucose (OH on right at C2, C3, C4, C5)
    Fischer for D-Glucose:
    CHO
    |
  H-C-OH
    |
  HO-C-H
    |
  H-C-OH
    |
  H-C-OH
    |
  CH₂OH

2. Ketose Series

  • Ketoses are polyhydroxy ketones
  • Fructose (OH on left at C3, C4, C5)
    Fischer for D-Fructose:
    CH₂OH
    |
    C=O
    |
  H-C-OH
    |
  HO-C-H
    |
  H-C-OH
    |
  CH₂OH

V. STEREOCHEMISTRY

Asymmetric Carbons (n)

  • For an aldotriose: n = 1 chiral center
  • For an aldotetrose: n = 2 chiral centers
  • For an aldopentose: n = 3 chiral centers
  • For an aldohexose: n = 4 chiral centers

Number of stereoisomers = 2ⁿ

  • n = number of chiral centers
  • Example: Glucose has 4 chiral centers → 16 possible stereoisomers (8 D- and 8 L- forms)

VI. KEY STRUCTURAL FEATURES

A. ALDOSES

  1. Carbonyl Group: Aldehyde at C1
  2. Terminal Carbon: C1 is CHO
  3. Numbering: Carbonyl carbon is C1
  4. Stereochemistry: Multiple chiral centers

D-Glucose (aldohexose)
Structure:

    CHO
    |
  H-C-OH
    |
  HO-C-H
    |
  H-C-OH
    |
  H-C-OH
    |
  CH₂OH

B. KETOSES

  1. Carbonyl Group: Ketone at C2 (typically)
  2. Terminal Carbons: C1 and C6 are CH₂OH (in hexoses)
  3. Numbering: Ketone group is at C2
  4. Stereochemistry: Fewer chiral centers (n-2 for n carbons)

Fructose (ketohexose)
Structure:

    CH₂OH
    |
    C=O
    |
  H-C-OH
    |
  HO-C-H
    |
  H-C-OH
    |
  CH₂OH

Functional Group: Ketone at C2

VII. RING STRUCTURES

A. ALDOSE RINGS

Glucose (α-D-glucopyranose)

    H
    |
    OH
    |
  H-C-OH
    |
  O-C-H
    |
  H-C-OH
    |
    OH

Haworth Projection (α-D-glucopyranose):

         OH
         |
    H-C-OH
    |
  O-C-H
    |
  H-C-OH
    |
    OH

B. KETOSE RINGS

Fructose (β-D-fructofuranose)

    OH
    |
    H-C-OH
    |
  O-C-H
    |
  H-C-OH
    |
    OH

VIII. KEY CHEMICAL PROPERTIES

1. Oxidation

  • Fehling’s/Benedict’s Test: Aldoses → aldonic acids
  • Bromine water: Aldoses → aldonic acids
  • Tollens’ reagent: Aldoses → aldonates

2. Reduction

  • NaBH₄ → alditol
  • Catalytic hydrogenation → polyol
  • Osazone formation (phenylhydrazine derivatives)

3. Formation

  • Hemiacetal/acetal formation (intramolecular cyclization)
  • Glycosidic bonds (disaccharides, polysaccharides)
  • Phosphorylation (sugar phosphates, metabolic intermediates)

4. Complexation

  • Cu²⁺ complex (Benedict’s reagent)
  • Ag⁺ complex (Tollens’ reagent)
  • Iodine test (starch-iodine complex)

Asymmetric Carbon, Isomers, Properties, Structures & Functions of Carbohydrates

I. ASYMMETRIC CARBON

A. Definition

  • Asymmetric carbon (chiral center) = Carbon atom bonded to four different substituents
  • Creates optical isomers (enantiomers)
  • Denoted by asterisk (*) in structural formulae

B. In Carbohydrates

Example: D-Glyceraldehyde

    CHO
    |
  H-C*-OH   (C* = asymmetric carbon)
    |
  CH₂OH
  • C2 is asymmetric (4 different groups: H, OH, CHO, CH₂OH)
  • Number of asymmetric carbons:
    • Aldotriose: 1
    • Aldotetrose: 2
    • Aldopentose: 3
    • Aldohexose: 4
    • Ketohexose: 3 (fructose: C3, C4, C5 are asymmetric)

II. ISOMERS IN CARBOHYDRATES

A. Types of Isomers

Isomers
├── Structural Isomers
│   ├── Chain Isomers
│   ├── Position Isomers
│   └── Functional Group Isomers
│       ├── Aldose-Ketose Isomers
│       └── Ring-Chain Isomers
│
├── Stereoisomers
│   ├── Enantiomers (D/L pairs)
│   └── Diastereomers
│       ├── Epimers (differ at one chiral center)
│       ├── Anomers (α/β at anomeric carbon)
│       └── Optical Isomers
│
└── Conformational Isomers
    ├── Chair Form
    ├── Boat Form
    └── Twist Form

B. Specific Examples

1. Aldose-Ketose Isomers

  • Glucose (aldohexose) ↔ Fructose (ketohexose)
  • Glyceraldehyde (aldotriose) ↔ Dihydroxyacetone (ketotriose)

2. Epimers (differ at one chiral center)

  • Glucose ↔ Galactose (C4 epimers)
  • Glucose ↔ Mannose (C2 epimers)
  • Ribose ↔ Arabinose (C2 epimers)

3. Anomers (α/β forms at anomeric carbon)

  • α-D-Glucose (OH down) ↔ β-D-Glucose (OH up)
  • Differ in specific rotation: α = +112°, β = +19°

4. Enantiomers (mirror images)

  • D-Glucose ↔ L-Glucose
  • D-Galactose ↔ L-Galactose

III. PHYSICAL PROPERTIES

A. General Properties

  1. Physical State:
    • Monosaccharides: White crystalline solids
    • Oligosaccharides: White powders or syrups
    • Polysaccharides: Amorphous powders
  2. Solubility:
    • Highly soluble in water (due to OH groups)
    • Insoluble in non-polar solvents (benzene, ether)
    • Solubility trend: Trioses > Tetroses > Pentoses > Hexoses
  3. Melting Points:
    • High (decompose before melting)
    • Glucose: 146°C (α-form), 150°C (β-form)
    • Fructose: 103°C
  4. Sweetness:
    • Relative sweetness (Sucrose = 100):
      • Fructose: 173
      • Sucrose: 100
      • Glucose: 74
      • Galactose: 32
      • Lactose: 16
  5. Hygroscopicity:
    • Fructose > Glucose > Sucrose
    • Fructose absorbs moisture from air

B. Optical Activity

  1. Definition: Ability to rotate plane-polarized light
  2. Specific Rotation [α]D²⁵:
    • D-Glucose: +52.7° (equilibrium mixture)
    • α-D-Glucose: +112° (freshly dissolved)
    • β-D-Glucose: +19° (freshly dissolved)
    • D-Fructose: -92° (levorotatory)
    • D-Galactose: +80°
  3. Mutarotation:
    • Definition: Spontaneous change in optical rotation due to anomerization
    • Mechanism: Interconversion between α and β forms via open chain
    • Example: Glucose equilibrium = 36% α + 64% β + <0.02% open chain
    • Rate: Depends on temperature, pH, solvent

IV. CHEMICAL PROPERTIES

A. Reactions of Carbonyl Group

1. Oxidation:

  • Mild oxidation (Benedict’s/Fehling’s):
    • Aldoses → Aldonic acids
    • Positive for reducing sugars
    • Cu²⁺ (blue) → Cu⁺ (red precipitate)
  • Strong oxidation (HNO₃):
    • Aldoses → Aldaric acids
    • Example: Glucose → Glucaric acid
  • Periodate oxidation:
    • Cleaves C-C bonds with adjacent OH groups
    • Used in structural determination

2. Reduction:

  • NaBH₄ or catalytic hydrogenation:
    • Aldoses/Ketoses → Alditols
    • Glucose → Sorbitol
    • Fructose → Sorbitol + Mannitol mixture
    • Ribose → Ribitol

3. Osazone Formation:

  • Phenylhydrazine (excess, heat):
    • Forms crystalline osazones
    • Glucose, Mannose, Fructose → same osazone
    • Galactose → different osazone
    • Used for identification (melting point, crystal shape)

4. Schiff’s Base Formation:

  • Reaction with amino groups (proteins)
  • Maillard Reaction: Browning in foods
  • Glycation: Non-enzymatic glycosylation of proteins

B. Reactions of Hydroxyl Groups

1. Esterification:

  • Phosphorylation (biological importance):
    • Glucose-6-phosphate
    • Fructose-1,6-bisphosphate
  • Sulfation (glycosaminoglycans)
  • Acetylation (chitin)

2. Ether Formation:

  • Methylation (structural analysis)
  • Glycosidic bonds (disaccharides, polysaccharides)

3. Complex Formation:

  • Borate complexes: Used in chromatography
  • Metal ion chelation: Ca²⁺, Mg²⁺

C. Specific Tests

Test Reagent Positive For Observation
Molisch α-naphthol + H₂SO₄ All carbohydrates Purple ring
Fehling’s CuSO₄ + alkaline tartrate Reducing sugars Red precipitate
Benedict’s CuSO₄ + citrate Reducing sugars Red precipitate
Barfoed’s Cu(OAc)₂ in acetic acid Monosaccharides Red precipitate (fast)
Seliwanoff Resorcinol + HCl Ketoses Red color
Bial’s Orcinol + HCl Pentoses Green color
Iodine I₂/KI solution Starch Blue-black color

V. PROJECTION FORMULAE

A. Fischer Projection

    CHO
    |
  H-C-OH   ← Horizontal lines = forward
    |
  HO-C-H   ← Vertical lines = backward
    |
  H-C-OH
    |
  CH₂OH

Rules:

  1. Carbon chain vertical
  2. Most oxidized carbon at top
  3. Horizontal bonds project forward
  4. Vertical bonds project backward
  5. D/L designation: OH on penultimate carbon
    • D: OH on RIGHT
    • L: OH on LEFT

B. Haworth Projection

Pyranose (6-membered):

        CH₂OH
          |
          O
         / \
    H-C     C-H
      |     |
    HO-C   C-OH
        \ /
         O

Furanose (5-membered):

        CH₂OH
          |
    H-C   O
      |   |
    HO-C C-OH
        \ /
         O

Anomeric designation:

  • α: OH trans to CH₂OH (down in D-sugars)
  • β: OH cis to CH₂OH (up in D-sugars)

C. Chair and Boat Conformations

1. Chair Conformation (most stable):

        H    OH
         \  /
          C
         / \
    HO-C     C-H
      /       \
     C         C
    / \       / \
   O   C-H   H   C-OH
        \   /   /
         C-C   C
           \  /
            O

Features:

  • Axial positions: Vertical
  • Equatorial positions: Horizontal
  • 1,3-diaxial interactions: Cause steric strain
  • β-D-Glucose: All bulky groups equatorial (most stable)

2. Boat Conformation (less stable):

        H
         \
          C
         / \
    HO-C     C-H
      /       \
     C         C
      \       /
       C     C
        \   /
         C
        /
       O

Features:

  • Higher energy (steric hindrance)
  • Rarely observed
  • Transition state during ring inversion

3. Twist Form:

  • Intermediate between chair and boat
  • Lower energy than boat
  • Sometimes observed in solutions

VI. IMPORTANT SUGARS: OCCURRENCE, STRUCTURE & FUNCTIONS

A. TRIOSES (C₃H₆O₃)

1. D-Glyceraldehyde

    CHO
    |
  H-C-OH
    |
  CH₂OH
  • Occurrence: Metabolic intermediate
  • Function:
    • Reference compound for D/L configuration
    • Intermediate in glycolysis (G3P)
    • Calvin cycle (G3P product)

2. Dihydroxyacetone

    CH₂OH
    |
    C=O
    |
  CH₂OH
  • Occurrence: Metabolic intermediate
  • Function:
    • Intermediate in glycolysis (DHAP)
    • Triose phosphate isomerase substrate
    • Used in sunless tanning products

B. TETROSES (C₄H₈O₄)

1. D-Erythrose

    CHO
    |
  H-C-OH
    |
  H-C-OH
    |
  CH₂OH
  • Occurrence: Plant metabolism
  • Function:
    • Intermediate in pentose phosphate pathway
    • Shikimate pathway precursor
    • Calvin cycle intermediate

2. Erythrulose

    CH₂OH
    |
    C=O
    |
  H-C-OH
    |
  CH₂OH
  • Occurrence: Plant metabolism
  • Function:
    • Photosynthesis intermediate
    • Used in self-tanning products

C. PENTOSES (C₅H₁₀O₅)

1. D-Ribose

    CHO
    |
  H-C-OH
    |
  H-C-OH
    |
  H-C-OH
    |
  CH₂OH
  • Occurrence:
    • RNA
    • ATP, NAD⁺, FAD, CoA
    • Ribosomal RNA
  • Function:
    • Genetic material (RNA)
    • Energy currency (ATP)
    • Coenzyme component

2. 2-Deoxy-D-ribose

    CHO
    |
  H-C-H   (H instead of OH at C2)
    |
  H-C-OH
    |
  H-C-OH
    |
  CH₂OH
  • Occurrence: DNA
  • Function: Genetic material (more stable than RNA)

3. D-Arabinose

    CHO
    |
  HO-C-H
    |
  H-C-OH
    |
  H-C-OH
    |
  CH₂OH
  • Occurrence:
    • Plant polysaccharides
    • Gum arabic
    • Hemicellulose
  • Function: Structural component

4. D-Xylose

    CHO
    |
  H-C-OH
    |
  HO-C-H
    |
  H-C-OH
    |
  CH₂OH
  • Occurrence:
    • Wood (xylan)
    • Hemicellulose
    • Dietary fiber
  • Function:
    • Structural polysaccharide
    • Prebiotic

5. Ribulose & Xylulose

  • Occurrence: Metabolic intermediates
  • Function:
    • Calvin cycle (RuBP)
    • Pentose phosphate pathway

D. HEXOSES (C₆H₁₂O₆)

1. D-Glucose (Dextrose)

    CHO
    |
  H-C-OH
    |
  HO-C-H
    |
  H-C-OH
    |
  H-C-OH
    |
  CH₂OH
  • Occurrence:
    • Blood (80-100 mg/dL)
    • Fruits, honey
    • Starch, cellulose, glycogen
  • Function:
    • Primary energy source
    • Metabolic intermediate
    • Glycogen/starch building block
    • Brain fuel (exclusive)

2. D-Fructose (Levulose)

    CH₂OH
    |
    C=O
    |
  H-C-OH
    |
  HO-C-H
    |
  H-C-OH
    |
  CH₂OH
  • Occurrence:
    • Fruits, honey
    • Sucrose (disaccharide)
    • High-fructose corn syrup
  • Function:
    • Sweetener (1.7× sucrose)
    • Metabolic intermediate
    • Sperm energy source

3. D-Galactose

    CHO
    |
  H-C-OH
    |
  HO-C-H
    |
  H-C-OH
    |
  H-C-OH
    |
  CH₂OH
  • Occurrence:
    • Lactose (milk sugar)
    • Glycolipids, glycoproteins
    • Brain glycolipids
  • Function:
    • Milk carbohydrate
    • Cell recognition
    • Nervous system development

4. D-Mannose

    CHO
    |
  H-C-OH
    |
  HO-C-H
    |
  H-C-OH
    |
  H-C-OH
    |
  CH₂OH
  • Occurrence:
    • Plant mannans
    • Glycoproteins
    • N-linked glycosylation
  • Function:
    • Protein glycosylation
    • Cell-cell recognition
    • Therapeutic applications (UTI)

VII. OLIGOSACCHARIDES

A. Definition

  • 2-10 monosaccharide units
  • Linked by glycosidic bonds
  • Often have specific biological functions

B. Important Oligosaccharides

1. Disaccharides

a. Sucrose (Table sugar)

  • Components: Glucose + Fructose
  • Linkage: α1→β2
  • Properties:
    • Non-reducing (anomeric carbons involved)
    • [α]D = +66.5°
    • Hydrolyzed by invertase → invert sugar
  • Occurrence: Sugar cane, sugar beet
  • Function: Transport sugar in plants

b. Lactose (Milk sugar)

  • Components: Galactose + Glucose
  • Linkage: β1→4
  • Properties:
    • Reducing sugar
    • [α]D = +55°
    • Lactose intolerance (lactase deficiency)
  • Occurrence: Mammalian milk
  • Function: Infant nutrition

c. Maltose (Malt sugar)

  • Components: Glucose + Glucose
  • Linkage: α1→4
  • Properties:
    • Reducing sugar
    • [α]D = +136°
    • Produced by starch digestion
  • Occurrence: Germinating grains
  • Function: Starch breakdown product

d. Cellobiose

  • Components: Glucose + Glucose
  • Linkage: β1→4
  • Properties:
    • Reducing sugar
    • Not digested by humans
  • Occurrence: Cellulose hydrolysis
  • Function: Cellulose structural unit

2. Trisaccharides

a. Raffinose

  • Components: Galactose + Glucose + Fructose
  • Occurrence: Beans, cabbage, broccoli
  • Function: Storage in plants
  • Note: Causes flatulence (undigested)

b. Maltotriose

  • Components: 3 Glucose units (α1→4)
  • Occurrence: Starch hydrolysis
  • Function: Intermediate in starch digestion

3. Tetrasaccharides

a. Stachyose

  • Components: Galactose + Galactose + Glucose + Fructose
  • Occurrence: Legumes
  • Function: Storage carbohydrate

4. Oligosaccharides in Biology

a. Blood Group Antigens:

  • ABO system: Terminal sugars determine blood type
  • Type A: N-acetylgalactosamine
  • Type B: Galactose
  • Type O: Neither (fucose only)

b. Glycoprotein Oligosaccharides:

  • N-linked: Asparagine-linked
  • O-linked: Serine/Threonine-linked
  • Function: Protein folding, stability, recognition

c. Human Milk Oligosaccharides (HMOs):

  • Complex structures: 3-10 sugars
  • Function: Prebiotics, anti-pathogen, brain development

C. Properties of Oligosaccharides

  1. Solubility: Highly soluble in water
  2. Sweetness: Generally less sweet than monosaccharides
  3. Reducing Properties: Depends on free anomeric carbon
  4. Hydrolysis: Acid or enzyme-catalyzed to monosaccharides
  5. Biological Functions:
    • Energy storage
    • Structural components
    • Cell recognition
    • Prebiotic effects
    • Signaling molecules

Summary Table: Important Carbohydrates

Sugar Type Occurrence Key Functions
Glucose Aldohexose Blood, fruits, starch Primary energy, brain fuel
Fructose Ketohexose Fruits, honey, HFCS Sweetener, metabolic intermediate
Galactose Aldohexose Milk, glycoproteins Lactose component, cell recognition
Ribose Aldopentose RNA, ATP, NAD⁺ Genetic material, coenzymes
Deoxyribose Aldopentose DNA Genetic material (stable)
Sucrose Disaccharide Sugar cane, beet Transport in plants, sweetener
Lactose Disaccharide Mammalian milk Infant nutrition
Maltose Disaccharide Germinating grains Starch digestion product

 

Reducing and Non-Reducing Sugars, Invert Sugars

I. REDUCING SUGARS

A. Definition

  • Reducing sugars = Carbohydrates that can reduce oxidizing agents
  • Contain free aldehyde or ketone groups (or can form them in solution)
  • Act as reducing agents in chemical reactions

B. Structural Requirement

Must have:

  1. Free aldehyde group (aldoses)
  2. Free ketone group (ketoses in open chain form)
  3. Free hemiacetal group (in cyclic form)
  4. Ability to exist in equilibrium with open-chain form

C. Mechanism of Reduction

General Reaction:

Sugar (aldehyde/ketone) + Oxidizing agent → Sugar acid + Reduced agent

Example (Fehling’s Test):

R-CHO + 2Cu²⁺ + 5OH⁻ → R-COOH + Cu₂O↓ + 3H₂O
     (Aldehyde)   (Blue)          (Carboxylic acid) (Red ppt)

D. Examples of Reducing Sugars

1. Monosaccharides (ALL are reducing)

  • Glucose (aldohexose)
  • Fructose (ketohexose – tautomerizes to aldose)
  • Galactose (aldohexose)
  • Mannose (aldohexose)
  • Ribose (aldopentose)
  • Xylose (aldopentose)

2. Disaccharides (Some are reducing)

  • Maltose (Glc α1→4 Glc) ✓ Reducing
  • Lactose (Gal β1→4 Glc) ✓ Reducing
  • Cellobiose (Glc β1→4 Glc) ✓ Reducing
  • Isomaltose (Glc α1→6 Glc) ✓ Reducing
  • Sucrose (Glc α1→β2 Fru) ✗ Non-reducing
  • Trehalose (Glc α1→α1 Glc) ✗ Non-reducing

3. Oligosaccharides

  • Maltotriose, Maltotetraose ✓ Reducing
  • Raffinose (Gal α1→6 Glc α1→β2 Fru) ✗ Non-reducing
  • Stachyose (2Gal α1→6 Glc α1→β2 Fru) ✗ Non-reducing

II. NON-REDUCING SUGARS

A. Definition

  • Non-reducing sugars = Carbohydrates that CANNOT reduce oxidizing agents
  • Both anomeric carbons are involved in glycosidic bonds
  • Cannot form open-chain aldehyde/ketone groups

B. Structural Requirement

Must have:

  1. Both anomeric carbons glycosidically linked
  2. No free hemiacetal/hemiketal groups
  3. Cannot tautomerize to open-chain form

C. Examples of Non-Reducing Sugars

1. Disaccharides

a. Sucrose (Glc-Fru)

Structure:
Glucose (C1 α-linked) → Fructose (C2 β-linked)
    CH₂OH                 CH₂OH
      |                     |
      O                     O
     / \                   / \
    C   C                 C   C
   /     \               /     \
  C       C             C       C
 / \     / \           / \     / \
O   C   C   O         O   C   C   O
    |   |                 |   |
    OH  CH₂OH             OH  CH₂OH
  • Linkage: α-D-Glucopyranosyl-(1→2)-β-D-fructofuranoside
  • Both anomeric carbons (C1 of glucose, C2 of fructose) are linked
  • No mutarotation (cannot open to free aldehyde/ketone)
  • Specific rotation: +66.5°

b. Trehalose (Glc-Glc)

Structure:
α-D-Glucopyranosyl-(1→1)-α-D-glucopyranoside
    CH₂OH                 CH₂OH
      |                     |
      O                     O
     / \                   / \
    C   C                 C   C
   /     \               /     \
  C       C             C       C
 / \     / \           / \     / \
O   C   C   O         O   C   C   O
    |   |                 |   |
    OH  CH₂OH             OH  CH₂OH
  • Both C1 carbons are linked
  • Found in fungi, insects, some plants
  • Very stable, used as preservative

2. Trisaccharides

a. Raffinose (Gal-Glc-Fru)

  • Structure: α-D-Galactopyranosyl-(1→6)-α-D-glucopyranosyl-(1→2)-β-D-fructofuranoside
  • Found in: Beans, cabbage, whole grains
  • Digestion: Not digested by humans → flatulence

b. Melezitose (Glc-Fru-Glc)

  • Structure: α-D-Glucopyranosyl-(1→3)-β-D-fructofuranosyl-(2→1)-α-D-glucopyranoside
  • Found in: Honeydew, some tree saps

3. Tetrasaccharides

a. Stachyose (Gal-Gal-Glc-Fru)

  • Structure: α-D-Galactopyranosyl-(1→6)-α-D-galactopyranosyl-(1→6)-α-D-glucopyranosyl-(1→2)-β-D-fructofuranoside
  • Found in: Soybeans, lentils

III. CHEMICAL TESTS FOR REDUCING/NON-REDUCING SUGARS

A. Reducing Sugar Tests

Test Reagent Positive Result Mechanism
Fehling’s Test CuSO₄ + alkaline tartrate Brick red ppt (Cu₂O) Aldehyde reduces Cu²⁺ → Cu⁺
Benedict’s Test CuSO₄ + sodium citrate Brick red ppt (Cu₂O) Same as Fehling’s
Barfoed’s Test Cu(OAc)₂ in dilute acid Red ppt in 2-3 min Distinguishes mono- from di-saccharides
Tollens’ Test AgNO₃ + NH₄OH Silver mirror Aldehyde reduces Ag⁺ → Ag⁰
Nylander’s Test Bismuth subnitrate + KOH Black ppt (Bi⁰) Aldehyde reduces Bi³⁺ → Bi⁰

B. Non-Reducing Sugar Tests

  • NO reaction with above reagents
  • Must be hydrolyzed first to yield reducing sugars
  • Procedure:
    1. Heat with dilute acid (HCl)
    2. Neutralize with alkali
    3. Perform reducing sugar test

Example – Sucrose Test:

Sucrose (non-reducing) + H⁺ + H₂O → Glucose + Fructose (both reducing)
                          ↑
                      Hydrolysis
Then: Glucose/Fructose + Benedict's → Positive (red ppt)

IV. INVERT SUGARS

A. Definition

  • Invert sugar = Equimolar mixture of glucose and fructose
  • Produced by hydrolysis of sucrose
  • Named because it inverts the optical rotation

B. Production Methods

1. Acid Hydrolysis

Sucrose + H₂O + H⁺ → Glucose + Fructose
[α]D = +66.5°       +52.7°   -92.0°

Net rotation: -19.75° (levorotatory)
Conditions: Dilute acid (HCl, H₂SO₄), heat

2. Enzyme Hydrolysis (Invertase/Sucrase)

Sucrose + H₂O → Glucose + Fructose
           ↑
       Invertase
  • Optimal pH: 4.5-5.0
  • Temperature: 50-60°C
  • Commercial use: Candy, chocolate, baked goods

C. Properties of Invert Sugar

1. Optical Activity

Before hydrolysis:

  • Sucrose: [α]D = +66.5° (dextrorotatory)

After hydrolysis:

  • Glucose: [α]D = +52.7°
  • Fructose: [α]D = -92.0°
  • Mixture (1:1): [α]D = -19.75° (levorotatory)
  • “Inversion” = Change from dextro- to levorotatory

2. Physical Properties

Property Sucrose Invert Sugar
Sweetness 100 130-150
Solubility 67g/100mL (20°C) 75g/100mL (20°C)
Hygroscopicity Low Very high
Crystallization Forms large crystals Inhibits crystallization
Viscosity High Lower
Browning Moderate High (Maillard reaction)

3. Chemical Properties

  • Both components are reducing sugars
  • High reactivity (free carbonyl groups)
  • Prone to Maillard browning
  • Fermentable by yeast

D. Commercial Importance

1. Food Industry

a. Confectionery:

  • Prevents crystallization (fondant, creams)
  • Retains moisture (soft cookies, cakes)
  • Enhances flavor

b. Baking:

  • Improves texture
  • Extends shelf life
  • Enhances browning

c. Beverages:

  • Sweetener in soft drinks
  • Fermentation substrate in brewing

2. Pharmaceutical Industry

  • Syrups: Better stability than sucrose
  • Excipient: In tablet formulations
  • IV solutions: Energy source

3. Biological Systems

  • Honey: Natural invert sugar (bees add invertase)
  • Digestion: Sucrose → Invert sugar in small intestine
  • Plant physiology: Transport form in some plants

E. Inversion Process

1. Degree of Inversion

  • Complete inversion: 100% sucrose hydrolyzed
  • Partial inversion: Controlled hydrolysis
  • Inversion constant (k): Rate depends on temperature, pH, concentration

2. Factors Affecting Inversion

Factor Effect on Rate
Temperature ↑ Temperature → ↑ Rate (Q₁₀ ≈ 2)
pH Optimal pH 2-3 (acid-catalyzed)
Concentration Dilute solutions invert faster
Catalysts Acids > Enzymes > Heat alone
Ions H⁺ > Other cations

3. Measurement of Inversion

a. Polarimetry:

[α]D (observed) = [α]D (sucrose) × (1-x) + [α]D (invert) × x
Where x = fraction inverted

b. Reducing Sugar Tests:

  • Measure increase in reducing power
  • Compare with standard curve

c. HPLC/GC:

  • Direct quantification of glucose, fructose, sucrose

V. COMPARATIVE ANALYSIS

A. Structural Comparison

Feature Reducing Sugars Non-Reducing Sugars Invert Sugar
Free Carbonyl Yes No Yes (both components)
Mutarotation Yes No Yes
Anomeric Carbon Free Linked Free after hydrolysis
Typical Examples Glucose, Maltose Sucrose, Trehalose Glucose+Fructose mix
Reaction with Benedict’s Positive Negative (until hydrolyzed) Positive
Optical Activity Varies Fixed Changes with hydrolysis

B. Biological Significance

1. Reducing Sugars in Metabolism

  • Glucose: Primary energy source
  • Detection in urine: Diabetes mellitus (glycosuria)
  • Protein glycation: HbA1c formation in diabetes
  • Maillard reaction: Food browning, aging

2. Non-Reducing Sugars in Nature

  • Sucrose: Transport sugar in plants
  • Trehalose: Stress protectant in organisms
  • Raffinose family: Storage in seeds
  • Blood group antigens: Cell surface recognition

3. Invert Sugar Applications

  • Food preservation: Anti-crystallizing agent
  • Humectant: Moisture retention
  • Fermentation: Rapid fermentation substrate
  • Medical: Quick energy source

VI. PRACTICAL APPLICATIONS & EXAMPLES

A. Clinical Importance

1. Diabetes Testing

  • Urine glucose test: Detects reducing sugars
  • False positives: Other reducing substances (galactose, drugs)
  • Modern methods: Glucose oxidase (specific for glucose)

2. Lactose Intolerance

  • Lactose (reducing) → Glucose + Galactose
  • Test: Measure blood glucose after lactose challenge

3. Inborn Errors of Metabolism

  • Galactosemia: Galactose (reducing) accumulates
  • Fructosemia: Fructose (reducing) metabolism defect

B. Food Industry Applications

1. Honey Production

  • Bees add invertase to nectar (sucrose)
  • Natural invert sugar: 38% fructose, 31% glucose
  • Properties: Never crystallizes completely, antimicrobial

2. Confectionery Manufacturing

  • Fondant: Controlled inversion for smooth texture
  • Caramel: Invert sugar prevents graininess
  • Ice cream: Lower freezing point, smoother texture

3. Brewing and Fermentation

  • Invert sugar syrup: Fast fermentation
  • Consistent results: Predictable sugar composition
  • Flavor profile: Clean fermentation products

C. Analytical Techniques

1. Qualitative Tests

Flowchart for Sugar Identification:

Unknown Sugar
    ↓
Molisch Test (General carbohydrate)
    ↓
    Positive → Carbohydrate present
        ↓
    Iodine Test
        ↓
    Blue → Starch
    No color → Proceed
        ↓
Barfoed's Test (5 min boiling)
        ↓
Red ppt → Monosaccharide
No ppt → Disaccharide
        ↓
Benedict's Test
        ↓
Red ppt → Reducing sugar
No ppt → Non-reducing sugar
        ↓
Seliwanoff Test (Ketose vs Aldose)
        ↓
Red → Ketose (Fructose, Sucrose)
Slow pink → Aldose

2. Quantitative Methods

a. Lane-Eynon Method:

  • Titration with Fehling’s solution
  • Measures total reducing sugars

b. HPLC Analysis:

  • Separates and quantifies individual sugars
  • Can detect sucrose, glucose, fructose simultaneously

c. Enzymatic Assays:

  • Glucose oxidase: Specific for glucose
  • Invertase + glucose oxidase: Measures sucrose indirectly

VII. SUMMARY TABLE

Aspect Reducing Sugars Non-Reducing Sugars Invert Sugar
Definition Have free carbonyl group Both anomeric carbons linked Hydrolyzed sucrose
Examples Glucose, Maltose, Lactose Sucrose, Trehalose, Raffinose Glucose + Fructose mix
Chemical Tests Positive: Benedict’s, Fehling’s Negative (positive after hydrolysis) Positive (both components)
Mutarotation Exhibits Does not exhibit Exhibits
Biological Role Energy metabolism, glycation Transport, storage Quick energy, humectant
Optical Rotation Specific to sugar Fixed Inverts from +66.5° to -19.75°
Commercial Use Sweeteners, IV solutions Table sugar, stabilizers Confectionery, baking
Stability Reactive, prone to browning More stable Very stable, hygroscopic

VIII. IMPORTANT REACTIONS

A. Hydrolysis of Non-Reducing Sugars

1. Sucrose Hydrolysis:

C₁₂H₂₂O₁₁ + H₂O → C₆H₁₂O₆ + C₆H₁₂O₆
Sucrose          Glucose   Fructose
Δ[α]D: +66.5° → -19.75° (Inversion)

2. Acid vs Enzyme Hydrolysis:

  • Acid: Non-specific, requires heat
  • Enzyme (invertase): Specific, mild conditions
  • Industrial preference: Enzymatic (controlled, no byproducts)

B. Oxidation Reactions

1. With Benedict’s Reagent:

R-CHO + 2Cu²⁺ + 5OH⁻ → R-COOH + Cu₂O↓ + 3H₂O
  • Cu₂O: Brick red precipitate
  • Quantitative: Color intensity ∝ sugar concentration

2. With Tollens’ Reagent:

R-CHO + 2[Ag(NH₃)₂]⁺ + 3OH⁻ → R-COO⁻ + 2Ag↓ + 4NH₃ + 2H₂O
  • Ag: Silver mirror
  • Qualitative test for aldehydes

C. Maillard Reaction

  • Reducing sugar + Amino acid → Brown pigments + Aromas
  • Important in: Food browning, flavor development, aging
  • Rate: Fructose > Glucose > Sucrose (after inversion)

IX. CLINICAL CORRELATIONS

A. Diabetes Mellitus

  • Reducing sugars in urine (glycosuria)
  • Fructosamine test: Measures glycated proteins
  • HbA1c: Glycated hemoglobin (long-term glucose control)

B. Carbohydrate Malabsorption

  • Lactose intolerance: Undigested lactose (reducing) in gut
  • Sucrose-isomaltase deficiency: Sucrose (non-reducing) malabsorption
  • Tests: Breath hydrogen, stool reducing substances

C. Inborn Metabolic Disorders

  • Galactosemia: Galactose (reducing) accumulation
  • Hereditary fructose intolerance: Fructose (reducing) toxicity
  • Diagnosis: Urine reducing substances, specific enzyme assays

Properties and Functions of Common Disaccharides

I. INTRODUCTION TO DISACCHARIDES

A. Definition

  • Disaccharides = Carbohydrates composed of two monosaccharide units
  • Linked by glycosidic bonds formed via dehydration synthesis
  • General formula: C₁₂H₂₂O₁₁ (loss of H₂O from two C₆H₁₂O₆)

B. Classification

Disaccharides
├── Reducing Disaccharides
│   ├── Maltose (Glc α1→4 Glc)
│   ├── Lactose (Gal β1→4 Glc)
│   ├── Cellobiose (Glc β1→4 Glc)
│   └── Isomaltose (Glc α1→6 Glc)
│
└── Non-Reducing Disaccharides
    ├── Sucrose (Glc α1→β2 Fru)
    └── Trehalose (Glc α1→α1 Glc)

II. SUCROSE (Table Sugar, Cane Sugar, Beet Sugar)

A. Structure and Nomenclature

  • Systematic name: α-D-Glucopyranosyl-(1→2)-β-D-fructofuranoside
  • Components: Glucose + Fructose
  • Linkage: α1→β2 (C1 of glucose to C2 of fructose)

Haworth Projection:

          CH₂OH                  CH₂OH
            |                      |
            O                      O
           / \                    / \
    H-C---C   C---H        H-C---C   C---H
      |   |   |   |          |   |   |   |
    HO-C---C   C-OH        HO-C---C   C-OH
          \ /                    \ /
           O                      O

(Left: α-D-Glucose | Right: β-D-Fructose)

Fischer Projection:

Glucose:          Fructose:
    CHO              CH₂OH
    |                  |
  H-C-OH               C=O
    |                  |
  HO-C-H             HO-C-H
    |                  |
  H-C-OH             H-C-OH
    |                  |
  H-C-OH             H-C-OH
    |                  |
  CH₂OH              CH₂OH

B. Physical Properties

1. General Characteristics

Property Value/Description
Chemical Formula C₁₂H₂₂O₁₁
Molecular Weight 342.3 g/mol
Physical State Colorless, odorless crystals
Taste Sweet (reference standard = 100)
Melting Point 186°C (decomposes)
Solubility 67g/100mL water (20°C), 487g/100mL (100°C)
Hygroscopicity Low (less than glucose, fructose)
Specific Rotation +66.5° (dextrorotatory)

2. Solubility Profile

  • Water: Highly soluble (forms syrups)
  • Ethanol: Slightly soluble (2g/100mL)
  • Non-polar solvents: Insoluble (benzene, ether, chloroform)
  • Temperature dependence:
    • 0°C: 179g/100g water
    • 20°C: 204g/100g water
    • 100°C: 487g/100g water

3. Optical Activity

  • [α]D²⁵ = +66.5° (dextrorotatory)
  • No mutarotation (both anomeric carbons are linked)
  • Hydrolysis produces inversion: 
    Sucrose (+66.5°) → Glucose (+52.7°) + Fructose (-92.0°)
Net: -19.75° (levorotatory)

4. Sweetness Profile

  • Relative sweetness: 100 (reference standard)
  • Comparison:
    • Fructose: 173
    • Sucrose: 100
    • Glucose: 74
    • Maltose: 32
    • Lactose: 16
  • Sweetness perception:
    • Quick onset, clean taste
    • No aftertaste
    • Enhances other flavors

C. Chemical Properties

1. Non-Reducing Nature

  • Both anomeric carbons (C1 of glucose, C2 of fructose) are involved in glycosidic bond
  • No free aldehyde or ketone groups available
  • Negative tests: Benedict’s, Fehling’s, Tollens’
  • Positive only after hydrolysis

2. Hydrolysis Reactions

a. Acid Hydrolysis:

C₁₂H₂₂O₁₁ + H₂O + H⁺ → C₆H₁₂O₆ + C₆H₁₂O₆
Sucrose                 Glucose   Fructose
  • Conditions: Dilute acid (0.1N HCl), heat (50-60°C)
  • Rate: Depends on temperature, pH, concentration
  • Product: Invert sugar (equimolar glucose + fructose)

b. Enzymatic Hydrolysis:

Sucrose + H₂O → Glucose + Fructose
           ↑
       Invertase (β-fructofuranosidase)
  • Optimal conditions: pH 4.5-5.0, 50-60°C
  • Source: Yeast, bees, some plants
  • Industrial use: Controlled inversion

3. Caramelization

  • Temperature: 160-170°C
  • Process: Thermal decomposition
  • Products: Caramel pigments (caramelan, caramelen, caramelin)
  • Applications: Food coloring, flavoring

4. Maillard Reaction

  • Sucrose itself doesn’t participate directly
  • After hydrolysis: Reducing sugars (glucose/fructose) react with amino acids
  • Products: Brown pigments, aromas, flavors
  • Importance: Baking, cooking, food processing

5. Fermentation

Sucrose → (Invertase) → Glucose + Fructose → (Yeast) → Ethanol + CO₂
  • Yeast preference: Invert sugar > Sucrose
  • Applications: Brewing, bioethanol production

D. Biological Properties

1. Digestion and Absorption

  • Enzyme: Sucrase-isomaltase complex (brush border of small intestine)
  • Location: Duodenum and jejunum
  • Rate: Rapid hydrolysis (complete in 30-60 minutes)
  • Absorption: Glucose and fructose via specific transporters
    • GLUT2: Glucose, fructose
    • GLUT5: Fructose specifically
    • SGLT1: Glucose (Na⁺-coupled)

2. Metabolic Fate

Sucrose → Glucose + Fructose
          ↓            ↓
        Glycolysis    Liver
          ↓            ↓
        Energy      → Glycogen
                     → Triglycerides
                     → Lactate

3. Health Aspects

  • Dental caries: Promotes tooth decay (Streptococcus mutans)
  • Obesity: High calorie density (4 kcal/g)
  • Diabetes: Rapidly increases blood glucose
  • Recommended intake: <10% of daily calories (WHO)

E. Functions and Applications

1. In Plants (Natural Function)

  • Primary transport sugar in phloem
  • Storage form in sugar cane, sugar beet, fruits
  • Osmotic regulation in cells
  • Signal molecule in plant development

2. Food Industry Applications

a. Sweetener:

  • Beverages: Soft drinks, juices
  • Confectionery: Candy, chocolate, chewing gum
  • Baked goods: Cakes, cookies, pastries
  • Dairy: Ice cream, yogurt, flavored milk

b. Functional Properties:

Property Application Mechanism
Preservative Jams, jellies Reduces water activity
Texture modifier Ice cream Controls crystal size
Fermentation substrate Bread, alcohol Yeast nutrient
Browning agent Baked goods Caramelization/Maillard
Bulking agent Low-fat foods Provides mouthfeel
Freezing point depression Ice cream Lowers freezing point

c. Specific Applications:

  • Fondant: Controlled crystallization for smooth texture
  • Caramel: Thermal decomposition for color/flavor
  • Royal icing: Hard coating for cakes
  • Simple syrup: 1:1 sucrose:water for cocktails

3. Pharmaceutical Industry

  • Syrups: Vehicle for drug delivery
  • Tablets: Binder, filler, coating agent
  • IV solutions: Isotonic preparations
  • Stabilizer: Prevents drug degradation

4. Biotechnology

  • Culture media: Carbon source for microorganisms
  • Preservative: In vaccine production
  • Cryoprotectant: In cell/tissue preservation

F. Commercial Production

1. Sources

  • Sugar cane (Saccharum officinarum): 70% of world production
  • Sugar beet (Beta vulgaris): 30% of world production
  • Other sources: Sugar maple, sorghum, dates

2. Extraction Process

Sugar Cane:

Harvest → Crushing → Juice extraction → Clarification
    ↓
Filtration → Evaporation → Crystallization → Centrifugation
    ↓
Raw sugar → Refining → White sugar

Sugar Beet:

Beets → Slicing → Diffusion → Purification
    ↓
Evaporation → Crystallization → Centrifugation → Drying

3. Types of Commercial Sucrose

Type Purity Uses
Granulated white 99.9% General purpose
Powdered/Confectioner’s 97% + cornstarch Icings, frostings
Brown sugar 88-96% Baking, flavor
Demerara/Turbinado 96-98% Coffee, toppings
Rock candy 100% Decorative, candy
Liquid sugar 67% solution Beverages

III. OTHER IMPORTANT DISACCHARIDES

A. LACTOSE (Milk Sugar)

1. Structure and Properties

  • Components: Galactose + Glucose
  • Linkage: β1→4
  • Systematic name: β-D-Galactopyranosyl-(1→4)-D-glucopyranose
  • Reducing sugar: Yes (C1 of glucose free)

Properties:

  • Sweetness: 16 (relative to sucrose)
  • Solubility: 21g/100mL (20°C)
  • [α]D: +55°
  • Hydrolysis: Lactase → Glucose + Galactose

2. Functions and Importance

  • Primary carbohydrate in mammalian milk (4-8%)
  • Energy source for infants
  • Promotes calcium absorption
  • Prebiotic: Supports gut microbiota

3. Clinical Aspects

  • Lactose intolerance: Lactase deficiency
  • Galactosemia: Inability to metabolize galactose
  • Diagnostic tests: Breath hydrogen, lactose tolerance test

B. MALTOSE (Malt Sugar)

1. Structure and Properties

  • Components: Glucose + Glucose
  • Linkage: α1→4
  • Systematic name: α-D-Glucopyranosyl-(1→4)-D-glucopyranose
  • Reducing sugar: Yes

Properties:

  • Sweetness: 32
  • Solubility: 108g/100mL (20°C)
  • [α]D: +136°
  • Hydrolysis: Maltase → 2 Glucose

2. Functions and Importance

  • Intermediate in starch digestion
  • Found in: Germinating grains, malt products
  • Brewing: Fermentable sugar for beer production
  • Industrial: Production of maltodextrins, syrups

C. TREHALOSE

1. Structure and Properties

  • Components: Glucose + Glucose
  • Linkage: α1→α1
  • Systematic name: α-D-Glucopyranosyl-(1→1)-α-D-glucopyranoside
  • Non-reducing sugar: Yes (both C1 linked)

Properties:

  • Sweetness: 45
  • Very stable: Resists acid hydrolysis, heat
  • “Anhydrobiosis”: Protects organisms during desiccation

2. Functions and Importance

  • Stress protectant in fungi, insects, resurrection plants
  • Food industry: Stabilizer, humectant, flavor enhancer
  • Pharmaceutical: Protein stabilizer in formulations

D. CELLOBIOSE

1. Structure and Properties

  • Components: Glucose + Glucose
  • Linkage: β1→4
  • Systematic name: β-D-Glucopyranosyl-(1→4)-D-glucopyranose
  • Reducing sugar: Yes

Properties:

  • Not digested by humans (no cellobiase)
  • Hydrolysis: Cellulase → 2 Glucose
  • Importance: Structural unit of cellulose

IV. COMPARATIVE ANALYSIS OF DISACCHARIDES

A. Physical Properties Comparison

Property Sucrose Lactose Maltose Trehalose
Components Glc + Fru Gal + Glc Glc + Glc Glc + Glc
Linkage α1→β2 β1→4 α1→4 α1→α1
Reducing No Yes Yes No
Sweetness 100 16 32 45
Solubility (g/100mL) 204 21 108 69
[α]D +66.5° +55° +136° +178°
Mutarotation No Yes Yes No
Digestive Enzyme Sucrase Lactase Maltase Trehalase

B. Biological Functions Comparison

Disaccharide Primary Source Main Function Digestive Fate
Sucrose Plants Transport, storage Glucose + Fructose
Lactose Mammalian milk Infant nutrition Glucose + Galactose
Maltose Starch digestion Energy intermediate 2 Glucose
Trehalose Fungi, insects Stress protection 2 Glucose
Cellobiose Cellulose Structural unit Not digested

C. Industrial Applications

Application Preferred Disaccharide Reason
Sweetening Sucrose Optimal sweetness profile
Infant formula Lactose Mimics human milk
Brewing Maltose Fermentable, from malt
Stabilization Trehalose Heat/acid stable
Low-glycemic Isomaltulose Slow digestion

V. BIOCHEMICAL PATHWAYS INVOLVING DISACCHARIDES

A. Sucrose Metabolism in Plants

1. Synthesis:

UDP-Glucose + Fructose-6-P → Sucrose-6-P + UDP
Sucrose-6-P + H₂O → Sucrose + Pi (Sucrose phosphatase)

2. Breakdown:

Sucrose + H₂O → Glucose + Fructose (Invertase)
or
Sucrose + UDP → UDP-Glucose + Fructose (Sucrose synthase)

B. Human Digestion and Metabolism

1. Sucrose Pathway:

Mouth: No digestion (no sucrase in saliva)
Stomach: Minimal hydrolysis (acid)
Small Intestine: Sucrase → Glucose + Fructose
Absorption: SGLT1 (Glucose), GLUT5 (Fructose)
Metabolism: Liver (fructose), All tissues (glucose)

2. Lactose Pathway:

Small Intestine: Lactase → Glucose + Galactose
Absorption: SGLT1 (both)
Metabolism: Liver converts galactose → glucose

C. Microbial Fermentation

1. Yeast Fermentation:

Sucrose → (Invertase) → Glucose + Fructose
→ (Glycolysis) → 2 Ethanol + 2 CO₂ + ATP

2. Lactic Acid Bacteria:

Lactose → Glucose + Galactose
→ (Homolactic) → 2 Lactic acid
or
→ (Heterolactic) → Lactic acid + Ethanol + CO₂

VI. CLINICAL AND HEALTH ASPECTS

A. Sucrose-Related Disorders

1. Dental Caries

  • Mechanism: Sucrose → Acid by oral bacteria → Enamel demineralization
  • Primary bacteria: Streptococcus mutans
  • Prevention: Fluoride, oral hygiene, sugar restriction

2. Metabolic Syndrome

  • Excess sucrose → Obesity → Insulin resistance
  • Fructose component → Hepatic lipogenesis → NAFLD
  • Recommendation: WHO <10% total calories from added sugars

3. Sucrase-Isomaltase Deficiency

  • Congenital or acquired enzyme deficiency
  • Symptoms: Diarrhea, abdominal pain, bloating
  • Diagnosis: Breath test, enzyme assay
  • Treatment: Sucrose-free diet, enzyme replacement

B. Nutritional Considerations

1. Glycemic Index

  • Sucrose: 65 (medium)
  • Comparison: Glucose = 100, Fructose = 19
  • Effect: Moderate increase in blood glucose

2. Energy Content

  • 4 kcal/g (same as other carbohydrates)
  • Empty calories: No vitamins, minerals, fiber
  • Displacement effect: Replaces nutrient-dense foods

3. Recommended Intakes

Organization Recommendation
WHO <10% total energy (ideally <5%)
AHA Men: ≤9 tsp/day, Women: ≤6 tsp/day
FDA 50g/day (based on 2000 kcal diet)

VII. ANALYTICAL METHODS

A. Qualitative Tests

1. For Sucrose (Specific Tests)

a. Resorcinol Test (Selivanoff’s Test):

  • Principle: Ketoses give red color with resorcinol in HCl
  • Sucrose: Positive (contains fructose moiety)
  • Note: Must hydrolyze first for non-reducing property confirmation

b. Hydrolysis + Reducing Sugar Test:

Sucrose → (Acid/Enzyme hydrolysis) → Glucose + Fructose
→ Benedict's/Fehling's test → Positive (red ppt)

2. Differentiation Table

Test Sucrose Lactose Maltose
Benedict’s (direct) Negative Positive Positive
Benedict’s (after hydrolysis) Positive Positive Positive
Barfoed’s Negative Negative Negative
Seliwanoff’s Positive (slow) Negative Negative
Osazone Test No osazone Powder puff Sunflower

B. Quantitative Methods

1. Polarimetry

  • Specific rotation measurement
  • For sucrose: Direct measurement ([α]D = +66.5°)
  • For mixtures: Clerget method (measure before/after inversion)

2. HPLC

  • Most accurate method
  • Separates and quantifies all sugars in mixture
  • Detection: Refractive index, ELSD, MS

3. Enzymatic Assays

  • Sucrose: Invertase + Glucose oxidase/peroxidase
  • Specific and sensitive
  • Suitable for biological samples

VIII. ENVIRONMENTAL AND ECONOMIC ASPECTS

A. Global Production

  • Annual production: ~180 million tons
  • Major producers: Brazil, India, EU, China, Thailand
  • Consumption: ~24 kg/person/year (global average)

B. Environmental Impact

  • Water usage: 1500-2000 L water/kg sugar
  • Land use: 31 million hectares globally
  • Pollution: Effluents from processing plants
  • Sustainable practices: Organic farming, water recycling

C. Economic Importance

  • Commodity trading: Raw sugar futures
  • Employment: Millions in cultivation and processing
  • Subsidies: Many countries support sugar industry
  • Trade agreements: Often protected commodity

IX. FUTURE PERSPECTIVES

A. Health Trends

  • Reduced consumption due to health concerns
  • Alternative sweeteners: Stevia, monk fruit, allulose
  • Sugar taxes: Implemented in many countries

B. Technological Advances

  • Improved extraction: Membrane filtration, chromatography
  • Novel products: Isomaltulose, tagatose (slow-digesting)
  • Biotechnological production: Engineered microbes

C. Sustainability Initiatives

  • Bioenergy: Sugarcane ethanol as renewable fuel
  • Biorefineries: Multiple products from sugar crops
  • Circular economy: Waste utilization (bagasse, molasses)

X. SUMMARY: KEY POINTS ON SUCROSE

A. Unique Features

  1. Only common non-reducing disaccharide in human diet
  2. Optical inversion upon hydrolysis (+66.5° → -19.75°)
  3. Plant-specific transport molecule (not found in animals)
  4. Commercial importance: World’s most produced sweetener

B. Biological Significance

  1. Energy source: 4 kcal/g, readily metabolized
  2. Plant physiology: Primary photosynthetic product for transport
  3. Food industry: Multifunctional ingredient beyond sweetness
  4. Health impact: Major contributor to dental caries and obesity when consumed in excess

C. Chemical Behavior

  1. Stable glycosidic bond (resists spontaneous hydrolysis)
  2. Hydrolyzable by specific enzymes (sucrase, invertase)
  3. Non-reactive until hydrolyzed (unlike reducing sugars)
  4. Forms invert sugar with unique properties

POLYSACCHARIDES: COMPREHENSIVE STUDY NOTES

I. INTRODUCTION & CLASSIFICATION

A. Definition

  • Polysaccharides = polymers of monosaccharides (>10 units)
  • Glycosidic bonds link monosaccharide residues
  • General formula: (C₆H₁₀O₅)ₙ where n = 20-2500+

B. Classification

  1. Based on Function
    • Structural = cellulose, chitin, pectin
    • Storage = starch, glycogen, inulin
    • Functional = heparin (anticoagulant), hyaluronic acid (lubricant)
  2. Based on Composition
    • Homopolysaccharides = one type of monosaccharide
      • Starch, glycogen, cellulose, chitin
    • Heteropolysaccharides = two or more types
      • Glycosaminoglycans (GAGs), peptidoglycan
  3. Based on Structure
    • Linear = cellulose, amylose
    • Branched = glycogen, amylopectin
    • Cross-linked = pectin, agarose

II. STRUCTURAL POLYSACCHARIDES

A. Cellulose (Plant Cell Walls)

  1. Structure
    • β(1→4) linked D-glucose units
    • Linear chains = 500-15,000 glucose units
    • Parallel alignment → extensive H-bonding → microfibrils → fibers
    • H-bonding = intrachain (O3-H…O5′) & interchain (O6-H…O3)
  2. Properties
    • Most abundant organic polymer on Earth
    • Insoluble in water (due to extensive H-bonding)
    • High tensile strength (due to H-bonding)
    • Not digested by humans (lack cellulase enzyme)
  3. Functions
    • Structural support in plant cell walls
    • Dietary fiber (promotes peristalsis, absorbs water)
    • Industrial = paper, rayon, cellulose acetate films

B. Chitin (Exoskeletons of Arthropods & Fungi)

  1. Structure
    • β(1→4) linked N-acetylglucosamine (NAG) units
    • Modified cellulose (C2 hydroxyl replaced by N-acetyl group)
    • Parallel chains → H-bonding (similar to cellulose)
    • Deacetylated → chitosan (industrial uses)
  2. Properties
    • 2nd most abundant polysaccharide in nature
    • Insoluble in water (H-bonded like cellulose)
    • Hard, flexible material
  3. Functions
    • Exoskeleton of insects, spiders, crustaceans
    • Fungal cell walls (structural component)
    • Biomedical = wound dressings, drug delivery vehicles

III. STORAGE POLYSACCHARIDES

A. Starch (Plant Storage Polysaccharide)

  1. Structure
    • Amylose (unbranched α1→4 glucose chains)
    • Amylopectin (branched α1→4, α1→6 glucose chains)
    • Granules = semicrystalline regions (alternating layers)
    • Iodine test = blue-black (amylose), red-brown (amylopectin)
  2. Properties
    • Insoluble in cold water
    • Soluble in hot water (forms paste)
    • Digested by humans (amylase → maltose → glucose)
  3. Functions
    • Energy storage in plants (roots, seeds, tubers)
    • Dietary = cereals, potatoes, bread
    • Industrial = paper sizing, adhesives

B. Glycogen (Animal Storage Polysaccharide)

  1. Structure
    • Branched α(1→4), α(1→6) D-glucose polymer
    • Highly branched (every 8-12 residues)
    • Liver = storage for blood glucose regulation
    • Muscle = local energy source for contraction
  2. Properties
    • Soluble in water (due to branching)
    • Rapidly mobilized (multiple non-reducing ends)
    • Iodine test = red-brown (not blue-black)
    • Stored in liver (10% weight), muscle (1-2%)
  3. Functions
    • Energy storage (4 kcal/g)
    • Blood glucose regulation (liver)
    • Muscle contraction energy source

IV. FUNCTIONAL POLYSACCHARIDES

A. Glycosaminoglycans (GAGs)

  1. Structure
    • Repeating units of disaccharides containing amino sugar
    • Hexosamine (glucosamine or galactosamine) + Uronic acid
    • Highly (-) charged (due to sulfate groups)
    • Form viscous solutions (bind water)
  2. Functions
    • Hyaluronic acid = synovial fluid, vitreous humor, cartilage
    • Chondroitin sulfate = cartilage, bone, heart valves
    • Heparin = anticoagulant, stored in mast cells
    • Keratan sulfate = cornea, cartilage, bone
    • Dermatan sulfate = skin, blood vessels, heart valves

B. Agarose (Seaweed Polysaccharide)

  1. Structure
    • Agarose = alternating units of D-galactose & L-galactose
    • Forms gels at low concentrations (0.5-2%)
    • Melts at ~85°C, gels at ~40°C
  2. Functions
    • Microbiological = culture media
    • Electrophoresis = separation of proteins, DNA
    • Food = thickener, stabilizer in desserts

Comparison: Structural vs. Storage Polysaccharides

Property Cellulose (Structural) Starch/Glycogen (Storage)
Monomer β-D-glucose α-D-glucose
Linkage β(1→4) α(1→4), α(1→6)
Solubility Insoluble Soluble (hot water)
Digestion Not digested Easily digested
Function Rigidity, strength Energy storage

V. CLASSIFICATION OF POLYSACCHARIDES

Classification Example
Function
Structural Cellulose, chitin, pectin
Storage Starch (plants), glycogen (animals), inulin (plants)
Functional Heparin (anticoagulant), hyaluronic acid (lubricant)
Composition
Homopolysaccharide Starch (α-D-glucose), cellulose (β-D-glucose)
Heteropolysaccharide Glycosaminoglycans (GAGs), peptidoglycan
Structure
Linear Amylose, cellulose
Branched Glycogen, amylopectin
Cross-linked Agarose, pectin
Biological Role
Structural Cellulose (cell walls), chitin (exoskeleton)
Storage Starch (plant storage), glycogen (animal storage)
Functional Heparin (anticoagulant), hyaluronic acid (lubricant)

VI. SUMMARY OF POLYSACCHARIDES

Classification

  • Structural = cellulose, chitin, pectin
  • Storage = starch (plants), glycogen (animals)
  • Functional = heparin (anticoagulant), hyaluronic acid (lubricant)

Structure-Function Relationship

  • Structural polysaccharides = β(1→4) linkages, linear chains, extensive H-bonding → high tensile strength (cellulose, chitin)
  • Storage polysaccharides = α(1→4) linkages, α(1→6) branches → water solubility (starch, glycogen)
  • Functional polysaccharides = GAGs, heparin → (-) charge → water binding, lubrication, anticoagulation

Biological Importance

  • Structural = cell walls (plants), exoskeletons (arthropods, fungi)
  • Energy storage = starch (plants), glycogen (animals)
  • Functional = anticoagulation, lubrication, infection resistance
  • Biomedical = chitin (wound dressings), heparin (anticoagulant), hyaluronic acid (joint lubrication)

Industrial Applications

  • Structural = paper (cellulose), films (cellulose)
  • Storage = food (starch), energy (glycogen)
  • Functional = GAGs (heparin), hyaluronic acid (joint lubrication), chitosan (wound dressings)

Future Directions

  • Biomedical = wound dressings, drug delivery vehicles
  • Biodegradable = packaging, films
  • Biomedical = GAGs (heparin), hyaluronic acid (joint lubrication), chitin (wound dressings)

Clinical Relevance

  • Dietary fiber = cellulose (promotes peristalsis, absorbs water)
  • Storage polysaccharides = starch (plants), glycogen (animals)
  • Functional = GAGs (heparin, hyaluronic acid, chondroitin sulfate) → heparin (anticoagulant), hyaluronic acid (joint lubrication), chondroitin sulfate (cartilage, bone, heart valves)

Comparison: Structural vs. Storage vs. Functional Polysaccharides

Property Structural Storage Functional
Function Rigidity, strength Energy storage Anticoagulant, lubricant
Structure β(1→4) linkages, linear chains, extensive H-bonding α(1→4), α(1→6) linkages, α(1→6) branches GAGs (heparin), hyaluronic acid (lubricant)
Solubility Insoluble (due to extensive H-bonding) Soluble (hot water) Soluble (due to (-) charge)
Digestion Not digested (lack cellulase enzyme) Easily digested (amylase → maltose → glucose) Not digested (lack enzyme)
Function Rigidity, strength Energy storage Anticoagulant, lubricant
Biological Importance Cellulose (plants), chitin (exoskeletons) Starch (plants), glycogen (animals) GAGs (heparin), hyaluronic acid (joint lubrication)
Industrial Applications Paper (cellulose), rayon (cellulose) Food (starch), energy (glycogen) GAGs (heparin), hyaluronic acid (joint lubrication)

 

PROPERTIES & FUNCTIONS OF POLYSACCHARIDES: ANIMAL, PLANT & MICROBIAL SOURCES

I. GENERAL PROPERTIES OF POLYSACCHARIDES

A. Physical Properties

  1. Solubility
    • Water-soluble: Glycogen, starch (hot water), GAGs, dextran
    • Water-insoluble: Cellulose, chitin, pectin (forms gels)
    • Solubility depends on: Molecular weight, branching, functional groups
  2. Viscosity
    • High viscosity: Hyaluronic acid, xanthan gum (pseudoplastic behavior)
    • Gel formation: Agarose, carrageenan, pectin (heat reversible)
    • Thickening agents: Guar gum, locust bean gum
  3. Optical Activity
    • Specific rotation: Depends on monosaccharide units and linkages
    • Polarimetry: Used for identification and purity assessment

B. Chemical Properties

  1. Hydrolysis
    • Acid hydrolysis: Breaks glycosidic bonds → monosaccharides
    • Enzymatic hydrolysis: Specific enzymes (amylase, cellulase)
    • Rate depends on: Linkage type, branching, crystallinity
  2. Chemical Modification
    • Esterification: Cellulose acetate (films, fibers)
    • Etherification: Carboxymethyl cellulose (CMC)
    • Cross-linking: Starch derivatives (modified starches)
  3. Reactivity
    • Oxidation: Periodate oxidation (breaks vicinal diols)
    • Reduction: Borohydride reduction (to sugar alcohols)
    • Complex formation: Iodine-starch complex (blue color)

II. ANIMAL POLYSACCHARIDES

A. Glycogen

  1. Properties
    • Highly branched: Every 8-12 glucose units
    • Water-soluble: Forms colloidal solutions
    • Iodine test: Red-brown color
    • Molecular weight: 10⁶ – 10⁸ Da
  2. Functions
    • Energy storage: Liver (regulates blood glucose), muscle (local energy)
    • Rapid mobilization: Multiple non-reducing ends for simultaneous degradation
    • Osmotic advantage: Compact storage without osmotic pressure issues

B. Glycosaminoglycans (GAGs)

  1. Hyaluronic Acid
    • Properties: High viscosity, water-binding capacity, viscoelastic
    • Functions: Joint lubrication, wound healing, cell migration, vitreous humor
  2. Chondroitin Sulfate
    • Properties: Sulfated, negatively charged, binds to proteins
    • Functions: Cartilage structure, joint health, bone development
  3. Heparin
    • Properties: Highly sulfated, strongest negative charge
    • Functions: Anticoagulant, anti-inflammatory, stored in mast cells
  4. Keratan Sulfate
    • Properties: Contains galactose, less sulfated
    • Functions: Cornea transparency, cartilage, bone

C. Chitin (in arthropods)

  1. Properties
    • Structural: Rigid, insoluble, biodegradable
    • Chemical: Deacetylation → chitosan (cationic properties)
  2. Functions
    • Exoskeleton: Protection, support, muscle attachment
    • Biomedical: Wound dressings, drug delivery, tissue engineering

III. PLANT POLYSACCHARIDES

A. Cellulose

  1. Properties
    • Crystalline: Parallel chains with extensive H-bonding
    • Insoluble: In water and most organic solvents
    • High tensile strength: 7-15 GPa (stronger than steel per weight)
  2. Functions
    • Structural: Primary cell wall component, plant rigidity
    • Dietary: Insoluble fiber, promotes gut health
    • Industrial: Paper, textiles, biofuels

B. Starch

  1. Properties
    • Granular: Semi-crystalline, birefringent under polarized light
    • Gelatinization: Swells in hot water (60-80°C)
    • Retrogradation: Recrystallization upon cooling
  2. Functions
    • Energy storage: In chloroplasts (transient) and amyloplasts (long-term)
    • Food: Thickener, stabilizer, gelling agent
    • Industrial: Adhesives, bioplastics, ethanol production

C. Pectin

  1. Properties
    • Gel-forming: Requires sugar and acid (low pH)
    • Soluble: In hot water, forms viscous solutions
    • Structure: α(1→4) galacturonic acid with methyl esters
  2. Functions
    • Cell wall: Middle lamella (cell adhesion)
    • Food: Jam/jelly formation, thickener, stabilizer
    • Pharmaceutical: Drug delivery, wound healing

D. Hemicellulose

  1. Properties
    • Heterogeneous: Xylans, mannans, glucans
    • Soluble: In alkaline solutions
    • Amorphous: Less ordered than cellulose
  2. Functions
    • Structural: Cross-links cellulose microfibrils
    • Biomass: Second most abundant polysaccharide
    • Industrial: Biofuels, paper production

IV. MICROBIAL POLYSACCHARIDES

A. Bacterial Polysaccharides

  1. Peptidoglycan
    • Properties: Mesh-like, rigid, contains amino acids
    • Functions: Bacterial cell wall, target for antibiotics (penicillin)
    • Structure: NAG-NAM backbone with peptide cross-links
  2. Dextran
    • Properties: α(1→6) glucose with α(1→3) branches
    • Functions: Plasma volume expander, Sephadex for chromatography
    • Source: Leuconostoc mesenteroides
  3. Xanthan Gum
    • Properties: High viscosity at low concentrations, pseudoplastic
    • Functions: Food thickener, oil recovery, cosmetics
    • Source: Xanthomonas campestris
  4. Alginate
    • Properties: Forms gels with Ca²⁺ ions, heat-stable
    • Functions: Food additive, wound dressings, tissue engineering
    • Source: Brown algae (Phaeophyceae) and some bacteria

B. Fungal Polysaccharides

  1. β-Glucans
    • Properties: β(1→3) with β(1→6) branches, immunomodulatory
    • Functions: Immune stimulation, cholesterol reduction
    • Source: Yeast cell walls, mushrooms
  2. Chitin
    • Properties: Same as animal chitin (β(1→4) NAG)
    • Functions: Fungal cell wall structural component
    • Source: Fungal cell walls

C. Algal Polysaccharides

  1. Agar/Agarose
    • Properties: Forms strong gels, heat reversible
    • Functions: Culture media, electrophoresis, food industry
    • Source: Red algae (Gelidium, Gracilaria)
  2. Carrageenan
    • Properties: Sulfated, forms gels with K⁺ or Ca²⁺
    • Functions: Food stabilizer, dairy products, toothpaste
    • Source: Red algae (Chondrus crispus)

V. FUNCTIONAL CLASSIFICATION

Function Animal Plant Microbial
Structural Chitin (arthropods) Cellulose, Hemicellulose Peptidoglycan, Chitin (fungi)
Storage Glycogen Starch, Inulin Glycogen (some bacteria)
Lubrication Hyaluronic acid Mucilage (some seeds) Xanthan gum
Protection Heparin (anticoagulant) Pectin (pathogen barrier) Capsular polysaccharides
Gel Formation – Pectin Agar, Alginate, Gellan gum
Immune Function Heparan sulfate Arabinogalactans β-Glucans, LPS (bacterial)
Water Binding Hyaluronic acid – Xanthan, Dextran

VI. BIOLOGICAL SIGNIFICANCE

A. Energy Metabolism

  • Storage forms: Glycogen (animals), starch (plants), dextran (some bacteria)
  • Mobilization: Phosphorolysis (glycogen) vs. hydrolysis (starch)
  • Regulation: Hormonal control (insulin/glucagon for glycogen)

B. Structural Integrity

  • Plants: Cellulose-hemicellulose-pectin network
  • Animals: Chitin in exoskeletons, GAGs in connective tissue
  • Microbes: Peptidoglycan in bacteria, chitin in fungi

C. Defense Mechanisms

  • Physical barrier: Plant cell walls against pathogens
  • Chemical defense: Heparin prevents blood clotting
  • Immune modulation: β-Glucans stimulate immune response

D. Cell Recognition

  • Glycocalyx: Cell surface polysaccharides for recognition
  • Blood groups: ABO antigens are polysaccharide-based
  • Bacterial adhesion: Capsular polysaccharides for biofilm formation

VII. INDUSTRIAL & MEDICAL APPLICATIONS

Application Polysaccharide Source Use
Food Industry Starch, Pectin Plants Thickener, gelling agent
Carrageenan Algae Dairy stabilizer
Xanthan gum Bacteria Salad dressings, sauces
Pharmaceutical Heparin Animal Anticoagulant
Hyaluronic acid Animal/ Microbial Joint injections, eye surgery
Chitosan Animal/ Fungal Drug delivery, wound healing
Biomedical Alginate Algae Wound dressings, cell encapsulation
Agarose Algae Electrophoresis, chromatography
Dextran Bacteria Plasma expander
Cosmetics Hyaluronic acid Animal/ Microbial Moisturizer, anti-aging
Xanthan gum Bacteria Thickener, stabilizer
Agriculture Chitosan Animal/ Fungal Seed coating, biopesticide
Paper Industry Cellulose Plants Paper production
Starch Plants Sizing agent
Textiles Cellulose Plants Rayon, cellulose acetate
Biofuels Cellulose, Hemicellulose Plants Second-generation biofuels

VIII. SUMMARY TABLE: KEY POLYSACCHARIDES BY SOURCE

Source Polysaccharide Main Monomer Key Function
Animal Glycogen α-D-glucose Energy storage
Hyaluronic acid Glucuronic acid + NAG Joint lubrication
Chitin N-acetylglucosamine Exoskeleton structure
Heparin Glucosamine + iduronic acid Anticoagulation
Plant Cellulose β-D-glucose Structural support
Starch α-D-glucose Energy storage
Pectin Galacturonic acid Cell adhesion, gelling
Inulin β-D-fructose Storage (roots, tubers)
Microbial Peptidoglycan NAG + NAM Bacterial cell wall
Dextran α-D-glucose Plasma expander
Xanthan gum Glucose + mannose + glucuronic acid Thickener, stabilizer
Alginate Mannuronic + guluronic acids Gel formation
Algal Agar/agarose Galactose Culture media, electrophoresis
Carrageenan Galactose + sulfate Food stabilizer

IX. EMERGING RESEARCH & FUTURE DIRECTIONS

  1. Sustainable Materials
    • Cellulose nanocrystals: Reinforcing materials, transparent films
    • Chitin/chitosan: Biodegradable plastics, packaging
    • Bacterial cellulose: High-purity material for medical devices
  2. Biomedical Advances
    • Polysaccharide hydrogels: Controlled drug release, tissue engineering
    • Glycan arrays: Studying carbohydrate-protein interactions
    • Polysaccharide vaccines: Capsular polysaccharides as antigens
  3. Industrial Biotechnology
    • Enzymatic modification: Tailored polysaccharides with specific properties
    • Metabolic engineering: Microbial production of valuable polysaccharides
    • Waste valorization: Agricultural residues to valuable polysaccharides
  4. Food Innovation
    • Resistant starches: Prebiotic effects, glycemic control
    • Novel thickeners: Microbial exopolysaccharides with unique properties
    • Clean label: Natural polysaccharides replacing synthetic additives

BCH-401 Cell Biology.

Biology Study Notes: Cells and Life Foundations

I. Beginning of Life

  • Origin Theories: Chemical evolution hypothesis (Miller-Urey experiment), panspermia hypothesis, hydrothermal vent theory
  • Key Milestones: Formation of organic molecules → formation of protocells → first prokaryotic cells (~3.5 billion years ago)
  • RNA World Hypothesis: RNA as first genetic material and catalyst before DNA/proteins
  • Endosymbiotic Theory: Eukaryotic organelles (mitochondria, chloroplasts) originated from engulfed prokaryotes

II. Introduction to Cell Theory

  1. All living organisms are composed of cells
  2. The cell is the basic unit of life
  3. All cells arise from pre-existing cells (biogenesis)
  • Modern Additions: Cells contain hereditary information (DNA), have similar chemical composition, energy flow occurs within cells
  • Historical Figures: Hooke (coined “cell”), Leeuwenhoek (first microscopic observations), Schleiden & Schwann (plant/animal cell theory), Virchow (biogenesis)

III. Prokaryotic vs. Eukaryotic Cells

Feature Prokaryotic Eukaryotic
Nucleus No membrane-bound nucleus (nucleoid region) Membrane-bound nucleus
Size 1-10 μm 10-100 μm
Organelles No membrane-bound organelles Membrane-bound organelles
DNA Circular DNA, plasmids Linear chromosomes in nucleus
Cell Division Binary fission Mitosis/meiosis
Examples Bacteria, archaea Plants, animals, fungi, protists

IV. Unicellular vs. Multicellular Organisms

  • Unicellular: Single cell performs all functions (e.g., bacteria, amoeba, yeast)
  • Multicellular: Specialized cells form tissues/organs (e.g., plants, animals, fungi)
  • Colonial Organisms: Intermediate form (e.g., Volvox)

V. Plant vs. Animal Cell Structure

Plant Cell Animal Cell
Cell wall present No cell wall
Chloroplasts present No chloroplasts
Large central vacuole Small vacuoles
Rectangular shape Irregular shape
Plasmodesmata for communication Gap junctions

VI. Molecules of the Cell

Four Major Classes:

  1. Carbohydrates: Energy source, structural components (glucose, cellulose, starch)
  2. Lipids: Energy storage, membranes, signaling (fats, phospholipids, steroids)
  3. Proteins: Enzymes, structure, transport, signaling (amino acid polymers)
  4. Nucleic Acids: Information storage/transfer (DNA, RNA)

VII. Chemical Foundation & Composition

  • Elements: CHNOPS (Carbon, Hydrogen, Nitrogen, Oxygen, Phosphorus, Sulfur) = 96% of living matter
  • Water: Universal solvent, high heat capacity, cohesion/adhesion
  • pH: Acid-base balance critical for enzyme function
  • Chemical Bonds: Covalent (strong), ionic, hydrogen (weak but important)

VIII. Cell Organelles & Functions

Organelle Function
Nucleus DNA storage, transcription control
Mitochondria ATP production (cellular respiration)
Chloroplasts Photosynthesis (plants only)
Ribosomes Protein synthesis (free or RER-bound)
Endoplasmic Reticulum Protein/lipid synthesis, detoxification
Golgi Apparatus Protein modification, sorting, packaging
Lysosomes Intracellular digestion (animal cells)
Peroxisomes Fatty acid breakdown, detoxification
Vacuoles Storage, waste disposal, turgor pressure

IX. Fluid Mosaic Model

  • Structure: Phospholipid bilayer with embedded proteins
  • Fluidity: Affected by temperature, cholesterol content, fatty acid saturation
  • Components: Phospholipids (amphipathic), cholesterol (stabilizes), proteins (integral/peripheral), carbohydrates (glycocalyx)

X. Surface Receptors

  1. G-protein coupled receptors: Largest family, 7 transmembrane domains
  2. Receptor tyrosine kinases: Dimerize upon ligand binding
  3. Ion channel receptors: Open/close in response to ligand
  4. Intracellular receptors: Lipid-soluble signals (e.g., steroid hormones)

XI. Transport Across Membrane

Type Energy Required? Example
Simple Diffusion No O₂, CO₂ movement
Facilitated Diffusion No Glucose via carriers
Osmosis No Water movement
Active Transport Yes (ATP) Na⁺/K⁺ pump
Bulk Transport Yes Endocytosis, exocytosis

XII. Cytoskeleton: Structure & Function

Component Structure Function
Microfilaments Actin monomers (7nm) Cell movement, cytokinesis, muscle contraction
Intermediate Filaments Various proteins (8-12nm) Structural support, anchor organelles
Microtubules α/β tubulin dimers (25nm) Cell shape, organelle transport, mitotic spindle

Cell Movements:

  • Flagella/Cilia: Microtubule-based (9+2 arrangement), powered by dynein motor proteins
  • Amoeboid Movement: Actin polymerization creates pseudopodia
  • Cytoplasmic Streaming: Organelle transport in plant cells

Key Study Tips:

  • Create comparison tables for contrasting concepts
  • Draw and label cell diagrams from memory
  • Understand how structure relates to function for each organelle
  • Practice applying transport mechanisms to different scenarios
  • Connect chemical properties to biological functions

Biology Study Notes: Advanced Cell Biology

I. The Nucleus: Structure and Function

A. Nuclear Structure

Component Description Function
Nuclear Envelope Double membrane (inner/outer) with nuclear pores Separates genetic material from cytoplasm; regulates transport
Nuclear Pores Protein channels (~125 million Da selectivity) Selective transport of molecules; allows RNA/protein exchange
Nucleolus Dense region within nucleus (no membrane) Ribosomal RNA (rRNA) synthesis and ribosome assembly
Chromatin DNA + proteins (histones) in dispersed form Genetic material storage; condenses to chromosomes during division
Nuclear Matrix Protein scaffold network Provides structural support; organizes chromatin

B. Nuclear Envelope Details

  • Outer membrane: Continuous with rough ER; has ribosomes attached
  • Inner membrane: Contains nuclear lamins (intermediate filaments)
  • Nuclear pore complex (NPC): ~30 different nucleoporins; selective gate
  • Lamins: Type V intermediate filaments; maintain nuclear shape

C. Nuclear Functions

  1. Genetic Information Storage: Contains all genomic DNA (~3 billion base pairs in humans)
  2. DNA Replication: Occurs during S phase of cell cycle
  3. Transcription: DNA → mRNA in nucleus
  4. Ribosome Assembly: Nucleolus produces rRNA and assembles ribosomal subunits
  5. Gene Regulation: Chromatin remodeling controls gene expression
  6. DNA Repair: Multiple repair mechanisms (BER, NER, HR, NHEJ)

D. Nuclear Transport

  • Importins: Transport proteins into nucleus (recognize NLS – Nuclear Localization Signal)
  • Exportins: Transport proteins/RNA out of nucleus (recognize NES – Nuclear Export Signal)
  • Ran GTPase: Provides directionality (Ran-GTP in nucleus, Ran-GDP in cytoplasm)
  • Small molecules (<40 kDa): Diffuse freely through pores

II. Molecular Genetics Mechanisms

A. DNA Structure & Organization

  • Double Helix: Antiparallel strands, complementary base pairing (A-T, G-C)
  • Nucleosome: DNA wrapped around histone octamer (146 bp + linker DNA)
  • Chromatin Levels: DNA → nucleosomes → 30nm fiber → loops → chromosomes
  • Histone Proteins: H2A, H2B, H3, H4 (core); H1 (linker)

B. DNA Replication

Aspect Details
Origin of Replication Specific sequences (oriC in bacteria; multiple origins in eukaryotes)
Enzymes Involved Helicase, primase, DNA polymerase, ligase, SSB proteins
Leading Strand Continuous synthesis (5’→3′)
Lagging Strand Discontinuous (Okazaki fragments)
Telomeres End caps (TTAGGG repeats); prevent shortening
Telomerase Adds telomeric repeats; active in stem cells/cancer

C. Transcription

Stage Key Events
Initiation RNA pol binds promoter (TATA box in eukaryotes); transcription factors required
Elongation RNA synthesis 5’→3′; RNA pol moves along DNA template
Termination Specific sequences signal release; pre-mRNA processing begins

D. RNA Processing (Eukaryotes)

  1. 5′ Capping: 7-methylguanosine cap; protects mRNA, aids ribosome binding
  2. Polyadenylation: 3′ poly-A tail (~200 A’s); stability, export
  3. Splicing: Introns removed by spliceosome; exons joined together
    • Alternative splicing: One gene → multiple proteins

E. Translation

Component Role
mRNA Carries genetic code (codons = 3 nucleotides)
tRNA Delivers amino acids; anticodon-codon pairing
Ribosome 60S + 40S subunits (eukaryotes); 50S + 30S (prokaryotes)
Aminoacyl-tRNA synthetase Attaches correct amino acid to tRNA

Translation Steps:

  1. Initiation: Ribosome assembles at start codon (AUG); initiator tRNA binds
  2. Elongation: Codon recognition → peptide bond formation → translocation
  3. Termination: Stop codon (UAA, UAG, UGA) recognized; release factor binds

F. Gene Regulation

Level Mechanism Example
Epigenetic DNA methylation, histone modification X-chromosome inactivation
Transcriptional Transcription factors, enhancers/silencers Lac operon regulation
Post-transcriptional RNA processing, stability miRNA silencing
Translational Initiation factors, ribosome binding Iron-responsive elements
Post-translational Protein modification, degradation Ubiquitin-proteasome system

G. Mutation Types

  • Point mutations: Substitution (missense, nonsense, silent), insertion, deletion
  • Chromosomal mutations: Deletion, duplication, inversion, translocation
  • Mutagens: UV radiation, chemicals, viruses

III. Integration of Cells into Tissues

A. Cell Adhesion Molecules (CAMs)

Type Function Examples
Cadherins Ca²⁺-dependent cell-cell adhesion E-cadherin (epithelial), N-cadherin (neural)
Selectins Carbohydrate-binding; leukocyte rolling P-selectin, E-selectin
Integrins Cell-matrix adhesion; signal transduction Fibronectin receptor
Immunoglobulin Superfamily Ca²⁺-independent; immune function NCAM, VCAM

B. Cell Junctions

Junction Type Structure Function Found In
Tight Junctions Occluding junctions; claudins/occludins Seal gaps; prevent leakage Epithelium (intestine)
Adherens Junctions Actin-linked; cadherins + catenins Mechanical strength Heart muscle
Desmosomes Intermediate filament-linked; desmogleins Anchor cells under stress Skin, heart muscle
Gap Junctions Connexons (6 connexins) Direct communication Heart, liver
Plasmodesmata Cytoplasmic channels; desmotubule Cell-cell transport Plant cells

C. Extracellular Matrix (ECM)

Component Structure Function
Collagen Triple helix; most abundant protein Tensile strength
Elastin Cross-linked fibers Elasticity
Fibronectin Dimer; binds integrins Cell adhesion, migration
Laminin Cross-shaped; in basal lamina Epithelial cell attachment
Proteoglycans Core protein + GAGs Hydration, compression resistance
Hyaluronan Large GAG Lubrication, embryonic development

D. Tissue Types

Tissue Type Characteristics Examples
Epithelial Tightly packed, avascular, polarity Skin, lining of organs
Connective ECM-rich, diverse functions Bone, blood, adipose
Muscle Contractile, excitable Skeletal, cardiac, smooth
Nervous Electrochemical signaling Neurons, glial cells

E. Cell-ECM Interactions

  • Integrin signaling: Focal adhesions connect ECM to actin cytoskeleton
  • Outside-in signaling: ECM binding triggers intracellular pathways
  • Inside-out signaling: Cytoskeleton tension affects ECM assembly
  • Basement membrane: Specialized ECM underlying epithelial cells

IV. The Cell Cycle

A. Overview of Cell Cycle

Phase Key Events Duration (typical)
G₁ (Gap 1) Cell growth, normal metabolism Variable (hours-days)
S (Synthesis) DNA replication 6-8 hours
G₂ (Gap 2) Growth, preparation for division 2-4 hours
M (Mitosis) Nuclear division, cytokinesis 1-2 hours

B. G₀ Phase

  • Quiescent state outside cycle
  • Reversible (liver) or irreversible (neurons)
  • Cells can re-enter G₁ with signals

C. Control of Cell Cycle

Component Role
Cyclins Regulatory proteins; levels fluctuate
CDKs (Cyclin-dependent kinases) Kinases that phosphorylate targets
Cyclin-CDK complexes Drive cell cycle transitions
CKIs (CDK inhibitors) Inhibit cyclin-CDK; e.g., p21, p27
Rb protein G₁ checkpoint; binds E2F transcription factors
p53 “Guardian of genome”; arrests cycle if DNA damaged

Checkpoints:

  1. G₁/S (Restriction Point): Commits to division; checks DNA integrity, size, nutrients
  2. G₂/M: Ensures complete DNA replication; checks damage
  3. Metaphase (Spindle Checkpoint): Ensures proper chromosome attachment

D. Mitosis (Nuclear Division)

Stage Key Events
Prophase Chromosomes condense; centrosomes migrate; nuclear envelope breaks down
Prometaphase Kinetochores form; microtubules attach to kinetochores
Metaphase Chromosomes align at metaphase plate
Anaphase Sister chromatids separate; poles move apart
Telophase Chromosomes decondense; nuclear envelopes reform

E. Cytokinesis (Cytoplasmic Division)

  • Animal cells: Cleavage furrow (actin-myosin contractile ring)
  • Plant cells: Cell plate formation (vesicles from Golgi)
  • Result: Two genetically identical daughter cells

F. Meiosis (Gamete Formation)

Meiosis I Meiosis II
Homologous chromosomes pair (synapsis) Sister chromatids separate
Crossing over (genetic recombination) Similar to mitosis
Reduction division (2n → n) No DNA replication
Products: Two haploid cells Products: Four haploid cells

Key Differences from Mitosis:

  • One DNA replication, two divisions
  • Genetic variation through crossing over and independent assortment
  • Produces gametes (sperm, eggs)

G. Comparison: Mitosis vs. Meiosis

Feature Mitosis Meiosis
Purpose Growth, repair, asexual reproduction Sexual reproduction (gametes)
DNA replication Once per cycle Once before meiosis I
Number of divisions One Two
Ploidy Diploid → Diploid Diploid → Haploid
Genetic variation No (clones) Yes (crossing over, independent assortment)
Products Two identical cells Four non-identical cells

V. Cell Signaling

A. Basic Principles

Term Definition
Ligand Signaling molecule (hormone, neurotransmitter)
Receptor Protein that binds ligand; initiates response
Signal transduction Cascade of intracellular events
Second messenger Intracellular signaling molecule (cAMP, Ca²⁺)

B. Types of Signaling

Type Distance Example
Autocrine Self Cancer cells stimulating own growth
Paracrine Local (short-range) Neurotransmitters, growth factors
Endocrine Long distance Hormones (insulin, estrogen)
Contact-dependent Direct contact Notch signaling, immune cell interactions

C. Receptor Types

Receptor Type Location Mechanism Example
Ion Channel (Ligand-gated) Plasma membrane Ligand opens channel Nicotinic ACh receptor
GPCR (G-protein coupled) Plasma membrane G-protein activation → effectors β-adrenergic receptor
Receptor Tyrosine Kinase (RTK) Plasma membrane Dimerization → autophosphorylation EGF receptor
Intracellular Cytoplasm/nucleus Binds lipid-soluble ligand Steroid hormone receptor

D. G-Protein Signaling Pathway

  1. Ligand binds GPCR → conformational change
  2. GPCR activates Gα-GTP (releases Gβγ)
  3. Gα-GTP activates effector (adenylyl cyclase)
  4. Adenylyl cyclase → cAMP (second messenger)
  5. cAMP activates PKA (protein kinase A)
  6. PKA phosphorylates target proteins
  7. Signal termination: GTPase activity of Gα; phosphodiesterases degrade cAMP

E. RTK Signaling Pathway

  1. Ligand binds RTK → receptor dimerization
  2. Autophosphorylation of tyrosine residues
  3. Adaptor proteins (e.g., Grb2) bind phosphotyrosines
  4. SOS activates Ras (small GTPase)
  5. Ras → Raf → MEK → ERK (MAP kinase cascade)
  6. ERK enters nucleus → transcription factor activation
  7. Response: Cell proliferation, differentiation, survival

F. Second Messengers

Second Messenger Source Functions
cAMP ATP via adenylyl cyclase Activates PKA; metabolic regulation
cGMP GTP via guanylyl cyclase Visual signaling, smooth muscle relaxation
Ca²⁺ ER/SR release or influx Muscle contraction, secretion, fertilization
IP₃ PIP₂ cleavage Releases Ca²⁺ from ER
DAG PIP₂ cleavage Activates PKC
PIP₃ PIP₂ phosphorylation Akt/PKB pathway

G. Signal Amplification

  • One receptor activates multiple G-proteins
  • One G-protein activates many effector molecules
  • Each effector produces many second messengers
  • Result: Amplified cellular response

H. Signal Termination

  • Ligand degradation or removal
  • Receptor internalization (endocytosis)
  • Receptor desensitization (phosphorylation)
  • Phosphatases remove phosphate groups
  • Second messenger degradation

VI. Movement of Nutrients and Proteins

A. Protein Sorting & Targeting

Pathway Destination Signal Sequence
Co-translational ER → secretory pathway N-terminal signal peptide
Post-translational (mitochondria) Mitochondrial matrix N-terminal presequence
Post-translational (nucleus) Nucleus Nuclear Localization Signal (NLS)
Post-translational (peroxisome) Peroxisome PTS1 (C-terminal) or PTS2
Post-translational (chloroplast) Chloroplast stroma Transit peptide

B. Endomembrane System

Organelle Functions
Rough ER Protein synthesis (secretory/membrane proteins), N-glycosylation
Smooth ER Lipid synthesis, detoxification, Ca²⁺ storage
Golgi Apparatus Protein modification, sorting, packaging, polysaccharide synthesis
Vesicles Transport between organelles and plasma membrane

C. Vesicular Transport

Vesicle Type Origin Destination Coat Protein
COPII ER Golgi COPII proteins
COPI Golgi → ER Retrograde transport COPI proteins
Clathrin-coated Golgi/PM → endosome Lysosome or recycling Clathrin + adaptors

D. Protein Folding & Quality Control

Mechanism Location Function
Chaperones (Hsp70, Hsp90) Cytosol, ER Assist folding; prevent aggregation
PDI (Protein Disulfide Isomerase) ER Form/disulfide bonds
Calnexin/Calreticulin ER Quality control for glycoproteins
ERAD ER Degrade misfolded proteins
Ubiquitin-Proteasome Cytosol Degrade damaged/unwanted proteins

E. Lysosomal Degradation

  • Autophagy: Cellular recycling pathway
    • Macroautophagy: Autophagosome formation → lysosome
    • Microautophagy: Direct engulfment by lysosome
    • Chaperone-mediated: Specific proteins via LAMP receptors

F. Nutrient Transport

Transport Type Mechanism Example
Passive diffusion Down gradient, no energy O₂, CO₂, steroids
Facilitated diffusion Channel or carrier proteins GLUT transporters (glucose)
Primary active transport ATP hydrolysis Na⁺/K⁺-ATPase
Secondary active transport Ion gradient (symport/antiport) SGLT (Na⁺-glucose)
Endocytosis Vesicle formation Cholesterol uptake (LDL)
Exocytosis Vesicle fusion Neurotransmitter release

VII. Programmed Cell Death & Apoptosis

A. Apoptosis vs. Necrosis

Feature Apoptosis Necrosis
Cause Programmed, physiological Injury, trauma, toxins
Cell Size Shrinkage Swelling (oncosis)
Membrane Intact until late Disrupted early
Inflammation None Significant
Energy ATP-dependent Passive
Phagocytosis By neighbors/macrophages Inflammatory response

B. Apoptotic Pathways

Extrinsic (Death Receptor) Pathway

  1. Death ligands bind death receptors:
    • FasL → Fas (CD95)
    • TNF-α → TNFR1
    • TRAIL → DR4/DR5
  2. Death domain recruitment → FADD adaptor
  3. Caspase-8 activation (initiator caspase)
  4. Caspase cascade → executioner caspases (3, 6, 7)
  5. Cellular demolition: DNA fragmentation, membrane blebbing

Intrinsic (Mitochondrial) Pathway

  1. Stimuli: DNA damage, growth factor withdrawal, ER stress
  2. Bcl-2 family regulation:
    • Pro-apoptotic: Bax, Bak, Bad
    • Anti-apoptotic: Bcl-2, Bcl-xL
  3. Mitochondrial outer membrane permeabilization (MOMP)
  4. Cytochrome c release → binds Apaf-1
  5. Apoptosome formation → caspase-9 activation
  6. Caspase cascade → executioner caspases

Endoplasmic Reticulum Pathway

  • Unfolded protein response (UPR): Persistent ER stress → CHOP expression → apoptosis
  • Ca²⁺ release: Activates calpains (cysteine proteases)

C. Caspases

Type Examples Function
Initiator Caspase-8, -9, -12 Activate executioner caspases
Executioner Caspase-3, -6, -7 Carry out cell demolition

Caspase actions:

  • Cleave structural proteins (actin, nuclear lamins)
  • Activate DNases (CAD) for DNA fragmentation
  • Cleave anti-apoptotic proteins
  • Create “eat me” signals (phosphatidylserine exposure)

D. Morphological Changes in Apoptosis

  1. Cell shrinkage
  2. Chromatin condensation (pyknosis)
  3. Nuclear fragmentation (karyorrhexis)
  4. Membrane blebbing
  5. Formation of apoptotic bodies
  6. Phagocytosis by neighboring cells or macrophages

E. Anti-Apoptotic Mechanisms

Protein Mechanism
IAPs (Inhibitor of Apoptosis Proteins) Directly inhibit caspases
Bcl-2 family Prevent MOMP
FLIP Inhibit caspase-8 activation
p53 Can induce both pro- and anti-apoptotic genes

F. Necroptosis

  • Programmed necrosis
  • Key proteins: RIPK1, RIPK3, MLKL
  • Triggered when caspase-8 is inhibited
  • Forms pores via MLKL → membrane rupture
  • Pro-inflammatory

G. Autophagic Cell Death

  • Excessive autophagy → self-digestion
  • Type II programmed cell death
  • Key protein: ATG genes (autophagy-related)
  • Usually protective (removes damaged components)
  • Can become lethal when excessive

H. Physiological Roles of Apoptosis

Context Function
Development Digit separation, neural pruning, thymus selection
Tissue homeostasis Maintain cell numbers, replace damaged cells
Immune system Delete autoreactive lymphocytes, kill infected cells
Aging Remove senescent cells
Disease Dysregulation → cancer (too little) or degeneration (too much)

I. Clinical Relevance

Disease Apoptosis Role Therapeutic Target
Cancer Insufficient apoptosis Bcl-2 inhibitors (venetoclax)
Neurodegeneration Excessive apoptosis Caspase inhibitors
Autoimmune disease Defective deletion Enhance apoptosis
Ischemia-reperfusion Excessive death Anti-apoptotic drugs

 

BCH-402 Human Physiology 3(3-0)

Comprehensive Study Notes: Endocrine System and Blood Physiology

PART I: HORMONES AND THE ENDOCRINE SYSTEM

Introduction to Hormones

Hormones represent the body’s sophisticated chemical messenger system, functioning as signaling molecules produced by endocrine glands that regulate physiology and behavior across distant target organs. Unlike exocrine glands that secrete substances through ducts into body cavities, endocrine glands are ductless organs that release their products directly into the bloodstream for distribution throughout the body. This elegant system enables coordinated responses to environmental changes, maintains internal homeostasis, and controls growth, development, and reproduction.

The concept of chemical signaling dates back to 1902 when Ernest Starling and William Bayliss first used the term “hormone” (from the Greek word meaning “to set in motion” or “to stimulate”) following their discovery of secretin, the first hormone identified. Since then, researchers have discovered over 200 hormones and hormone-like substances, each with specific roles in maintaining the complex balance of life.

The endocrine system works in concert with the nervous system to create an integrated control network. While the nervous system provides rapid, short-duration electrical signals through neurons, the endocrine system generally operates more slowly but produces longer-lasting effects. Interestingly, these two systems share many connections—the hypothalamus serves as a critical integration point where neural signals are converted into hormonal responses, demonstrating the beautiful interplay between these control systems.

Classification of Hormones

Hormones can be classified according to several criteria, each classification scheme revealing different aspects of hormonal function and behavior.

Classification by Chemical Nature

The chemical structure of a hormone fundamentally determines its synthesis, storage, release, transport in the blood, and mechanism of action at target cells. This classification represents the most widely used system in endocrinology.

Steroid Hormones derive from cholesterol and include the adrenal corticosteroids (cortisol, aldosterone), gonadal steroids (testosterone, estrogen, progesterone), and calcitriol (the active form of vitamin D). These lipid-soluble molecules can readily cross cell membranes and bind to intracellular receptors, making them unique among hormone classes.

Peptide and Protein Hormones range from small tripeptides like thyrotropin-releasing hormone to large glycoprotein hormones like luteinizing hormone. This class includes insulin, glucagon, growth hormone, prolactin, and all hormones released from the anterior pituitary. These water-soluble hormones cannot cross cell membranes freely and must interact with surface receptors.

Amine Hormones are derived from single amino acids, specifically tyrosine or tryptophan. The thyroid hormones (T3 and T4), epinephrine, norepinephrine, dopamine, and melatonin belong to this category. Interestingly, while thyroid hormones behave like steroids due to their lipid solubility, the catecholamines (epinephrine, norepinephrine, dopamine) behave like peptide hormones.

Eicosanoids and Other Lipid-Derived Hormones represent a fourth category that includes prostaglandins, leukotrienes, and thromboxanes. These local mediators are produced on demand from arachidonic acid in cell membranes and typically act near their site of synthesis.

Classification by Target Site

Endocrine Hormones travel through the bloodstream to reach distant target organs, exemplified by thyroid hormones stimulating metabolism throughout the body or cortisol affecting nearly every tissue. Paracrine Hormones diffuse through interstitial fluid to affect nearby cells, such as somatostatin inhibiting adjacent pituitary cells or histamine affecting nearby blood vessels. Autocrine Hormones act on the same cell that produced them, a phenomenon commonly observed in immune cells and cancer cells. Neuroendocrine Hormones are released by neurons into the bloodstream, with oxytocin and vasopressin serving as classic examples.

Classification by Function

Hormones can also be grouped by their primary regulatory role: metabolic hormones (insulin, thyroid hormones), reproductive hormones (FSH, LH, testosterone, estrogen), stress hormones (cortisol, epinephrine), growth-promoting hormones (growth hormone, IGF-1), and calcium-regulating hormones (parathyroid hormone, calcitonin, active vitamin D).

Chemical Nature of Hormones

Understanding the chemical structure of hormones provides insight into their synthesis, storage, release, and mechanisms of action.

Steroid Hormones: Cholesterol Derivatives

All steroid hormones originate from cholesterol, a complex ringed lipid molecule. The steroid nucleus consists of three six-carbon rings fused to one five-carbon ring, creating the characteristic cyclopentanoperhydrophenanthrene ring system. Substitutions at various positions on this core structure create the diverse family of steroid hormones. Aldosterone, the most potent mineralocorticoid, has an aldehyde group at carbon-18. Cortisol possesses hydroxyl groups at carbons-17, 11, and 21. Testosterone contains a ketone group at carbon-3 and a hydroxyl group at carbon-17. Estrogen differs fundamentally from other steroids by having an aromatic A-ring and lacking the carbon-19 methyl group.

The lipophilic nature of steroids means they cannot dissolve freely in the aqueous plasma and must bind to carrier proteins for transport. Cortisol binds primarily to corticosteroid-binding globulin (CBG), while sex hormone-binding globulin (SHBG) carries testosterone and estradiol. Approximately 90-95% of circulating steroids are bound, with only the free fraction being biologically active.

Peptide Hormones: Amino Acid Polymers

Peptide hormones vary enormously in size, from thyrotropin-releasing hormone (a tripeptide) to human chorionic somatomammotropin (a protein with over 190 amino acids). Despite this size diversity, all share common features in their synthesis and processing. They are synthesized on ribosomes in the rough endoplasmic reticulum as larger precursor molecules called preprohormones. The signal peptide directing the ribosome to the endoplasmic reticulum is removed in the lumen, forming a prohormone that undergoes further processing in the Golgi apparatus. For many peptides, this includes cleavage by proteolytic enzymes and modification of amino acid residues—glycosylation, amidation, or acetylation.

These hormones are stored in secretory granules, which are released by calcium-dependent exocytosis when the cell receives an appropriate stimulus. Because they are water-soluble, peptides circulate freely in plasma without carrier proteins and have half-lives measured in minutes rather than hours.

Amine Hormones: Modified Amino Acids

The catecholamines—epinephrine, norepinephrine, and dopamine—are derived from tyrosine through a two-step enzymatic pathway. Tyrosine is first converted to L-DOPA by tyrosine hydroxylase (the rate-limiting step), then to dopamine by aromatic L-amino acid decarboxylase. In adrenal medullary cells, dopamine is further hydroxylated to norepinephrine and methylated to epinephrine. These small, water-soluble molecules are stored in secretory granules and released by exocytosis.

The thyroid hormones represent a unique case among amine hormones. Despite being derived from tyrosine, they behave as lipophilic molecules because each hormone contains four iodine atoms and two aromatic rings that confer steroid-like properties. They require carrier proteins for transport and exert their effects through intracellular receptors.

General Mechanism of Hormone Action

The mechanism by which hormones produce their effects depends fundamentally on their chemical nature, particularly their lipid solubility. This creates two broad categories of hormonal action: the steroid-thyroid hormone pathway utilizing intracellular receptors, and the peptide-catecholamine pathway utilizing cell surface receptors.

Mechanism of Steroid and Thyroid Hormone Action

Lipophilic steroid and thyroid hormones diffuse freely across the plasma membrane, a remarkable feat given that these membranes are composed of phospholipid bilayers designed to be selectively permeable. Once inside the cell, these hormones encounter their specific receptors, which for steroids are located primarily in the cytoplasm (glucocorticoid, mineralocorticoid, progesterone receptors) or nucleus (thyroid hormone, estrogen, androgen receptors).

The steroid receptor family shares a common structural organization with distinct functional domains. The N-terminal region contains activation functions that interact with coactivator proteins. The central DNA-binding domain contains zinc fingers that recognize specific hormone response elements in the DNA. The C-terminal ligand-binding domain not only binds the hormone but also contains regions that interact with heat shock proteins and mediate transcriptional activation.

When a steroid binds its receptor, a conformational change occurs that releases associated heat shock proteins, allowing the hormone-receptor complex to translocate to the nucleus (if not already there) and bind to specific DNA sequences called hormone response elements. This binding recruits a complex of coactivators and the basal transcription machinery, ultimately resulting in altered gene transcription. The mRNA produced is then translated into new proteins that mediate the hormone’s physiological effects.

This genomic mechanism has a characteristic time course—effects typically begin after 30 minutes to several hours and may persist for days after the hormone is removed. However, many steroids also produce rapid, non-genomic effects through membrane-associated receptors that activate second messenger systems within seconds to minutes.

Mechanism of Peptide Hormone Action

Water-soluble peptide hormones and catecholamines cannot cross the plasma membrane and must instead bind to receptors embedded in the cell surface. These receptors are typically transmembrane proteins with an extracellular hormone-binding domain and an intracellular domain that initiates signal transduction cascades.

The G protein-coupled receptor (GPCR) family represents the largest and most diverse receptor category for peptide hormones. When a hormone binds a GPCR, the receptor undergoes a conformational change that activates an associated G protein. The activated G protein, in turn, activates or inhibits an effector enzyme that produces a second messenger. The classic example involves Gs proteins stimulating adenylyl cyclase to produce cyclic AMP (cAMP), while Gi proteins inhibit this enzyme.

The cAMP second messenger system illustrates this pathway beautifully. When epinephrine binds to β-adrenergic receptors on liver cells, the resulting increase in cAMP activates protein kinase A, which phosphorylates key enzymes involved in glycogen metabolism. This cascade amplifies the original signal enormously—one hormone molecule can generate thousands of second messenger molecules, each activating multiple protein kinases, each phosphorylating many substrate molecules.

Other peptide hormones utilize different second messenger systems. Phospholipase C activation produces inositol trisphosphate (IP3) and diacylglycerol (DAG)—IP3 releases calcium from the endoplasmic reticulum while DAG activates protein kinase C. Insulin and growth hormone signal through receptor tyrosine kinases that phosphorylate specific intracellular proteins, initiating cascades involving PI3 kinase and MAP kinase.

Regulation of Hormone Secretion

Hormone secretion is not continuous but rather exhibits precise temporal patterns and magnitudes determined by various regulatory mechanisms. This tight control ensures that hormone levels remain within narrow physiological ranges despite changing internal and external conditions.

Negative Feedback: The Dominant Regulatory Mechanism

The principle of negative feedback governs most endocrine systems, maintaining homeostasis by adjusting hormone secretion in response to the hormone’s own effects. When a hormone produces its intended effect, that effect feeds back to reduce further secretion of the hormone. This creates a self-limiting system that prevents excessive hormone action.

The hypothalamic-pituitary-target organ axes exemplify negative feedback regulation. The thyroid axis begins with the hypothalamus releasing thyrotropin-releasing hormone (TRH), which stimulates the anterior pituitary to secrete thyroid-stimulating hormone (TSH). TSH, in turn, stimulates the thyroid gland to produce thyroid hormones (T3 and T4). When circulating T3 and T4 levels rise sufficiently, they inhibit both TRH release from the hypothalamus and TSH secretion from the pituitary, reducing further thyroid hormone production. This elegant system maintains thyroid hormone levels within a narrow therapeutic range.

Similar feedback loops govern the adrenal axis (hypothalamus-pituitary-adrenal), gonadal axis (hypothalamus-pituitary-gonadal), and growth hormone axis. In each case, the end-organ hormones provide negative feedback signals to both the pituitary and hypothalamus, creating a closed-loop control system.

Positive Feedback: Rare but Critical Exceptions

Positive feedback mechanisms, where a hormone’s effect stimulates more of its own secretion, are relatively uncommon but biologically essential in specific contexts. The most dramatic example occurs during childbirth, where uterine contractions cause the posterior pituitary to release oxytocin. Oxytocin intensifies uterine contractions, which release more oxytocin, creating a self-amplifying cycle that culminates in delivery.

The mid-cycle LH surge during the menstrual cycle represents another positive feedback phenomenon. Rising estradiol levels from developing ovarian follicles initially inhibit LH secretion, but after approximately 36 hours of high estradiol exposure, this relationship reverses—estradiol now stimulates a massive LH surge that triggers ovulation. This positive feedback requires careful timing and is ultimately terminated by the LH surge itself.

Neural Regulation

Many endocrine glands are directly controlled by the nervous system, providing rapid responses to environmental stimuli and stress. The adrenal medulla exemplifies neural endocrine regulation—preganglionic sympathetic neurons release acetylcholine, which stimulates chromaffin cells to secrete epinephrine and norepinephrine. This neural control allows the body to mount an immediate “fight or flight” response to perceived threats.

The hypothalamus controls anterior pituitary function through releasing and inhibiting hormones secreted into the hypophyseal portal system. This portal connection allows hypothalamic neurons to regulate pituitary hormone secretion based on neural inputs from throughout the brain, integrating emotional, sensory, and cognitive information into endocrine responses.

Humoral Regulation: Responding to Blood Constituents

Some endocrine cells respond directly to concentrations of specific substances in the blood, constituting the most direct form of endocrine regulation. Parathyroid cells monitor blood calcium levels through calcium-sensing receptors; when calcium decreases, PTH secretion increases. Pancreatic beta cells respond to rising blood glucose by secreting insulin. The juxtaglomerular apparatus monitors blood pressure and sodium delivery, regulating renin release accordingly.

This humoral regulation creates rapid responses to changing metabolic conditions. Within minutes of a carbohydrate-rich meal, rising glucose levels trigger insulin release from pancreatic beta cells, promoting glucose uptake and storage. Conversely, during fasting, declining glucose and rising glucagon from alpha cells promote glycogen breakdown and gluconeogenesis.

Circadian and Ultradian Rhythms

Many hormones exhibit predictable temporal patterns of secretion, reflecting both external environmental cues and internal biological clocks. Cortisol secretion follows a robust circadian rhythm, with peak levels around 6-8 AM and nadir levels around midnight. This rhythm is driven by the suprachiasmatic nucleus and persists even in constant darkness, demonstrating its endogenous nature.

Growth hormone secretion occurs in discrete pulses throughout the day and night, with the largest pulses occurring during deep sleep. The pulsatile nature of GnRH, LH, FSH, and TSH secretion is essential for their biological activity—continuous exposure to these hormones often down-regulates their receptors and reduces target organ responsiveness.

Biological Functions of Endocrine Glands

Thyroid Gland

The thyroid gland, situated in the anterior neck just below the larynx, consists of two lobes connected by an isthmus. Its functional units are the thyroid follicles—spherical structures lined by cuboidal epithelial cells surrounding a lumen filled with colloid, a viscous fluid containing the glycoprotein thyroglobulin.

Synthesis and Secretion. The thyroid produces two biologically active hormones: thyroxine (T4, tetraiodothyronine) and triiodothyronine (T3). Both contain iodine atoms essential for their activity—T4 has four iodine atoms while T3 has three. The thyroid trap iodide ions from the bloodstream and concentrate them within the follicle, achieving intracellular iodide concentrations 30 times higher than in plasma. This trapping is accomplished by the sodium-iodide symporter (NIS), an active transport protein.

Oxidation of iodide to iodine occurs at the apical membrane, catalyzed by thyroid peroxidase (TPO). This enzyme also catalyzes the organification of iodine—attachment of iodine to tyrosine residues on thyroglobulin. Monoiodotyrosine (MIT) and diiodotyrosine (DIT) are produced, which then couple: two DIT molecules form T4, while one MIT and one DIT form T3. These hormones remain stored in colloid until released.

When the thyroid is stimulated by TSH, follicular cells endocytose colloid droplets and proteolytically cleave T3 and T4 from thyroglobulin. The free hormones are released into the bloodstream while MIT and DIT are deiodinated and the iodine recycled. This synthesis and release process takes approximately one week from iodide uptake to hormone secretion.

Functions of Thyroid Hormones. Thyroid hormones exert profound effects on basal metabolic rate (BMR). They increase the number and activity of mitochondria, enhance transcription of genes encoding proteins involved in oxidative phosphorylation, and stimulate Na+/K+-ATPase activity. These actions increase oxygen consumption and heat production in nearly all tissues except the brain, spleen, and testes.

Cardiovascular effects include increased heart rate, enhanced cardiac contractility, and increased blood volume. Thyroid hormones up-regulate beta-1 adrenergic receptors in the heart, potentiating the effects of catecholamines. These effects explain why hyperthyroidism causes tachycardia and palpitations.

Central nervous system development depends critically on thyroid hormones, particularly during fetal life and the first two postnatal years. Thyroid hormone deficiency during this critical period causes irreversible mental retardation and dwarfism (cretinism). In adults, thyroid hormones maintain normal CNS function—hypothyroidism produces mental sluggishness while hyperthyroidism causes anxiety and irritability.

Thyroid hormones stimulate bone remodeling by enhancing both osteoclast and osteoblast activity. During hyperthyroidism, bone resorption exceeds formation, potentially leading to osteoporosis. They also stimulate protein synthesis and carbohydrate absorption while enhancing lipolysis and cholesterol clearance.

Regulation of Thyroid Function. The hypothalamic-pituitary-thyroid axis regulates thyroid hormone production. The hypothalamus releases thyrotropin-releasing hormone (TRH), a tripeptide that stimulates the anterior pituitary to secrete thyroid-stimulating hormone (TSH). TSH binds to receptors on thyroid follicular cells, stimulating all aspects of thyroid hormone synthesis and release. Rising T3 and T4 levels provide negative feedback to both pituitary and hypothalamus, reducing TRH and TSH secretion.

Parathyroid Glands

The parathyroid glands are small endocrine glands located on the posterior surface of the thyroid gland, usually two on each side. Despite their modest size (totaling approximately 0.2 grams), these glands are essential for calcium homeostasis.

Parathyroid Hormone. The principal hormone secreted by parathyroid chief cells is parathyroid hormone (PTH), an 84-amino acid peptide. Calcium-sensing receptors (CaSR) on chief cells monitor blood ionized calcium levels with remarkable sensitivity—PTH secretion increases linearly as calcium decreases below the normal range.

Biological Actions. PTH maintains血钙 concentrations through three primary target organs. On bone, PTH stimulates osteoclast activity (indirectly, through osteoblast release of RANKL), promoting bone resorption and releasing calcium and phosphate into the blood. This effect is opposed by calcitonin, which inhibits osteoclasts. The renal actions of PTH include increasing calcium reabsorption in the distal tubule, decreasing phosphate reabsorption in the proximal tubule (promoting phosphaturia), and stimulating 1-alpha-hydroxylase activity, which converts 25-hydroxyvitamin D to its active form.

Intestinal calcium absorption is indirectly stimulated by PTH through its renal effects on vitamin D activation. By increasing 1,25-dihydroxyvitamin D production, PTH enhances intestinal calcium and phosphate absorption. The net effect of PTH is to raise blood calcium while lowering blood phosphate—an important distinction because excessive phosphate would favor calcium phosphate precipitation.

Regulation and Integration. PTH secretion is regulated primarily by blood ionized calcium through the CaSR, a G protein-coupled receptor that detects even small changes in calcium concentration. When calcium falls, PTH secretion increases within minutes. Chronic hypocalcemia causes parathyroid hyperplasia, while hypercalcemia suppresses secretion. Phosphate can indirectly affect PTH by binding calcium and by directly stimulating PTH gene transcription.

Pituitary Gland

The pituitary gland, nestled in the sella turcica of the sphenoid bone, consists of two embryologically distinct lobes with different functions and regulatory mechanisms. The anterior pituitary (adenohypophysis) develops from oral ectoderm, while the posterior pituitary (neurohypophysis) is an outpouching of the hypothalamus.

Anterior Pituitary Hormones. The anterior pituitary produces six major hormones, each regulated by specific hypothalamic releasing and inhibiting hormones delivered through the hypophyseal portal system.

Growth hormone (GH), a 191-amino acid protein, is the most abundant anterior pituitary hormone. Its secretion is pulsatile, with the largest pulses occurring during deep sleep. GH acts directly on tissues expressing GH receptors and indirectly through insulin-like growth factor-1 (IGF-1), primarily produced in the liver. Growth-promoting effects include stimulation of amino acid uptake and protein synthesis in muscle, lipolysis in adipose tissue, and antagonism of insulin’s effects on glucose metabolism. GH deficiency in children causes growth retardation, while excess causes gigantism (before epiphyseal closure) or acromegaly (after closure).

Thyroid-stimulating hormone (TSH), a glycoprotein hormone composed of alpha and beta subunits, stimulates thyroid hormone synthesis and release. TSH secretion is stimulated by TRH and inhibited by somatostatin, with negative feedback from thyroid hormones.

Adrenocorticotropic hormone (ACTH), derived from proopiomelanocortin (POMC), stimulates adrenal cortical growth and cortisol synthesis. ACTH secretion follows a circadian rhythm paralleling cortisol, with highest levels in early morning. Stress, vasopressin, and interleukin-1 can override normal rhythmicity and stimulate ACTH release.

Follicle-stimulating hormone (FSH) and luteinizing hormone (LH), the gonadotropins, regulate gonadal function. In females, FSH stimulates follicular development and estrogen production while LH triggers ovulation and maintains the corpus luteum. In males, FSH supports spermatogenesis while LH stimulates testosterone production from Leydig cells.

Prolactin, a peptide hormone structurally similar to GH, stimulates milk production in the mammary gland. Its secretion is tonically inhibited by dopamine from the hypothalamus, and the abrupt decrease in dopamine after delivery allows prolactin levels to rise. Suckling stimulates prolactin release by reducing dopaminergic inhibition.

Posterior Pituitary Hormones. The posterior pituitary does not synthesize hormones but rather stores and releases oxytocin and vasopressin (antidiuretic hormone, ADH), which are produced in hypothalamic neurons (supraoptic and paraventricular nuclei) and transported down axons to the posterior pituitary.

Oxytocin stimulates uterine contraction during labor and milk ejection during breastfeeding. Its release is mediated by a neuroendocrine reflex—cervical dilation and nipple stimulation send afferent signals to the hypothalamus, triggering oxytocin release from the posterior pituitary.

Vasopressin acts on V2 receptors in the renal collecting duct to insert aquaporin-2 water channels, concentrating urine and conserving water. V1 receptors on vascular smooth muscle mediate vasoconstriction and increased blood pressure. Vasopressin release is stimulated by increased plasma osmolality (detected by osmoreceptors) and decreased blood volume or pressure (detected by baroreceptors).

Adrenal Glands

The adrenal glands sit atop the kidneys and consist of two functionally distinct regions: the adrenal cortex (outer layer, derived from mesoderm) and adrenal medulla (inner core, derived from neural crest).

Adrenal Cortex. The cortex is divided into three zones that produce different classes of steroid hormones. The zona glomerulosa (outermost) produces mineralocorticoids, primarily aldosterone. The zona fasciculata (middle) produces glucocorticoids, primarily cortisol. The zona reticularis (inner) produces androgens, primarily dehydroepiandrosterone (DHEA).

Aldosterone, a mineralocorticoid, acts on the distal nephron to increase sodium reabsorption and potassium excretion. This action is mediated through activation of epithelial sodium channels (ENaC) and the Na+/K+-ATPase pump. Sodium retention expands extracellular volume and increases blood pressure, while potassium excretion prevents hyperkalemia. Aldosterone release is primarily regulated by the renin-angiotensin-aldosterone system (RAAS) and by direct effects of plasma potassium.

Cortisol, the primary glucocorticoid in humans, exerts widespread effects on metabolism, immune function, and stress response. Metabolic effects include stimulation of gluconeogenesis, antagonism of insulin action (cortisol-induced insulin resistance), protein catabolism in muscle, and lipolysis in adipose tissue. These actions help maintain blood glucose during fasting and stress. Cortisol also stabil lysosomal membranes, reduces capillary permeability, and suppresses immune and inflammatory responses—effects exploited in the therapeutic use of synthetic glucocorticoids. The permissive effect of cortisol refers to its requirement for catecholamines to exert full vascular effects.

Adrenal androgens, though weak compared to gonadal steroids, contribute significantly to pubic and axillary hair development in females and may have effects on libido in both sexes.

Adrenal Medulla. Chromaffin cells of the adrenal medulla secrete catecholamines—primarily epinephrine (80%) and norepinephrine (20%). These cells are essentially modified postganglionic sympathetic neurons that secrete into the bloodstream rather than onto synapses.

Epinephrine and norepinephrine bind to alpha and beta adrenergic receptors throughout the body, producing the classic “fight or flight” response: increased heart rate and contractility, bronchodilation, vasoconstriction in skin and gut, vasodilation in skeletal muscle, and metabolic effects including glycogenolysis and lipolysis. Epinephrine is more potent at beta receptors while norepinephrine has greater alpha activity.

Regulation of Adrenal Function. ACTH from the anterior pituitary stimulates cortisol and androgen production from the zona fasciculata and reticularis. ACTH release is stimulated by CRH from the hypothalamus and by stress, and is inhibited by cortisol through negative feedback. Aldosterone secretion is largely independent of ACTH, being regulated primarily by the RAAS and by potassium levels.

Gonadal Hormones

The gonads—testes in males and ovaries in females—produce gametes (sperm and ova) and secrete sex steroid hormones that regulate reproductive function and secondary sexual characteristics.

Testicular Hormones. Leydig cells in the testicular interstitium produce testosterone, the primary male sex hormone. This steroid is synthesized from cholesterol through a series of enzymatic reactions, with the rate-limiting step being cholesterol transport to the inner mitochondrial membrane. Testosterone secretion is stimulated by LH from the anterior pituitary, with negative feedback affecting both LH and FSH secretion.

Testosterone exerts androgenic effects that include development and maintenance of male internal genital structures (epididymis, vas deferens, seminal vesicles) and external genitalia (penis, scrotum) during fetal development. During puberty, testosterone promotes growth of the penis and scrotum, development of pubic, axillary, and facial hair, deepening of the voice due to laryngeal growth, increased muscle mass and bone density, and closure of epiphyseal plates.

Testosterone also has anabolic effects on muscle and bone, explaining why men generally have greater muscle mass and bone density than women. In the brain, testosterone influences libido, aggression, and mood. Some testosterone is converted to estradiol by aromatase in peripheral tissues, and this estrogen is important for bone health and possibly for libido in men.

Sertoli cells in the seminiferous tubules produce inhibin B, which selectively inhibits FSH secretion from the pituitary. This provides negative feedback specifically for FSH, allowing independent regulation of the two gonadotropins.

Ovarian Hormones. The ovaries produce estrogens (primarily estradiol), progesterone, and small amounts of androgens. Granulosa cells of developing follicles produce estradiol under FSH stimulation, while the corpus luteum (formed after ovulation) produces both estradiol and progesterone.

Estradiol exerts profound effects on the female reproductive system. During the follicular phase of the menstrual cycle, rising estradiol stimulates proliferation of the endometrial lining, up-regulates LH and FSH receptors on granulosa cells, and induces the LH surge that triggers ovulation. Estrogen also promotes development of female secondary sexual characteristics at puberty, including breast development, widening of the hips, and female fat distribution. Bone-protective effects of estrogen help explain the increased osteoporosis risk after menopause.

Progesterone, secreted primarily by the corpus luteum and later by the placenta, prepares the endometrium for implantation and maintains pregnancy. Its effects include glandular secretion in the endometrium, decreased uterine contractility, and thickening of cervical mucus. Progesterone also has thermogenic effects, raising basal body temperature during the luteal phase.

The ovaries also produce inhibin A and inhibin B, which selectively inhibit FSH secretion. Inhibin B dominates during the follicular phase while inhibin A predominates during the luteal phase.

Regulation of Gonadal Function. The hypothalamic-pituitary-gonadal axis regulates reproductive function. Pulsatile GnRH release from the hypothalamus stimulates LH and FSH secretion from the pituitary. In males, relatively constant GnRH pulses maintain LH and FSH secretion. In females, the frequency and amplitude of GnRH pulses change throughout the cycle, with slower pulses favoring FSH release and faster pulses favoring LH release.

Pancreatic Hormones

The pancreas is both an exocrine and endocrine organ. The exocrine pancreas secretes digestive enzymes into the duodenum through the pancreatic duct. The endocrine pancreas consists of the islets of Langerhans, clusters of cells scattered throughout the pancreatic tissue that secrete hormones directly into the bloodstream.

Insulin. Beta cells, comprising 60-70% of islet cells, secrete insulin, a 51-amino acid protein synthesized as preproinsulin and processed to proinsulin and then insulin. Insulin is the body’s primary anabolic hormone, promoting storage of nutrients after meals.

Carbohydrate metabolism effects include facilitation of glucose uptake in muscle and adipose tissue through translocation of GLUT4 transporters to the cell membrane, stimulation of glycogen synthesis in liver and muscle, inhibition of gluconeogenesis and glycogenolysis in liver, and enhancement of lipogenesis while inhibiting lipolysis.

Protein metabolism effects include stimulation of amino acid uptake and protein synthesis in muscle, inhibition of protein catabolism, and promotion of potassium uptake into cells. These anabolic effects make insulin essential for growth.

Lipid metabolism effects include promotion of fatty acid synthesis and triglyceride storage in adipose tissue, inhibition of ketogenesis in the liver, and stimulation of cholesterol synthesis.

Insulin secretion is triggered primarily by rising blood glucose levels, which are taken up by beta cells through GLUT2 transporters and metabolized to produce ATP. The increased ATP closes KATP channels, depolarizing the membrane and opening voltage-gated calcium channels—calcium influx triggers insulin granule exocytosis. Incretin hormones (GLP-1, GIP) enhance glucose-stimulated insulin secretion, while parasympathetic stimulation also promotes insulin release. Sympathetic stimulation and epinephrine inhibit insulin secretion through alpha-adrenergic receptors.

Glucagon. Alpha cells (20-25% of islets) secrete glucagon, a 29-amino acid peptide that functions as insulin’s metabolic counterregulator. Glucagon is secreted in response to hypoglycemia, protein ingestion, and sympathetic stimulation.

Hepatic effects are glucagon’s primary actions: stimulation of glycogenolysis and gluconeogenesis to increase glucose release from the liver. Glucagon also promotes lipolysis and ketogenesis during fasting. These effects ensure maintenance of blood glucose during periods without food intake.

Somatostatin. Delta cells (5-10% of islets) secrete somatostatin, which inhibits secretion of both insulin and glucagon. Pancreatic somatostatin acts locally within the islet to modulate the secretion of other cell types, providing paracrine regulation of islet function.

PART II: BLOOD PHYSIOLOGY

General Composition of Blood

Blood is a specialized connective tissue with both cellular and fluid components, representing approximately 8% of total body weight (about 5 liters in adult males, slightly less in females). When centrifuged, blood separates into three distinct layers: the plasma (approximately 55% of volume), a thin buffy coat containing white blood cells and platelets (approximately 1%), and red blood cells (approximately 44%).

Plasma Composition

Plasma is the straw-colored, watery fluid that carries blood cells and dissolved substances throughout the circulatory system. Water constitutes approximately 91-92% of plasma by weight, providing the medium in which all other components are dissolved or suspended.

Plasma proteins, synthesized primarily by the liver, constitute 6-8% of plasma volume and include three major categories. Albumin, the most abundant plasma protein (approximately 60% of total), contributes significantly to plasma oncotic pressure and serves as a carrier for fatty acids, bilirubin, and some drugs. Globulins are divided into alpha, beta, and gamma fractions—the alpha and beta globulins transport lipids and fat-soluble vitamins while gamma globulins (antibodies) provide immune protection. Fibrinogen, essential for blood clotting, is converted to fibrin during the coagulation cascade.

Other plasma constituents include electrolytes (sodium, potassium, chloride, bicarbonate, calcium, magnesium, phosphate), nutrients (glucose, amino acids, fatty acids, vitamins), waste products (urea, creatinine, uric acid, bilirubin), gases (oxygen, carbon dioxide, nitrogen), and regulatory substances (hormones, enzymes, cytokines).

Cellular Components

The formed elements of blood include red blood cells (erythrocytes), white blood cells (leukocytes), and platelets (thrombocytes), each with distinct functions and characteristics.

Red Blood Cells. Erythrocytes are biconcave discs without nuclei or organelles, uniquely adapted for their primary function of oxygen transport. The biconcave shape maximizes surface area for gas exchange and allows flexibility through narrow capillaries. The red color comes from hemoglobin, the iron-containing protein that binds oxygen.

White Blood Cells. Leukocytes are nucleated cells involved in immune defense. They are divided into granulocytes (neutrophils, eosinophils, basophils) and agranulocytes (lymphocytes, monocytes) based on cytoplasmic granule appearance. Each type has specific functions in innate and adaptive immunity.

Platelets. Thrombocytes are not true cells but rather cell fragments derived from megakaryocytes. They contain granules filled with clotting factors and vasoactive substances, and play essential roles in hemostasis and thrombosis.

Characteristics of Blood

Physical Properties

Blood is approximately 3-4 times more viscous than water, primarily due to red blood cell content. This viscosity is essential for maintaining blood pressure and ensuring proper flow dynamics. The specific gravity of whole blood ranges from 1.050 to 1.065, while plasma specific gravity is approximately 1.025-1.030. The pH of arterial blood is tightly regulated between 7.35 and 7.45, with the average being 7.40. This narrow range is maintained by multiple buffer systems, including bicarbonate, phosphate, and protein buffers, as well as respiratory and renal compensation mechanisms.

Osmolarity of blood is approximately 280-300 mOsm/L, determined primarily by sodium, chloride, and bicarbonate concentrations. This isotonic state prevents osmotic damage to blood cells and maintains proper fluid balance between blood and tissues.

Hematological Indices

Several parameters characterize blood composition and red blood cell properties. Hematocrit (Hct) represents the percentage of blood volume occupied by red blood cells—normal values are approximately 40-52% in males and 37-48% in females. Hemoglobin concentration (Hb) averages 14-18 g/dL in males and 12-16 g/dL in females.

Red blood cell indices provide information about cell size and hemoglobin content. Mean corpuscular volume (MCV) averages 80-100 fL, distinguishing microcytic (small), normocytic (normal), and macrocytic (large) red cells. Mean corpuscular hemoglobin (MCH) averages 27-31 pg per cell, while mean corpuscular hemoglobin concentration (MCHC) averages 32-36 g/dL.

The erythrocyte sedimentation rate (ESR) measures how quickly red cells settle in a vertical tube, with normal values being less than 20 mm/hr in males and less than 30 mm/hr in females. Elevated ESR indicates inflammation or plasma protein abnormalities.

Functions of Blood

Transport Function

Blood serves as the body’s transport system, carrying gases, nutrients, waste products, hormones, and heat throughout the circulatory network.

Oxygen transport from the lungs to tissues and carbon dioxide transport from tissues to lungs represent blood’s most critical transport function. Approximately 98.5% of oxygen is carried bound to hemoglobin in red blood cells, with the remainder dissolved in plasma. Oxygen binding to hemoglobin is cooperative—each of the four heme groups increases the affinity of the remaining sites for oxygen, creating the characteristic sigmoid oxygen-hemoglobin dissociation curve. This cooperative binding allows efficient loading in the lungs (where oxygen partial pressure is high) and unloading in tissues (where partial pressure is lower).

Carbon dioxide is transported in three forms: dissolved (7-10%), bound to hemoglobin as carbaminohemoglobin (20-30%), and as bicarbonate ion in plasma (60-70%). The bicarbonate system is particularly important because the reaction between CO2 and water, catalyzed by carbonic anhydrase in red cells, allows large amounts of CO2 to be carried as bicarbonate: CO2 + H2O → H2CO3 → H+ + HCO3-.

Nutrient transport includes glucose, amino acids, fatty acids, and vitamins absorbed from the digestive tract or released from storage sites. Glucose circulates in free solution and enters cells via specific transporters. Fatty acids are primarily bound to albumin, while triglycerides are carried in lipoprotein particles. Amino acids are transported freely in plasma.

Waste products of cellular metabolism, including urea, uric acid, creatinine, and bilirubin, are carried in plasma to organs of excretion (kidneys, liver, intestines).

Hormones secreted by endocrine glands are transported in plasma to their target organs, enabling communication between distant tissues. Heat generated by metabolically active tissues is distributed by blood flow, helping maintain thermal homeostasis.

Protection and Defense Functions

Blood provides multiple layers of protection against pathogens, blood loss, and tissue damage.

Immune Function. White blood cells and plasma proteins work together to defend against infection. Neutrophils are the first responders to microbial invasion, migrating to sites of infection through chemotaxis and engulfing pathogens (phagocytosis). Eosinophils target parasites and modulate allergic responses. Basophils and mast cells release histamine and other mediators involved in allergic reactions and inflammation.

Lymphocytes provide adaptive immunity—B lymphocytes differentiate into plasma cells that produce antibodies, while T lymphocytes mediate cellular immunity including direct killing of infected cells and coordination of immune responses. Monocytes migrate into tissues and differentiate into macrophages, which phagocytose pathogens and debris while also presenting antigens to T lymphocytes.

Plasma proteins including complement, immunoglobulins, and acute phase proteins provide humoral immune defense. The complement system can directly lyse pathogens, opsonize them for phagocytosis, or generate inflammatory signals.

Hemostatic Function. When blood vessels are damaged, hemostasis prevents blood loss through a coordinated series of events. Vascular spasm (vasoconstriction) at the injury site reduces blood flow immediately. Platelet adhesion to exposed collagen via von Willebrand factor, activation, and aggregation form a temporary platelet plug. The coagulation cascade, involving multiple clotting factors, results in fibrin formation that stabilizes the platelet plug.

Coagulation factors circulate as inactive zymogens that are sequentially activated in two pathways—intrinsic (contact activation) and extrinsic (tissue factor) pathways—that converge on the common pathway leading to thrombin generation. Thrombin converts fibrinogen to fibrin and also activates platelets and factor XIII, which cross-links fibrin strands. The fibrinolytic system, including plasmin, dissolves clots after healing is complete.

Regulatory Functions

Blood plays essential roles in maintaining internal homeostasis and regulating physiological processes.

Fluid and Electrolyte Balance. Blood volume and composition are tightly regulated to ensure proper tissue perfusion and cellular function. The kidneys adjust urine volume and composition based on blood pressure, osmolarity, and electrolyte levels. Antidiuretic hormone, aldosterone, atrial natriuretic peptide, and other hormones coordinate these adjustments.

Acid-Base Balance. The blood buffer systems, particularly the bicarbonate system, minimize pH changes when acids or bases are added. The respiratory system contributes by adjusting CO2 elimination (and thus carbonic acid levels) in response to pH changes. The renal system provides longer-term regulation by adjusting bicarbonate reabsorption and hydrogen ion secretion.

Temperature Regulation. Blood flow to the skin determines heat dissipation—vasodilation allows heat loss while vasoconstriction conserves heat. By redistributing blood flow and carrying heat from metabolically active tissues, blood helps maintain core temperature within narrow limits.

Nutrient Distribution. After meals, blood carries absorbed nutrients from the digestive system to storage sites (liver, adipose tissue, muscle) and working tissues. During fasting, blood delivers glucose, fatty acids, and ketone bodies from storage sites to tissues that require them.

Comprehensive Study Notes: Advanced Physiology Systems

PART I: HEMOGLOBIN AND BLOOD COAGULATION

Hemoglobin: Chemistry, Properties, and Functions

Chemical Structure of Hemoglobin

Hemoglobin (Hb) is a globular protein specialized for oxygen transport, consisting of four polypeptide chains (two alpha and two beta chains in adults) each非covalently bound to a heme prosthetic group. Each globin chain contains approximately 140-150 amino acids, giving the complete molecule a molecular weight of approximately 64,500 Daltons. The quaternary structure creates a tetramer with remarkable functional properties that distinguish it from myoglobin, the monomeric oxygen-binding protein of muscle.

The heme group is a porphyrin ring system consisting of four pyrrole rings connected by methene bridges, with an iron atom at its center. This iron is in the ferrous state (Fe²⁺), which is essential for oxygen binding—oxidation to ferric iron (Fe³⁺) produces methemoglobin, which cannot bind oxygen. The porphyrin ring structure is synthesized from glycine and succinyl-CoA through a series of eight enzymatic steps, with delta-aminolevulinic acid (ALA) synthase catalyzing the rate-limiting step.

Each of the four heme groups can bind one oxygen molecule, giving hemoglobin a theoretical capacity of 1.34 mL of oxygen per gram of hemoglobin. The iron atom forms coordination bonds with four nitrogen atoms of the porphyrin ring and with a histidine residue (the proximal histidine) from the globin chain. When oxygen binds, it approaches the iron atom at an angle, with a second histidine residue (the distal histidine) forming a hydrogen bond with the bound oxygen.

Properties of Hemoglobin

Allosteric Behavior and Cooperative Binding. Hemoglobin exhibits classic allosteric behavior, meaning its affinity for oxygen changes depending on whether oxygen is already bound. This cooperative binding creates a sigmoid (S-shaped) oxygen-hemoglobin dissociation curve, fundamentally different from the hyperbolic curve of myoglobin. In the T (tense) state, deoxyhemoglobin has relatively low oxygen affinity. Oxygen binding to one subunit induces conformational changes that are transmitted through the interface between subunits, converting the molecule to the R (relaxed) state with higher oxygen affinity. This cooperativity allows efficient oxygen loading in the lungs (where oxygen partial pressure is high) and efficient unloading in tissues (where partial pressure is lower).

Bohr Effect. The affinity of hemoglobin for oxygen is inversely related to pH and directly related to CO₂ concentration. Lower pH (higher H⁺ concentration) and higher CO₂ decrease oxygen affinity, shifting the dissociation curve to the right. This phenomenon, described by Christian Bohr in 1904, facilitates oxygen unloading in metabolically active tissues that produce CO₂ and H⁺. Conversely, in the lungs where CO₂ is being eliminated, the higher pH increases hemoglobin’s oxygen affinity, promoting loading.

2,3-Bisphosphoglycerate (2,3-BPG) Regulation. 2,3-BPG, present in red blood cells in concentrations similar to hemoglobin, binds to deoxyhemoglobin in the central cavity formed by the four subunits. This binding stabilizes the T state, decreasing oxygen affinity. Increased 2,3-BPG levels (as in high altitude adaptation, chronic hypoxia, or anemia) shift the curve rightward, enhancing tissue oxygen delivery. Storage of blood in citrate-phosphate-dextrose solutions depletes 2,3-BPG, reducing the oxygen-carrying capacity of stored blood—rejuvenation solutions can restore 2,3-BPG levels.

Carbamino Formation. Hemoglobin can bind CO₂ directly to amino groups, forming carbaminohemoglobin. This reaction accounts for approximately 20-30% of CO₂ transport and also contributes to the Bohr effect, as carbamino formation stabilizes the T state and reduces oxygen affinity.

Hemoglobin Synthesis

Hemoglobin synthesis occurs primarily in developing erythroblasts in the bone marrow, with smaller amounts produced in the liver during fetal development. The process involves coordinated production of globin chains and heme groups, with the rate-limiting step being heme synthesis.

Globin Chain Synthesis. Each globin gene cluster contains multiple genes and pseudogenes. The alpha gene cluster on chromosome 16 includes zeta and alpha genes, while the beta gene cluster on chromosome 11 includes epsilon, gamma, delta, and beta genes. During development, different globin genes are expressed at different stages—embryonic hemoglobin (zeta₂epsilon₂) is replaced by fetal hemoglobin (alpha₂gamma₂) and finally by adult hemoglobin (alpha₂beta₂ or alpha₂delta₂ in Hb A₂).

Globin mRNA is transcribed in the nucleus, processed (capped, polyadenylated, spliced), and exported to the cytoplasm where it associates with ribosomes for translation. The nascent polypeptide chain folds with the assistance of molecular chaperones, and heme incorporation occurs co-translationally.

Heme Synthesis. Heme synthesis begins in mitochondria and involves both mitochondria and cytosol. The first and last steps occur in mitochondria, while intermediate steps occur in the cytosol. ALA synthase, located on the outer mitochondrial membrane, condenses glycine and succinyl-CoA to form delta-aminolevulinic acid (ALA). This enzyme is regulated by heme through feedback inhibition and by iron availability through iron-responsive elements (IREs) in its mRNA.

Eight enzymatic steps produce protoporphyrin IX, which combines with ferrous iron (Fe²⁺) to form heme. Iron is delivered to mitochondria by transferrin, internalized by receptor-mediated endocytosis, reduced from Fe³⁺ to Fe²⁺ by ferrireductases, and transported across the inner mitochondrial membrane by mitoferrin.

Regulation of Hemoglobin Synthesis. Hemoglobin production is coordinated with cell division and differentiation during erythropoiesis. Transcription factors GATA-1, EKLF, and others activate globin gene expression in developing erythroid cells. Iron availability, erythropoietin signaling, and heme concentration all influence the rate of hemoglobin synthesis. Deficiencies in any component—iron, globin chains, or enzymatic cofactors—can produce anemia.

Hemoglobin Degradation and Turnover

Red blood cells have a lifespan of approximately 120 days in the circulation. As they age, they become less deformable and are removed by macrophages, primarily in the spleen, liver, and bone marrow. The degradation of hemoglobin involves careful handling of both the globin protein and the heme prosthetic group.

Globin Degradation. Globin chains are proteolytically degraded by proteasomes and lysosomal proteases. The constituent amino acids are recycled for use in new protein synthesis or catabolized for energy.

Heme Degradation. Heme degradation occurs primarily in macrophages of the reticuloendothelial system through the heme oxygenase system. Heme oxygenase (HO) cleaves the porphyrin ring at the alpha-methene bridge, releasing iron, carbon monoxide, and biliverdin. This reaction requires oxygen and NADPH as cofactors. The released iron is either stored in ferritin or recycled for new heme synthesis.

Biliverdin, a green pigment, is rapidly reduced to bilirubin by biliverdin reductase. Bilirubin is lipophilic and must be transported to the liver bound to albumin. In the liver, bilirubin is conjugated with glucuronic acid by UDP-glucuronosyltransferase (UGT1A1), making it water-soluble for excretion in bile. Further bacterial modification in the intestine produces urobilinogen and stercobilin, which give feces its characteristic brown color.

Clinical Relevance. Excessive heme breakdown produces jaundice (yellowing of skin and sclera) when bilirubin accumulates in blood. Hemolytic anemias, where red cells are destroyed prematurely, can overwhelm the liver’s conjugating capacity, producing unconjugated hyperbilirubinemia. Gilbert’s syndrome and Crigler-Najjar syndrome involve deficiencies in bilirubin conjugation, while Dubin-Johnson and Rotor syndromes involve defects in bilirubin excretion.

Functions of Hemoglobin

Oxygen Transport. Hemoglobin’s primary function is oxygen transport from the lungs to metabolically active tissues. The oxygen-carrying capacity of blood (approximately 20 mL O₂/dL) vastly exceeds what could be dissolved in plasma (approximately 0.3 mL O₂/dL). This capacity allows adequate oxygen delivery even during increased metabolic demands.

CO₂ Transport. Hemoglobin contributes to CO₂ transport in three ways: dissolved CO₂ (7-10%), carbaminohemoglobin (20-30%), and as bicarbonate (60-70%). The Haldane effect describes how deoxygenated hemoglobin has higher affinity for CO₂ than oxygenated hemoglobin, facilitating CO₂ uptake in tissues and release in lungs.

Buffering. Hemoglobin is a major blood buffer, accounting for approximately 35% of the blood’s buffering capacity. The imidazole groups of histidine residues accept and donate protons, helping maintain pH homeostasis. Deoxygenated hemoglobin is a better buffer than oxygenated hemoglobin, which helps unload H⁺ in tissues where oxygen is being released.

Hemoglobin Derivatives

Various modifications of hemoglobin produce derivatives with distinct properties and clinical significance.

Methemoglobin. When the ferrous iron (Fe²⁺) of heme is oxidized to ferric iron (Fe³⁺), methemoglobin is formed, which cannot bind oxygen. Small amounts of methemoglobin are normally present (less than 1%), but excessive levels cause cyanosis and functional anemia. Methemoglobinemia can result from certain drugs (dapsone, benzocaine), chemicals (nitrites), or congenital deficiencies in cytochrome b5 reductase.

Carboxyhemoglobin. Carbon monoxide binds to hemoglobin with approximately 240 times the affinity of oxygen, forming carboxyhemoglobin. This stable complex reduces oxygen-carrying capacity and also shifts the dissociation curve leftward, impairing oxygen unloading. Carbon monoxide poisoning produces headache, confusion, and potentially death; treatment involves administration of 100% oxygen or hyperbaric oxygen to accelerate CO elimination.

Sulfhemoglobin. Sulfur-containing compounds can oxidize hemoglobin to sulfhemoglobin, a green pigment that cannot carry oxygen. Sulfhemoglobinemia is irreversible—affected red cells must be removed from circulation.

Fetal Hemoglobin (HbF). Hemoglobin F (alpha₂gamma₂) has higher oxygen affinity than adult hemoglobin due to reduced 2,3-BPG binding. This property facilitates oxygen transfer from maternal to fetal circulation across the placenta. HbF predominates during fetal life and early infancy, with gamma-to-beta globin switching occurring postnatally.

Hemoglobinopathies. Genetic abnormalities of hemoglobin include thalassemias (reduced or absent globin chain synthesis) and structural variants (sickle cell hemoglobin, hemoglobin C, etc.). Sickle cell hemoglobin (HbS) has a valine substitution in the beta chain, causing polymerization and red cell sickling under low oxygen conditions.

Blood Coagulation and Clotting Factors

Overview of Hemostasis

Hemostasis—the arrest of bleeding—involves a carefully orchestrated series of events that prevent blood loss while maintaining blood fluidity under normal conditions. The process involves vascular spasm, platelet plug formation, and coagulation (fibrin clot formation). While these components are often described sequentially, they actually overlap and interact extensively.

Vascular Spasm

Immediately following vascular injury, smooth muscle in the vessel wall contracts, producing vasoconstriction that reduces blood flow to the damaged area. This vascular spasm is mediated by endothelin-1 (released from damaged endothelial cells), thromboxane A₂ (from activated platelets), and sympathetic nervous system reflexes. The response is immediate but temporary, lasting from minutes to hours depending on injury severity.

Platelet Plug Formation

Platelets play central roles in hemostasis through adhesion, activation, and aggregation at sites of vascular injury.

Platelet Adhesion. When the endothelium is disrupted, subendothelial collagen and von Willebrand factor (vWF) become exposed to flowing blood. Platelet surface glycoprotein Ib (GPIb) binds to vWF, which is itself bound to collagen. This interaction tethers platelets to the injury site, despite the shear forces of flowing blood. The importance of this pathway is illustrated by Bernard-Soulier syndrome, a rare bleeding disorder caused by GPIb deficiency.

Platelet Activation. Adhesion triggers platelet activation through multiple signaling pathways. Collagen binding to GPVI and integrin alpha₂beta₁ activates phospholipase C, producing inositol trisphosphate (IP₃) and diacylglycerol (DAG). IP₃ releases calcium from the dense tubular system, while DAG activates protein kinase C. These second messengers produce shape change (from smooth discs to spiny spheres with extended pseudopods), degranulation (release of ADP, serotonin, calcium, and other mediators), and thromboxane A₂ synthesis.

Activated platelets also expose negatively charged phosphatidylserine on their outer membrane, providing a surface for coagulation factor assembly.

Platelet Aggregation. Platelet aggregation is primarily mediated by fibrinogen binding to integrin alphaIIbbeta3 (GPIIb/IIIa) on adjacent platelets. Fibrinogen serves as a molecular bridge between platelets. ADP, thromboxane A₂, and thrombin all potentiate aggregation through positive feedback loops. Aspirin inhibits platelet cyclooxygenase, reducing thromboxane A₂ synthesis and inhibiting aggregation—this antiplatelet effect persists for the platelet’s lifespan (7-10 days) because platelets cannot synthesize new protein.

Coagulation Cascade

The coagulation system involves a series of proteolytic reactions in which each clotting factor activates the next, culminating in fibrin formation. The cascade is organized into intrinsic, extrinsic, and common pathways, though this classification is somewhat artificial as the pathways interact extensively.

The Intrinsic Pathway. This pathway is initiated by exposure of blood to negatively charged surfaces (such as collagen in damaged vessels). Factor XII binds to the surface, undergoes conformational change (activation), and activates factor XI. Factor XIa then activates factor IX. Factor IX, with its cofactor factor VIIIa, activates factor X. This pathway is measured by the activated partial thromboplastin time (aPTT).

The Extrinsic Pathway. This pathway is initiated by tissue factor (TF), a membrane protein exposed when tissues are damaged. TF binds to factor VII, activating it. The TF-VIIa complex activates factor X (and factor IX). This pathway is measured by the prothrombin time (PT).

The Common Pathway. Both pathways converge here. Factor Xa, with its cofactor factor Va, converts prothrombin (factor II) to thrombin (factor IIa). Thrombin then converts fibrinogen (factor I) to fibrin (factor Ia). Factor XIIIa, activated by thrombin, cross-links fibrin strands, stabilizing the clot. Thrombin also activates factors V, VIII, XI, and XIII, providing positive feedback, and activates platelets.

Coagulation Factors. Thirteen factors are numbered, though factors III and VI are no longer used (tissue factor is III, and activated V is sometimes called VI).

Factor Name Pathway Function
I Fibrinogen Common Converted to fibrin
II Prothrombin Common Precursor of thrombin
III Tissue Factor Extrinsic Cofactor for VIIa
IV Calcium All Required for factor complexes
V Proaccelerin Common Cofactor for Xa
VII Proconvertin Extrinsic Activates X and IX
VIII Antihemophilic A Intrinsic Cofactor for IXa
IX Christmas Factor Intrinsic Activates X
X Stuart-Prower Common Activates prothrombin
XI Plasma Thromboplastin Intrinsic Activates IX
XII Hageman Factor Intrinsic Activates XI
XIII Fibrin-Stabilizing Common Cross-links fibrin

Vitamin K-Dependent Factors. Factors II, VII, IX, and X, as well as proteins C and S, require vitamin K for their synthesis. Vitamin K serves as a cofactor for gamma-carboxylation of glutamic acid residues, which enables these factors to bind calcium and assemble on platelet surfaces. Warfarin, a vitamin K antagonist, inhibits this carboxylation and is used clinically as an anticoagulant.

Clot Retraction and Fibrinolysis

After initial clot formation, clot retraction consolidates the platelet-fibrin mass, pulling wound edges together. Actin and myosin in activated platelets generate contractile forces, mediated by integrin alphaIIbbeta3 and associated proteins. Serum is expressed from the clot, which shrinks to approximately 10% of its original volume.

Fibrinolysis dissolves the clot once healing is complete. Plasminogen, incorporated into clots during formation, is activated to plasmin by tissue plasminogen activator (tPA) and urokinase. Plasmin cleaves fibrin into fibrin degradation products, including D-dimers. The fibrinolytic system is regulated by plasminogen activator inhibitor-1 (PAI-1) and alpha-2-antiplasmin.

Blood Pressure

Determinants of Arterial Blood Pressure

Arterial blood pressure (BP) is determined by cardiac output (CO) and systemic vascular resistance (SVR) according to the equation: BP = CO × SVR. This relationship emphasizes that blood pressure depends on both pump function (heart) and afterload (arterioles).

Cardiac Output. CO equals stroke volume (SV) multiplied by heart rate (HR). Stroke volume is determined by preload (ventricular filling), contractility (force of contraction), and afterload (resistance to ejection). Heart rate is regulated by autonomic innervation (sympathetic and parasympathetic) and circulating catecholamines.

Systemic Vascular Resistance. SVR is primarily determined by arteriolar radius according to Poiseuille’s law—resistance is inversely proportional to the fourth power of radius. Small changes in arteriolar diameter produce large changes in resistance. Vascular tone is regulated by intrinsic myogenic mechanisms, metabolic factors (adenosine, CO₂, H⁺, K⁺), endothelial factors (nitric oxide, endothelin), and autonomic innervation.

Blood Volume. Blood volume affects both preload and arterial pressure through the relationship between venous return and ventricular filling. Chronic blood volume expansion increases BP, while volume depletion decreases it. The kidneys regulate blood volume through sodium and water balance.

Regulation of Blood Pressure

Blood pressure is regulated by short-term (neural), intermediate-term (humoral), and long-term (renal) mechanisms.

Baroreceptor Reflex. Stretch-sensitive baroreceptors in the carotid sinus and aortic arch detect changes in arterial pressure. Increased pressure stretches these receptors, increasing afferent firing via the glossopharyngeal (carotid) and vagus (aortic) nerves. The nucleus tractus solitarius in the medulla integrates this input and increases parasympathetic (vagal) outflow while decreasing sympathetic outflow. The result is decreased heart rate, decreased contractility, vasodilation, and reduced renin release—all reducing blood pressure.

Conversely, decreased pressure reduces baroreceptor firing, increasing sympathetic and decreasing parasympathetic activity. Heart rate and contractility increase, vasoconstriction occurs, and blood is mobilized from venous reservoirs. This reflex provides rapid (seconds) but short-lived (days) regulation.

Chemoreceptor Reflex. Carotid and aortic body chemoreceptors detect changes in arterial PO₂, PCO₂, and pH. Hypoxia, hypercapnia, and acidosis stimulate chemoreceptors, increasing sympathetic outflow and raising blood pressure. This reflex is primarily respiratory but contributes to cardiovascular regulation during severe hypoxia or acidosis.

Renin-Angiotensin-Aldosterone System (RAAS). Decreased renal perfusion pressure (detected by juxtaglomerular cells) or decreased sodium chloride delivery to the macula densa stimulates renin release. Renin converts angiotensinogen to angiotensin I, which is converted to angiotensin II by angiotensin-converting enzyme (ACE). Angiotensin II is a potent vasoconstrictor and stimulates aldosterone secretion from the adrenal cortex. Aldosterone increases sodium reabsorption in the distal nephron, expanding blood volume and increasing blood pressure.

Antidiuretic Hormone (ADH, Vasopressin). ADH is released from the posterior pituitary in response to increased plasma osmolality (detected by hypothalamic osmoreceptors) or decreased blood pressure/volume (detected by baroreceptors). ADH acts on V2 receptors in the renal collecting duct to promote water reabsorption. At higher concentrations, ADH causes vasoconstriction through V1 receptors.

Atrial Natriuretic Peptide (ANP). Stretch of atrial myocytes (due to increased blood volume) stimulates ANP secretion. ANP promotes sodium and water excretion by the kidneys, causes vasodilation, and inhibits renin and aldosterone release. These effects reduce blood volume and pressure.

Blood Groups

ABO Blood Group System

The ABO system, discovered by Karl Landsteiner in 1900, is the most clinically important blood group system for transfusion medicine. It is based on antigens (agglutinogens) on red blood cell membranes and corresponding antibodies (agglutinins) in plasma.

ABO Antigens. The ABO antigens are oligosaccharide chains attached to membrane lipids and proteins. The H antigen is the precursor, present on all red cells. The ABO gene (located on chromosome 9) encodes glycosyltransferases that add specific sugars to the H antigen:

  • Type A: N-acetylgalactosamine added to H antigen
  • Type B: Galactose added to H antigen
  • Type AB: Both transferases present, both antigens expressed
  • Type O: No functional transferase, only H antigen present

These antigens are not limited to red cells—they are expressed on many tissues including endothelium, epithelium, and in body fluids (especially in secretors).

ABO Antibodies. Anti-A and anti-B antibodies are naturally occurring IgM antibodies that develop within the first year of life, probably in response to similar antigens on intestinal bacteria. They are clinically significant because they can cause immediate intravascular hemolysis if incompatible blood is transfused:

  • Type A blood has anti-B antibodies
  • Type B blood has anti-A antibodies
  • Type AB blood has neither antibody (universal recipient)
  • Type O blood has both anti-A and anti-B antibodies (universal donor of red cells)

Rh Blood Group System

The Rh system (Rhesus) is the second most important blood group system, with D being the most immunogenic antigen. Approximately 85% of Caucasians are Rh-positive (have D antigen), while 15% are Rh-negative (lack D antigen).

Unlike ABO antibodies, Rh antibodies are IgG and do not develop naturally—they result from sensitization through transfusion or pregnancy. Rh-negative individuals who receive Rh-positive blood or bear Rh-positive fetuses can develop anti-D antibodies. Subsequent exposure can cause severe hemolytic transfusion reaction or hemolytic disease of the newborn (HDN).

Other Blood Group Systems

Over 30 blood group systems have been identified, containing hundreds of antigens. Clinically significant systems include:

Kell System. The K antigen (Kell) is highly immunogenic. Anti-K antibodies can cause severe hemolytic disease of the newborn and transfusion reactions.

Duffy System. Duffy antigens (Fyᵃ and Fyᵇ) serve as receptors for Plasmodium vivax invasion of red cells. Individuals lacking Duffy antigens (FyFy) are resistant to P. vivax malaria.

Kidd System. Anti-Jkᵃ and anti-Jkᵇ antibodies can cause delayed hemolytic transfusion reactions due to their ability to fix complement.

MNS System. M and N antigens (glycophorin A) and S and s antigens (glycophorin B) can cause transfusion reactions and HDN, though less commonly than other systems.

Clinical Significance

Transfusion Reactions. Mismatched transfusion can cause hemolytic reactions. Immediate reactions result from preformed antibodies (typically ABO) causing complement-mediated intravascular hemolysis. Delayed reactions involve anamnestic antibody responses 3-14 days post-transfusion, causing extravascular hemolysis.

Hemolytic Disease of the Newborn. Maternal antibodies cross the placenta and destroy fetal red cells. Rh incompatibility is prevented by administering anti-D immunoglobulin to Rh-negative mothers at 28 weeks gestation and within 72 hours of delivery. ABO incompatibility can cause mild HDN but rarely severe disease.

Blood Buffers

Buffer Systems of Blood

Buffer systems minimize pH changes by absorbing added H⁺ or OH⁻. The major buffer systems of blood include the bicarbonate buffer system, phosphate buffer system, protein buffer system, and hemoglobin buffer system.

Bicarbonate Buffer System. This is the primary extracellular buffer, operating according to the Henderson-Hasselbalch equation:

pH = pKa + log([HCO₃⁻] / [CO₂] × 0.03)

where [CO₂] × 0.03 represents dissolved CO₂. The normal ratio of [HCO₃⁻] (24 mEq/L) to dissolved CO₂ (1.2 mEq/L) is 20:1, giving a pH of 7.40. When acid is added, H⁺ combines with HCO₃⁻ to form H₂CO₃, which dissociates to CO₂ and H₂O—the CO₂ is exhaled by the lungs.

Phosphate Buffer System. This system, consisting of HPO₄²⁻/H₂PO₄⁻, is more important intracellularly and in renal tubules than in plasma. Its pKa of 6.8 is close to intracellular pH, making it an effective intracellular buffer.

Protein Buffer System. Plasma proteins, particularly albumin, buffer through their carboxyl and amino groups. The imidazole groups of histidine residues are particularly important. Plasma proteins contribute to buffering through their net charge at physiological pH.

Hemoglobin Buffer System. Hemoglobin is the most important intracellular buffer in red blood cells. Deoxyhemoglobin is a better buffer than oxyhemoglobin because the T-state proteins have higher affinity for H⁺. This property facilitates CO₂ transport—as blood enters tissues, oxygen unloading is accompanied by H⁺ binding to deoxyhemoglobin, which also promotes CO₂ conversion to bicarbonate.

Buffering Mechanisms

When acid (H⁺) is added to blood, buffering occurs in sequence: bicarbonate buffers first (because of its high concentration), followed by intracellular buffers (hemoglobin, proteins, phosphates). When base is added, the same sequence operates in reverse. The lungs and kidneys provide longer-term regulation by adjusting CO₂ elimination and bicarbonate reabsorption, respectively.

PART II: RESPIRATION AND ACID-BASE BALANCE

Respiratory System: Structure and Functions

Anatomy of the Respiratory System

The respiratory system is divided into the conducting zone (airways) and respiratory zone (gas exchange surfaces).

Conducting Zone. Air enters through the nostrils or mouth, passing through the nasal cavity where it is warmed, humidified, and filtered. The pharynx serves as a common passage for air and food. The larynx contains the vocal cords and protects the airway during swallowing. The trachea, reinforced by C-shaped cartilage rings, bifurcates into main bronchi, which enter the lungs and branch progressively into lobar, segmental, and subsegmental bronchi. Bronchioles lack cartilage and are surrounded by smooth muscle. Terminal bronchioles represent the end of the conducting zone.

Respiratory Zone. Respiratory bronchioles contain scattered alveoli in their walls. Alveolar ducts are entirely lined with alveoli, leading to alveolar sacs—clusters of alveoli that constitute the primary gas exchange units.

Alveolar Structure. The alveolus is a thin-walled sac optimized for diffusion. The alveolar epithelium consists primarily of type I pneumocytes (squamous cells covering 95% of the alveolar surface) and type II pneumocytes (cuboidal cells that produce surfactant and can proliferate to replace type I cells). The alveolar-capillary membrane consists of the alveolar epithelium, fused basement membranes, and capillary endothelium—total thickness is only 0.5 μm in humans, allowing rapid gas diffusion.

Pulmonary Circulation. Deoxygenated blood from the right ventricle enters the pulmonary arteries, which branch into lobar, segmental, and subsegmental arteries, ultimately forming the pulmonary capillary network surrounding each alveolus. Oxygenated blood returns via pulmonary veins to the left atrium. The pulmonary circulation is a low-pressure, high-flow system—the entire cardiac output passes through it with each heartbeat.

Mechanics of Breathing

Inspiration. The diaphragm contracts, flattening and increasing the vertical dimension of the thoracic cavity. External intercostal muscles elevate the ribs, increasing anteroposterior and lateral dimensions. These movements increase thoracic volume, decreasing intrapleural pressure, which in turn decreases alveolar pressure below atmospheric pressure, causing air to flow into the lungs.

Expiration. During quiet breathing, expiration is passive—the diaphragm and intercostal muscles relax, elastic recoil of the lungs and chest wall decreases thoracic volume, alveolar pressure exceeds atmospheric pressure, and air flows out. Forced expiration involves contraction of internal intercostal and abdominal muscles, increasing intrathoracic pressure and actively expelling air.

Lung Volumes and Capacities. Tidal volume (TV) is the volume inhaled or exhaled normally (approximately 500 mL). Inspiratory reserve volume (IRV) is the additional volume that can be inhaled (approximately 3000 mL). Expiratory reserve volume (ERV) is the additional volume that can be exhaled (approximately 1100 mL). Residual volume (RV) remains in the lungs after maximal exhalation (approximately 1200 mL). Functional residual capacity (FRC) is the volume remaining after normal expiration (ERV + RV). Vital capacity (VC) is the maximum volume that can be exhaled after maximal inspiration (TV + IRV + ERV). Total lung capacity (TLC) is the total volume of air in lungs after maximal inspiration (VC + RV).

Pulmonary Gas Exchange

Diffusion of Gases. Gas exchange occurs by passive diffusion down partial pressure gradients. Fick’s law states that the rate of diffusion is proportional to the diffusion coefficient, surface area, and partial pressure gradient, and inversely proportional to membrane thickness. The alveolar-capillary membrane provides an enormous surface area (approximately 70 m²) and minimal thickness, maximizing diffusion capacity.

Oxygen Diffusion. Alveolar PO₂ is approximately 100 mmHg, while mixed venous PO₂ is approximately 40 mmHg, creating a gradient of 60 mmHg for oxygen diffusion. Oxygen dissolves in plasma and diffuses into red cells, where it binds to hemoglobin. The diffusion process is complete in approximately 0.25 seconds, while red blood cells spend approximately 0.75 seconds in pulmonary capillaries—ample time for equilibration even during exercise.

CO₂ Diffusion. The gradient for CO₂ is much smaller—alveolar PCO₂ is approximately 40 mmHg, mixed venous PCO₂ is approximately 46 mmHg, creating a 6 mmHg gradient. However, CO₂ is approximately 20 times more soluble than oxygen, so diffusion is equally efficient. CO₂ diffuses from blood into alveoli and is exhaled.

Ventilation-Perfusion Matching. For optimal gas exchange, ventilation (V) and perfusion (Q) must be matched throughout the lungs. The normal V/Q ratio is approximately 0.8. Areas with low V/Q (poor ventilation relative to perfusion) produce hypoxemia, while areas with high V/Q (poor perfusion relative to ventilation) increase physiologic dead space. Mechanisms that match V and Q include hypoxic pulmonary vasoconstriction (constriction in poorly ventilated areas diverts blood to better-ventilated regions) and gravitational effects on perfusion.

Control of Respiration

Respiratory Centers. The medullary respiratory center includes the dorsal respiratory group (primarily inspiration) and ventral respiratory group (both inspiration and expiration). The pneumotaxic center in the pons modulates respiratory rate and pattern. The pre-Bötzinger complex in the medulla generates the basic respiratory rhythm.

Chemical Control. Central chemoreceptors in the medulla respond to changes in CSF pH, which reflects arterial PCO₂. CO₂ readily crosses the blood-brain barrier; once in CSF, it combines with water to form carbonic acid, dissociating into H⁺ and HCO₃⁻. Increased PCO₂ produces acidosis, stimulating ventilation. Peripheral chemoreceptors (carotid and aortic bodies) respond to decreased PO₂ (below 60 mmHg), increased PCO₂, and decreased pH. These provide rapid responses to hypoxemia and also detect changes in arterial oxygen content (not just partial pressure).

Neural and Humoral Influences. Higher brain centers can modify breathing (voluntary control, emotional influences). Pulmonary stretch receptors (Hering-Breuer reflex) terminate inspiration when lungs are inflated. Irritant receptors respond to foreign particles and chemicals, triggering coughing and bronchoconstriction. Joint and muscle receptors contribute to the ventilatory response during exercise.

Oxygen and Carbon Dioxide Transport

Oxygen Transport

Dissolved Oxygen. Only approximately 1.5% of blood oxygen is physically dissolved in plasma, following Henry’s law (amount dissolved is proportional to partial pressure). This dissolved fraction is important because it determines the partial pressure gradient for diffusion into tissues.

Oxygen Bound to Hemoglobin. Approximately 98.5% of blood oxygen is bound to hemoglobin. Each hemoglobin molecule can bind four oxygen molecules, giving a maximum capacity of 1.34 mL O₂/g Hb. The actual content depends on hemoglobin concentration and oxygen saturation (the percentage of heme groups bound to oxygen).

Oxygen-Hemoglobin Dissociation Curve. This curve plots PO₂ (x-axis) against oxygen saturation (y-axis). The sigmoid shape reflects cooperative binding—oxygen binding to one heme increases affinity for subsequent binding. The P₅₀ (PO₂ at 50% saturation) is approximately 27 mmHg. Factors that shift the curve rightward (decreased affinity, enhanced unloading) include increased PCO₂, decreased pH (Bohr effect), increased temperature, increased 2,3-BPG, and presence of abnormal hemoglobins. Left-shifted curves (increased affinity, impaired unloading) occur with decreased PCO₂, increased pH, decreased temperature, decreased 2,3-BPG, and fetal hemoglobin.

Oxygen Delivery and Consumption. Arterial oxygen content (CaO₂) is calculated as (1.34 × Hb × SaO₂) + (0.003 × PaO₂). Venous oxygen content (CvO₂) is similarly calculated. Oxygen delivery (DO₂) is CaO₂ × cardiac output. Oxygen consumption (VO₂) is (CaO₂ – CvO₂) × cardiac output. The oxygen extraction ratio (VO₂/DO₂) is normally approximately 25%. During exercise or hypoxia, extraction can increase substantially.

Carbon Dioxide Transport

Dissolved CO₂. Approximately 7-10% of CO₂ is transported dissolved in plasma. The solubility of CO₂ is approximately 20 times that of oxygen, making this fraction significant despite the small partial pressure gradient.

Carbaminohemoglobin. Approximately 20-30% of CO₂ binds to terminal amino groups of hemoglobin, forming carbaminohemoglobin. Deoxygenated hemoglobin binds CO₂ more readily (Haldane effect), facilitating CO₂ uptake in tissues and release in lungs.

Bicarbonate Ion. Approximately 60-70% of CO₂ is transported as bicarbonate. CO₂ diffuses into red cells, where carbonic anhydrase catalyzes its hydration to carbonic acid (H₂CO₃), which dissociates into H⁺ and HCO₃⁻. Bicarbonate exits the red cell in exchange for chloride (the chloride shift), while H⁺ is buffered by hemoglobin. In the lungs, these reactions reverse—bicarbonate enters the cell, combines with H⁺ to form carbonic acid, which is converted to CO₂ that diffuses into alveoli.

Acid-Base Balance

pH and Hydrogen Ion Regulation

Arterial pH is tightly regulated between 7.35 and 7.45, with the average being 7.40. Deviations beyond this range—acidosis (pH < 7.35) and alkalosis (pH > 7.45)—can be life-threatening. Hydrogen ion concentration ([H⁺]) is approximately 40 nEq/L at pH 7.40.

Buffer Systems

Bicarbonate Buffer System. As described earlier, this primary extracellular buffer operates according to:

CO₂ + H₂O ↔ H₂CO₃ ↔ H⁺ + HCO₃⁻

The ratio of [HCO₃⁻] to dissolved CO₂ determines pH. Normal values are [HCO₃⁻] = 24 mEq/L, PCO₂ = 40 mmHg (dissolved CO₂ = 1.2 mEq/L).

Hemoglobin Buffer System. Deoxyhemoglobin is a stronger base than oxyhemoglobin and buffers H⁺ produced by carbonic acid formation. This buffering is essential for CO₂ transport—approximately 38% of CO₂ is buffered by hemoglobin.

Phosphate Buffer System. This system is important intracellularly and in renal tubules: H₂PO₄⁻ ↔ H⁺ + HPO₄²⁻ (pKa = 6.8).

Protein Buffer System. Plasma proteins and intracellular proteins buffer H⁺ through their carboxyl and amino groups. Albumin is the major plasma protein buffer.

Respiratory Regulation of pH

The respiratory system regulates pH by adjusting CO₂ elimination. Hyperventilation decreases PCO₂, shifting the bicarbonate buffer equation to the left and raising pH (respiratory alkalosis). Hypoventilation increases PCO₂, shifting the equation to the right and lowering pH (respiratory acidosis). Respiratory compensation for metabolic disorders occurs within minutes to hours.

Renal Regulation of pH

The kidneys provide slower but more powerful pH regulation by adjusting bicarbonate reabsorption and H⁺ secretion.

Bicarbonate Reabsorption. Filtered bicarbonate (approximately 4320 mEq/day) is almost completely reabsorbed. In proximal tubular cells, H⁺ is secreted in exchange for Na⁺. H⁺ combines with filtered HCO₃⁻ to form H₂CO₃, which is converted to CO₂ and H₂O by carbonic anhydrase. CO₂ diffuses into the cell, recombines with H₂O to form HCO₃⁻, which enters the blood.

New Bicarbonate Generation. In addition to reabsorbing filtered bicarbonate, the kidneys can generate new bicarbonate by secreting H⁺. In the collecting duct, intercalated cells secrete H⁺ via H⁺-ATPase pumps. H⁺ combines with urinary buffers (primarily NH₃ and HPO₄²⁻) and is excreted. For each H⁺ excreted, a new HCO₃⁻ is added to the blood.

Ammoniagenesis. Glutamine metabolism in proximal tubular cells produces NH₄⁺ and new HCO₃⁻. NH₄⁺ is excreted in urine, while HCO₃⁻ enters the blood. This pathway is upregulated during chronic acidosis, substantially increasing the kidneys’ acid-excreting capacity.

Acid-Base Disorders

Respiratory Acidosis. Caused by hypoventilation (drug overdose, COPD, neuromuscular disease). Primary change is increased PCO₂; HCO₃⁻ increases due to renal compensation (if chronic).

Respiratory Alkalosis. Caused by hyperventilation (anxiety, pulmonary embolism, high altitude). Primary change is decreased PCO₂; HCO₃⁻ decreases due to renal compensation.

Metabolic Acidosis. Caused by increased acid production (ketoacidosis, lactic acidosis), decreased acid excretion (renal failure), or bicarbonate loss (diarrhea). Primary change is decreased HCO₃⁻; PCO₂ decreases due to respiratory compensation.

Metabolic Alkalosis. Caused by bicarbonate gain (antacids, citrate) or H⁺ loss (vomiting, diuretics). Primary change is increased HCO₃⁻; PCO₂ increases due to respiratory compensation.

PART III: SPECIALIZED TISSUES—MUSCLE

Structure and Functions of Muscle Tissue

Types of Muscle Tissue

Three distinct types of muscle tissue exist in the body, each with specialized structure and function.

Skeletal Muscle. Attached to bones, skeletal muscle is responsible for voluntary movement, posture, and heat production. These muscles are striated (alternating light and dark bands) and multinucleated, with nuclei located peripherally. Contraction is voluntary, controlled by somatic motor neurons.

Cardiac Muscle. Found only in the heart, cardiac muscle is striated but typically uninucleate (sometimes binucleate), with nuclei located centrally. Intercalated discs connect cells electrically (gap junctions) and mechanically (desmosomes). Contraction is involuntary and autorhythmic.

Smooth Muscle. Found in walls of hollow organs and blood vessels, smooth muscle is non-striated and spindle-shaped with a single central nucleus. Contraction is involuntary and can be tonically maintained.

Skeletal Muscle Structure

Gross Organization. Skeletal muscles are organized hierarchically: muscle → fascicles → muscle fibers (cells) → myofibrils → sarcomeres. This organization allows force transmission from the molecular level (actin-myosin interactions) to the whole muscle.

Muscle Fiber Structure. Each muscle fiber is a cylindrical cell 10-100 μm in diameter and up to 30 cm long. The cell membrane is called the sarcolemma, and the cytoplasm is sarcoplasm. The sarcoplasmic reticulum (SR) is a specialized endoplasmic reticulum that stores calcium. T-tubules (transverse tubules) are invaginations of the sarcolemma that penetrate the cell at the A-I junction, allowing rapid transmission of action potentials into the cell interior.

Myofibrils and Sarcomeres. Each muscle fiber contains hundreds to thousands of myofibrils, approximately 1-2 μm in diameter. Myofibrils are composed of repeating units called sarcomeres, the functional units of muscle. Sarcomeres are bounded by Z lines (discs), with actin (thin filaments) anchored at Z lines and extending toward the M line. Myosin (thick filaments) occupies the center of the sarcomere, overlapping with actin.

The A band (anisotropic) corresponds to the length of myosin. The I band (isotropic) contains only actin and appears lighter. The H zone contains only myosin. The M line is the center of the sarcomere, where myosin is anchored.

Molecular Components. Myosin consists of two heavy chains (with heads that bind actin and hydrolyze ATP) and four light chains. Actin is a double helix of globular (G) actin monomers, associated with troponin and tropomyosin. Troponin has three subunits: TnT (binds tropomyosin), TnC (binds Ca²⁺), and TnI (inhibits actin-myosin interaction). Tropomyosin blocks myosin-binding sites on actin in the resting state.

Molecular Mechanism of Contraction

Excitation-Contraction Coupling. An action potential travels down the motor neuron to the neuromuscular junction, causing acetylcholine release and subsequent muscle fiber depolarization. The action potential propagates along the sarcolemma and down T-tubules, where it triggers voltage-sensitive receptors (dihydropyridine receptors) that mechanically couple to ryanodine receptors on the sarcoplasmic reticulum. Calcium is released from the SR into the sarcoplasm.

Cross-Bridge Cycle. Calcium binds to troponin C, causing a conformational change that moves tropomyosin away from myosin-binding sites on actin. Myosin heads, already energized by ATP hydrolysis, bind to actin (cross-bridge formation). Power stroke occurs as the myosin head pivots, pulling the actin filament toward the M line. ATP binds to the myosin head, causing detachment. ATP hydrolysis re-energizes the head, returning it to the original position. The cycle repeats as long as calcium and ATP are present.

Sliding Filament Theory. During contraction, actin and myosin filaments slide past each other without changing length. The A band remains constant, I bands and H zones shorten. Force generation depends on the number of cross-bridges formed and their force of contraction.

Muscle Contraction Types

Isometric Contraction. Muscle length remains constant while tension increases—used for posture and holding objects. Tension develops but no movement occurs.

Isotonic Contraction. Muscle shortens while tension remains constant—used for movement. Concentric contraction involves muscle shortening against a load; eccentric contraction involves lengthening while generating force.

Twitch, Tetanus, and Fatigue. A single action potential produces a twitch (brief contraction followed by relaxation). Summation of twitches produces unfused (incomplete) or fused (complete) tetanus. Fatigue—the inability to maintain force—results from depletion of ATP and glycogen, accumulation of metabolites, or neuromuscular junction exhaustion.

Energy Metabolism in Muscle

ATP Sources. Muscle ATP is replenished from three sources: creatine phosphate (immediate, anaerobic), glycolysis (rapid, anaerobic), and oxidative phosphorylation (sustained, aerobic). Creatine phosphate transfers a phosphate to ADP, regenerating ATP within milliseconds. Glycolysis produces 2 ATP per glucose anaerobically. Oxidative phosphorylation yields approximately 30-32 ATP per glucose aerobically but requires oxygen.

Oxygen Debt. After exercise, oxygen consumption remains elevated to repay the oxygen debt—replenishing ATP and creatine phosphate stores, converting lactate back to glucose (Cori cycle), and restoring normal body temperature and function.

Fiber Types. Type I (slow-twitch, red) fibers have high mitochondria, myoglobin, and oxidative capacity; they fatigue slowly and are suited for endurance. Type IIa (fast-twitch oxidative-glycolytic) fibers have intermediate properties. Type IIb/IIx (fast-twitch, white) fibers have low mitochondria, high glycogen, and high glycolytic capacity; they fatigue rapidly and are suited for short bursts of power.

Smooth Muscle

Structure. Smooth muscle cells are spindle-shaped (10-300 μm long, 2-10 μm wide) with a single central nucleus. Actin and myosin are arranged in a lattice rather than sarcomeres, anchored to dense bodies throughout the cytoplasm and at the membrane. Calcium binds to calmodulin rather than troponin.

Regulation. Smooth muscle contraction is regulated by calcium-calmodulin activation of myosin light chain kinase (MLCK), which phosphorylates myosin, enabling cross-bridge formation. Myosin phosphatase dephosphorylates myosin, causing relaxation. This phosphorylation-dephosphorylation cycle allows tone maintenance with minimal energy expenditure.

Types of Regulation. Single-unit smooth muscle (visceral) is electrically coupled through gap junctions and contracts as a unit—found in walls of hollow organs. Multiunit smooth muscle has individual motor units and is found in large blood vessels, arrector pili muscles, and ciliary muscle. Regulation is by autonomic nerves, hormones, and local factors (paracrine agents, stretch).

PART IV: KIDNEY STRUCTURE AND FUNCTIONS

Renal Anatomy and Physiology

Gross Anatomy of Kidneys

The kidneys are bean-shaped organs approximately 10-12 cm long, 5-6 cm wide, and 3-4 cm thick, located retroperitoneally on either side of the vertebral column. Each kidney weighs approximately 150 grams and receives approximately 20-25% of cardiac output (1200 mL/min) through the renal arteries.

The kidney is divided into an outer cortex and inner medulla. The medulla consists of renal pyramids, with their bases facing the cortex and apices (renal papillae) pointing toward the renal pelvis. The renal pelvis is the expanded upper end of the ureter, which collects urine and transports it to the bladder.

Microscopic Anatomy

Nephron. The functional unit of the kidney is the nephron, of which each kidney contains approximately 1-1.3 million. Each nephron consists of a renal corpuscle (glomerulus and Bowman’s capsule) and a renal tubule (proximal convoluted tubule, Loop of Henle, distal convoluted tubule, collecting duct).

Renal Corpuscle. The glomerulus is a capillary tuft formed by the afferent arteriole and drained by the efferent arteriole. Blood is filtered across the glomerular capillary endothelium, basement membrane, and podocyte foot processes (filtration slits) into Bowman’s capsule. The filtration barrier has three layers: fenestrated endothelium (pores 70-100 nm), basement membrane (negatively charged glycoproteins providing charge selectivity), and podocyte foot processes with slit diaphragms (proteins including nephrin).

Tubular Segments. The proximal convoluted tubule (PCT) is highly convoluted and lined with cuboidal epithelium with abundant microvilli (brush border), maximizing surface area for reabsorption. The Loop of Henle descends into the medulla and ascends back to the cortex—its thin and thick segments have different permeabilities that create the medullary osmotic gradient. The distal convoluted tubule (DCT) is shorter than the PCT and lacks a brush border. The collecting duct receives urine from multiple nephrons and consists of principal cells (water and sodium handling) and intercalated cells (acid-base regulation).

Blood Supply. Renal artery → segmental → interlobar → arcuate → interlobular → afferent arteriole → glomerulus → efferent arteriole → peritubular capillaries (cortex) or vasa recta (medulla) → interlobular → arcuate → interlobular → renal vein.

Functions of the Kidney

Excretion of Metabolic Wastes. The kidneys eliminate nitrogenous waste products—urea (from protein catabolism), creatinine (from muscle metabolism), uric acid (from nucleic acid catabolism), and metabolites of drugs and toxins.

Regulation of Water and Electrolyte Balance. The kidneys adjust urine volume and composition to maintain homeostasis. Sodium, potassium, chloride, calcium, phosphate, and magnesium balances are regulated by filtration and reabsorption. Water balance is regulated by adjusting urine concentration.

Regulation of Acid-Base Balance. As described earlier, the kidneys regulate pH by excreting H⁺, reabsorbing bicarbonate, and generating new bicarbonate.

Endocrine Functions. The kidneys produce erythropoietin (stimulates red blood cell production), renin (initiates the RAAS), and 1-alpha-hydroxylase (activates vitamin D). They also degrade insulin and clear various hormones and drugs.

Gluconeogenesis. The kidneys can produce glucose from non-carbohydrate precursors during prolonged fasting, contributing to blood glucose homeostasis.

Glomerular Filtration

Filtration Rate

The glomerular filtration rate (GFR) is the volume of fluid filtered from the glomerulus into Bowman’s capsule per unit time, normally approximately 125 mL/min (180 L/day). Approximately 20% of renal plasma flow is filtered, giving a filtration fraction of 0.2.

Starling Forces. GFR is determined by the balance of forces across the glomerular capillary wall:

GFR = Kf × [(PGC – PBS) – (πGC – πBS)]

where Kf is the filtration coefficient (surface area × hydraulic conductivity), PGC is glomerular capillary hydrostatic pressure, PBS is Bowman’s capsule hydrostatic pressure, πGC is glomerular capillary oncotic pressure, and πBS is Bowman’s capsule oncotic pressure (normally zero).

Glomerular Capillary Pressure. PGC is approximately 55 mmHg, higher than in other capillaries due to the afferent arteriole being larger than the efferent arteriole. This high pressure favors filtration.

Autoregulation. Renal blood flow and GFR are maintained relatively constant over a wide range of arterial pressures (80-180 mmHg) through myogenic mechanisms (afferent arteriole constricts when stretched) and tubuloglomerular feedback (macula densa detects NaCl delivery and signals afferent arteriole to constrict or dilate).

Clearance

Renal clearance is the volume of plasma from which a substance is completely removed per unit time. Clearance of a substance (C) is calculated as:

C = (U × V) / P

where U is urine concentration, V is urine flow rate, and P is plasma concentration. Inulin (a polysaccharide) is freely filtered and neither reabsorbed nor secreted, so its clearance equals GFR. PAH (para-aminohippuric acid) is filtered and actively secreted, so its clearance approximates renal plasma flow.

Tubular Reabsorption and Secretion

Proximal Convoluted Tubule

Approximately 65% of filtered water and sodium is reabsorbed in the PCT, along with essentially all filtered glucose, amino acids, bicarbonate, and phosphate. The PCT reabsorbs by both passive (solvent drag, electrochemical gradients) and active (Na⁺/K⁺-ATPase, co-transporters) mechanisms. The high capacity of PCT reabsorption ensures that valuable substances are reclaimed efficiently.

Loop of Henle

The Loop of Henle creates the medullary osmotic gradient through countercurrent multiplication. The descending limb is permeable to water but not solute; the ascending limb is impermeable to water but actively transports Na⁺, K⁺, and Cl⁻ (via Na⁺-K⁺-2Cl⁻ cotransporter in the thick ascending limb). This creates a hypertonic medulla—essential for concentrating urine.

Distal Convoluted Tubule and Collecting Duct

The DCT and collecting duct fine-tune sodium, potassium, and water reabsorption under hormonal control. Na⁺ reabsorption occurs via epithelial sodium channels (ENaC), regulated by aldosterone. Water reabsorption occurs via aquaporin-2 channels, regulated by ADH (vasopressin).

Water and Electrolyte Balance

Sodium Balance

Total body sodium is approximately 5800 mEq, with approximately 65% in extracellular fluid and 35% in bone. Sodium balance is regulated by the RAAS—decreased sodium intake or effective circulating volume stimulates renin release, leading to angiotensin II formation and aldosterone secretion. Aldosterone increases sodium reabsorption in the collecting duct, expanding extracellular volume.

Potassium Balance

Total body potassium is approximately 3500 mEq, with 98% intracellular. Potassium balance is regulated primarily by aldosterone, which increases potassium secretion in the collecting duct. Hyperkalemia directly stimulates aldosterone secretion and also stimulates renin release.

Water Balance

Water balance is regulated by ADH and thirst. Increased plasma osmolality stimulates osmoreceptors in the hypothalamus, triggering ADH release from the posterior pituitary. ADH increases water reabsorption in the collecting duct by inserting aquaporin-2 channels. Thirst is also stimulated by hyperosmolality and hypovolemia.

Calcium and Phosphate Balance

Calcium is filtered at the glomerulus and reabsorbed throughout the tubule: 65% PCT, 25% thick ascending limb, 10% DCT/collecting duct. PTH increases calcium reabsorption in the DCT and thick ascending limb while stimulating 1-alpha-hydroxylase for vitamin D activation. Phosphate reabsorption occurs primarily in the PCT (via Na⁺-Pi cotransporters) and is inhibited by PTH—this prevents hypercalcemia when PTH is secreted.

PART V: LIVER STRUCTURE AND DETOXIFICATION

Hepatic Anatomy and Physiology

Gross and Microscopic Anatomy

The liver, weighing approximately 1.5 kg, is the largest internal organ, located in the right upper quadrant beneath the diaphragm. It receives dual blood supply: approximately 25% from the hepatic artery (oxygen-rich) and 75% from the portal vein (nutrient-rich from intestines).

Lobular Architecture. The liver is organized into hexagonal lobules, each approximately 1-2 mm in diameter. At each corner of the lobule are portal triads (portal vein branch, hepatic artery branch, bile duct). Hepatocytes are arranged in plates radiating from the central vein. Blood flows from portal triads through sinusoids (specialized capillaries lined by fenestrated endothelium and Kupffer cells) to the central vein. Bile flows in the opposite direction, from hepatocytes to bile canaliculi to bile ducts.

Hepatocyte Polarity. Hepatocytes are polarized cells with distinct apical (canalicular) and basolateral (sinusoidal) membranes. The basolateral membrane faces the sinusoid and is specialized for uptake and release of substances. The apical membrane forms the bile canaliculus and is specialized for bile secretion.

Non-Parenchymal Cells. Kupffer cells (resident macrophages) phagocytose bacteria and debris. Stellate cells (Ito cells) store vitamin A and produce collagen in fibrosis. Sinusoidal endothelial cells are highly fenestrated, allowing direct contact between blood and hepatocytes.

Hepatic Functions

Carbohydrate Metabolism. The liver maintains blood glucose homeostasis. After meals, it takes up glucose and stores it as glycogen (glycogenesis). During fasting, it breaks down glycogen (glycogenolysis) and produces glucose from non-carbohydrate sources (gluconeogenesis). The liver also converts fructose and galactose to glucose.

Lipid Metabolism. The liver synthesizes fatty acids and triglycerides, packages them into lipoproteins (VLDL), and oxidizes fatty acids for energy or ketogenesis. It synthesizes cholesterol and phospholipids and converts excess carbohydrate to fat.

Protein Metabolism. Hepatocytes synthesize plasma proteins (albumin, clotting factors, transport proteins). They deaminate amino acids, converting the carbon skeleton to glucose or ketone bodies and producing urea for nitrogen excretion. Transamination reactions interconvert amino acids.

Vitamin and Mineral Storage. The liver stores vitamins A, D, B₁₂, and iron (as ferritin and hemosiderin). These stores can sustain the body for weeks to months during deficiency states.

Bile Production and Excretion. Bile, produced by hepatocytes, contains bile acids (cholesterol derivatives), bilirubin, phospholipids (lecithin), cholesterol, and electrolytes. Bile acids emulsify dietary fats, facilitating digestion and absorption. The liver produces approximately 500-800 mL of bile daily.

Immune Function. Kupffer cells phagocytose bacteria, debris, and aged red blood cells. The liver produces acute phase proteins (C-reactive protein, fibrinogen, complement components) during inflammation.

Detoxification Functions of the Liver

Phase I and Phase II Reactions

The liver is the primary organ for detoxification of endogenous waste products and xenobiotics (foreign compounds). These reactions are categorized into Phase I (functionalization) and Phase II (conjugation) reactions.

Phase I Reactions. These reactions introduce or expose functional groups on molecules through oxidation, reduction, or hydrolysis. The cytochrome P450 monooxygenase system is the most important Phase I pathway. Cytochrome P450 enzymes (over 50 isoforms in humans) are located in the smooth endoplasmic reticulum and catalyze reactions of the general form:

RH + O₂ + NADPH + H⁺ → ROH + H₂O + NADP⁺

Substrates include drugs (warfarin, acetaminophen, statins), environmental toxins (pesticides, pollutants), endogenous steroids, and fatty acids. Phase I reactions can produce more toxic intermediates (e.g., acetaminophen’s NAPQI metabolite) that require Phase II conjugation for safe excretion.

Other Phase I enzymes include alcohol dehydrogenase (ethanol oxidation), aldehyde dehydrogenases, and various esterases and amidases.

Phase II Reactions. These reactions conjugate the products of Phase I (or sometimes the parent compound) with endogenous substances, making them more water-soluble for excretion. Major conjugation pathways include:

Glucuronidation. Uridine diphosphate glucuronosyltransferase (UGT) transfers glucuronic acid from UDP-glucuronic acid to substrates. This is the most common conjugation pathway, acting on bilirubin, drugs (morphine, acetaminophen), hormones, and bilirubin. Gilbert’s syndrome and Crigler-Najjar syndrome involve UGT deficiencies.

Sulfation. Sulfotransferases (SULT) transfer sulfate from 3′-phosphoadenosine-5′-phosphosulfate (PAPS) to substrates. Steroids, thyroid hormones, and some drugs are sulfated. This pathway is important for estrogen and catecholamine metabolism.

Glutathione Conjugation. Glutathione S-transferases (GST) conjugate glutathione (a tripeptide: gamma-glutamyl-cysteinyl-glycine) to electrophilic compounds. This pathway is critical for detoxifying reactive intermediates, including the NAPQI metabolite of acetaminophen. N-acetylcysteine is used to treat acetaminophen overdose by replenishing glutathione.

Acetylation. N-acetyltransferases transfer acetyl groups from acetyl-CoA to amines. Isoniazid and other drugs are acetylated. Polymorphisms in NAT enzymes produce slow and fast acetylator phenotypes with implications for drug dosing and toxicity.

Methylation. Methyltransferases transfer methyl groups from S-adenosylmethionine (SAM) to substrates. Catecholamines, histamine, and some drugs are methylated.

Enterohepatic Circulation

Many substances excreted in bile are not permanently eliminated—they may be deconjugated by intestinal bacteria and reabsorbed, returning to the liver via the portal vein. This enterohepatic circulation recycles bile acids, bilirubin, and some drugs. Interrupting enterohepatic circulation (e.g., with cholestyramine that binds bile acids) can enhance elimination of certain compounds.

Clinical Relevance of Hepatic Detoxification

Drug Interactions. Many drugs induce or inhibit cytochrome P450 enzymes, altering the metabolism of other drugs. Rifampin, phenytoin, and carbamazepine are enzyme inducers that can reduce the efficacy of other drugs. Cimetidine, ketoconazole, and grapefruit juice are inhibitors that can increase drug levels and toxicity.

First-Pass Metabolism. Orally administered drugs are absorbed from the intestines and travel to the liver via the portal vein before reaching systemic circulation. The liver may metabolize a significant portion of the dose (first-pass effect), reducing bioavailability. Drugs with high first-pass metabolism (propranolol, nitroglycerin) are often administered via non-oral routes.

Hepatic Failure. When hepatic detoxification fails, toxins accumulate, causing encephalopathy (asterixis, confusion, coma), coagulopathy (reduced clotting factor synthesis), and drug toxicity. The Child-Pugh and MELD scores assess hepatic function based on bilirubin, albumin, PT/INR, ascites, and encephalopathy.

Liver Disease and Drug Dosing. Patients with liver disease may require dose adjustments of hepatically metabolized drugs. The severity of liver dysfunction, the drug’s extraction ratio (high vs. low), and therapeutic index guide dosing decisions.

Bch Biochemistry of Lipids 4(3-1)

Study Notes: Lipids – Structure, Functions, and Biological Roles

1. Define and Identify Structure and Functions of Fats and Fatty Acids

A. Fatty Acids: The Building Blocks

  • Definition: Fatty acids are long-chain carboxylic acids that serve as the fundamental components of most lipids.
  • General Structure: R-COOH
    • R = A long hydrocarbon chain (typically 4-36 carbons).
    • COOH = Carboxyl head group (hydrophilic, “water-loving”).
    • The hydrocarbon chain is hydrophobic (“water-fearing”).
  • Classification & Identification:
    1. Chain Length:
      • Short-chain (≤6 C): e.g., butyric acid (in butter).
      • Medium-chain (8-12 C): e.g., caprylic acid (in coconut oil).
      • Long-chain (14-20 C): most common, e.g., palmitic acid (16 C).
      • Very-long-chain (>20 C): e.g., in brain lipids.
    2. Saturation (Based on C-C Bonds):
      • Saturated Fatty Acids (SFAs): No double bonds. The chain is “saturated” with hydrogen. Straight, flexible structure. Solid at room temp. Example: Stearic acid (animal fat).
      • Unsaturated Fatty Acids (UFAs): Contain one or more carbon-carbon double bonds.
        • Monounsaturated (MUFAs): One double bond. Example: Oleic acid (olive oil).
        • Polyunsaturated (PUFAs): Two or more double bonds. Example: Linoleic acid (vegetable oils).
      • Cis vs. Trans: In nature, double bonds are almost always in the cis configuration, causing a kink in the chain. Trans fats (from industrial processing) are straighter and behave like saturated fats.
  • Key Function: Fatty acids are primarily fuel molecules (oxidized to release energy) and are the precursors for more complex lipids.

B. Fats (Triacylglycerols/Triacylglycerides)

  • Definition: Fats are the storage form of fatty acids. They are esters formed from one molecule of glycerol and three molecules of fatty acids.
  • Structure:
    • Glycerol Backbone: A 3-carbon alcohol with a hydroxyl (-OH) group on each carbon.
    • Ester Linkage: Each fatty acid attaches to a glycerol -OH via a dehydration (condensation) reaction, forming an ester bond (-O-CO-).
    • The three fatty acids can be identical (simple TAG) or different (mixed TAG).
  • Functions:
    1. Energy Storage: Primary long-term energy reserve in animals (adipose tissue) and plants (oils in seeds). Provides more than double the energy per gram compared to carbohydrates or proteins.
    2. Insulation & Protection: Subcutaneous fat acts as thermal insulation. Fat pads protect vital organs (e.g., kidneys) from physical shock.
    3. Metabolic Water Source: Oxidation of fats yields a significant amount of metabolic water, crucial for desert animals.

2. Demonstrate the Importance of Lipids in Biological Processes

Lipids are a diverse class of hydrophobic biomolecules crucial for life, far beyond just energy storage.

  • 1. Structural Role: Membrane Formation
    • Phospholipids are amphipathic (have both hydrophilic head and hydrophobic tails). In aqueous environments, they spontaneously form the lipid bilayer—the fundamental architecture of all cell membranes (plasma membrane, organelle membranes). This bilayer forms a semi-permeable barrier that defines the cell and compartments within it.
  • 2. Energy Storage and Metabolism
    • As described, triacylglycerols are the body’s most efficient energy reservoir. They are stored in a concentrated, anhydrous form.
    • Fatty acids are broken down via β-oxidation in mitochondria to produce large amounts of ATP.
  • 3. Insulation and Protection
    • Physical and thermal protection (as above).
  • 4. Co-factors and Electron Carriers
    • Fat-soluble vitamins (A, D, E, K) are lipids that act as cofactors for enzymes or have hormone-like roles (e.g., Vitamin A in vision).
    • Coenzyme Q (Ubiquinone) is a lipid that shuttles electrons in the mitochondrial electron transport chain.
  • 5. Essential Nutrients
    • Essential Fatty Acids (e.g., linoleic acid, alpha-linolenic acid) cannot be synthesized by humans and must be obtained from the diet. They are precursors for important signaling molecules.

3. Understand the Role of Lipids in Signal Transduction and Pigments

A. Lipids in Signal Transduction
Lipids act as crucial signaling molecules, both as extracellular hormones and intracellular second messengers.

  • 1. Steroid Hormones:
    • Derived from cholesterol.
    • Examples: Estrogen, testosterone, cortisol.
    • Mechanism: Being hydrophobic, they diffuse across the plasma membrane and bind to intracellular receptors in the cytoplasm or nucleus. The hormone-receptor complex then acts as a transcription factor, directly regulating gene expression. (Slow, genomic response).
  • 2. Eicosanoids:
    • Potent, local signaling molecules derived from the 20-carbon PUFA arachidonic acid.
    • Classes: Prostaglandins (inflammation, fever, pain), thromboxanes (blood clotting), leukotrienes (allergic response, asthma).
    • Mechanism: Act as autocrine/paracrine signals by binding to cell-surface G-protein coupled receptors (GPCRs), triggering rapid intracellular changes. Aspirin and ibuprofen work by inhibiting their synthesis.
  • 3. Phospholipid-Derived Second Messengers:
    • Cleavage of membrane phospholipids generates key signaling molecules.
    • Phosphatidylinositol Bisphosphate (PIP₂): Cleaved by Phospholipase C (PLC) into:
      • Inositol trisphosphate (IP₃): Diffuses to release Ca²⁺ from the endoplasmic reticulum.
      • Diacylglycerol (DAG): Remains in the membrane and activates Protein Kinase C (PKC).
      • Together, they amplify signals from hormones like adrenaline.

B. Lipids as Pigments

  • Carotenoids:
    • Lipid-soluble pigments found in plants, algae, and some bacteria.
    • Examples: β-carotene (orange, in carrots), lycopene (red, in tomatoes), lutein (yellow, in leaves).
    • Functions:
      1. Accessory Pigments in Photosynthesis: Absorb light energy in the blue-green spectrum and transfer it to chlorophyll.
      2. Photoprotection: Quench reactive oxygen species generated by excess light.
      3. Precursors: β-carotene is cleaved to form Vitamin A (retinal), the light-absorbing pigment in the vertebrate eye (rhodopsin).
  • Chlorophylls: While containing a porphyrin ring, they have a long hydrophobic phytol tail, making them lipid-soluble and anchoring them in the thylakoid membranes of chloroplasts.

Summary & Key Takeaways

Lipid Type Core Structure Primary Biological Role
Fatty Acids Hydrocarbon chain + COOH Fuel molecules; Building blocks
Triacylglycerols Glycerol + 3 Fatty Acids Energy Storage, Insulation, Protection
Phospholipids Glycerol + 2 FAs + Phosphate Head Group Membrane Structure (Bilayer Formation)
Steroids Four fused carbon rings Signaling (Hormones), Membrane fluidity (Cholesterol)
Eicosanoids Derived from Arachidonic Acid Local Signaling (Inflammation, Clotting)
Carotenoids Long conjugated polyene chain Pigments (Photosynthesis, Photoprotection)

Remember: The unifying theme for lipids is hydrophobicity, which dictates their roles—from forming barriers (membranes) and storing energy in a compact form, to serving as hormones that can cross membranes and pigments embedded in lipid environments.

Study Notes: Fatty Acids – Nomenclature, Classification, and Properties

I. NOMENCLATURE OF FATTY ACIDS

A. Systematic (IUPAC) Naming:

  • Named as derivatives of the parent hydrocarbon with the same number of carbons
  • Format: [Prefix] + [root indicating chain length] + [suffix]
  • Example: Octadecanoic acid (18 carbons, saturated)
    • “Octadec” = 18 carbons
    • “anoic” = saturated carboxylic acid

B. Common Naming:

  • Based on natural sources
  • Examples: Palmitic acid (palm oil), Stearic acid (Greek “stear” = tallow), Oleic acid (olive oil)

C. Omega (ω) or “n” Naming:

  • Identifies position of first double bond counting from methyl (CH₃) end
  • Format: ω-x or n-x (where x = carbon number of first double bond)
  • Examples:
    • ω-3: Linolenic acid (first double bond at carbon 3 from methyl end)
    • ω-6: Linoleic acid (first double bond at carbon 6 from methyl end)
    • ω-9: Oleic acid (first double bond at carbon 9 from methyl end)

D. Delta (Δ) Naming:

  • Indicates position of double bonds counting from carboxyl (COOH) end
  • Format: Δ⁹ means double bond between carbons 9 and 10
  • Example: Oleic acid = Δ⁹,18:1 (18 carbons, 1 double bond at position 9)

II. CLASSIFICATION OF FATTY ACIDS

A. By Saturation:

Type Double Bonds Structure Physical State Examples
Saturated None Straight chain Solid at room temp Palmitic (16:0), Stearic (18:0)
Monounsaturated One One kink Liquid at room temp Oleic (18:1, ω-9)
Polyunsaturated ≥ Two Multiple kinks Liquid, less stable Linoleic (18:2, ω-6), ALA (18:3, ω-3)

B. By Chain Length:

Type Carbon Atoms Examples Properties
Short-chain 2-6 Butyric (4:0) Volatile, water-soluble
Medium-chain 8-12 Capric (10:0), Lauric (12:0) Quick energy, liver metabolism
Long-chain 14-20 Palmitic (16:0), Oleic (18:1) Most common in diet
Very-long-chain >20 Erucic (22:1), Nervonic (24:1) Brain lipids, specialized functions

C. By Nutritional Requirement:

Type Definition Examples Sources
Essential Cannot be synthesized by humans; must be obtained from diet ω-3: ALA (18:3) ω-6: Linoleic (18:2) Flaxseeds, fish, nuts, vegetable oils
Non-essential Can be synthesized by the body Saturated: Palmitic (16:0) MUFA: Oleic (18:1) Body synthesis, various foods

III. STRUCTURE OF FATTY ACIDS

General Formula: R-COOH

  • R = Hydrocarbon chain (typically 4-36 carbons)
  • COOH = Carboxyl group (polar, hydrophilic)

Key Structural Features:

  1. Hydrocarbon Chain:
    • Nonpolar, hydrophobic
    • Even-numbered carbons (most common in nature)
  2. Carboxyl Head:
    • Polar, hydrophilic
    • Acidic (can donate H⁺)
  3. Geometric Isomers (in unsaturated FA):
    • Cis: Hydrogens on same side → creates kink/bend
    • Trans: Hydrogens on opposite sides → straighter chain
    • Natural unsaturated FA are almost exclusively cis configuration

IV. PROPERTIES OF FATTY ACIDS

A. Physical Properties:

  1. Solubility:
    • Decreases as chain length increases
    • Short-chain: water-soluble
    • Long-chain: water-insoluble, soluble in organic solvents
  2. Melting Point:
    • Increases with chain length (more London forces)
    • Decreases with more double bonds (less packing efficiency)
    • Saturated > Trans > Cis
  3. Acidity:
    • Weak acids (pKa ~4.8)
    • Exist as anions at physiological pH (~7.4)
    • Called “soaps” in salt form

B. Chemical Properties:

  1. Esterification: React with alcohols to form esters (glycerol → triacylglycerol)
  2. Saponification: Base hydrolysis → fatty acid salts (soaps)
  3. Hydrogenation: Addition of H₂ to convert unsaturated to saturated (food industry)
  4. Oxidation: Susceptible to oxidation (rancidity)

V. SOURCES AND FUNCTIONS

A. Dietary Sources:

Fatty Acid Type Major Sources
Butyric (4:0) Saturated Butter, dairy
Lauric (12:0) Saturated Coconut oil, palm kernel oil
Palmitic (16:0) Saturated Palm oil, meat, dairy
Oleic (18:1, ω-9) MUFA Olive oil, canola oil, nuts
Linoleic (18:2, ω-6) PUFA (Essential) Vegetable oils, seeds
α-Linolenic (18:3, ω-3) PUFA (Essential) Flaxseed, chia seeds, walnuts
Arachidonic (20:4) ω-6 Meat, eggs (can be synthesized from LA)
EPA (20:5, ω-3) ω-3 Fish, algae
DHA (22:6, ω-3) ω-3 Fish, algae

B. Functions in the Body:

Function Fatty Acid Examples Notes
Energy Storage Most saturated and unsaturated Stored as triacylglycerols
Membrane Components Mainly unsaturated Maintain fluidity
Precursors Arachidonic acid (20:4) Eicosanoids (prostaglandins)
Signaling Arachidonic acid derivatives Secondary messengers
Brain Development DHA (22:6) Particularly critical in fetal and infant development
Gene Expression ω-3 and ω-6 derivatives Nuclear receptors
Insulation Long-chain saturated Subcutaneous fat

VI. IMPORTANT ESSENTIAL FATTY ACIDS

EFA Type Derived Longer FA Major Functions
α-Linolenic Acid (ALA, 18:3, ω-3) Parent ω-3 EPA (20:5), DHA (22:6) Anti-inflammatory, brain, retina
Linoleic Acid (LA, 18:2, ω-6) Parent ω-6 Arachidonic acid (20:4) Inflammatory mediators

Ratio of ω-6:ω-3 matters: Western diets often have ratio ~15:1, while ideal is ~1:1 to 5:1.

VII. STRUCTURAL IMPLICATIONS

  1. Chain Length → Melting Point:
    • Longer chains = higher melting points
  2. Number of Double Bonds → Melting Point:
    • More double bonds = lower melting point
  3. Position of Double Bonds → Stability:
    • ω-3 are more susceptible to oxidation (more double bonds)
  4. Trans vs. Cis:
    • Trans behave like saturated (higher melting points)
    • Cis have lower melting points (more fluid at room temp)

Clinical Relevance:

  • Essential Fatty Acid Deficiency: Skin, hair, vision, immune function
  • Saturated Fat Intake: Associated with cardiovascular disease
  • Trans Fat Intake: Raises LDL, lowers HDL, inflammation
  • ω-3 vs ω-6 balance: Imbalance promotes inflammatory pathways

VIII. SUMMARY TABLE

Property Saturated FA Cis-Unsaturated FA Trans FA
C-C Bonds Single only One or more cis double trans double
Chain Shape Straight Kinked Straight
Packing Very efficient Kinks disrupt packing Efficient
MP Highest Lower Intermediate
State Solid Liquid Semi-solid
Health Neutral to harmful Beneficial Harmful
Food Animal fat Most vegetable oils Hydrogenated oils

Key Points to Remember:

  1. Nomenclature: ω vs Δ numbering systems indicate different counting directions
  2. Chain Length → MP: Longer chains have higher MP
  3. Double Bonds → MP: More double bonds lower MP (less packing)
  4. Essential Fatty Acids: Must be obtained from diet
  5. Structural Implications: Cis creates kinks, trans more like saturated FA

TRIACYLGLYCEROL (TAG)

A. Nomenclature:

  • Systematic: Number glycerol from 1-3 (sn notation)
  • Example: 1-palmitoyl-2-oleoyl-3-linoleoyl-sn-glycerol
  • Common: “triglyceride” (misnomer – glycerol + 3 acids)

B. Fats vs Oils:

Property Fats Oils
State Solid Liquid
Chain More saturated More unsaturated
Origin Animal Plant
Example Tallow (beef) Olive oil (plant)

C. Waxes:

  • Definition: Long-chain alcohols esterified to long-chain fatty acids
  • Example: Beeswax (C30 alcohol + C16 FA → C46 ester)
  • Function: Waterproof coating (cuticle in plants, feathers in birds)

D. Compound Lipids:

Class Backbone Attachments Function
Glycerophospholipids Glycerol 2 FA + 1 phosphate + 1 head group Membrane structure
Sphingomyelins Sphingosine 1 FA + 1 phosphate + 1 choline Myelin sheath
Glycolipids Sphingosine (ceramide) 1 FA + 1 sugar (≥1) Cell recognition, blood antigens

E. Functions:

  • Energy Storage: ~9 kcal/g (vs ~4 kcal/g for protein/carbohydrate)
  • Membrane: Glycerophospholipids (amphipathic), sphingomyelins (myelin sheath)
  • Signaling: Inositol phospholipids → IP3 + DAG (second messengers)

F. Properties:

  • Hydrophobic: Water-insoluble → stored anhydrous
  • Reduced: More hydrogens → more energy per gram
  • Neutral: Non-polar → no charge repulsion → dense packing

II. STEROIDS

A. Structure:

  • Cholesterol: 4 fused rings (A,B,C,D) + side chain (C27)
  • Steroid: 4 fused rings (A,B,C,D) + functional groups
  • Steroid: 4 fused rings (A,B,C,D) + functional groups

B. Classification:

Class Example Function
Sterols Cholesterol Membrane fluidity, precursor to bile acids, steroid hormones
Bile Acids Cholic acid Emulsify dietary fats in intestine
Steroid Hormones Testosterone, estradiol, cortisol Regulation of metabolism, reproduction, stress response
Steroid Hormones Testosterone, estradiol, cortisol Regulation of metabolism, reproduction, stress response
Other Steroids Cholic acid, steroid hormones, bile acids Emulsify dietary fats in intestine

C. Nomenclature:

  • Systematic: Based on parent hydrocarbon with -ol suffix for alcohols
  • Common: Based on natural source or trivial name
  • Examples: Cholestane (parent for cholesterol), pregnane (parent for progesterone)

D. Biological Role:

Class Example Role
Sterols Cholesterol Membrane fluidity, precursor to bile acids, steroid hormones
Bile Acids Cholic acid Emulsify dietary fats in intestine
Steroid Hormones Testosterone, estradiol, cortisol Regulation of metabolism, reproduction, stress response
Other Steroids Vitamin D Calcium metabolism

III. LIPIDS AS SIGNALS, COFACTORS, VITAMINS, PIGMENTS

A. Signals:

  • Eicosanoids: 20-carbon polyunsaturated fatty acids (PUFAs) → prostaglandins, thromboxanes, leukotrienes
  • Steroid hormones: Cholesterol-derived → estrogen, testosterone, cortisol
  • Phospholipids: PIP2 → IP3 (Ca2+) + DAG (PKC)

B. Cofactors:

  • Vitamin K: Blood coagulation (γ-carboxylation of glutamic acid)
  • Vitamin D: Calcium metabolism (bone health)
  • Vitamin E: Antioxidant (protects membranes from oxidative damage)

C. Vitamins:

  • Vitamin A: Vision (retinal), growth (retinoic acid)
  • Vitamin D: Calcium metabolism (bone health)
  • Vitamin E: Antioxidant (protects membranes from oxidative damage)
  • Vitamin K: Blood coagulation (γ-carboxylation of glutamic acid)

D. Pigments:

  • Carotenoids: β-carotene (orange), lycopene (red), lutein (yellow)
  • Chlorophylls: Phytol tail (lipid-soluble) → thylakoid membrane anchoring

IV. EICOSANOIDS

A. General:

  • Eicosanoids: 20-carbon (Greek “eicosa”) → derived from arachidonic acid (C20:4)
  • Derived from: Arachidonic acid (C20:4) → prostaglandins, thromboxanes, leukotrienes

B. Classification:

Class Example Function
Prostaglandins (PG) PGE2, PGI2 Inflammation, fever, pain
Thromboxanes (TX) TXA2, TXB2 Blood clotting
Leukotrienes (LT) LTB4, LTC4 Allergic response, asthma

C. Specific Classes:

Class Example Function
Prostaglandins (PG) PGE2, PGI2 Inflammation, fever, pain
Thromboxanes (TX) TXA2, TXB2 Blood clotting
Leukotrienes (LT) LTB4, LTC4 Allergic response, asthma

D. Synthesis:

  • Step 1: Cyclooxygenase (COX) → prostaglandins (PG), thromboxanes (TX)
  • Step 2: Lipoxygenase (LOX) → leukotrienes (LT)

E. Action:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

F. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

G. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

H. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

I. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

J. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

K. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

L. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

M. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

N. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

O. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

P. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

Q. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

R. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

S. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

T. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

U. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

V. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

W. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

X. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

Y. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

Z. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

AA. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

AB. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

AC. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

AD. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

AE. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

AF. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

AG. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

AH. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

AI. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

AJ. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

AK. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

AL. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

AM. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

AN. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

AO. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

AP. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

AQ. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

AR. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

AS. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

AT. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

AU. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

AV. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

AW. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

AX. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

AY. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

AZ. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

BA. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

BB. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

BC. Mechanism:

  • PG: Inflammation, fever, pain
  • TX: Blood clotting (platelet aggregation)
  • LT: Allergic response, asthma (bronchoconstriction)

BCH-501 AMINO ACIDS AND PROTEINS

AMINO ACIDS: Introduction, Building Blocks, Standard & Non-Standard

I. Introduction to Proteins

A. Definition of Proteins

  • Proteins: Complex, large molecules made up of one or more chains of amino acids.
  • Functions: Catalysis, transport, structure, movement, protection, storage, regulation.

B. Building Blocks of Proteins

  • Amino acids are the monomers (building blocks) of proteins.
  • Peptide bond: Covalent bond between the carboxyl group of one amino acid and the amino group of another.
  • Polypeptide: A chain of many amino acids linked by peptide bonds.
  • Protein: One or more polypeptides folded into a functional 3D structure.

II. AMINO ACIDS

A. Amino Acid Structure

  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group (side chain): Different for each amino acid.
  • Standard amino acids: 20 common amino acids encoded by DNA.
  • Non-standard amino acids: Not directly encoded by DNA; formed post-translationally.

B. Standard Amino Acids

  • 20 common amino acids encoded by DNA.
  • Examples: Alanine, glycine, lysine, arginine, etc.

C. Non-Standard Amino Acids

  • Not directly encoded by DNA; formed post-translationally.
  • Examples:
    • Hydroxyproline: Found in collagen.
    • Hydroxylysine: Found in collagen.
    • Gamma-carboxyglutamate: Found in vitamin K.

III. Standard Amino Acids (20 Common Amino Acids)

A. Classification Based on R Groups (Side Chains)

1. Non-Polar (Hydrophobic)

  • Alanine (Ala): Hydrophobic.
  • Valine (Val): Hydrophobic.
  • Leucine (Leu): Hydrophobic.
  • Isoleucine (Ile): Hydrophobic.

2. Polar (Hydrophilic)

  • Serine (Ser): Hydrophilic.
  • Threonine (Thr): Hydrophilic.
  • Asparagine (Asn): Hydrophilic.
  • Glutamine (Gln): Hydrophilic.

3. Acidic (Negatively Charged)

  • Aspartic acid (Asp): Negatively charged.
  • Glutamic acid (Glu): Negatively charged.

4. Basic (Positively Charged)

  • Lysine (Lys): Positively charged.
  • Arginine (Arg): Positively charged.
  • Histidine (His): Positively charged.

5. Essential

  • Lysine (Lys): Positively charged.
  • Arginine (Arg): Positively charged.
  • Histidine (His): Positively charged.

6. Non-Essential

  • Alanine (Ala): Hydrophobic.
  • Valine (Val): Hydrophobic.
  • Leucine (Leu): Hydrophobic.
  • Isoleucine (Ile): Hydrophobic.

IV. Non-Standard Amino Acids (Non-Standard Amino Acids)

A. Definition

  • Non-standard amino acids: Not directly encoded by DNA; formed post-translationally.
  • Examples:
    • Hydroxyproline: Found in collagen.
    • Hydroxylysine: Found in collagen.
    • Gamma-carboxyglutamate: Found in vitamin K.

V. Classification Based on R Groups (Side Chains)

A. Classification Based on R Groups (Side Chains)

1. Non-Polar (Hydrophobic)

  • Alanine (Ala): Hydrophobic.
  • Valine (Val): Hydrophobic.
  • Leucine (Leu): Hydrophobic.
  • Isoleucine (Ile): Hydrophobic.

2. Polar (Hydrophilic)

  • Serine (Ser): Hydrophilic.
  • Threonine (Thr): Hydrophilic.
  • Asparagine (Asn): Hydrophilic.
  • Glutamine (Gln): Hydrophilic.

VI. Classification Based on Nutritional Requirements

A. Essential Amino Acids

  • Cannot be synthesized by the body; must be obtained from the diet.
  • Examples:
    • Lysine (Lys): Positively charged.
    • Arginine (Arg): Positively charged.
    • Histidine (His): Positively charged.

B. Non-Essential Amino Acids

  • Can be synthesized by the body; not required in the diet.
  • Examples:
    • Alanine (Ala): Hydrophobic.
    • Valine (Val): Hydrophobic.
    • Leucine (Leu): Hydrophobic.
    • Isoleucine (Ile): Hydrophobic.

VII. Isomerism, Structure, Properties, Functions

A. Isomerism

  • Optical activity:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group (side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group (side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group (side chain): Different for each amino acid.

B. Isomerism

  • Optical activity:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group (side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group (side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group (side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group (side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group (side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group (side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group (side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group (side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group (side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(sidechain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General Formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.
  • General formula:
    • Central carbon (α-carbon): Attached to:
      • Amino group (NH2)
      • Carboxyl group (COOH)
      • Hydrogen atom (H)
      • R group(side chain): Different for each amino acid.

STUDY NOTES: PROTEINS – STRUCTURE, FUNCTION, & ANALYSIS

I. OVERVIEW OF PROTEINS

  • Definition: Large, complex biomolecules composed of amino acid chains folded into specific 3D structures
  • Key Elements: Carbon, Hydrogen, Oxygen, Nitrogen, Sulfur
  • Biological Significance: Essential for virtually all cellular processes

II. PROTEIN STRUCTURE HIERARCHY

A. Primary Structure

  • Definition: Linear sequence of amino acids joined by peptide bonds
  • Determined by: Genetic code (DNA → mRNA → protein)
  • Bond: Covalent peptide bonds
  • Significance: Determines all higher levels of structure; single amino acid change can alter function (e.g., sickle cell anemia)

B. Secondary Structure

  • Definition: Local folding of polypeptide backbone into regular patterns stabilized by hydrogen bonds
  • Major Types:
    • α-Helix: Right-handed spiral stabilized by H-bonds between every 4th amino acid (C=O…H-N)
    • β-Pleated Sheet: Extended strands connected side-by-side; can be parallel or antiparallel
    • β-Turns: Reverse turns allowing polypeptide chain to change direction
    • Random Coil: Irregular, non-repetitive folding

C. Tertiary Structure

  • Definition: Overall 3D arrangement of a single polypeptide chain
  • Stabilized by:
    • Hydrophobic interactions (major force)
    • Hydrogen bonds
    • Ionic interactions
    • Disulfide bridges (covalent, between cysteine residues)
    • Van der Waals forces
  • Domains: Independently folded, functional units within a protein

D. Quaternary Structure

  • Definition: Arrangement of multiple polypeptide chains (subunits) into a functional protein complex
  • Examples: Hemoglobin (4 subunits), DNA polymerase (multiple subunits), collagen (triple helix)
  • Stabilized by: Same forces as tertiary structure (except disulfide bridges between subunits are rare)

III. METHODS FOR DETERMINING 3D STRUCTURE

Method Principle Resolution Applications
X-ray Crystallography X-ray diffraction from protein crystals Atomic (0.1-0.2 nm) Most common; requires crystals
NMR Spectroscopy Nuclear magnetic resonance in solution Atomic (0.1-0.5 nm) Small proteins (<40 kDa); solution state
Cryo-Electron Microscopy Electron microscopy of frozen samples Near-atomic to molecular Large complexes, membrane proteins
Circular Dichroism Differential absorption of polarized light Secondary structure only α-helix/β-sheet content
Mass Spectrometry Mass-to-charge ratio of ions Molecular weight Protein identification, modifications

IV. CLASSIFICATION & BIOLOGICAL FUNCTIONS

A. By Biological Function

Class Examples Functions
Enzymes Amylase, DNA polymerase Catalyze biochemical reactions
Structural Collagen, keratin Provide support and shape
Transport Hemoglobin, albumin Carry molecules (O₂, lipids, ions)
Contractile Actin, myosin Muscle contraction, cell movement
Hormonal Insulin, growth hormone Regulation of physiological processes
Storage Ferritin, casein Store ions or nutrients
Protective Antibodies, complement Immune defense
Receptor Insulin receptor Signal transduction

B. By Shape/Solubility

1. Fibrous Proteins

  • Structure: Long, parallel polypeptide chains forming fibers or sheets
  • Properties: Insoluble in water, mechanically strong, structural roles
  • Examples:
    • Collagen: Triple helix; skin, bones, tendons
    • Keratin: α-helix or β-sheet; hair, nails, feathers
    • Elastin: Cross-linked; elastic tissues (lungs, arteries)
    • Fibrin: Blood clotting

2. Globular Proteins

  • Structure: Compact, spherical, folded polypeptide chains
  • Properties: Soluble in water, diverse functions (enzymes, transporters, etc.)
  • Examples: Hemoglobin, myoglobin, enzymes, antibodies

V. PROTEIN DENATURATION, DEGRADATION & FOLDING

A. Denaturation

  • Definition: Loss of 3D structure (secondary, tertiary, quaternary) without breaking peptide bonds
  • Causes:
    • Heat (breaks weak bonds)
    • Extreme pH (alters charges)
    • Organic solvents (disrupt hydrophobic interactions)
    • Detergents (disrupt hydrophobic interactions)
    • Heavy metals (disrupt disulfide bonds)
    • Chaotropic agents (urea, guanidinium chloride)
  • Effects: Loss of biological function, increased susceptibility to proteolysis
  • Reversibility: Sometimes (if primary structure intact), but usually irreversible

B. Protein Folding

  • Process: Spontaneous adoption of native conformation
  • Driving Forces: Hydrophobic effect (major), hydrogen bonding, electrostatic interactions
  • Chaperones: Helper proteins (Hsp70, chaperonins) that assist folding and prevent aggregation
  • Misfolding Diseases: Alzheimer’s (amyloid-β), Parkinson’s (α-synuclein), prion diseases

C. Protein Degradation

  • Purpose: Remove damaged/misfolded proteins, regulate protein levels
  • Pathways:
    • Ubiquitin-Proteasome System: ATP-dependent; targets specific proteins
    • Lysosomal Degradation: Autophagy; bulk degradation
    • Calpain System: Calcium-dependent proteases

VI. DIGESTION & ABSORPTION OF DIETARY PROTEINS

A. Digestion

Site Enzyme Source Action
Stomach Pepsin Gastric chief cells Cleaves proteins to peptides
Duodenum Trypsin, Chymotrypsin, Elastase Pancreas Cleave peptides to smaller peptides
Intestine Carboxypeptidases Pancreas Remove C-terminal amino acids
Brush Border Aminopeptidases, Dipeptidases Intestinal cells Cleave peptides to amino acids/dipeptides

B. Absorption

  • Mechanism: Active transport via specific transporters
  • Enterocytes: Absorb amino acids and small peptides
  • Transporters: Na⁺-dependent (most amino acids), H⁺-dependent (di/tripeptides)
  • Blood: Amino acids enter portal circulation to liver

VII. METHODS OF PROTEIN ISOLATION, PURIFICATION & CHARACTERIZATION

A. Isolation & Purification

  1. Cell Lysis: Sonication, homogenization, detergents
  2. Centrifugation: Differential (organelles) and density gradient
  3. Chromatography Techniques:
    • Size Exclusion: Separation by molecular size
    • Ion Exchange: Separation by charge
    • Affinity: Specific binding (antibody-antigen, ligand-receptor)
    • Hydrophobic Interaction: Separation by hydrophobicity
    • Reverse Phase: Separation by hydrophobicity (organic solvents)
  4. Electrophoresis: SDS-PAGE (denaturing), Native-PAGE (non-denaturing)
  5. Dialysis/Ultrafiltration: Remove salts/concentrate proteins

B. Characterization

Property Method Information Obtained
Molecular Weight SDS-PAGE, Mass spectrometry Subunit size, purity
Isoelectric Point Isoelectric focusing Charge properties
Concentration Bradford/Lowry/BCA assays, UV absorbance Protein amount
Activity Enzyme assays, binding assays Functional integrity
Structure CD, X-ray, NMR Secondary/tertiary structure
Sequence Edman degradation, Mass spec Amino acid sequence

VIII. PLASMA PROTEINS & BIOLOGICAL ROLES

A. Major Plasma Proteins

Protein Concentration (g/dL) Molecular Weight (kDa) Major Functions
Albumin 3.5-5.0 66.5 Osmotic pressure, transport (fatty acids, hormones, drugs)
Globulins 2.0-3.5 Variable Multiple functions (see below)
Fibrinogen 0.2-0.4 340 Blood clotting
Complement Trace Variable Immune defense

B. Globulin Classes

  1. α₁-Globulins:
    • α₁-Antitrypsin: Protease inhibitor (protects lungs)
    • Thyroxine-binding globulin: Thyroid hormone transport
    • Retinol-binding protein: Vitamin A transport
  2. α₂-Globulins:
    • Haptoglobin: Binds free hemoglobin
    • Ceruloplasmin: Copper transport and oxidation
    • α₂-Macroglobulin: Protease inhibitor
  3. β-Globulins:
    • Transferrin: Iron transport
    • LDL: Cholesterol transport
    • Complement components: Immune response
  4. γ-Globulins (Immunoglobulins):
    • IgG, IgA, IgM, IgD, IgE: Antibodies for immune defense

C. Biological Roles of Plasma Proteins

  1. Maintain Osmotic Pressure: Albumin (75-80% of osmotic pressure)
  2. Transport: Lipids, hormones, vitamins, minerals, drugs
  3. Buffering: Maintain blood pH
  4. Immune Defense: Antibodies, complement proteins
  5. Blood Coagulation: Fibrinogen, coagulation factors
  6. Protease Inhibition: Prevent tissue damage (α₁-antitrypsin)
  7. Acute Phase Response: Increase during inflammation (C-reactive protein)

D. Clinical Significance

  • Hypoalbuminemia: Liver disease, malnutrition, nephrotic syndrome
  • Multiple Myeloma: Overproduction of monoclonal immunoglobulins
  • Inflammation: Increased acute phase proteins (C-reactive protein, fibrinogen)
  • Genetic Disorders: α₁-Antitrypsin deficiency (emphysema), ceruloplasmin deficiency (Wilson’s disease)

BCH-503 Enzymology 3(2-1)

STUDY NOTES: ENZYMES – CATALYSTS OF LIFE

I. INTRODUCTION TO ENZYMES

A. Definition

  • Enzymes: Biological catalysts that accelerate chemical reactions without being consumed
  • Nature: Mostly proteins (some RNAs)
  • Characteristics: Highly specific, efficient, and regulated

B. Historical Background

  • 1833: Payen and Persoz discovered diastase (first enzyme)
  • 1878: Wilhelm Kühne coined term “enzyme” (Greek: en zyme = “in yeast”)
  • 1897: Eduard Buchner demonstrated fermentation by cell-free extracts
  • 1926: James Sumner crystallized urease (first enzyme crystallization)
  • 1965: Discovery of ribozymes (RNA enzymes)

II. NOMENCLATURE & CLASSIFICATION

A. Naming Systems

  1. Trivial Names: Based on substrate + “ase” (e.g., urease, lipase, protease)
  2. Systematic Names: Based on reaction type + substrate (IUBMB system)
  3. Common Names: Historical names (e.g., trypsin, pepsin)

B. International Classification (EC System)

Six major classes based on reaction type:

EC Class Name Reaction Catalyzed Examples
EC 1 Oxidoreductases Oxidation-reduction Dehydrogenases, oxidases
EC 2 Transferases Group transfer Kinases, transaminases
EC 3 Hydrolases Hydrolysis Proteases, lipases, nucleases
EC 4 Lyases Addition/removal to double bonds Decarboxylases, dehydratases
EC 5 Isomerases Isomerization Racemases, epimerases
EC 6 Ligases (Synthetases) Bond formation with ATP cleavage DNA ligase, aminoacyl-tRNA synthetase

EC Number Format: EC X.X.X.X (e.g., EC 1.1.1.1 = Alcohol dehydrogenase)

III. RIBOZYMES

A. Definition

  • Ribozymes: Catalytic RNA molecules (RNA enzymes)
  • Discovery: Thomas Cech (1982) and Sidney Altman (1989) – Nobel Prize 1989

B. Types & Examples

  1. Self-splicing introns: Group I and Group II introns
  2. RNase P: Processes tRNA precursors
  3. Ribosome: Peptidyl transferase activity (23S rRNA)
  4. Hammerhead ribozyme: Small, self-cleaving RNA
  5. Hairpin ribozyme: Found in plant viruses

C. Significance

  • Supports “RNA World” hypothesis
  • Important in gene regulation and RNA processing
  • Potential therapeutic applications

IV. ISOZYMES (ISOENZYMES)

A. Definition

  • Multiple forms of an enzyme that catalyze the same reaction but differ in:
    • Amino acid sequence
    • Kinetic properties
    • Regulatory mechanisms
    • Tissue distribution

B. Examples

  1. Lactate Dehydrogenase (LDH):
    • LDH1 (H₄): Heart, RBCs (aerobic tissues)
    • LDH5 (M₄): Skeletal muscle, liver (anaerobic tissues)
    • Clinical use: Diagnose myocardial infarction
  2. Creatine Kinase (CK):
    • CK-MM: Skeletal muscle
    • CK-MB: Heart muscle (cardiac marker)
    • CK-BB: Brain
  3. Hexokinase/Glucokinase: Different tissue distribution and Km values

C. Biological Significance

  • Tissue-specific adaptation
  • Developmental regulation
  • Diagnostic markers for diseases

V. COFACTORS, COENZYMES & PROSTHETIC GROUPS

A. Definitions

Term Definition Examples Binding
Cofactor Non-protein component required for enzyme activity Metal ions, organic molecules May be loosely or tightly bound
Coenzyme Organic cofactor (often vitamin-derived) NAD⁺, FAD, CoA, TPP Loosely bound, transient association
Prosthetic Group Tightly bound cofactor (covalently or non-covalently) Heme, biotin, pyridoxal phosphate Tightly bound, integral part

B. Important Coenzymes & Their Vitamin Precursors

Coenzyme Vitamin Precursor Function Enzymes
NAD⁺/NADP⁺ Niacin (B₃) Electron transfer Dehydrogenases
FAD/FMN Riboflavin (B₂) Electron transfer Oxidases, dehydrogenases
Coenzyme A Pantothenic acid (B₅) Acyl group transfer Transferases
TPP Thiamine (B₁) Aldehyde transfer Decarboxylases
Pyridoxal phosphate Pyridoxine (B₆) Amino group transfer Transaminases
Biotin Biotin (B₇) CO₂ transfer Carboxylases
Tetrahydrofolate Folate (B₉) One-carbon transfer Methyltransferases
Cobalamin Vitamin B₁₂ Rearrangements Mutases

C. Metal Ions as Cofactors

  • Fe²⁺/Fe³⁺: Cytochromes, catalase, peroxidase
  • Zn²⁺: Carbonic anhydrase, alcohol dehydrogenase
  • Mg²⁺: Kinases, ATPases, polymerases
  • Cu²⁺: Cytochrome oxidase, superoxide dismutase
  • Mn²⁺: Arginase, superoxide dismutase
  • Mo: Xanthine oxidase, nitrate reductase

VI. MECHANISMS OF ENZYME ACTION

A. Key Concepts

  1. Activation Energy (Eₐ): Energy barrier for reaction
  2. Transition State: High-energy intermediate
  3. Enzyme-Substrate Complex (ES): Temporary association

B. Theories of Enzyme Action

  1. Lock-and-Key Model (Emil Fischer, 1894):
    • Rigid active site complementary to substrate
    • Limitations: Doesn’t explain enzyme flexibility
  2. Induced Fit Model (Daniel Koshland, 1958):
    • Active site changes conformation upon substrate binding
    • Widely accepted model

C. Mechanisms of Catalysis

  1. Proximity & Orientation Effect:
    • Brings substrates together in correct orientation
  2. Acid-Base Catalysis:
    • Transfer of protons (histidine common in active sites)
  3. Covalent Catalysis:
    • Transient covalent bond formation (serine proteases)
  4. Metal Ion Catalysis:
    • Stabilization of charges, redox reactions
  5. Electrostatic Catalysis:
    • Stabilization of transition state charges
  6. Strain & Distortion:
    • Enzyme strains substrate toward transition state

D. Example: Serine Proteases

  • Catalytic Triad: Ser-His-Asp
  • Mechanism: Covalent catalysis via acyl-enzyme intermediate
  • Examples: Trypsin, chymotrypsin, elastase

VII. PROPERTIES OF ENZYMES

A. Catalytic Properties

  1. High Efficiency: Rate acceleration of 10⁶-10¹² fold
  2. High Specificity:
    • Absolute: Single substrate (urease)
    • Group: Class of substrates (peptidases)
    • Stereospecific: One enantiomer only (L-amino acid oxidase)
    • Geometric: Cis-trans isomers
  3. Mild Reaction Conditions: Physiological pH, temperature, pressure

B. Physical Properties

  1. Molecular Weight: 10-1000 kDa
  2. Temperature Optimum: Usually 35-40°C (human enzymes)
  3. pH Optimum: Varies with enzyme (pepsin: pH 2, trypsin: pH 8)

C. Kinetic Properties

  1. Michaelis-Menten Kinetics:
    • Vmax: Maximum velocity
    • Km: Substrate concentration at ½ Vmax (measure of affinity)
    • kcat: Turnover number (molecules converted per active site per second)
    • Catalytic Efficiency: kcat/Km
  2. Lineweaver-Burk Plot: Double reciprocal plot for kinetic analysis

VIII. REGULATION OF ENZYME ACTIVITY

A. Allosteric Regulation

  • Definition: Regulation by binding at sites other than active site
  • Allosteric Effectors: Modifiers (activators/inhibitors)
  • Characteristics:
    • Cooperativity (sigmoidal kinetics)
    • Quaternary structure required
  • Examples: ATCase (aspartate transcarbamoylase), phosphofructokinase

B. Covalent Modification

  • Reversible:
    • Phosphorylation/dephosphorylation (most common)
    • Acetylation/deacetylation
    • Methylation/demethylation
    • ADP-ribosylation
  • Irreversible: Zymogen activation (proteolytic cleavage)
    • Examples: Trypsinogen → trypsin, Pepsinogen → pepsin

C. Compartmentalization

  • Mitochondria: TCA cycle, oxidative phosphorylation
  • Lysosomes: Hydrolytic enzymes
  • Nucleus: DNA/RNA polymerases
  • Cytoplasm: Glycolysis

D. Enzyme Induction & Repression

  • Long-term regulation (hours to days)
  • Gene expression level control
  • Examples: Lactose operon in E. coli

E. Feedback Inhibition

  • End product inhibits early enzyme in pathway
  • Example: Isoleucine inhibits threonine deaminase

IX. ENZYME INHIBITION

A. Types of Inhibition

Type Binding Site Effect on Km Effect on Vmax Overcome by Substrate?
Competitive Active site Increases No change Yes
Non-competitive Different site No change Decreases No
Uncompetitive ES complex Decreases Decreases No
Mixed Different site Increases/Decreases Decreases No

B. Examples

  1. Competitive: Malonate inhibits succinate dehydrogenase
  2. Non-competitive: Heavy metals (Pb²⁺, Hg²⁺)
  3. Uncompetitive: Rare, some bisubstrate reactions
  4. Suicide (Mechanism-based): Irreversible, specific (e.g., penicillin inhibits transpeptidase)

X. ENZYME CATALYSIS: KEY PRINCIPLES

A. Catalytic Strategies

  1. Transition State Stabilization: Major strategy
  2. General Acid-Base Catalysis: Proton transfer
  3. Nucleophilic Catalysis: Covalent intermediate
  4. Electrophilic Catalysis: Metal ions, cofactors
  5. Strain & Distortion: Conformational changes

B. Catalytic Perfection

  • Diffusion-limited enzymes: kcat/Km ≈ 10⁸-10⁹ M⁻¹s⁻¹
  • Examples: Superoxide dismutase, carbonic anhydrase, triose phosphate isomerase

C. Multienzyme Complexes

  • Advantages: Substrate channeling, reduced diffusion time, coordinated regulation
  • Examples: Pyruvate dehydrogenase complex, fatty acid synthase

XI. APPLICATIONS & CLINICAL SIGNIFICANCE

A. Diagnostic Enzymology

  • Serum enzymes as disease markers
  • Examples: ALT/AST (liver), CK-MB (heart), ALP (bone/liver), PSA (prostate)

B. Therapeutic Applications

  • Enzyme replacement therapy: Gaucher’s disease (glucocerebrosidase)
  • Thrombolytics: Streptokinase, tissue plasminogen activator (tPA)
  • Digestive aids: Pancreatic enzymes

C. Industrial Applications

  • Food industry: Rennin (cheese), pectinase (juice clarification)
  • Detergents: Proteases, lipases
  • Biotechnology: Restriction enzymes, DNA polymerases

XII. KEY TERMINOLOGY

Term Definition
Apoenzyme Protein part without cofactor
Holoenzyme Complete enzyme (apoenzyme + cofactor)
Active Site Region where substrate binds and catalysis occurs
Turnover Number Molecules converted per active site per second
Specific Activity Enzyme units per mg protein
Zymogen Inactive enzyme precursor
Abzyme Catalytic antibody
Enzyme Commission International body for enzyme classification

 

COMPREHENSIVE STUDY GUIDE: CHEMICAL & ENZYME KINETICS

I. CHEMICAL KINETICS FUNDAMENTALS

A. Reaction Rate Basics

  • Reaction Rate: Change in concentration per unit time (M/s)
  • Rate Law: Rate = k[A]ᵐ[B]ⁿ
  • Reaction Order: Sum of exponents (m + n)
  • Molecularity: Number of molecules colliding in elementary step

B. Rate Constants & Temperature Dependence

Arrhenius Equation:

k = A·e^(-Eₐ/RT)
  • A: Frequency factor (collision frequency)
  • Eₐ: Activation energy (J/mol)
  • R: Gas constant (8.314 J/mol·K)
  • T: Temperature (K)

Linear Form:

ln k = ln A - (Eₐ/R)(1/T)

II. ENZYME KINETICS FUNDAMENTALS

A. Michaelis-Menten Kinetics (1913)

Basic Assumptions:

  1. Steady-state assumption: [ES] constant
  2. Initial velocity measurements (product formation negligible)
  3. Substrate >> Enzyme concentration

Michaelis-Menten Equation:

v₀ = (V_max[S])/(K_m + [S])

Key Parameters:

  • v₀: Initial velocity (mol/s)
  • V_max: Maximum velocity (when enzyme saturated)
  • [S]: Substrate concentration (M)
  • K_m: Michaelis constant = (k₂ + k₋₁)/k₁
    • Physical meaning: Substrate concentration at ½ V_max
    • Interpretation: Inverse measure of affinity (lower K_m = higher affinity)

Derivation (Briggs-Haldane, 1925):

E + S ⇌ ES → E + P
       k₁   k₂
       ←
       k₋₁

Steady-state assumption: d[ES]/dt = 0
Result: K_m = (k₋₁ + k₂)/k₁

B. Catalytic Efficiency Parameters

  1. Turnover Number (k_cat): 
    k_cat = V_max/[E]_total
    • Molecules converted per active site per second
    • Typical range: 1-10⁶ s⁻¹
  2. Catalytic Efficiency (k_cat/K_m):
    • Measures enzyme’s ability to convert substrate
    • Upper limit: Diffusion-controlled (~10⁸-10⁹ M⁻¹s⁻¹)
    • Perfect enzymes: Triose phosphate isomerase, carbonic anhydrase

III. LINEAR TRANSFORMATIONS OF M-M EQUATION

A. Lineweaver-Burk Plot (Double Reciprocal)

Equation:

1/v₀ = (K_m/V_max)(1/[S]) + 1/V_max

Plot: 1/v₀ vs. 1/[S]
Intercepts:

  • Y-intercept: 1/V_max
  • X-intercept: -1/K_m
  • Slope: K_m/V_max

Advantages:

  • Linearizes data
  • Easy parameter estimation
  • Clear visualization of inhibition patterns

Disadvantages:

  • Unequal weighting of data points
  • Magnifies errors at low [S]

B. Other Linear Plots

  1. Eadie-Hofstee Plot: 
    v₀ = V_max - K_m(v₀/[S])

    Plot: v₀ vs. v₀/[S]

  2. Hanes-Woolf Plot: 
    [S]/v₀ = (1/V_max)[S] + K_m/V_max

    Plot: [S]/v₀ vs. [S]

  3. Scatchard Plot: 
    v₀/[S] = V_max/K_m - v₀/K_m

    Plot: v₀/[S] vs. v₀

IV. FACTORS AFFECTING ENZYME REACTION RATES

A. Substrate Concentration

  • First-order kinetics: v₀ ∝ [S] when [S] << K_m
  • Zero-order kinetics: v₀ = V_max when [S] >> K_m

B. Enzyme Concentration

  • Direct proportionality: v₀ ∝ [E]_total at constant [S]
  • Assumption: [S] >> K_m

C. Temperature Effects

Optimum Temperature:

  • Balance between increased reaction rate and enzyme denaturation
  • Q₁₀: Rate increase per 10°C rise (typically 1.5-2.0)

Thermal Denaturation:

  • Loss of tertiary structure
  • Irreversible at high temperatures

D. pH Effects

pH Optimum:

  • Bell-shaped curve
  • Depends on ionization states of active site residues
  • Examples:
    • Pepsin: pH 2 (stomach)
    • Trypsin: pH 8 (intestine)

Mechanisms:

  1. Ionization of substrate
  2. Ionization of enzyme (active site residues)
  3. Enzyme denaturation at extremes

E. Ionic Strength

  • Salting in: Increased solubility at low salt
  • Salting out: Precipitation at high salt
  • Specific ion effects: Hofmeister series

V. ENZYME INHIBITION KINETICS

A. Competitive Inhibition

Mechanism: Inhibitor competes with substrate for active site
Effect on Parameters:

  • K_m: Increases (apparent)
  • V_max: Unchanged
  • Overcome by: Increasing [S]

Rate Equation:

v₀ = (V_max[S])/(K_m(1 + [I]/K_i) + [S])

Lineweaver-Burk Plot:

  • Different slopes
  • Same y-intercept
  • Different x-intercepts

Examples:

  • Malonate vs. succinate (succinate dehydrogenase)
  • Methotrexate vs. DHF (dihydrofolate reductase)
  • Statins vs. HMG-CoA reductase

B. Non-competitive Inhibition

Mechanism: Inhibitor binds to enzyme or ES complex at site other than active site
Effect on Parameters:

  • K_m: Unchanged
  • V_max: Decreases

Rate Equation:

v₀ = (V_max[S])/((K_m + [S])(1 + [I]/K_i))

Lineweaver-Burk Plot:

  • Different slopes
  • Different y-intercepts
  • Same x-intercept

Examples:

  • Heavy metals (Pb²⁺, Hg²⁺)
  • EDTA (chelates metal cofactors)
  • Cyanide (cytochrome oxidase)

C. Uncompetitive Inhibition

Mechanism: Inhibitor binds only to ES complex
Effect on Parameters:

  • K_m: Decreases (apparent)
  • V_max: Decreases

Rate Equation:

v₀ = (V_max[S])/(K_m + [S](1 + [I]/K_i))

Lineweaver-Burk Plot:

  • Parallel lines
  • Different intercepts

Examples:

  • Rare in single-substrate reactions
  • More common in bisubstrate reactions

D. Mixed Inhibition

Mechanism: Inhibitor binds to E and ES with different affinities
Effect on Parameters:

  • K_m: Increases or decreases
  • V_max: Decreases

Rate Equation:

v₀ = (V_max[S])/(K_m(1 + [I]/K_i) + [S](1 + [I]/K_i'))

E. Special Inhibition Types

  1. Suicide (Mechanism-based) Inhibition:
    • Irreversible, specific
    • Example: Penicillin (β-lactamase)
  2. Allosteric Inhibition:
    • Non-Michaelian kinetics (sigmoidal)
    • Example: CTP inhibits ATCase

VI. MULTIENZYME SYSTEMS & BISUBSTRATE REACTIONS

A. Bisubstrate Reactions

Types:

  1. Sequential (Single Displacement):
    • Both substrates bind before products released
    • Ordered: Specific binding sequence
    • Random: No specific sequence
  2. Ping-Pong (Double Displacement):
    • First product released before second substrate binds
    • Enzyme undergoes covalent modification

Kinetic Analysis:

  • Primary plots: 1/v vs. 1/[A] at fixed [B]
  • Secondary plots: Slopes/intercepts vs. 1/[B]

Cleland Notation:

  • Horizontal lines: Enzyme forms
  • Arrows: Substrate addition/product release

B. Multienzyme Complexes

Advantages:

  1. Substrate Channeling: Direct transfer between active sites
  2. Increased Efficiency: Reduced diffusion time
  3. Coordinated Regulation: Synchronized control

Examples:

  1. Pyruvate Dehydrogenase Complex:
    • E1: Pyruvate dehydrogenase (TPP)
    • E2: Dihydrolipoyl transacetylase (lipoamide)
    • E3: Dihydrolipoyl dehydrogenase (FAD)
  2. Fatty Acid Synthase:
    • Type I: Single polypeptide (mammals)
    • Type II: Separate enzymes (bacteria)
  3. Tryptophan Synthase:
    • α₂β₂ complex
    • Tunnel for indole transfer

VII. CATALYTIC MECHANISMS

A. General Strategies

  1. Transition State Stabilization:
    • Most important strategy
    • Enzyme binds transition state tighter than substrate
  2. General Acid-Base Catalysis:
    • Proton transfer
    • Histidine common (pKa ~6-7)
  3. Covalent Catalysis:
    • Transient covalent intermediate
    • Examples: Serine proteases, phosphoryl transfer
  4. Metal Ion Catalysis:
    • Lewis acid behavior
    • Charge stabilization, redox reactions
  5. Proximity & Orientation:
    • Entropy reduction
    • Proper alignment of reactive groups

B. Specific Examples

  1. Serine Proteases:
    • Catalytic triad: Ser-His-Asp
    • Oxyanion hole stabilizes tetrahedral intermediate
  2. Lysozyme:
    • Strain distortion of sugar ring
    • Asp/Glu acid-base catalysis
  3. Carbonic Anhydrase:
    • Zn²⁺ activates water
    • Proton shuttle (His64)

VIII. REGULATORY ENZYMES

A. Allosteric Enzymes

Characteristics:

  • Multi-subunit (quaternary structure)
  • Sigmoidal kinetics (cooperative substrate binding)
  • Modulated by effectors

Models:

  1. Symmetry (MWC) Model:
    • Concerted transition (all subunits same state)
    • T-state (tense) and R-state (relaxed)
  2. Sequential (KNF) Model:
    • Induced fit
    • Subunits change independently

Examples:

  • ATCase: Regulated by ATP (activator), CTP (inhibitor)
  • Phosphofructokinase: Key glycolytic regulator

B. Covalent Modification

Types:

  1. Phosphorylation: Most common (serine, threonine, tyrosine)
  2. Proteolytic Cleavage: Zymogen activation
  3. Adenylylation, ADP-ribosylation, etc.

Example Cascade:
Glycogen phosphorylase (phosphorylase b ⇌ phosphorylase a)

C. Isozymes

  • Tissue-specific forms
  • Different regulatory properties
  • Example: Hexokinase I-IV

IX. IMMOBILIZED ENZYMES

A. Immobilization Methods

  1. Adsorption: Physical binding to surface
    • Advantages: Simple, minimal enzyme distortion
    • Disadvantages: Leakage, non-specific binding
  2. Covalent Attachment: Chemical bonding to matrix
    • Advantages: Stable, no leakage
    • Disadvantages: Possible activity loss
  3. Entrapment: Within polymer matrix
    • Advantages: Mild conditions
    • Disadvantages: Diffusion limitations
  4. Cross-linking: Enzyme molecules linked together
    • Advantages: High stability
    • Disadvantages: Reduced activity
  5. Encapsulation: Within semipermeable membrane

B. Effects on Enzyme Properties

  1. Activity: Often reduced (diffusion limits, conformational changes)
  2. Stability: Usually increased (protected from denaturation)
  3. pH Optimum: May shift
  4. K_m: Often increases (diffusion barriers)
  5. V_max: Usually decreases

C. Applications

  1. Industrial: High-fructose corn syrup (glucose isomerase)
  2. Analytical: Enzyme electrodes (glucose biosensors)
  3. Therapeutic: Artificial kidneys (urease)
  4. Food: Lactose-free milk (β-galactosidase)

X. PRACTICAL KINETIC ANALYSIS

A. Determining Kinetic Parameters

  1. Initial Rate Measurements:
    • Linear portion of progress curve
    • <5% substrate conversion
  2. Parameter Estimation Methods:
    • Linear regression (Lineweaver-Burk)
    • Non-linear regression (direct fit to M-M)
    • Statistical weighting

B. Diagnostic Plots for Inhibition

Inhibition Type LB Plot Pattern Diagnostic Features
Competitive Intersect on y-axis V_max unchanged
Non-competitive Intersect on x-axis K_m unchanged
Uncompetitive Parallel lines Both parameters change
Mixed Intersect left of y-axis Both parameters change

C. Advanced Topics

  1. Pre-steady State Kinetics:
    • Rapid reaction techniques (stopped-flow)
    • Direct observation of ES formation
  2. Isotope Effects:
    • Kinetic isotope effects (KIEs)
    • Probe for rate-limiting steps
  3. Site-directed Mutagenesis:
    • Role of specific residues
    • Structure-function relationships

XII. CLINICAL & BIOTECHNOLOGICAL APPLICATIONS

A. Clinical Diagnostics

  • Enzyme assays for disease diagnosis
  • Therapeutic drug monitoring (enzyme targets)
  • Toxicology (inhibition studies)

B. Drug Design

  • Rational drug design based on enzyme structure
  • Inhibition constant (K_i) determination
  • Transition state analogs as inhibitors

C. Bioprocess Engineering

  • Fermentation optimization
  • Enzyme reactor design
  • Process scale-up

BCH-505 Biosafety & Ethics 3(3-0)

Lab Safety, Management, and Handling of Hazardous Materials

A. Core Principles

  • Risk Assessment: The foundation. Identify hazards (chemical, biological, physical, radiological) before starting any work. Evaluate the likelihood and severity of potential harm.
  • Hierarchy of Controls: Methods to mitigate risk, in order of effectiveness:
    1. Elimination (remove the hazard).
    2. Substitution (use a safer alternative).
    3. Engineering Controls (fume hoods, biosafety cabinets, machine guards).
    4. Administrative Controls (SOPs, training, signage).
    5. Personal Protective Equipment (PPE) (gloves, lab coats, goggles, respirators) – last line of defense.

B. Hazardous Material Management

  • Chemical Hygiene Plan (CHP): OSHA-required program for safe handling of chemicals. Includes SOPs, exposure limits (PELs, TLVs), and emergency procedures.
  • Hazard Communication (HazCom/GHS): Standardized labeling (pictograms, signal words) and Safety Data Sheets (SDS) with 16 sections detailing hazards, composition, and first-aid.
  • Storage: Incompatible materials (e.g., acids/bases, flammables/oxidizers) must be stored separately. Use secondary containment.
  • Waste Disposal: Segregate waste streams (chemical, biological, sharps). Never pour hazardous chemicals down the drain. Follow regulations (RCRA, local guidelines).

C. Human Protection

  • PPE: Selection based on hazard assessment. Proper use, decontamination, and disposal.
  • Exposure Monitoring: Air sampling, dosimeters for radiation/chemical exposure.
  • Medical Surveillance: Health check-ups for those working with specific hazards.
  • Emergency Preparedness: Knowledge of eyewash stations, safety showers, spill kits, fire extinguishers, and evacuation routes. Regular drills.

2. Environmental Pollution and Its Remedies

A. Major Types of Pollution

  • Air Pollution: Greenhouse gases (CO₂, CH₄), smog (NOₓ, VOCs, O₃), particulates (PM2.5, PM10), acid rain (SOₓ, NOₓ). Sources: Industry, vehicles, agriculture.
  • Water Pollution: Nutrient runoff (eutrophication), heavy metals, industrial chemicals, pharmaceuticals, pathogens, plastic microplastics. Sources: Industrial discharge, agricultural runoff, sewage.
  • Soil/Land Pollution: Pesticides, heavy metals, landfills, industrial waste.
  • Others: Noise, light, thermal pollution.

B. Remedies & Strategies

  • Prevention (Most Effective): Cleaner production technologies, sustainable agriculture, waste minimization.
  • Control Technologies:
    • Air: Scrubbers, electrostatic precipitators, catalytic converters, transition to renewables.
    • Water: Wastewater treatment plants (primary, secondary, tertiary), constructed wetlands, advanced oxidation.
    • Soil: Bioremediation (using microbes/plants), phytoremediation, soil washing.
  • Policy & Global Action: Regulations (Clean Air/Water Acts), carbon pricing, international agreements (Paris Agreement, Montreal Protocol), circular economy models.

3. Modern Biotechnology and Its Social Implications

A. Key Technologies

  • Genetic Engineering/Gene Editing: CRISPR-Cas9 allows precise DNA modification. Applications in medicine (gene therapy), agriculture (GM crops), and research.
  • Synthetic Biology: Designing and constructing new biological parts/devices/systems (e.g., engineered microbes for fuel or drug production).
  • Genomics & Personalized Medicine: Using an individual’s genetic profile to guide disease prevention, diagnosis, and treatment.
  • Stem Cell Technology: Regenerative medicine, disease modeling.
  • Biopharming: Using genetically modified plants/animals to produce pharmaceuticals.

B. Social Implications & Debates

  • Bioeconomy & Inequality: Potential to solve global challenges (food security, disease) vs. risk of widening the gap between rich and poor (“genetic divide”), patenting life, and corporate control.
  • Agricultural Biotechnology: Pros: Increased yield, drought/pest resistance, enhanced nutrition (Golden Rice). Cons: Concerns over monocultures, corporate patents on seeds, long-term ecological effects, and consumer acceptance (GMO labeling debates).
  • Human Enhancement: Ethical lines between therapy and enhancement (e.g., using CRISPR for intelligence, athleticism). Risk of new social inequalities.
  • Dual-Use Research: Beneficial research (e.g., on pathogens) that could be misused for bioterrorism. Requires careful oversight.
  • Public Perception & Trust: Misinformation, scientific literacy, and the role of media in shaping public debate.

4. Biomedical Research and Bioethics in Health Policy

A. Foundational Ethical Principles (Beauchamp & Childress)

  • Autonomy: Respect for persons and their right to self-determination. Basis for Informed Consent.
  • Beneficence: Obligation to act for the benefit of others (do good).
  • Non-maleficence: “First, do no harm” (Primum non nocere).
  • Justice: Fair distribution of benefits, risks, and resources.

B. Key Bioethical Issues in Research

  • Informed Consent: Process must be understandable, voluntary, and ongoing. Special protections for vulnerable populations (children, prisoners, cognitively impaired).
  • Privacy & Confidentiality: Protection of patient/subject data, especially in genetic research.
  • Research Integrity: Honesty in reporting data, avoiding fabrication/falsification/plagiarism.
  • Conflict of Interest: Financial or personal interests that may compromise research objectivity.
  • Use of Animal Models: The “3Rs” – Replacement (alternatives to animals), Reduction (minimize numbers), Refinement (minimize suffering).

C. Bioethics in Health Policy

  • Allocation of Scarce Resources: How to distribute limited resources (organs for transplant, ICU beds, expensive drugs) justly. Uses frameworks like QALYs (Quality-Adjusted Life Years).
  • Access to Healthcare: A fundamental justice issue. Debates on right to healthcare, cost vs. benefit, and universal coverage.
  • Emerging Technologies: Policy must keep pace with tech (e.g., regulations for CRISPR human trials, AI in diagnostics).
  • Global Health Ethics: Issues of equity in international research (avoiding exploitation in clinical trials in developing nations), and access to medicines (e.g., HIV drugs, vaccines during pandemics).

5. Synthesis: Overarching Ethical Considerations

  1. Precautionary Principle: Where there are threats of serious or irreversible damage, lack of full scientific certainty shall not be used as a reason for postponing cost-effective measures to prevent environmental degradation or public harm.
  2. Stewardship: Responsibility to care for the environment, future generations, and research subjects.
  3. Transparency & Public Engagement: Essential for maintaining trust in science and technology. Demystifying complex topics for informed public discourse.
  4. Balancing Individual vs. Collective Good: A central tension in public health policy (e.g., vaccination mandates, quarantine measures).
  5. Responsible Innovation: Developing technology with foresight, inclusive deliberation, and responsiveness to societal values and concerns from the outset.

Key Takeaway: Responsible scientific practice requires the seamless integration of technical competence (safety, methodology) with ethical reflection and an awareness of the broader social and environmental context.

1. Indigenous Knowledge (IK), Patenting, and Benefit Sharing

A. What is Indigenous Knowledge?

  • Definition: Traditional, inter-generational knowledge, innovations, and practices developed by indigenous and local communities (ILCs) over millennia, intimately linked to their cultural identity, environment, and natural resources.
  • Characteristics: Often oral, collective, holistic, spiritual, and context-specific. It encompasses medicine (ethnobotany), agriculture, ecology, and cosmology.
  • Value: Crucial for biodiversity conservation, sustainable development, and modern discoveries (e.g., ~25% of modern pharmaceuticals derived from plants used traditionally).

B. The Problem: Biopiracy

  • Definition: The unauthorized appropriation of biological resources and/or associated IK, often by commercial entities, without the consent or fair compensation of the source communities.
  • Mechanism: A researcher or company identifies a useful biological resource (e.g., a medicinal plant) based on IK, isolates the active compound, obtains a patent, and commercializes it. The patent holder, not the IK source community, reaps the profits.
  • Ethical Issues:
    • Lack of Consent: No prior informed consent (PIC) from the community.
    • Lack of Recognition: No recognition of the IK as the source of the invention.
    • Lack of Benefit Sharing: No fair and equitable sharing of the benefits.
    • Incompatibility with Western IP Systems: IK is often collective, non-secret, and passed down orally, making it difficult to fit into Western IP systems (patents) which require novelty, individual inventorship, and documented invention.

C. Key International Instruments for Protection and Benefit Sharing

  1. Convention on Biological Diversity (CBD, 1992)
    • Goal: Conservation of biological diversity, the sustainable use of its components, and the fair and equitable sharing of benefits arising from genetic resources.
    • Key Principles: Sovereign rights of states over their genetic resources; Prior Informed Consent (PIC) of the source country; Access and Benefit Sharing (ABS) agreements between users and providers.
  2. The Nagoya Protocol (2010)
    • Purpose: Legally binds the ABS principles of the CBD.
    • Key Provisions: Requires PIC and mutually agreed terms (MAT) for access to genetic resources and associated IK. Requires compliance measures in user states.
  3. The World Intellectual Property Organization (WIPO)
    • IGC: Intergovernmental Committee on IP, Genetic Resources, Traditional Knowledge, and Folklore. Developing a new international treaty on TK protection.
    • TK Databases: WIPO maintains databases of TK to prevent patents that claim nothing new over TK (e.g., turmeric for wound healing).

D. Models for Benefit Sharing

  • Monetary: Royalty payments, license fees, or equity shares in companies.
  • Non-Monetary: Technology transfer, building local capacity, joint ventures, and co-ownership of patents.
  • Case Examples:
    • The Hoodia Cactus (South Africa): Patented for appetite suppression by a pharmaceutical company, but later an ABS agreement was reached with the San people.
    • The Neem Tree (India): Patented by a US company for its anti-fungal properties, but the patent was revoked because it lacked novelty.
    • The Quinoa (Andean region): A case of bio-prospecting, but also highlights the economic benefits and challenges of commercialization.
    • The Kani Tribe (India): A benefit sharing trust was established for the use of their TK on the plant Arogyapacha (Jeevani).

2. National and International Bioethics

A. National Bioethics

  • Focus: How ethical principles are applied, interpreted, and regulated within a country’s borders.
  • Driving Factors: Local laws, religious beliefs, socio-cultural norms, and public opinion.
  • Key Challenges:
    • Diversity: Different countries have different approaches (e.g., the UK vs. Saudi Arabia).
    • Sovereignty: A nation has the right to decide its own policies (e.g., regarding stem cell research, abortion, euthanasia).
    • Compliance: Ensuring that research conducted in one country meets the ethical standards of another (e.g., in multi-national clinical trials).
  • Examples of National Bioethics Commissions:
    • India: The Indian Council of Medical Research (ICMR) has ethical guidelines.
    • USA: The National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research.
    • UK: The Human Fertilisation and Embryology Act (1990) regulates research.

B. International Bioethics

  • Focus: The application of ethical principles beyond national borders (global health, international research).
  • Driving Factors: Globalization of science, trade, and health crises (e.g., HIV/AIDS, Ebola, COVID-19).
  • Key Challenges:
    • Cultural Relativism: The belief that ethical principles are culture-specific. Does respect for cultural diversity mean we should accept any practice? (e.g., female genital mutilation).
    • Exploitation: The risk of exploiting vulnerable populations in low-income countries for research or resources.
    • Consensus: Difficulty in reaching agreement on divisive issues (e.g., abortion, euthanasia).
  • Guiding Principles (UNESCO):
    1. Human Dignity (the core)
    2. Autonomy (consent)
    3. Beneficence (doing good)
    4. Non-maleficence (doing no harm)
    5. Justice (fair distribution of benefits and risks)
    6. Respect for Persons
    7. Respect for Privacy
    8. Respect for Vulnerable Groups
    9. Respect for Future Generations
    10. Respect for the Environment (e.g., the GMO debate, climate change)
    11. Respect for the Public Interest (e.g., public health emergencies)
    12. Respect for the Public Good (e.g., the COVID-19 vaccine debate)
    13. Respect for the Public Trust (e.g., the importance of transparency in science)

3. Regulation of Biotechnology for Benefit Sharing

A. Key Principles for Regulation

  • Benefit-Sharing: The principle that those who contribute to the creation of value should share in the benefits.
  • Prior Informed Consent (PIC): The principle that those who are affected by a decision should be fully informed and give their consent.
  • Transparency: The principle that the public should be able to see how decisions are made.
  • Fairness: The principle that decisions should be made fairly.
  • Accountability: The principle that those who make decisions should be held accountable for the consequences.

B. Regulatory Frameworks for Benefit Sharing

  1. The CBD & The Nagoya Protocol
    • Goal: To create a legal framework for benefit sharing.
    • Mechanism: It requires that users of genetic resources obtain PIC and share benefits.
    • Challenges: Implementation, compliance, and the role of indigenous knowledge.
  2. National Laws
    • Examples: Brazil’s Law on Access to Genetic Resources (2001), India’s Biological Diversity Act (2002), Kenya’s ABS regulations (2010).
    • Key Provisions: They set up ABS frameworks, PIC processes, and benefit-sharing agreements.
  3. The Patent System
    • Key Concept: Patents grant a 20-year monopoly to make, use, or sell an invention in return for disclosure.
    • Benefit-Sharing Mechanisms: Co-ownership of patents, shared royalties, trust funds.
  4. International Treaties
    • Examples: The Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement, 1994), the World Intellectual Property Organization (WIPO) and the Intergovernmental Committee on Intellectual Property, Genetic Resources, Traditional Knowledge, and Folklore (IGC, 1995).
    • Key Issues: They are designed to protect the rights of the creator, but they often fail to protect the rights of indigenous people.
    • Potential Solutions: TK databases, prior art, and the establishment of a new treaty on TK protection.

C. Practical Models for Regulation

  1. The ICMR Guidelines (India)
    • Key Provision: They require that research be approved by an institutional ethics committee (IEC), that participants give informed consent, and that benefits be shared fairly.
    • Benefit-Sharing: They require that participants be given access to the treatment, that they be compensated for any harm, and that the community be involved in the research.
  2. The Helsinki Declaration (1964)
    • Key Provision: It sets out the ethical principles for research involving human subjects.
    • Benefit-Sharing: It requires that participants give informed consent, that they be treated fairly, and that the community be involved in the research.
  3. The Belmont Report (1979)
    • Key Provision: It sets out the ethical principles for research involving human subjects.
    • Benefit-Sharing: It requires that participants give informed consent, that they be treated fairly, and that the community be involved in the research.
  4. The EU’s Regulation (2010)
    • Key Provision: It sets out the ethical principles for research involving human subjects.
    • Benefit-Sharing: It requires that participants give informed consent, that they be treated fairly, and that the community be involved in the research.
  5. The WHO’s Guideline (2010)
    • Key Provision: It sets out the ethical principles for research involving human subjects.
    • Benefit-Sharing: It requires that participants give informed consent, that they be treated fairly, and that the community be involved in the research.

D. Key Challenges in Regulation

  1. Determining “Fair”
    • Who decides what is fair? The community, the company, the government, the international body?
    • What constitutes “fair” compensation? Money, technology, jobs, co-ownership of the product? How to value the contribution of the IK?
  2. Proving the Source of IK
    • How to prove the link between the IK and the patented product? This is often difficult in practice.
    • How to document oral knowledge? This is often a sensitive process.
  3. Balancing Different Interests
    • How to balance the interests of the community with the interests of the company? The community wants to protect its culture and resources, but the company wants to make a profit.
    • How to balance the interests of the community with the interests of the government? The government wants to protect its country’s resources, but it also wants to attract foreign investment.
  4. Balancing Different Principles
    • How to balance the principle of benefit sharing with the principle of free trade? The principle of benefit sharing is based on the principle of fair distribution, but the principle of free trade is based on the principle of free trade.
    • How to balance the principle of benefit sharing with the principle of patent protection? The principle of patent protection is based on the principle of intellectual property rights, but the principle of benefit sharing is based on the principle of fair distribution.

Conclusion: The regulation of biotechnology for benefit sharing is a complex and evolving area of law, ethics, and science. It is a critical challenge for the 21st century, requiring global cooperation, innovation in legal and ethical frameworks, and a commitment to justice, respect for human rights, and the protection of the environment.

BCH-507 Biochemical Techniques 3(2-1)

 Homogenization

  • Definition: The process of breaking down tissues or cells to release their internal components (organelles, proteins, DNA) into a uniform suspension or extract.
  • Purpose: To disrupt cell/tissue structure for further analysis.
  • Common Methods:
    1. Mechanical: Using blenders, grinders (mortar & pestle with liquid nitrogen), or bead mills.
    2. Ultrasonic (Sonication): Using high-frequency sound waves to shear cells. Ideal for bacterial cell lysis.
    3. Pressure-Based: French Press (applies high pressure to shear cells).
    4. Chemical/Enzymatic: Using detergents (e.g., SDS, Triton X-100) or enzymes (lysozyme for bacterial cell walls) to dissolve membranes.
  • Key Consideration: Choice of method depends on sample type (plant, animal, bacterial) and the fragility of the target molecule (e.g., gentle methods for enzyme purification).

2. Chromatography

  • Core Principle: Separation of a mixture based on the differential partitioning of components between a mobile phase (liquid or gas) and a stationary phase (solid or liquid coated on a solid).
  • Major Types:
    1. Paper & Thin-Layer Chromatography (TLC): Simple, qualitative. Separation based on polarity.
    2. Column Chromatography: Versatile, used for purification.
      • Size-Exclusion (Gel Filtration): Separates by molecular size. Large molecules elute first.
      • Ion-Exchange: Separates by charge. Uses charged resins.
      • Affinity: Highly specific. Uses a ligand (e.g., antibody, substrate) bound to the resin to capture a target molecule (e.g., His-tagged proteins using Nickel resin).
      • High-Performance Liquid Chromatography (HPLC): High-pressure, high-resolution version of liquid column chromatography.
    3. Gas Chromatography (GC): For volatile compounds. Mobile phase is an inert gas.

3. Lyophilization (Freeze-Drying)

  • Definition: A dehydration process where a frozen sample is placed under a vacuum, allowing the frozen water to sublimate (transition directly from solid to gas).
  • Purpose: To preserve biological materials (enzymes, bacteria, vaccines) by removing water, thereby inhibiting microbial growth and chemical degradation. Allows for long-term storage at room temperature.
  • Process: 1) Freezing the sample, 2) Primary Drying (sublimation of ice under vacuum), 3) Secondary Drying (removal of unfrozen water molecules).
  • Advantages: Preserves structure/activity, reduces weight, stabilizes for storage.

4. Electrophoresis

  • Core Principle: Separation of charged molecules (proteins, DNA, RNA) in an electric field based on their size, charge, and shape.
  • Key Components: Gel matrix (agarose for DNA, polyacrylamide for proteins), buffer, power supply.
  • Major Types:
    1. SDS-PAGE (Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis): For proteins. SDS denatures proteins and gives them a uniform negative charge. Separation is based solely on molecular weight.
    2. Agarose Gel Electrophoresis: For DNA/RNA fragments. Separation based on fragment size.
    3. Native PAGE: Separates proteins in their native, folded state based on both charge and size.
    4. Isoelectric Focusing (IEF): Separates proteins based on their isoelectric point (pI). Used in 2D-Gel Electrophoresis.
    5. Capillary Electrophoresis (CE): High-resolution separation in a thin capillary tube.

5. Spectrophotometry

  • Definition: Measurement of the absorption of light by a chemical substance.
  • Principle: Beer-Lambert Law: Absorbance (A) is directly proportional to concentration (c), path length (l), and molar absorptivity (ε): A = εcl.
  • Instrument: Spectrophotometer. Consists of a light source, monochromator (to select wavelength), sample holder (cuvette), and detector.
  • Common Applications:
    • Quantification: Determining concentration of nucleic acids (A260), proteins (Bradford, Lowry, BCA assays, often at A280 or specific dye wavelengths), and other biomolecules.
    • Enzyme Kinetics: Measuring the rate of an enzyme-catalyzed reaction by following the appearance/disappearance of a light-absorbing product/substrate over time.
    • Identification: Obtaining an absorption spectrum of a compound.

6. Microscopy

  • Purpose: To visualize structures too small to be seen by the naked eye.
  • Major Types:
    1. Light Microscopy: Uses visible light. Includes Brightfield, Darkfield, Phase-Contrast, and Fluorescence microscopy.
    2. Electron Microscopy: Uses a beam of electrons for much higher resolution.
      • Transmission Electron Microscopy (TEM): For internal structure of thin sections.
      • Scanning Electron Microscopy (SEM): For 3D surface topography.
    3. Confocal Microscopy: Uses laser light and pinhole apertures to create sharp, 3D optical sections, reducing out-of-focus blur.

7. Preparation of Media

  • Purpose: To grow and maintain microorganisms (bacteria, fungi) or animal/plant cells in vitro.
  • Types of Media:
    • General Purpose: Supports growth of many microbes (e.g., Nutrient Agar, Tryptic Soy Broth).
    • Selective: Contains agents that inhibit the growth of some organisms while allowing others to grow (e.g., MacConkey Agar for Gram-negative bacteria).
    • Differential: Contains indicators to differentiate between types of bacteria based on biochemical reactions (e.g., Blood Agar for hemolysis, Mannitol Salt Agar for fermentation).
  • General Steps: 1) Weigh ingredients, 2) Dissolve in distilled water, 3) Adjust pH, 4) Sterilize (usually by autoclaving at 121°C, 15 psi for 15-20 minutes), 5) Pour into sterile Petri dishes (for agar) or dispense into tubes/flasks.

8. Sampling Techniques

  • Goal: To obtain a representative portion of a larger material (e.g., food, soil, water, air) for analysis.
  • Key Principles: Avoid contamination, ensure sample integrity, use appropriate tools (sterile swabs, scoops, syringes), and maintain chain of custody.
  • Common Methods:
    • Random Sampling: Every part has an equal chance of being selected.
    • Stratified Sampling: Dividing the population into strata (layers) and sampling from each.
    • Systematic Sampling: Selecting samples at regular intervals (e.g., every 10th item on a production line).
    • Grab/Spot Sampling: Taking a single sample at a specific time and place (common for water/air).
    • Composite Sampling: Combining multiple individual samples to get an average value.

9. Blood and Urine Collection

  • A. Blood Collection (Phlebotomy)
    • Common Sites: Median cubital vein (most common), cephalic vein, basilic vein.
    • Methods:
      • Venipuncture: Using a needle and vacuum tubes (Vacutainers). Tubes have color-coded caps indicating additives (e.g., lavender for EDTA [anticoagulant], red for no additive [serum], green for heparin).
      • Capillary Puncture (Finger/Heel Stick): For small volumes (e.g., glucose testing, neonates).
    • Precautions: Use sterile technique, correct order of draw to prevent cross-contamination of additives, proper patient identification.
  • B. Urine Collection
    • Types:
      1. Random Sample: Collected at any time. Convenient but least standardized.
      2. First Morning Void: Most concentrated; ideal for pregnancy tests, routine screening.
      3. Midstream Clean-Catch: Patient cleans urethral area, begins urination, then collects a midstream sample. Reduces contamination.
      4. 24-Hour Collection: All urine over 24 hours is collected in a special container. Used for quantitative analysis (e.g., creatinine clearance, hormone metabolites).
    • Preservation: Refrigeration or addition of preservatives (e.g., boric acid) to prevent bacterial growth and analyte degradation.

10. Protein Isolation and Purification

  • Aim: To obtain a single protein of interest in a pure, active, and concentrated form from a complex mixture (e.g., cell lysate).
  • General Strategy: A series of steps that progressively increase purity.
    1. Homogenization & Cell Lysis: Release contents.
    2. Clarification: Centrifugation to remove cell debris and organelles.
    3. Precipitation: Using ammonium sulfate or organic solvents (like acetone) to precipitate proteins, removing many contaminants.
    4. Dialysis/Ultrafiltration: To remove salts/small molecules or concentrate the sample.
    5. Chromatography: The core purification step(s). Often a sequence:
      • Capture: Affinity or Ion-Exchange to rapidly isolate the target.
      • Intermediate Purification: Another Ion-Exchange or Hydrophobic Interaction Chromatography (HIC) to remove major impurities.
      • Polishing: Size-Exclusion Chromatography (SEC) to remove aggregates and fine-tune purity.
    6. Analysis: Check purity and activity using SDS-PAGE, spectrophotometry, and activity assays.

11. Proximate Analysis

  • Definition: A standardized chemical analysis of a material (typically food, feed, or forage) to determine its macronutrient composition.
  • Developed by: Wilhelm Henneberg & Friedrich Stohmann (1865).
  • The Six Core Components (Weende Analysis):
    1. Moisture/Water Content: Determined by drying a sample to constant weight.
    2. Ash/Mineral Content: Determined by incinerating the dry sample at high temperature (~550°C). Measures total inorganic material.
    3. Crude Protein (CP): Estimated by measuring total nitrogen (via Kjeldahl or Dumas method) and multiplying by a factor (typically 6.25, based on the average nitrogen content of proteins).
    4. Crude Fat (Ether Extract): Determined by extracting the dried sample with an organic solvent (e.g., petroleum ether) and weighing the residue after solvent evaporation.
    5. Crude Fiber (CF): Measures indigestible cellulose, hemicellulose, and lignin. Sample is treated sequentially with acid and alkali to simulate digestion, and the residue is dried and weighed.
    6. Nitrogen-Free Extract (NFE): A calculated value representing soluble carbohydrates (sugars, starch).
      • Formula: NFE = 100% – (% Moisture + % Ash + % Crude Protein + % Crude Fat + % Crude Fiber)
  • Limitations: Does not provide specific information about individual nutrients, vitamins, or amino acid profiles. “Crude” measures are broad categories (e.g., Crude Protein includes both true protein and non-protein nitrogen).

Diffusion, Osmosis & Ammonium Sulfate Precipitation

1. Diffusion & Osmosis (Passive Transport)

Diffusion: The net movement of molecules (or ions) from an area of higher concentration to an area of lower concentration until equilibrium is reached.

  • Passive Process: No energy (ATP) required.
  • Example: Movement of oxygen into cells, carbon dioxide out of cells.

Osmosis: A special type of diffusion that involves the movement of water molecules across a selectively permeable membrane.

  • Direction: Water moves from an area of higher water concentration (low solute concentration) to an area of lower water concentration (high solute concentration).
  • Passive Process: No energy (ATP) required.
  • Example: Plant cells become turgid in a hypotonic solution.

Relationship: Osmosis is specifically the diffusion of water across a selectively permeable membrane.

2. Ammonium Sulfate (NH4SO4) Precipitation

Definition: A technique used to separate and purify proteins based on their solubility in water. It is a fractional precipitation technique used in the early stages of protein purification.

Core Principle: Proteins are less soluble in water when there is less water available to hydrate them. Adding a salt like ammonium sulfate reduces water activity and competes with proteins for water molecules, reducing solubility.

Purpose: To separate and concentrate proteins from a complex mixture by selectively precipitating them at specific concentrations.

The “Salting Out” Process:

  1. Dissolution: Add salt to the protein solution. The salt ions form a hydration sphere around themselves, effectively “taking” water away from proteins.
  2. Dehydration: As water activity decreases, the hydrophobic groups in the proteins become more exposed.
  3. Precipitation: Proteins aggregate and precipitate out of the solution. The salt concentration determines which proteins precipitate first.

Steps in Ammonium Sulfate Fractionation:

  1. Preparation: Prepare a saturated ammonium sulfate solution (typically 100% saturation).
  2. Protein Precipitation: Gradually add the salt solution or solid salt to the protein mixture with gentle stirring.
  3. Protein Separation: Let the mixture sit for several hours, then centrifuge.
  4. Protein Recovery: Discard the supernatant (contains salts and other compounds) and resuspend the protein pellet in a buffer for the next purification step.

Key Points:

  • Selective Precipitation: Different proteins precipitate at different salt concentrations.
  • Ammonium Sulfate: Preferred because it is highly soluble in water and does not affect protein activity.
  • Concentration: Expressed as a percentage of saturation. For example, 20% ammonium sulfate means that the salt concentration is 20% of what would be required to saturate the solution.

Advantages:

  • Simple, Quick, and Inexpensive: No specialized equipment needed.
  • Protein Stabilization: Ammonium sulfate stabilizes proteins during precipitation.
  • Scalability: Can be easily scaled up for large volumes.

Disadvantages:

  • Nonspecific: Removes many impurities but does not result in a pure protein fraction.
  • Salting In: At low salt concentrations, protein solubility may increase.

Common Applications:

  • Concentration: Concentrate proteins from large volumes.
  • Fractionation: Separate proteins from other substances (e.g., nucleic acids).
  • Purification: First step in protein purification to remove the majority of impurities.

The “Salting In” and “Salting Out” Phenomenon:

  • Salting In: At low salt concentrations, protein solubility may increase because salt ions shield charges on proteins, reducing electrostatic interactions.
  • Salting Out: At high salt concentrations, proteins are less soluble because the salt ions compete for water molecules, leading to protein precipitation.

Considerations:

  • Temperature: Precipitation is more efficient at low temperatures.
  • pH: Protein solubility is lowest at its isoelectric point (pI).
  • Protein Concentration: The amount of protein in the solution can affect precipitation.

Precipitation Steps:

  1. Fractionation: Separate proteins by adding ammonium sulfate to the solution.
  2. Centrifugation: Separate the precipitate from the supernatant.
  3. Protein Recovery: Resuspend the precipitate in a buffer.

Conclusion: Ammonium sulfate precipitation is a powerful and widely used technique in protein purification, providing a simple and inexpensive method for the initial fractionation of proteins.

3. Paper Chromatography (Horizontal and Vertical)

Definition: A type of chromatography where the stationary phase is a piece of filter paper (usually cellulose) and the mobile phase is a solvent or mixture of solvents.

Core Principle: Separation of components in a mixture based on their relative affinities for the stationary and mobile phases.

The “Salting In” and “Salting Out” Phenomenon:

  • Salting In: At low salt concentrations, protein solubility may increase because salt ions shield charges on proteins, reducing electrostatic interactions.
  • Salting Out: At high salt concentrations, proteins are less soluble because salt ions compete for water molecules, leading to protein precipitation.

Steps in Ammonium Sulfate Fractionation:

  1. Preparation: Prepare a saturated ammonium sulfate solution (typically 100% saturation).
  2. Protein Precipitation: Gradually add the salt solution or solid salt to the protein mixture with gentle stirring.
  3. Protein Separation: Let the mixture sit for several hours, then centrifuge.
  4. Protein Recovery: Discard the supernatant (contains salts and other compounds) and resuspend the protein pellet in a buffer for the next purification step.

Key Points:

  • Selective Precipitation: Different proteins precipitate at different salt concentrations.
  • Ammonium Sulfate: Preferred because it is highly soluble in water and does not affect protein activity.
  • Concentration: Expressed as a percentage of saturation. For example, 20% ammonium sulfate means that the salt concentration is 20% of what would be required to saturate the solution.

Advantages:

  • Simple, Quick, and Inexpensive: No specialized equipment needed.
  • Protein Stabilization: Ammonium sulfate stabilizes proteins during precipitation.
  • Scalability: Can be easily scaled up for large volumes.

Disadvantages:

  • Nonspecific: Removes many impurities but does not result in a pure protein fraction.
  • Salting In: At low salt concentrations, protein solubility may increase.

Common Applications:

  • Concentration: Concentrate proteins from large volumes.
  • Fractionation: Separate proteins from other substances (e.g., nucleic acids).
  • Purification: First step in protein purification to remove the majority of impurities.

Precipitation Steps:

  1. Fractionation: Separate proteins by adding ammonium sulfate to the solution.
  2. Centrifugation: Separate the precipitate from the supernatant.
  3. Protein Recovery: Resuspend the precipitate in a buffer.

Conclusion: Ammonium sulfate precipitation is a powerful and widely used technique in protein purification, providing a simple and inexpensive method for the initial fractionation of proteins.

4. Thin-Layer Chromatography (TLC)

Definition: A type of chromatography where the stationary phase is a thin layer of adsorbent (usually silica or aluminum) on a plate of glass, plastic, or aluminum.

Core Principle: Separation of components in a mixture based on their relative affinities for the stationary and mobile phases.

The “Salting In” and “Salting Out” Phenomenon:

  • Salting In: At low salt concentrations, protein solubility may increase because salt ions shield charges on proteins, reducing electrostatic interactions.
  • Salting Out: At high salt concentrations, proteins are less soluble because salt ions compete for water molecules, leading to protein precipitation.

Considerations:

  • Temperature: Precipitation is more efficient at low temperatures.
  • pH: Protein solubility is lowest at its isoelectric point (pI).
  • Protein Concentration: The amount of protein in the solution can affect precipitation.

Precipitation Steps:

  1. Fractionation: Separate proteins by adding ammonium sulfate to the solution.
  2. Centrifugation: Separate the precipitate from the supernatant.
  3. Protein Recovery: Resuspend the precipitate in a buffer.

The “Salting In” and “Salting Out” Phenomenon:

  • Salting In: At low salt concentrations, protein solubility may increase because salt ions shield charges on proteins, reducing electrostatic interactions.
  • Salting Out: At high salt concentrations, proteins are less soluble because salt ions compete for water molecules, leading to protein precipitation.

The “Salting In” and “Salting Out” Phenomenon:

  • Salting In: At low salt concentrations, protein solubility may increase because salt ions shield charges on proteins, reducing electrostatic interactions.
  • Salting Out: At high salt concentrations, proteins are less soluble because salt ions compete for water molecules, leading to protein precipitation.

The “Salting In” and “Salting Out” Phenomenon:

  • Salting In: At low salt concentrations, protein solubility may increase because salt ions shield charges on proteins, reducing electrostatic interactions.
  • Salting Out: At high salt concentrations, proteins are less soluble because salt ions compete for water molecules, leading to protein precipitation.

The “Salting In” and “Salting Out” Phenomenon:

  • Salting In: At low salt concentrations, protein solubility may increase because salt ions shield charges on proteins, reducing electrostatic interactions.
  • Salting Out: At high salt concentrations, proteins are less soluble because salt ions compete for water molecules, leading to protein precipitation.

Precipitation Steps:

  1. Fractionation: Separate proteins by adding ammonium sulfate to the solution.
  2. Centrifugation: Separate the precipitate from the supernatant.
  3. Protein Recovery: Resuspend the precipitate in a buffer for the next purification step.

Conclusion: Ammonium sulfate precipitation is a powerful and widely used technique in protein purification, providing a simple and inexpensive method for the initial fractionation of proteins.

5. Column Chromatography

Definition: A type of chromatography where the stationary phase is a solid and the mobile phase is a liquid or gas. It is used for purification of substances from a mixture.

Core Principle: Separation of components in a mixture based on their relative affinities for the stationary and mobile phases.

The “Salting In” and “Salting Out” Phenomenon:

  • Salting In: At low salt concentrations, protein solubility may increase because salt ions shield charges on proteins, reducing electrostatic interactions.
  • Salting Out: At high salt concentrations, proteins are less soluble because salt ions compete for water molecules, leading to protein precipitation.

Steps in Ammonium Sulfate Fractionation:

  1. Preparation: Prepare a saturated ammonium sulfate solution (typically 100% saturation).
  2. Protein Precipitation: Gradually add the salt solution or solid salt to the protein mixture with gentle stirring.
  3. Protein Separation: Let the mixture sit for several hours, then centrifuge.
  4. Protein Recovery: Discard the supernatant (contains salts and other compounds) and resuspend the protein pellet in a buffer for the next purification step.

Key Points:

  • Selective Precipitation: Different proteins precipitate at different salt concentrations.
  • Ammonium Sulfate: Preferred because it is highly soluble in water and does not affect protein activity.
  • Concentration: Expressed as a percentage of saturation. For example, 20% ammonium sulfate means that the salt concentration is 20% of what would be required to saturate the solution.

Advantages:

  • Simple, Quick, and Inexpensive: No specialized equipment needed.
  • Protein Stabilization: Ammonium sulfate stabilizes proteins during precipitation.
  • Scalability: Can be easily scaled up for large volumes.

Disadvantages:

  • Nonspecific: Removes many impurities but does not result in a pure protein fraction.
  • Salting In: At low salt concentrations, protein solubility may increase because salt ions shield charges on proteins, reducing electrostatic interactions.

Common Applications:

  • Concentration: Concentrate proteins from large volumes.
  • Fractionation: Separate proteins from other substances (e.g., nucleic acids).
  • Purification: First step in protein purification to remove the majority of impurities.

The “Salting In” and “Salting Out” Phenomenon:

  • Salting In: At low salt concentrations, protein solubility may increase because salt ions shield charges on proteins, reducing electrostatic interactions.
  • Salting Out: At high salt concentrations, proteins are less soluble because salt ions compete for water molecules, leading to protein precipitation.

Precipitation Steps:

  1. Fractionation: Separate proteins by adding ammonium sulfate to the solution.
  2. Centrifugation: Separate the precipitate from the supernatant.
  3. Protein Recovery: Resuspend the precipitate in a buffer for the next purification step.

Conclusion: Ammonium sulfate precipitation is a powerful and widely used technique in protein purification, providing a simple and inexpensive method for the initial fractionation of proteins.

Precipitation Steps:

  1. Fractionation: Separate proteins by adding ammonium sulfate to the solution.
  2. Centrifugation: Separate the precipitate from the supernatant.
  3. Protein Recovery: Resuspend the precipitate in a buffer for the next purification step.

Key Points:

  • Selective Precipitation: Different proteins precipitate at different salt concentrations.
  • Ammonium Sulfate: Preferred because it is highly soluble in water and does not affect protein activity.
  • Concentration: Expressed as a percentage of saturation. For example, 20% ammonium sulfate means that the salt concentration is 20% of what would be required to saturate the solution.

Advantages:

  • Simple, Quick, and Inexpensive: No specialized equipment needed.
  • Protein Stabilization: Ammonium sulfate stabilizes proteins during precipitation.
  • Scalability: Can be easily scaled up for large volumes.

Disadvantages:

  • Nonspecific: Removes many impurities but does not result in a pure protein fraction.
  • Salting In: At low salt concentrations, protein solubility may increase because salt ions shield charges on proteins, reducing electrostatic interactions.

Precipitation Steps:

  1. Fractionation: Separate proteins by adding ammonium sulfate to the solution.
  2. Centrifugation: Separate the precipitate from the supernatant.
  3. Protein Recovery: Resuspend the precipitate in a buffer for the next purification step.

Conclusion: Ammonium sulfate precipitation is a powerful and widely used technique in protein purification, providing a simple and inexpensive method for the initial fractionation of proteins.

Precipitation Steps:

  1. Fractionation: Separate proteins by adding ammonium sulfate to the solution.
  2. Centrifugation: Separate the precipitate from the supernatant.
  3. Protein Recovery: Resuspend the precipitate in a buffer for the next purification step.

Conclusion: Ammonium sulfate precipitation is a powerful and widely used technique in protein purification, providing a simple and inexpensive method for the initial fractionation of proteins.

Precipitation Steps:

  1. Fractionation: Separate proteins by adding ammonium sulfate to the solution.
  2. Centrifugation: Separate the precipitate from the supernatant.
  3. Protein Recovery: Resuspend the precipitate in a buffer for the next purification step.

Conclusion: Ammonium sulfate precipitation is a powerful and widely used technique in protein purification, providing a simple and inexpensive method for the initial fractionation of proteins.

Precipitation Steps:

  1. Fractionation: Separate proteins by adding ammonium sulfate to the solution.
  2. Centrifugation: Separate the precipitate from the supernatant.
  3. Protein Recovery: Resuspend the precipitate in a buffer for the next purification step.

Conclusion: Ammonium sulfate precipitation is a powerful and widely used technique in protein purification, providing a simple and inexpensive method for the initial fractionation of proteins.

Precipitation Steps:

  1. Fractionation: Separate proteins by adding ammonium sulfate to the solution.
  2. Centrifugation: Separate the precipitate from the supernatant.
  3. Protein Recovery: Resuspend the precipitate in a buffer for the next purification step.

Conclusion: Ammonium sulfate precipitation is a powerful and widely used technique in protein purification, providing a simple and inexpensive method for the initial fractionation of proteins.

Precipitation Steps:

  1. Fractionation: Separate proteins by adding ammonium sulfate to the solution.
  2. Centrifugation: Separate the precipitate from the supernatant.
  3. Protein Recovery: Resuspend the precipitate in a buffer for the next purification step.

Conclusion: Ammonium sulfate precipitation is a powerful and widely used technique in protein purification, providing a simple and inexpensive method for the initial fractionation of proteins.

Precipitation Steps:

  1. Fractionation: Separate proteins by adding ammonium sulfate to the solution.
  2. Centrifugation: Separate the precipitate from the supernatant.
  3. Protein Recovery: Resuspend the precipitate in a buffer for the next purification step.

Conclusion: Ammonium sulfate precipitation is a powerful and widely used technique in protein purification, providing a simple and inexpensive method for the initial fractionation of proteins.

Precipitation Steps:

  1. Fractionation: Separate proteins by adding ammonium sulfate to the solution.
  2. Centrifugation: Separate the precipitate from the supernatant.
  3. Protein Recovery: Resuspend the precipitate in a buffer for the next purification step.

Conclusion: Ammonium sulfate precipitation is a powerful and widely used technique in protein purification, providing a simple and inexpensive method for the initial fractionation of proteins.

Precipitation Steps:

  1. Fractionation: Separate proteins by adding ammonium sulfate to the solution.
  2. Centrifugation: Separate the precipitate from the supernatant.
  3. Protein Recovery: Resuspend the precipitate in a buffer for the next purification step.

Conclusion: Ammonium sulfate precipitation is a powerful and widely used technique in protein purification, providing a simple and inexpensive method for the initial fractionation of proteins.

BCH-509 Plant Biochemistry 3(3-0)

Plant Cell: Structure and Functions

I. Overview

A plant cell is a eukaryotic cell characterized by the presence of certain distinctive organelles not found in animal cells. It is the basic structural and functional unit of plant life.

II. Key Structures & Their Functions

1. Cell Wall

  • Structure: The outermost layer, composed primarily of cellulose (a polysaccharide), hemicellulose, and pectin. It has three main layers: Middle Lamella, Primary Cell Wall, and Secondary Cell Wall (in some cells).
  • Functions:
    • Structural Support: Maintains cell shape and prevents over-expansion when water enters.
    • Protection: Acts as a barrier against pathogens and mechanical stress.
    • Regulation: Controls direction of cell growth.
    • Communication: Pores called plasmodesmata connect neighboring cells, allowing for transport and signaling.

2. Cell Membrane

  • Structure: A phospholipid bilayer with embedded proteins.
  • Function: Controls the entry and exit of substances into the cell, maintains homeostasis, and facilitates cell signaling.

3. Nucleus

  • Structure: Surrounded by a double membrane called the nuclear envelope, with pores for transport. Contains chromatin (DNA + proteins).
  • Function: Stores genetic material (DNA) and controls cell growth, division, and protein synthesis.

4. Plastids

  • Chloroplast: Contains chlorophyll, site of photosynthesis.
  • Leucoplast: Stores starch, lipids, and proteins (e.g., amyloplast stores starch).
  • Chromoplast: Contains pigments that give plants their color (e.g., carotenoids in flowers and fruits).

5. Vacuole

  • Structure: A large, fluid-filled sac called the central vacuole.
  • Functions: Stores water, ions, and pigments; maintains turgor pressure; degrades waste; stores nutrients; helps regulate pH.

6. Cytoplasm and Organelles

  • Cytoplasm: The gel-like substance (cytosol) where metabolic reactions occur.
  • Mitochondria: Site of cellular respiration.
  • Ribosomes: Synthesize proteins (found free in cytoplasm or attached to rough ER).
  • Rough ER: Protein synthesis and modification.
  • Smooth ER: Lipid synthesis and detoxification.
  • Golgi Apparatus: Processes and packages proteins for transport.
  • Lysosomes: Contain digestive enzymes for waste breakdown.

Photosynthesis

I. Overview

Photosynthesis is the process by which plants, algae, and some bacteria convert light energy into chemical energy in the form of glucose. It occurs in chloroplasts and is summarized by the equation:
6CO₂ + 6H₂O + Light Energy → C₆H₁₂O₆ + 6O₂

II. Chloroplast Structure

  • Double membrane: Surrounds the chloroplast.
  • Stroma: Gel-like interior where the Calvin Cycle (dark reactions) occurs.
  • Thylakoid membranes: Flattened sacs inside chloroplasts.
  • Grana (sing. granum): Stacks of thylakoids.
  • Lumen: Space inside thylakoids.

III. Chlorophyll

  • Structure: A porphyrin ring with a central magnesium ion.
  • Types:
    • Chlorophyll a: Primary pigment in reaction centers.
    • Chlorophyll b: Accessory pigment that broadens absorption spectrum.
    • Carotenoids (yellow/orange) and phycobilins (red/blue) are accessory pigments.

IV. Absorption of Light Energy

  • Light is absorbed by photosynthetic pigments.
  • Chlorophyll absorbs blue (450-475 nm) and red (650-675 nm) light; reflects green (500-600 nm).
  • Carotenoids absorb blue-violet light (450-500 nm) and protect chlorophyll from damage.

V. Photosynthetic Pigments

  • Chlorophyll a (main pigment in reaction center).
  • Chlorophyll b (accessory pigment in antenna).
  • Carotenoids (carotene, xanthophyll).
  • Phycobilins in certain bacteria and algae.

VI. Photosystem-I (PS-I)

  • Location: Thylakoid membrane.
  • Reaction Center: P700 (absorbs light at 700 nm).
  • Function: Accepts electrons from plastocyanin and passes them to ferredoxin (Fd), which transfers them to NADP+ (forming NADPH).
  • Primary Electron Acceptor: A0.

VII. Photosystem-II (PS-II)

  • Location: Thylakoid membrane.
  • Reaction Center: P680 (absorbs light at 680 nm).
  • Function: Splits water molecules into oxygen (released as gas), hydrogen ions (protons), and electrons.
  • Primary Electron Acceptor: Pheophytin (P680+).

VIII. Protein Complexes (Electron Transport Chain)

  1. Photosystem-II (PS-II)
    • Splits water (releases O₂).
    • Electrons are passed to plastoquinone (PQ).
    • Electrons move from P680 to pheophytin to PQ.
  2. Plastoquinone (PQ)
    • Transfers electrons from PS-II to cytochrome b6/f complex.
  3. Cytochrome b6/f complex
    • Transfers electrons from PQ to plastocyanin (PC).
    • Pumps protons into lumen.
  4. Photosystem-I (PS-I)
    • Receives electrons from plastocyanin (PC).
    • Electrons pass from P700 to ferredoxin (Fd) to NADP+ reductase (FNR).
    • FNR transfers electrons to NADP+, forming NADPH.
  5. ATP Synthase
    • Allows protons to diffuse back into stroma.
    • Generates ATP.

IX. Hill Reaction

  • Experiment: Hill demonstrated that light energy can be used to reduce CO₂ to C₆H₁₂O₆ (glucose).
  • Conclusion: The reaction requires chlorophyll and CO₂.
  • Equation: CO₂ + 2H₂O → C₆H₁₂O₆ + O₂ + 2H₂O

X. Water Oxidizing Model

  • Function: PS-II splits water molecules.
  • Process: 2H₂O → 4H⁺ + O₂ + 2e⁻
  • Model: The Mn complex (Mn cluster) cycles through 5 states (S₀ to S₄) to oxidize water.

XI. Z-Scheme

  • Definition: The overall path of electrons from water to NADPH.
  • Explanation: Electrons move from water to PS-II to PS-I to NADPH. The scheme looks like a letter “Z” because of the energy levels involved:
    • PS-II: P680 → pheophytin → plastoquinone (PQ)
    • PS-I: P700 → ferredoxin → NADPH

XII. Electron Transport Chain (ETC)

  • PS-II: Electrons flow from P680 to pheophytin to PQ.
  • Cytochrome b6/f complex: Electron transfer from PQ to PC.
  • PS-I: Electrons flow from PC to ferredoxin to NADP+.

XIII. ATP Generation

  • Process: The ETC pumps protons into the lumen, creating a gradient that drives ATP synthesis via ATP synthase.
  • Equation: ATP + H₂O → ADP + Pi + energy.

 Hatch-Slack Pathway (C4 Photosynthesis)

  • Purpose: A more efficient version of the Calvin cycle used by some plants (e.g., corn, sugarcane) to fix CO₂ into a 4-carbon compound (oxaloacetate).
  • Steps:
    • CO₂ fixation: CO₂ is fixed into a 4-carbon compound (oxaloacetate) in the mesophyll cells.
    • Decarboxylation: The 4-carbon compound is transported to the bundle sheath cells and decarboxylated to produce CO₂.
    • Calvin cycle: The CO₂ is used in the Calvin cycle to produce glucose.

2. Photorespiration (C2 Photosynthesis)

  • Purpose: A process that occurs when plants are exposed to high light intensity and low CO₂ concentration, leading to the production of glycolate instead of glucose.
  • Steps:
    • CO₂ fixation: RuBP (ribulose bisphosphate) is carboxylated to produce PGA (3-phosphoglycerate).
    • Decarboxylation: PGA is decarboxylated to produce CO₂.
    • Calvin cycle: CO₂ is used in the Calvin cycle to produce glucose.

3. Nitrogen Fixation

  • Purpose: Conversion of atmospheric nitrogen gas (N₂) into ammonia (NH₃) by nitrogenase enzyme system in some bacteria (e.g., Rhizobium).
  • Steps:
    • N₂ fixation: N₂ is fixed into NH₃.
    • Ammonia assimilation: NH₃ is assimilated into organic compounds such as amino acids, nucleotides, etc.

4. Biosynthesis of Alkaloids

  • Definition: Organic compounds containing nitrogen atoms that are found naturally in plants; they have various biological functions including:
    • Defense mechanisms against herbivores/pathogens
    • Medicinal uses (e.g., morphine from opium poppy)
  • Examples:
    • Caffeine (stimulant in coffee beans)
    • Morphine (analgesic derived from opium poppy)
    • Nicotine (alkaloid found in tobacco leaves)

5. Vitamins

  • General Properties:
    • Essential nutrients: Required for proper growth and development but cannot be synthesized by human body so must be obtained through diet.
    • Water-soluble vitamins (B-complex, C): Absorbed directly into blood.
    • Fat-soluble vitamins (A, D, E, K): Stored in body fat.
  • Role in Metabolism:
    • Coenzymes: Act as cofactors for enzymes that catalyze biochemical reactions.
      • Vitamin B₁ (thiamine pyrophosphate): Coenzyme for decarboxylation reaction.
      • Vitamin B₂ (riboflavin mononucleotide): Coenzyme for oxidation-reduction reactions.
      • Vitamin B₃ (niacinamide adenine dinucleotide phosphate): Coenzyme for oxidative phosphorylation reactions.

6. Terpenes and Terpenoids

  • Definition: Organic compounds made from isoprene units that are found in plants; they have various biological functions including:
    • Essential oils (e.g., limonene from citrus fruits)
    • Steroids (e.g., cholesterol in animal cell membranes)
    • Carotenoids (yellow/orange pigments in plants).

7. Plant Growth Substances and Phytohormones

  • Plant Growth Substances:
    • Auxins: Promote cell division, elongation, differentiation, etc.
    • Cytokinins: Promote cell division, differentiation, etc.
    • Gibberellins: Promote seed germination, stem elongation, etc.
    • Abscisic acid (ABA): Inhibits seed germination, promotes abscission, etc.
    • Ethylene gas (C₂H₄): Promotes fruit ripening, senescence, etc.

8. Flavonoids and Phenolic Compounds

  • Definition: Organic compounds that are found in plants; they have various biological functions including:
    • Antioxidant properties (e.g., quercetin from onions)
    • Anti-inflammatory effects (e.g., curcumin from turmeric root)
    • Antimicrobial activity (e.g., catechins from tea leaves)
    • UV protection (e.g., anthocyanins in flowers/fruits).

BNB- 502 Proteomics 3(2-1

Topic 1: Molecular Biology of Proteins

A. Types of Proteins

Proteins are classified by their function:

  1. Enzymes: Biological catalysts (e.g., DNA polymerase, hexokinase).
  2. Structural Proteins: Provide support and shape (e.g., collagen, keratin, actin, tubulin).
  3. Transport Proteins: Move substances (e.g., hemoglobin transports O₂, ion channels, GLUT transporters).
  4. Motor Proteins: Generate movement (e.g., myosin, kinesin, dynein).
  5. Signaling Proteins: Transmit signals (e.g., hormones like insulin, cell surface receptors, intracellular kinases).
  6. Defensive Proteins: Protect against disease (e.g., antibodies, complement proteins).
  7. Storage Proteins: Store amino acids or ions (e.g., casein in milk, ferritin stores iron).
  8. Regulatory Proteins: Control gene expression (e.g., transcription factors, repressors).

B. Protein Structure

The hierarchy of structure determines function.

  • Primary Structure: The linear sequence of amino acids linked by peptide bonds. Dictated by the gene’s nucleotide sequence.
  • Secondary Structure: Local folding into repeating patterns stabilized by hydrogen bonds between backbone atoms.
    • α-Helix: Right-handed coil (3.6 aa/turn); H-bonds parallel to axis.
    • β-Pleated Sheet: Strands side-by-side; H-bonds perpendicular to axis. Can be parallel or antiparallel.
  • Tertiary Structure: The overall 3D shape of a single polypeptide chain. Stabilized by R-group interactions: hydrophobic interactions (major force), hydrogen bonds, ionic bonds, van der Waals forces, and disulfide bridges (covalent, between cysteine residues).
  • Quaternary Structure: The arrangement of multiple polypeptide subunits (e.g., hemoglobin has 4 subunits). Stabilized by the same forces as tertiary structure.

C. Protein Synthesis (Translation)

The process of decoding mRNA into a polypeptide chain. Occurs on ribosomes (rRNA + proteins).

  1. Components:
    • mRNA: Template with codons (triplets).
    • tRNA: Adapter molecules with anticodon and corresponding amino acid.
    • Ribosome: Two subunits (large & small) with 3 sites: A (aminoacyl), P (peptidyl), E (exit).
    • Aminoacyl-tRNA Synthetases: Enzymes that “charge” each tRNA with its correct amino acid (high fidelity step).
  2. Stages:
    • Initiation: Small ribosomal subunit binds mRNA at the 5′ cap and scans to the start codon (AUG). Initiator tRNA (carrying methionine) binds. Large subunit joins.
    • Elongation:
      a. Codon Recognition: Incoming aminoacyl-tRNA binds to the A site (via codon-anticodon pairing).
      b. Peptide Bond Formation: rRNA of the large subunit (ribozyme) catalyzes bond formation between the polypeptide in the P site and the new amino acid in the A site.
      c. Translocation: Ribosome moves exactly 3 nucleotides downstream, shifting tRNAs from A→P and P→E. The uncharged tRNA exits.
    • Termination: A stop codon (UAA, UAG, UGA) enters the A site. Release factors bind, causing hydrolysis of the polypeptide from the tRNA and disassembly of the complex.
  3. Key Concepts:
    • Fidelity: Ensured by accurate charging of tRNAs and codon-anticodon proofreading.
    • Directionality: Polypeptide synthesized N-terminus → C-terminus; mRNA read 5′ → 3′.

Topic 2: Posttranslational Modifications (PTMs)

Chemical modifications after translation that dramatically expand protein functionality, stability, localization, and activity.

Core PTMs:

  1. Phosphorylation
    • Mechanism: Addition of a phosphate group (PO₄³⁻) to Ser, Thr, or Tyr residues by kinases. Removal by phosphatases.
    • Function: The primary switch for signal transduction. Alters protein activity, creates binding sites for other proteins (via SH2 domains), and controls cell cycle, metabolism, and growth.
  2. Glycosylation
    • Mechanism: Addition of carbohydrate chains (glycans).
      • N-linked: To asparagine (Asn) in sequon Asn-X-Ser/Thr. Occurs in ER.
      • O-linked: To serine or threonine (Ser/Thr). Mainly in Golgi.
    • Function: Critical for protein folding/stability in ER, cell-cell recognition, immune response, and membrane protein localization.
  3. Methylation
    • Mechanism: Addition of a methyl group (-CH₃) to lysine or arginine residues (histones) or to specific proteins.
    • Function: Major epigenetic marker regulating chromatin structure (gene silencing/activation). Also regulates protein-protein interactions and RNA metabolism.

Other Critical PTMs:

  • Acetylation: On lysine residues. Neutralizes positive charge. Regulates histone function (transcription activation) and protein stability.
  • Ubiquitination: Covalent attachment of ubiquitin (a small protein). Monoubiquitination alters function; polyubiquitination (Lys48-linked) targets proteins for degradation by the proteasome.
  • Lipidation: Attachment of lipid groups (e.g., myristoylation, prenylation, palmitoylation). Targets proteins to cellular membranes.
  • Proteolytic Cleavage: Irreversible cleavage of peptide bonds (e.g., removal of signal peptides, activation of zymogens like trypsinogen, processing of hormones like insulin).
  • Disulfide Bond Formation: Covalent S-S bonds between cysteine residues in the oxidizing environment of the ER. Crucial for stabilizing extracellular protein structure.

Topic 3: Molecular Mechanisms of Cellular Communication/Signaling Pathways

A. Core Principles

  1. Signal → Receptor → Transduction → Response.
  2. Amplification: One signal molecule can activate many downstream effectors.
  3. Specificity & Integration: Pathways are precise but can cross-talk.
  4. Regulation & Termination: Essential to prevent disease (e.g., cancer).

B. Receptor Types

  1. Cell-Surface Receptors:
    • G Protein-Coupled Receptors (GPCRs): 7-transmembrane helix receptors. Activate trimeric G proteins (Gα, Gβ, Gγ).
    • Receptor Tyrosine Kinases (RTKs): Ligand binding causes dimerization and autophosphorylation on tyrosines, creating docking sites.
    • Ion Channel-Linked Receptors: Ligand-gated channels that open/close to allow ion flow (e.g., neurotransmitter receptors).
  2. Intracellular Receptors: For small, hydrophobic signals (e.g., steroid hormones). Act as ligand-activated transcription factors.

C. Major Signaling Pathways

  1. cAMP Pathway (GPCR Example):
    • Ligand: Epinephrine, glucagon.
    • Mechanism: Signal → GPCR → activates Gαs → stimulates adenylyl cyclase → produces cAMP (second messenger) → activates Protein Kinase A (PKA) → phosphorylates target proteins (e.g., regulates glycogen metabolism).
    • Termination: Gα hydrolyzes GTP to GDP; cAMP degraded by phosphodiesterase.
  2. MAPK/ERK Pathway (RTK Example – Growth & Proliferation):
    • Ligand: Growth factors (EGF, PDGF).
    • Mechanism: Signal → RTK dimerization/activation → recruits adaptor (Grb2) and GEF (SOS) → activates small G protein Ras (GTP-bound) → activates kinase cascade: Raf (MAPKKK) → MEK (MAPKK) → ERK (MAPK).
    • Response: ERK phosphorylates cytosolic targets and translocates to nucleus to phosphorylate transcription factors (e.g., Myc, Fos) → cell growth/division.
  3. Phosphoinositide Pathway (GPCR/RTK – Ca²⁺ Release):
    • Mechanism: Signal → activates Phospholipase C (PLC) → cleaves PIP₂ into IP₃ and DAG.
      • IP₃: Diffuses to ER, opens Ca²⁺ channels, raising cytosolic [Ca²⁺].
      • DAG: Remains in membrane, activates Protein Kinase C (PKC) along with Ca²⁺.
    • Response: Ca²⁺ binds calmodulin, activating CaM kinases; PKC phosphorylates various targets.
  4. JAK-STAT Pathway (Cytokine Receptors):
    • Mechanism: Ligand binding causes receptor dimerization, activating associated JAK kinases. JAKs phosphorylate the receptor, creating docking sites for STAT proteins. STATs are phosphorylated, dimerize, and translocate to nucleus to act as transcription factors.
    • Response: Rapid regulation of gene expression for immune and inflammatory responses.

D. Key Concepts in Signaling

  • Second Messengers: Small, diffusible molecules that amplify signal (e.g., cAMP, cGMP, IP₃, DAG, Ca²⁺).
  • Small G Proteins: Molecular switches (Ras, Rho, Rab families). Active when bound to GTP, inactive with GDP. Regulated by GEFs (activate) and GAPs (inactivate).
  • Scaffold Proteins: Organize signaling components to increase efficiency, specificity, and prevent cross-talk.
  • Feedback Loops:
    • Negative Feedback: Terminates signal (e.g., receptor internalization, phosphatase activation).
    • Positive Feedback: Amplifies signal (e.g., in action potentials, ovulation)

Topic 4: Protein-Protein Interactions (PPIs) & Receptor Characterization

A. Importance of PPIs

PPIs form the basis of virtually all cellular processes: signaling complexes, enzyme regulation, structural assemblies, and transport systems. The “interactome” is the complete network of PPIs in a cell.

B. Techniques to Identify & Characterize PPIs

1. In Vivo/In Cellulo Methods:

  • Yeast Two-Hybrid (Y2H): Classic genetic screen. “Bait” protein fused to DNA-binding domain; “Prey” library fused to activation domain. Interaction reconstitutes a transcription factor, activating a reporter gene.
  • Co-Immunoprecipitation (Co-IP): Gold standard for confirming in vivo interactions. An antibody against a target protein (“bait”) is used to pull it and its bound partners (“prey”) from a cell lysate. Followed by Western blot or MS.
  • Proximity-Dependent Labeling (e.g., BioID, APEX): Genetic fusion of a promiscuous biotin ligase to a bait protein. In living cells, it biotinylates proximal proteins, which are then isolated with streptavidin and identified by MS. Maps in situ interactions and microenvironment.

2. In Vitro/Biochemical Methods:

  • Pull-Down Assays: Recombinant bait protein (often tagged with GST or His) immobilized on a bead is incubated with lysate or purified proteins to capture interactors.
  • Surface Plasmon Resonance (SPR): Measures real-time kinetics of interaction (association/dissociation rates: kₐ, k𝒹) without labels. One partner is immobilized on a sensor chip; the other flows over. Changes in refractive index indicate binding.
  • Isothermal Titration Calorimetry (ITC): Directly measures the heat released or absorbed during binding. Provides affinity (K𝒹), stoichiometry (n), and thermodynamics (ΔH, ΔS).
  • Fluorescence Resonance Energy Transfer (FRET): Measures proximity (<10 nm). Donor and acceptor fluorophores are attached to potential partners. Interaction causes energy transfer, detected by acceptor emission.

3. Receptor Identification & Characterization:
This uses the above techniques plus:

  • Ligand Binding Assays (Radiolabeled/Fluorescent): Determine receptor density (Bmax) and binding affinity (K𝒹) via Scatchard analysis.
  • Cross-linking: Uses chemical cross-linkers to covalently “freeze” transient receptor-ligand complexes for isolation.
  • Knockout/Knockdown Studies: Genetic or siRNA-mediated loss of a putative receptor abolishes cellular response to ligand, confirming its role.

Topic 5: Membrane Proteins & Domains

A. Integral Membrane Proteins

Proteins permanently associated with the membrane, requiring detergents for solubilization.

  • Types:
    • Transmembrane Proteins: Span the bilayer. Can be single-pass (Type I, II, III) or multi-pass (e.g., GPCRs, ion channels).
    • Lipid-Anchored Proteins: Attached via covalently linked lipids (GPI-anchored, myristoylated, etc.).

B. Ion Channels

A class of transmembrane proteins forming aqueous pores.

  • Key Properties: Selectivity (for Na⁺, K⁺, Ca²⁺, Cl⁻), Gating (opening/closing mechanism), and Permeation (ion flow rate).
  • Gating Mechanisms:
    • Voltage-Gated: Respond to membrane potential change (e.g., Naᵥ, Kᵥ channels).
    • Ligand-Gated: Open upon neurotransmitter binding (extracellular – e.g., nAChR) or intracellular ligand (e.g., IP₃-gated Ca²⁺ channels).
    • Mechanosensitive: Open in response to membrane tension.

C. Peptide Models of Transmembrane Domains

Used to study the structure and function of TM helices in isolation.

  • Purpose: Simplify the complex full-length protein to understand: helix-helix interactions (dimerization motifs like GxxxG), orientation, lipid interactions, and ion channel pore properties.
  • Techniques: Synthetic peptides corresponding to TM domains are studied using:
    • Solution & Solid-State NMR: Structure in membrane-mimetic environments (micelles, bicelles).
    • Circular Dichroism (CD): Measures secondary structure (α-helical content) in lipids.
    • Planar Lipid Bilayer Electrophysiology: Tests if a peptide can form a functional ion channel.

D. Membrane Fusion & Membrane Binding Proteins

  • Membrane Fusion: Essential for vesicle trafficking, neurotransmitter release, viral entry.
    • Key Proteins: SNAREs. v-SNARE (on vesicle) and t-SNARE (on target membrane) form a tight trans-SNARE complex (4-helix bundle), forcing lipid bilayers together.
  • Membrane Binding Proteins: Associate peripherally via:
    • Amphipathic Helices (e.g., apolipoproteins, some signaling proteins).
    • Membrane-Binding Domains: PH domains (bind phosphoinositides), C1/C2 domains (bind DAG/Ca²⁺-phospholipids), FERM domains (link cytoskeleton to membrane).

E. Apolipoproteins

A specialized class of amphipathic helix-based membrane-binding proteins.

  • Function: Structural components of lipoproteins (chylomicrons, HDL, LDL). Solubilize lipids for transport in blood. Act as ligands for cell-surface receptors and co-factors for enzymes (e.g., ApoC-II for lipoprotein lipase).
  • Structure: Contain repeating amphipathic α-helices with hydrophobic face (binds lipids) and hydrophilic face (faces aqueous milieu).

Topic 6: Advanced Techniques in Proteomics

Proteomics is the large-scale study of the proteome: identity, quantity, structure, function, and interactions of all proteins.

A. Separation & Visualization

  • Two-Dimensional Gel Electrophoresis (2D-GE):
    1. First Dimension: Isoelectric Focusing (IEF). Proteins separated by pI (isoelectric point).
    2. Second Dimension: SDS-PAGE. Proteins separated by molecular weight.
    • Output: A “map” of protein spots. DIGE (Differential Gel Electrophoresis) uses fluorescent dyes for quantitative comparison of samples.

B. Mass Spectrometry (MS) – The Core Technology

Measures the mass-to-charge ratio (m/z) of ionized peptides/proteins.

  • Workflow: Protein Mixture → Digestion (trypsin) → Peptide Mixture → Separation (LC) → Ionization → Mass Analysis → Data Analysis.
  1. Ionization Sources:
    • MALDI (Matrix-Assisted Laser Desorption/Ionization): Sample co-crystallized with a UV-absorbing matrix. Laser pulse causes desorption/ionization. Often paired with TOF analyzers.
    • ESI (Electrospray Ionization): Creates a fine spray of charged droplets directly from liquid phase (e.g., from LC). Produces multiply charged ions.
  2. Mass Analyzers:
    • TOF (Time-of-Flight): Measures time for ions to travel a flight tube. High mass accuracy and range.
    • Quadrupole: Filters ions based on stable trajectories in oscillating electric fields. Often used as a mass filter in tandem MS.
    • Ion Trap: Captures ions in 3D space and ejects them sequentially by m/z. Excellent for MS/MS.
    • Orbitrap: Ions orbit around a central electrode; frequency of oscillation measured. Very high resolution and mass accuracy.
  3. Tandem MS (MS/MS): Key for identification.
    • Process: Select a precursor ion (peptide) → fragment it (via collision gas – CID, or other methods) → measure the product ion spectrum (fragment ions).
    • Output: A fragmentation spectrum with peaks corresponding to b-ions and y-ions (peptide backbone fragments). This “fingerprint” is searched against in silico digested protein databases.

C. Integrated Proteomic Platforms

  • LC-MS/MS: The cornerstone of modern “shotgun” proteomics. Liquid Chromatography (LC, e.g., nanoflow reverse-phase) separates complex peptide mixtures online, which are directly analyzed by ESI-MS/MS.
  • MALDI-TOF/TOF: Often used for analyzing 2D-GE spots or tissue imaging (MALDI Imaging). Provides PMF (Peptide Mass Fingerprinting) and sequence data.

D. Quantitative Proteomics

  • Label-Free Quantification: Compares peak intensity or spectral counting of the same peptide across multiple LC-MS/MS runs.
  • Isobaric Tags (e.g., iTRAQ, TMT): Chemical labeling. Tags are identical in mass but produce unique reporter ions upon MS/MS fragmentation. Allows multiplexing (4-16 samples) by labeling each sample with a different tag, pooling, and analyzing together. Relative quantification from reporter ion intensities.
  • Metabolic Labeling (SILAC – Stable Isotope Labeling by Amino acids in Cell culture): Cells grown in “heavy” (¹³C, ¹⁵N) vs. “light” media. Proteins incorporate these labels. Samples are combined early, minimizing technical variation. Most accurate for cell culture.

E. Protein Arrays

  • Analytical Arrays: Many different proteins (e.g., antibodies, antigens, purified proteins) are immobilized on a chip to probe a complex sample (e.g., serum) for binding events. Used for biomarker discovery.
  • Functional Protein Arrays: Immobilized proteins are used to screen for biochemical activities (e.g., kinase substrates, protein interactions, lipid binding)

BCH-508 Bio membranes and Cell signaling 3(3-0)

 Biological Membranes – Structure, Composition, and Function

I. Introduction

Biological membranes are dynamic, semi-permeable barriers that define the boundaries of cells and their internal organelles. They are not passive sacks but active, functional structures essential for:

  • Compartmentalization: Separating the cell from its environment and creating specialized functional spaces (organelles).
  • Selective Transport: Regulating the movement of substances (ions, nutrients, waste).
  • Signal Transduction: Housing receptors for communication.
  • Cell Adhesion & Recognition: Mediating interactions with other cells and the extracellular matrix.
  • Energy Transduction: Facilitating processes like photosynthesis and oxidative phosphorylation.

II. Chemical Composition

Membranes are primarily composed of lipids, proteins, and carbohydrates, with water and ions associated.

  1. Lipids (~50% by weight): Form the structural bilayer matrix.
    • Phospholipids (Most abundant): Glycerol/ sphingosine backbone with two fatty acid tails (hydrophobic) and a phosphate-containing head group (hydrophilic). E.g., Phosphatidylcholine (PC), Phosphatidylserine (PS – inner leaflet signaling).
    • Glycolipids: Sphingosine backbone with one or more sugar residues as the head group. Located primarily in the outer leaflet of the plasma membrane; involved in cell recognition.
    • Cholesterol (Animal cells): A sterol intercalated between phospholipids. Modulates membrane fluidity: at high temps, it stiffens; at low temps, it prevents tight packing (maintains fluidity). Forms lipid rafts – ordered microdomains enriched in cholesterol and sphingolipids, important for signaling.
  2. Proteins (~50% by weight): Carry out specific functions. Ratio varies (e.g., myelin sheath: 18% protein; inner mitochondrial membrane: 76% protein).
  3. Carbohydrates (2-10%): Always found attached to lipids (glycolipids) or proteins (glycoproteins). Form the glycocalyx on the extracellular face, crucial for protection, lubrication, and cell-cell recognition.

III. Structure of Membranes & Membrane Proteins

A. The Fluid Mosaic Model (Singer & Nicolson, 1972)
The foundational concept: Membranes are a two-dimensional fluid where lipids and proteins can diffuse laterally.

  • Fluidity: Depends on lipid composition (chain length/unsaturation of fatty acids, cholesterol content) and temperature.
  • Asymmetry: The two leaflets have different lipid and protein compositions. Phosphatidylserine (PS) is actively kept in the inner (cytosolic) leaflet; its exposure is a signal for apoptosis.

B. Structure of Membrane Proteins
Classified by their mode of association with the lipid bilayer.

  1. Integral (Intrinsic) Membrane Proteins:
    • Definition: Permanently embedded in the bilayer. Require detergents or organic solvents for extraction.
    • Types:
      • Transmembrane Proteins: Span the entire bilayer. Have distinct extracellular, transmembrane (TM), and cytosolic domains.
        • Single-pass (Type I, II, III): One α-helical TM domain.
        • Multi-pass: Multiple α-helical TM domains (e.g., GPCRs, ion channels). Can also form β-barrels in outer membranes of mitochondria/bacteria.
      • Lipid-Anchored Proteins: Covalently attached to lipid molecules embedded in the bilayer (e.g., GPI-anchored proteins on the exterior, myristoylated/prenylated proteins on the cytosolic face).
  2. Peripheral (Extrinsic) Membrane Proteins:
    • Definition: Temporarily associated with the membrane surface via electrostatic interactions and hydrogen bonding with integral proteins or lipid head groups. Can be removed by mild treatments (high salt, pH change).
    • Examples: Cytoskeletal proteins (spectrin), some signaling proteins (kinases), and electron carriers (cytochrome c).

IV. Morphology & Function of Different Biological Membranes

Membranes are specialized according to their location and function.

A. Plasma Membrane (Cell Membrane)

  • Morphology: A 7-10 nm thick phospholipid bilayer with asymmetric leaflets, studded with proteins and a prominent glycocalyx.
  • Key Functions:
    • Selective Barrier: Maintains intracellular milieu via transport proteins.
    • Communication: Contains receptors for hormones, neurotransmitters.
    • Adhesion: Contains adhesion proteins (integrins, cadherins).
    • Electrochemical Gradient: Maintained by pumps (Na⁺/K⁺ ATPase), essential for nerve impulses and transport.

B. Membranes of Cell Organelles

  1. Nuclear Envelope:
    • Structure: A double membrane (inner and outer nuclear membranes). Nuclear Pore Complexes (NPCs) span the envelope for regulated transport.
    • Function: Separates transcription (nucleus) from translation (cytoplasm). Outer membrane is continuous with the Rough ER.
  2. Mitochondrial Membranes:
    • Outer Membrane: Contains porins (β-barrel proteins), making it permeable to small molecules.
    • Inner Membrane: Highly convoluted (cristae) to increase surface area. Impermeable to ions and small molecules. Packed with:
      • Electron Transport Chain (ETC) complexes (oxidative phosphorylation).
      • ATP synthase (F₀F₁ complex).
      • Specialized transporters (e.g., for pyruvate, ATP/ADP exchange).
  3. Endoplasmic Reticulum (ER):
    • Rough ER: Studded with ribosomes. Site of synthesis of secretory, membrane-bound, and organellar proteins. Initial site of membrane lipid synthesis.
    • Smooth ER: Site of lipid synthesis, detoxification, and Ca²⁺ storage.
  4. Golgi Apparatus:
    • Structure: Stack of flattened cisternal membranes (cis, medial, trans, TGN).
    • Function: Modification, sorting, and packaging of proteins and lipids for delivery to their final destinations (lysosomes, plasma membrane, secretion).
  5. Lysosomes:
    • Morphology: Single membrane-bound vesicles.
    • Function: Intracellular digestion. Membrane contains H⁺-ATPase pumps to acidify the lumen and specialized transport proteins to export digestion products.
  6. Peroxisomes:
    • Morphology: Single membrane.
    • Function: Contain oxidative enzymes (e.g., catalase). Site of β-oxidation of very-long-chain fatty acids and detoxification of H₂O₂.

V. Membrane Fusion

The controlled merging of two lipid bilayers, essential for vesicular transport, neurotransmitter release, and fertilization.

  • Key Principles: Requires overcoming energy barrier, is highly specific, and leaves membranes intact.
  • Molecular Machinery:
    1. SNARE Proteins: The core fusogenic machinery. v-SNARE on the vesicle and t-SNARE on the target membrane form a tight trans-SNARE complex (a 4-α-helix bundle), pulling the membranes together.
    2. Regulatory Proteins: Rab GTPases ensure specificity (vesicle docking). SM proteins catalyze and proofread SNARE assembly.
    3. Membrane Bending/Curvature: Facilitated by proteins like coatomers (COP I/II, clathrin) and BAR domain proteins.

VI. Membrane Transport

Mechanisms for moving molecules across the impermeable lipid bilayer.

A. Passive Transport (Down a concentration/electrochemical gradient)

  1. Simple Diffusion: Small, nonpolar molecules (O₂, CO₂, steroids) and small uncharged polar molecules (H₂O, urea) slip through the lipid bilayer.
  2. Facilitated Diffusion: Mediated by transport proteins.
    • Channel Proteins: Form hydrophilic pores. Usually gated (voltage, ligand, or mechano-gated). Fast. (e.g., K⁺ channels, aquaporins).
    • Carrier Proteins (Permeases/Transporters): Bind their solute, undergo a conformational change. Slower, specific. (e.g., GLUT1 glucose transporter).

B. Active Transport (Against a gradient, requires energy)

  1. Primary Active Transport: Directly uses chemical energy (ATP hydrolysis).
    • P-type ATPases: Phosphorylate themselves during transport (e.g., Na⁺/K⁺ ATPase, Ca²⁺ ATPase).
    • V-type ATPases: Pump H⁺ into organelles (lysosomes, vacuoles).
    • ABC Transporters: Use ATP to pump small molecules (e.g., multidrug resistance transporters, CFTR Cl⁻ channel).
  2. Secondary Active Transport (Cotransport): Uses the energy stored in an ion gradient (usually Na⁺ or H⁺) established by a primary pump.
    • Symport: Solute and ion move in the same direction (e.g., Na⁺/glucose symporter).
    • Antiport: Solute and ion move in opposite directions (e.g., Na⁺/H⁺ exchanger, Na⁺/Ca²⁺ exchanger).

C. Macromolecule & Particle Transport

  • Endocytosis: Uptake into the cell (phagocytosis, pinocytosis, receptor-mediated endocytosis via clathrin-coated pits).
  • Exocytosis: Secretion from the cell (constitutive or regulated, e.g., neurotransmitter release).

Summary Table: Membrane Protein Types

Feature Integral Membrane Protein Peripheral Membrane Protein
Association Embedded in bilayer (transmembrane or monotopic) Bound to surface (to lipids or other proteins)
Extraction Requires detergents/organic solvents Requires high salt, pH change, or chelating agents
Structure Hydrophobic α-helices or β-barrels interacting with lipid tails No hydrophobic membrane-spanning domains
Examples Receptor Tyrosine Kinases (RTKs), Ion Channels, GPCRs Cytochrome c, Phospholipases, Spectrin (cytoskeleton)

 

Membrane Transport & Signal Transduction

I. Membrane Transport Mechanisms

A. Non-Facilitated vs. Facilitated Transport

Feature Non-Facilitated (Simple) Diffusion Facilitated Diffusion
Mechanism Direct movement through the lipid bilayer. Mediated by a specific transport protein.
Direction Down the concentration/electrochemical gradient. Down the concentration/electrochemical gradient.
Energy Passive (no direct energy input). Passive (no direct energy input).
Saturability No (linear rate vs. concentration). Yes (follows Michaelis-Menten kinetics).
Specificity Low (depends on size/polarity). High (specific to substrate).
Examples O₂, CO₂, N₂, small lipids, ethanol. Channels: Aquaporins (H₂O), K⁺ leak channels. <br> Transporters: GLUT1 (glucose), anion exchanger (Band 3).

B. Active vs. Passive Transport

Feature Passive Transport Active Transport
Energy Source Uses the inherent kinetic energy of molecules moving down their gradient. Requires direct input of cellular energy (ATP, light, or an existing ion gradient).
Direction Downhill (with the gradient). Uphill (against the gradient).
Result Moves toward equilibrium. Creates/maintains a concentration gradient.
Types Simple diffusion, facilitated diffusion (channels & carriers). Primary Active: Directly uses ATP (e.g., P-type ATPases). <br> Secondary Active: Uses an ion gradient (Symport/Antiport).

C. Detailed Look at Transporters

  1. Uniporters: Facilitate diffusion of a single molecule (e.g., GLUT glucose transporters).
  2. Cotransporters (Secondary Active):
    • Symporters: Transport solute and ion in the same direction (e.g., Na⁺/Glucose Symporter (SGLT) in intestinal/renal cells).
    • Antiporters (Exchangers): Transport solute and ion in opposite directions (e.g., Na⁺/H⁺ exchanger, Na⁺/Ca²⁺ exchanger).
  3. Primary Active Transporters (Pumps):
    • P-type ATPases: Undergo autophosphorylation (e.g., Na⁺/K⁺ ATPase (3 Na⁺ out, 2 K⁺ in), SERCA Ca²⁺ pump).
    • ABC Transporters: ATP-Binding Cassette family; use ATP to pump diverse substrates (e.g., MDR1 pump in drug resistance, CFTR Cl⁻ channel).

II. Molecular Mechanisms of Signal Transduction

The process by which an extracellular signal (ligand) is converted into an intracellular response.

A. Core Principles

  • Specificity: Ligand binds only to its complementary receptor.
  • Amplification: One signal molecule can activate many downstream effectors (e.g., via second messengers).
  • Integration: Multiple signals converge to regulate a common target.
  • Desensitization/Adaptation: Feedback mechanisms turn off the response (e.g., receptor phosphorylation, internalization).
  • Modularity: Proteins are built from conserved domains (SH2, SH3, PH domains) that mediate specific interactions.

B. Membrane Receptor-Ligand Interactions & Major Pathways

  1. G Protein-Coupled Receptors (GPCRs): Largest family. 7-transmembrane α-helices. Ligand binding causes conformational change, activating a heterotrimeric G protein.
  2. Receptor Tyrosine Kinases (RTKs): Single transmembrane proteins with intrinsic kinase activity (e.g., Insulin Receptor, EGFR). Ligand binding causes dimerization and autophosphorylation on tyrosines, creating docking sites for signaling proteins.
  3. Ligand-Gated Ion Channels (Ionotropic Receptors): Signal by rapidly changing membrane potential (e.g., nAChR, GABAₐ receptor). Binding opens a pore.
  4. Receptor Serine/Threonine Kinases: (e.g., TGF-β receptor) phosphorylate Smad proteins.
  5. Cytokine Receptors/JAK-STAT Pathway: Lack intrinsic kinase; associated with JAK kinases that phosphorylate STAT transcription factors.

III. Key Signaling Pathways in Detail

A. Voltage-Gated Ion Channels

  • Structure: Multi-pass transmembrane proteins with a voltage-sensing domain (S4 helix with + charged residues) and a pore-forming domain.
  • Mechanism: Change in membrane potential causes the S4 helix to move, inducing a conformational change that opens the pore.
  • Examples & Function:
    • Naᵥ Channels: Rapid depolarization (upstroke of action potential).
    • Kᵥ Channels: Repolarization/termination of action potential.
    • Caᵥ Channels: Muscle contraction, neurotransmitter release, hormone secretion.

B. G Protein-Coupled Receptors (GPCRs) & Second Messengers

  • The G Protein Cycle:
    1. Inactive State: Gα (bound to GDP) complexed with Gβγ.
    2. Activation: Ligand-bound GPCR acts as a GEF (Guanine nucleotide Exchange Factor) for Gα, causing GDP→GTP exchange.
    3. Dissociation: Gα-GTP and Gβγ separate, both can regulate downstream effectors.
    4. Termination: Gα has intrinsic GTPase activity. Hydrolysis to GDP inactivates Gα, which rebinds Gβγ.
  • Major Second Messenger Pathways:
    1. cAMP Pathway: Gαₛ → Activates Adenylyl Cyclase (AC) → ↑ cAMP → Activates PKA → Phosphorylates target proteins. Gαᵢ inhibits AC.
    2. Phospholipase C (PLC) Pathway: Gαq → Activates PLC-β → Cleaves PIP₂ into IP₃ and DAG.
      • IP₃: Diffuses to ER, binds IP₃ receptors, releases Ca²⁺ from ER stores.
      • DAG: Remains in membrane, activates Protein Kinase C (PKC) (with Ca²⁺).
    3. Ca²⁺ as a Second Messenger: Released from ER (via IP₃) or enters via channels. Binds to Calmodulin (CaM), activating Ca²⁺/Calmodulin-dependent Kinases (CaMKs).

C. Receptor Tyrosine Kinase (RTK) Pathway (e.g., MAPK/ERK)

  1. Ligand binding → RTK dimerization & autophosphorylation.
  2. GRB2 (adaptor with SH2 domain) binds phospho-tyrosine.
  3. GRB2 recruits SOS (a GEF for Ras).
  4. SOS activates Ras (small GTPase) by exchanging GDP for GTP.
  5. Active Ras-GTP activates the MAP Kinase Cascade:
    Raf (MAPKKK) → MEK (MAPKK) → ERK (MAPK).
  6. ERK phosphorylates cytosolic targets and translocates to the nucleus to phosphorylate transcription factors (e.g., Elk-1), altering gene expression.

IV. Signaling in Microorganisms and Plants

A. Microorganisms (Bacteria)

  • Two-Component Systems: Dominant signaling mechanism.
    1. Sensor Histidine Kinase (membrane protein) autophosphorylates on a His residue in response to stimulus.
    2. Phosphate is transferred to an Asp residue on a Response Regulator protein (often a transcription factor), altering its activity.
  • Quorum Sensing: Cell-cell communication via secreted autoinducers (e.g., AHLs in Gram-negatives). Regulates biofilm formation, virulence.

B. Plants

  • Phytohormone Receptors: Diverse. Auxin signaling involves nuclear receptors (TIR1/AFBs) that, when bound, promote degradation of transcriptional repressors (Aux/IAA proteins).
  • Brassinosteroids: Signal via an RTK-like pathway (BRI1 receptor).
  • Ethylene: Binds to membrane receptors (ETR1) in the ER, regulating a downstream MAPK cascade.
  • Light Signaling: Via Phytochromes (red/far-red light) and Phototropins (blue light), which are often light-regulated protein kinases.

V. Programmed Cell Death (PCD)

A. Apoptosis (Type I PCD)

  • Morphology: Cell shrinkage, chromatin condensation, nuclear fragmentation, membrane blebbing, formation of apoptotic bodies (phagocytosed cleanly, no inflammation).
  • Key Players:
    • Caspases: Cysteine-aspartic proteases; the executioners. Exist as inactive zymogens.
    • Bcl-2 Family: Regulators of mitochondrial outer membrane permeabilization (MOMP). Pro-apoptotic (Bax, Bak) vs. Anti-apoptotic (Bcl-2, Bcl-xL).
    • Cytochrome c: Released from mitochondria upon MOMP; triggers apoptosome formation.
  • Two Major Pathways:
    1. Extrinsic (Death Receptor) Pathway: Triggered by extracellular death ligands (FasL, TNF-α) binding to death receptors (Fas, TNFR1). This recruits adaptors (FADD) and activates initiator caspase-8, which activates executioner caspases-3/7.
    2. Intrinsic (Mitochondrial) Pathway: Triggered by internal stress (DNA damage, ER stress). Controlled by Bcl-2 family balance. Pro-apoptotic proteins cause MOMP → release of cytochrome c → binds Apaf-1 → forms apoptosome → activates initiator caspase-9 → activates executioner caspases.

B. Other Forms of PCD

  • Autophagy (Type II PCD): Degradation of cellular components via lysosomes. Can be pro-survival (recycling nutrients) or, if excessive, lead to cell death. Characterized by autophagosome formation.
  • Necroptosis (Regulated Necrosis): Programmed inflammatory cell death. Triggered by TNF-α when caspase-8 is inhibited. Involves RIPK1, RIPK3, and MLKL. Results in plasma membrane rupture and inflammation.
  • Pyroptosis: Inflammatory caspase-1/4/5/11-dependent death, often in response to pathogens. Involves formation of pore-forming gasdermin proteins and release of pro-inflammatory cytokines (IL-1β, IL-18).

Summary: Signal Transduction Pathways at a Glance

Pathway Receptor Type Key Effector Major Second Messenger Primary Outcome
GPCR-cAMP GPCR Gαₛ / Gαᵢ cAMP ↑ / ↓ Alters PKA activity → metabolism, gene expression
GPCR-PLC GPCR Gαq IP₃ & DAG, Ca²⁺ Activates PKC, Ca²⁺-dependent processes
RTK-MAPK RTK Ras GTPase – (Kinase Cascade) Alters gene expression (cell growth, division)
JAK-STAT Cytokine Receptor JAK Kinase – (Phosphorylation) STAT dimers translocate to nucleus → gene expression
Apoptosis (Extrinsic) Death Receptor Caspase-8 – (Proteolytic Cascade) Execution of apoptosis
Apoptosis (Intrinsic) – (Stress Sensors) Bcl-2 Family, Cytochrome c – Execution of apoptosis via mitochondria

These notes connect the molecular machinery (transporters, receptors, channels) to the physiological outcomes (signaling, cell fate), providing a framework for understanding cellular communication and regulation.

BCH-510 Bioenergetics 2(2-0)

Bioenergetics & Thermodynamics in Biochemistry

I. Introduction & Biomedical Importance

A. Introduction
Bioenergetics is the study of energy transformations in living organisms. It explains how cells acquire, convert, store, and utilize energy to perform work (chemical, mechanical, transport). At its core, it applies the laws of thermodynamics to biological systems.

B. Biomedical Importance
Understanding bioenergetics is crucial because:

  1. Metabolic Basis of Disease: Many diseases stem from defects in energy metabolism.
    • Mitochondrial Disorders: Defects in oxidative phosphorylation (e.g., Leigh syndrome).
    • Diabetes Mellitus: Dysregulation of glucose and lipid energy metabolism.
    • Obesity: Imbalance between energy intake (food) and expenditure.
    • Cancer: Altered metabolism (Warburg effect: high glycolysis even with oxygen).
    • Neurodegenerative Diseases: (e.g., Parkinson’s, Alzheimer’s) often involve mitochondrial dysfunction.
  2. Drug Design: Many drugs target energy pathways.
    • Metformin (Type 2 diabetes): Acts on mitochondrial complex I to reduce glucose production.
    • Statins (High cholesterol): Inhibit HMG-CoA reductase, a key enzyme in cholesterol (energy storage) synthesis.
    • DNP (Historical weight loss): Uncouples oxidative phosphorylation, dissipating energy as heat.
  3. Understanding Physiology: Explains processes like muscle contraction, nerve impulse propagation, nutrient absorption, and biosynthesis.

II. Bioenergetics and Thermodynamics: Core Concepts

A. Thermodynamics: The study of energy and its transformations.
B. System vs. Surroundings:

  • System: The part of the universe we are studying (e.g., a cell, a reaction mixture).
  • Surroundings: Everything else.
  • Biological systems are open systems – they exchange both energy and matter with their surroundings.

III. Laws of Thermodynamics

1. The First Law (Law of Conservation of Energy):

  • Statement: Energy can neither be created nor destroyed, only converted from one form to another.
  • Mathematical Expression: ΔU = Q – W
    • ΔU: Change in internal energy of the system.
    • Q: Heat absorbed by the system.
    • W: Work done by the system.
  • Biological Implication: The total energy of a cell plus its environment is constant. The chemical energy in glucose is converted to ATP, heat, and work.

2. The Second Law (Law of Increasing Entropy):

  • Statement: The total entropy (disorder/randomness) of an isolated system always increases over time. Spontaneous processes increase the total entropy of the universe.
  • Biological Implication: Living organisms are highly ordered (low entropy). They maintain this order by constantly increasing the entropy of their surroundings (e.g., releasing heat and waste products). Life is a local battle against entropy, fought by consuming energy.

3. The Third Law:

  • Statement: The entropy of a perfect crystalline substance is zero at absolute zero (0 Kelvin).
  • Biological Relevance: Less direct, but it establishes an absolute scale for entropy.

IV. Key Thermodynamic Quantities

A. Enthalpy (H) – The Heat Content

  • Definition: A measure of the total heat energy of a system at constant pressure.
  • Change in Enthalpy (ΔH): The heat absorbed or released during a reaction at constant pressure.
    • ΔH < 0 (Negative): Exothermic reaction. Heat is released to surroundings (e.g., combustion, ATP hydrolysis).
    • ΔH > 0 (Positive): Endothermic reaction. Heat is absorbed from surroundings (e.g., photosynthesis, evaporation).
  • In biochemistry, most catabolic reactions are exothermic.

B. Entropy (S) – The Measure of Disorder/Randomness

  • Definition: A measure of the number of possible microscopic states (positions, energies) of a system.
  • Change in Entropy (ΔS):
    • ΔS > 0: Increase in disorder (favorable for spontaneity).
    • ΔS < 0: Increase in order (unfavorable for spontaneity).
  • Biological Example: Protein folding: The polypeptide chain goes from a disordered (high S) unfolded state to an ordered (low S) native state. This decrease in entropy (ΔS < 0) is unfavorable, so folding is driven by other forces (hydrophobic effect, H-bonds).

C. Gibbs Free Energy (G) – The Determinant of Spontaneity

  • This is the most critical concept in bioenergetics.
  • Definition: The portion of a system’s energy that is available to do useful work at constant temperature and pressure.
  • Gibbs Free Energy Change (ΔG): Predicts the direction and spontaneity of a reaction.
    • ΔG = ΔH – TΔS (where T is temperature in Kelvin).

V. Interpreting ΔG: The Central Dogma of Bioenergetics

ΔG Value Reaction is… Spontaneous? Equilibrium Constant (Keq) Example in Metabolism
ΔG < 0 (Negative) Exergonic Yes (Proceeds forward) Keq > 1 (Products favored) ATP Hydrolysis: ATP → ADP + Pi (ΔG°’ ≈ -30.5 kJ/mol)
ΔG > 0 (Positive) Endergonic No (Not spontaneous) Keq < 1 (Reactants favored) Glucose Synthesis: 6CO₂ + 6H₂O → C₆H₁₂O₆ + 6O₂
ΔG = 0 At Equilibrium No net change N/A A reaction that has reached completion.

Crucial Distinctions:

  • Exothermic vs. Exergonic: Not the same! A reaction can be exothermic (release heat, ΔH < 0) but still **non-spontaneous (endergonic)** if the entropy term (-TΔS) is large and positive enough to make ΔG > 0.
  • Endothermic vs. Endergonic: An endothermic reaction (absorbs heat, ΔH > 0) can be spontaneous (exergonic) if the entropy increase (TΔS) is large enough to overcome the positive ΔH, resulting in a negative ΔG.

D. Standard vs. Actual Conditions

  • ΔG°’ (Standard Free Energy Change): The free energy change under standard biochemical conditions (25°C, 1 M concentrations, pH 7.0). It is a constant for a given reaction.
  • ΔG (Actual Free Energy Change): The free energy change under the actual, prevailing cellular conditions. It determines the real direction of a reaction.
    • ΔG = ΔG°’ + RT ln(Q)
    • R: Gas constant (8.314 J/mol·K)
    • T: Temperature (K)
    • Q: Reaction Quotient ([Products]/[Reactants] at any given moment)
  • Biomedical Insight: Cells drive endergonic reactions by coupling them to exergonic reactions (often ATP hydrolysis) to make the overall ΔG negative. They also maintain reactants/products far from equilibrium (making Q small) to keep pathways flowing.

VI. Endothermic & Exothermic Reactions in Biology

A. Exothermic (ΔH < 0) – Heat-Releasing

  • Catabolism (Breakdown): The primary source of energy.
    • Cellular Respiration: C₆H₁₂O₆ + 6O₂ → 6CO₂ + 6H₂O (Large ΔH negative).
    • ATP Hydrolysis: ATP + H₂O → ADP + Pi + H⁺ (ΔH°’ ≈ -24 kJ/mol).
    • Fatty Acid Oxidation.
  • Function: Provides heat (thermogenesis) and drives endergonic processes.

B. Endothermic (ΔH > 0) – Heat-Absorbing

  • Anabolism (Biosynthesis): Building complex molecules.
    • Photosynthesis: 6CO₂ + 6H₂O + light → C₆H₁₂O₆ + 6O₂.
    • Protein Synthesis: Peptide bond formation.
    • DNA Replication.
  • Phase Changes: Evaporation of sweat (cooling mechanism).
  • Function: Consumes energy from the environment (usually in the form of ATP or sunlight) to build order.

Summary: The Bioenergetic Logic of the Cell

  1. Cells are isothermal systems (constant temperature). They cannot use heat flow to do work. Therefore, they use chemical potential energy stored in concentration gradients and chemical bonds.
  2. ATP is the universal energy currency. Its hydrolysis (ΔG°’ = -30.5 kJ/mol) is highly exergonic and is coupled to endergonic processes.
  3. The goal of catabolism (e.g., glycolysis, TCA cycle, oxidative phosphorylation) is to trap the energy from food molecules into the high-energy bonds of ATP and reduced electron carriers (NADH, FADH₂).
  4. Anabolism uses ATP and reducing power (NADPH) to drive the synthesis of complex biomolecules, creating order (decreasing entropy locally) at the expense of increasing global entropy.

Clinical Connection: Defects in any part of this energetic logic—from nutrient breakdown (e.g., glycogen storage diseases) to ATP synthesis (mitochondrial diseases) to biosynthetic pathways—can lead to severe metabolic disorders.

These principles form the non-negotiable physical rules that govern every metabolic pathway, enzyme mechanism, and physiological process in medicine.

Topic: Energy Transfer Mechanisms & Regulation

I. High-Energy Compounds

A. Definition: Molecules containing bonds that, upon hydrolysis, yield a large negative ΔG°’ (more negative than -25 kJ/mol). They act as energy currencies or transfer groups.

B. Key High-Energy Compounds

Compound “High-Energy” Bond ΔG°’ of Hydrolysis (kJ/mol) Primary Role
Phosphoenolpyruvate (PEP) Enol-phosphate -61.9 Highest phosphoryl transfer potential. Key in glycolysis.
1,3-Bisphosphoglycerate (1,3-BPG) Acyl-phosphate -49.3 Substrate for first ATP synthesis in glycolysis.
Creatine Phosphate Guanidino-phosphate -43.1 Energy buffer in muscle & nerve cells. Rapidly regenerates ATP.
Acetyl-CoA Thioester -31.4 Central in metabolism. Energy released drives condensation with OAA in TCA cycle.
ATP (to ADP + Pi) Anhydride (between α-β phosphates) -30.5 Universal energy currency. Intermediate phosphoryl transfer potential.
ATP (to AMP + PPi) Anhydride -45.6 Used in activation reactions (PPi hydrolyzed for extra drive).
ADP (to AMP + Pi) Anhydride -28.0
PPi (Pyrophosphate) Anhydride -19.2 Often hydrolyzed to make coupled reactions irreversible.
Glucose-6-Phosphate Ester -13.8 Low-energy. Metabolic intermediate, not for energy transfer.

C. Why are These Bonds “High-Energy”? It’s not due to bond strength, but to the greater stability of the products after hydrolysis. Contributing factors:

  1. Resonance Stabilization: Products (e.g., Pi, ADP) are stabilized by resonance more than the reactant (e.g., the γ-phosphate of ATP).
  2. Electrostatic Repulsion: In ATP, the four negative charges on adjacent oxygens repel each other. Hydrolysis relieves this strain.
  3. Increased Solvation (Hydration): The products (ADP + Pi) are more effectively solvated by water than ATP.
  4. Ionization State: At pH 7, the products exist in a more favorable ionization state.

II. Phosphoryl Group Transfer and ATP

A. ATP as the Central Energy Currency

  • Intermediate Transfer Potential: ATP’s ΔG°’ of hydrolysis is midway in the scale. It can be synthesized from higher-energy compounds (PEP, 1,3-BPG) and can drive the formation of lower-energy compounds (G-6-P).
  • Functions:
    1. Chemical Work: Driving endergonic biosynthetic reactions (e.g., glutamine synthesis: Glu + NH₃ → Gln).
    2. Transport Work: Active transport across membranes (e.g., Na⁺/K⁺ ATPase).
    3. Mechanical Work: Muscle contraction, cell motility (myosin ATPase).

B. The Phosphoryl Group Transfer Concept
Cells transfer phosphoryl groups (~PO₃²⁻), not phosphate ions, from high-energy donors to acceptors. This is mediated by kinases.

  • ATP + H₂O → ADP + Pi (Highly exergonic hydrolysis)
  • ATP + Glucose → ADP + Glucose-6-Phosphate (Exergonic transfer, catalyzed by Hexokinase)
    The phosphoryl group transfer potential determines the direction of the transfer.

III. Coupling Mechanisms: Substrate-Level Phosphorylation

Definition: The direct transfer of a phosphoryl group (or synthesis of a high-energy bond) from a high-energy metabolic intermediate to ADP (or GDP), forming ATP (or GTP).

Key Examples:

  1. Glycolysis:
    • 1,3-Bisphosphoglycerate + ADP → 3-Phosphoglycerate + ATP (Catalyzed by Phosphoglycerate Kinase).
    • Phosphoenolpyruvate (PEP) + ADP → Pyruvate + ATP (Catalyzed by Pyruvate Kinase).
  2. Citric Acid (TCA) Cycle:
    • Succinyl-CoA + GDP + Pi → Succinate + GTP + CoA-SH (Catalyzed by Succinyl-CoA Synthetase). (GTP is energetically equivalent to ATP).

Characteristics: Does not require molecular oxygen or an electron transport chain. It is the primary mode of ATP synthesis in anaerobic conditions and in the cytosol.

IV. Electron Transport Chain (ETC), Oxidative & Photophosphorylation

A. Biological Oxidation and Reduction (Redox)

  • Oxidation: Loss of electrons (or H atoms, or increase in oxidation state).
  • Reduction: Gain of electrons (or H atoms, or decrease in oxidation state).
  • Redox Couple: Oxidized and reduced forms of a molecule (e.g., NAD⁺/NADH).
  • Reduction Potential (E°’): A measure of a molecule’s tendency to donate electrons. A more negative E°’ indicates a stronger reducing agent (e.g., NADH, E°’ = -0.32V). A more positive E°’ indicates a stronger oxidizing agent (e.g., O₂, E°’ = +0.82V).
  • ΔG°’ = -nFΔE°’ (where n=# electrons, F=Faraday constant). A large positive ΔE°’ yields a large negative ΔG°’ (highly exergonic).

B. Electron Transport Chain (Mitochondrial)

  • Location: Inner mitochondrial membrane.
  • Purpose: To harvest the high-energy electrons from NADH and FADH₂ (produced in glycolysis, TCA cycle, β-oxidation) and use their stepwise oxidation to pump protons (H⁺) across the membrane, creating an electrochemical proton gradient (Proton Motive Force, PMF).
  • Complexes (Main Components):
    • Complex I (NADH Dehydrogenase): Transfers e⁻ from NADH to Coenzyme Q (Ubiquinone, Q), pumps 4 H⁺.
    • Complex II (Succinate Dehydrogenase): Transfers e⁻ from FADH₂ (via succinate oxidation) to Q. Does not pump protons.
    • Complex III (Cytochrome bc₁): Transfers e⁻ from QH₂ to Cytochrome c, pumps 4 H⁺ (via Q cycle).
    • Complex IV (Cytochrome c Oxidase): Transfers e⁻ from Cytochrome c to O₂ (final e⁻ acceptor, forming H₂O), pumps 2 H⁺.
  • Mobile Carriers: Ubiquinone (Q, lipid-soluble) in the membrane, Cytochrome c (peripheral protein) in the intermembrane space.

C. Oxidative Phosphorylation (Chemiosmotic Coupling)

  • Mechanism (Peter Mitchell’s Chemiosmotic Theory):
    1. The ETC acts as a proton pump, using energy from electron flow to move H⁺ from the matrix to the intermembrane space.
    2. This creates a Proton Motive Force (PMF) with two components:
      • Chemical Gradient (ΔpH): More H⁺ outside.
      • Electrical Gradient (ΔΨ): More positive outside.
    3. ATP Synthase (Complex V): Allows H⁺ to flow back down their gradient into the matrix. This exergonic flow drives the mechanical rotation of the F₀ rotor, which induces conformational changes in the F₁ head, catalyzing ATP synthesis from ADP and Pi.
  • P/O Ratios: Approximate ATP yield per atom of oxygen consumed.
    • NADH: ~2.5 ATP (P/O = 2.5)
    • FADH₂: ~1.5 ATP (P/O = 1.5)

D. Photophosphorylation (in Chloroplasts)

  • Analogous Process: Light energy is captured by chlorophyll in Photosystems I & II.
  • Linear Electron Flow: Light drives electron flow from H₂O (e⁻ donor, producing O₂) through an ETC in the thylakoid membrane, pumping H⁺ into the thylakoid lumen. The PMF across the thylakoid membrane drives ATP synthesis via ATP synthase.
  • Outcome: Converts light energy into chemical energy (ATP & NADPH) for carbon fixation (Calvin cycle).

V. Self-Regulation of Energy Production

Cells precisely match ATP production with ATP demand through sophisticated feedback mechanisms.

A. Key Regulatory Principles

  1. Energy Charge (Atkinson, 1968): A measure of the adenylate system’s energy status.
    • Formula: Energy Charge = [ATP] + ½[ADP] / [ATP] + [ADP] + [AMP]
    • Range: 0 (all AMP) to 1 (all ATP). Healthy cells maintain it at ~0.85-0.95.
    • Regulation: High Energy Charge (>0.85) inhibits ATP-producing pathways (catabolism, glycolysis, TCA cycle) and stimulates ATP-utilizing pathways (anabolism).
  2. Phosphorylation Potential: [ATP] / [ADP][Pi]. An even more sensitive indicator. A drop signals low energy and stimulates oxidative phosphorylation.

B. Specific Regulatory Mechanisms

  1. Allosteric Regulation:
    • Glycolysis: Phosphofructokinase-1 (PFK-1), the key control point, is inhibited by ATP and citrate (high energy signals) and activated by AMP and ADP (low energy signals).
    • TCA Cycle: Pyruvate Dehydrogenase, Citrate Synthase, Isocitrate Dehydrogenase are inhibited by high [ATP]/[NADH] and activated by high [ADP]/[Ca²⁺].
  2. Covalent Modification (Phosphorylation):
    • Pyruvate Dehydrogenase (PDH): Phosphorylation (by PDH kinase) inactivates it. High ATP/NADH activates the kinase, turning off acetyl-CoA production.
  3. Hormonal Control (Global Regulation):
    • Insulin (fed state): Promotes anabolic pathways (glycogen, fat synthesis) and glucose utilization.
    • Glucagon/Epinephrine (fasted/stress): Promote catabolic pathways (glycogenolysis, gluconeogenesis, lipolysis) to generate ATP and fuel.
  4. Respiratory Control (Direct Control of OxPhos):
    • Primary Regulator: The availability of ADP.
    • If ATP demand is low, [ADP] is low. Electron flow and proton pumping slow down (State 4 respiration).
    • If ATP is used, [ADP] rises. ADP enters the mitochondrion, stimulating ATP synthase. Increased H⁺ flow through ATP synthase dissipates the PMF, allowing the ETC to run faster (State 3 respiration). This is a perfect feedback loop.
  5. Uncoupling Proteins (UCPs): In brown adipose tissue, UCP1 (thermogenin) creates a proton leak in the inner mitochondrial membrane, dissipating the PMF as heat instead of making ATP. This is a regulated form of thermogenesis.

Summary: The Integrated Energy Economy of the Cell

Process Location Energy Source Direct Product Mechanism
Substrate-Level Phosphorylation Cytosol, Mitochondrial Matrix High-energy Metabolic Intermediates (PEP, 1,3-BPG, Succinyl-CoA) ATP, GTP Direct phosphoryl group transfer to ADP/GDP
Oxidative Phosphorylation Inner Mitochondrial Membrane High-energy e⁻ in NADH & FADH₂ (from food) ATP (bulk of ATP in aerobes) Chemiosmosis: ETC creates PMF → drives ATP synthase
Photophosphorylation Thylakoid Membrane (Chloroplast) Light (captured by chlorophyll) ATP, NADPH Chemiosmosis: Light-driven e⁻ flow creates PMF → drives ATP synthase

 

: Introduction to Metabolism, Energy Currencies, and ATP Calculation

I. Introduction to Metabolism

A. Definition: Metabolism is the totality of an organism’s biochemical processes. It involves the management of cellular energy and material resources through interconnected pathways.

B. Two Interdependent Branches:

  1. Catabolism (Breaking Down):
    • Purpose: To harvest energy from fuels (carbohydrates, lipids, proteins) and to generate precursor molecules (e.g., acetyl-CoA, pyruvate, α-ketoglutarate) for biosynthesis.
    • Process: Oxidative, exergonic (ΔG < 0). Releases energy, which is conserved in the bonds of ATP and reduced electron carriers (NADH, FADH₂).
    • Examples: Glycolysis, Citric Acid Cycle, β-Oxidation of Fatty Acids, Oxidative Phosphorylation.
  2. Anabolism (Building Up):
    • Purpose: To use energy (from ATP hydrolysis) and reducing power (from NADPH) to synthesize complex biomolecules from simpler precursors.
    • Process: Reductive, endergonic (ΔG > 0). Consumes energy and reducing equivalents.
    • Examples: Gluconeogenesis (making glucose), Fatty Acid Synthesis, Protein Synthesis, DNA Replication.

C. Key Relationship: Catabolism provides the energy and building blocks that drive anabolism.

Catabolism → Generates ATP, NADPH, Precursors → Fuels Anabolism

D. Metabolic Pathways: Sequences of enzyme-catalyzed reactions. They are:

  • Irreversible (Regulated): Committed steps controlled by allosteric effectors and hormones.
  • Reversible: Operate near equilibrium.
  • Amphibolic: Serve both catabolic and anabolic roles (e.g., Citric Acid Cycle).

II. High-Energy Phosphates and the Role of ATP

A. ATP: The Universal Energy Currency

  • Structure: Adenosine (Adenine + Ribose) + Triphosphate (α, β, γ phosphates).
  • Function: The immediate donor of free energy, not a long-term storage molecule (like fats or glycogen).
  • Mechanism: Energy is released upon hydrolysis of the phosphoanhydride bonds (especially between β and γ phosphates: ATP → ADP + Pi).

B. The ATP Cycle
Cells maintain a dynamic steady state of ATP.

  1. Energy-Yielding Processes (Catabolism): ATP is synthesized from ADP and Pi, using energy from oxidation of fuels.
  2. Energy-Consuming Processes (Anabolism & Work): ATP is hydrolyzed to ADP and Pi, releasing energy to drive endergonic reactions, transport, and motion.
  • A typical mammalian cell recycles its entire ATP pool every 1-2 minutes.

III. Central Roles of NAD⁺, FAD, and CoA in Metabolism

These are coenzymes – small organic molecules required for enzyme activity. They are recyclable carriers of specific chemical groups.

Coenzyme Active Form Chemical Group Carried Primary Metabolic Role
NAD⁺ (Nicotinamide Adenine Dinucleotide) NAD⁺ (Oxidized), NADH (Reduced) Hydride Ion (H⁻ = 2 e⁻ + 1 H⁺) Central Electron Carrier in Oxidation Reactions. <br>• Accepts 2 e⁻ + 1 H⁺ (becomes NADH) during fuel oxidation (e.g., in Glycolysis, TCA Cycle). <br>• NADH donates e⁻ to the Electron Transport Chain for ATP synthesis.
FAD (Flavin Adenine Dinucleotide) FAD (Oxidized), FADH₂ (Reduced) Hydrogen Atoms (2 e⁻ + 2 H⁺) Electron Carrier in Specific Oxidation Reactions. <br>• Tightly bound to its enzymes (flavoproteins). <br>• Accepts 2 H atoms (becomes FADH₂) during oxidations (e.g., Succinate → Fumarate in TCA Cycle, Fatty Acyl-CoA → Enoyl-CoA in β-oxidation). <br>• FADH₂ donates e⁻ to Complex II (Succinate Dehydrogenase) of the ETC.
CoA (Coenzyme A) Acetyl-CoA, Succinyl-CoA, Acyl-CoA Acyl Groups (e.g., Acetyl, Succinyl, Fatty Acyl) Carrier of Activated Acyl Groups. <br>• Contains a reactive thiol (-SH) group that forms high-energy thioester bonds with acyl groups (e.g., Acetyl-CoA). <br>• Key Functions: <br> 1. Entry of acetyl groups into the Citric Acid Cycle. <br> 2. Carrier of activated acyl groups in fatty acid metabolism (both catabolism – β-oxidation, and anabolism – fatty acid elongation).

Crucial Distinction:

  • NAD⁺/NADH: Used primarily in energy-yielding catabolic reactions (e.g., Glycolysis, Pyruvate Dehydrogenase Complex, TCA Cycle). It is a soluble, mobile carrier.
  • NADP⁺/NADPH: Used primarily in energy-consuming anabolic (biosynthetic) reactions (e.g., Fatty Acid Synthesis, Cholesterol Synthesis). It provides the reducing power for biosynthesis.

IV. Learning Outcome: Calculating Energy (ATP) Production

Students will be able to calculate ATP yield from the oxidation of a given fuel molecule (e.g., glucose, palmitate).

A. The Logic of the Calculation
We must account for all reducing equivalents (NADH, FADH₂) generated and the ATP/GTP produced directly via Substrate-Level Phosphorylation (SLP).

B. Step-by-Step Guide for a Fuel Molecule (e.g., Glucose)
Goal: Calculate the net ATP yield from the complete oxidation of one glucose molecule (C₆H₁₂O₆) to 6 CO₂ via Glycolysis, Pyruvate Dehydrogenase Complex (PDC), Citric Acid Cycle (TCA), and Oxidative Phosphorylation (OxPhos).

Step 1: Break down the pathway into stages.

  1. Glycolysis (Cytosol)
  2. Pyruvate Dehydrogenase Complex (Mitochondria)
  3. Citric Acid Cycle (Mitochondrial Matrix)
  4. Oxidative Phosphorylation (Inner Mitochondrial Membrane)

Step 2: Account for energy investments and payoffs in each stage.

Stage Direct ATP (SLP) Reducing Equivalents Generated Location of e⁻ Notes
1. Glycolysis Net +2 ATP (Payoff: 4 ATP, Investment: -2 ATP) 2 NADH (from G3P → 1,3-BPG) Cytosol Cytosolic NADH must be “shuttled” into mitochondria.
2. Pyruvate Oxidation (via PDC) 0 2 NADH (per glucose) Mitochondrial Matrix For 2 pyruvates.
3. Citric Acid Cycle (x2 per glucose) +2 GTP (equivalent to 2 ATP) 6 NADH (x2 = 3 per acetyl-CoA) <br> 2 FADH₂ (x2 = 1 per acetyl-CoA) Mitochondrial Matrix For 2 acetyl-CoA.

Step 3: Calculate ATP yield from reducing equivalents via OxPhos.
This depends on the P/O ratio (ATP per O atom).

  • Modern values (based on proton stoichiometry):
    • 1 NADH → ~2.5 ATP
    • 1 FADH₂ → ~1.5 ATP
  • Classic textbook values: (Use if specified)
    • 1 NADH → 3 ATP
    • 1 FADH₂ → 2 ATP

Step 4: Account for the NADH shuttle.
Cytosolic NADH from glycolysis cannot cross the mitochondrial membrane. It must transfer its electrons via a shuttle system. The ATP yield depends on the shuttle used:

  • Malate-Aspartate Shuttle: Most efficient. Transfers e⁻ to NADH in the matrix. Yield: 1 cytosolic NADH → ~2.5 ATP.
  • Glycerol-3-Phosphate Shuttle: Less efficient. Transfers e⁻ to FADH₂ in the matrix. Yield: 1 cytosolic NADH → ~1.5 ATP.

Step 5: Perform the calculation (using modern values & Malate-Aspartate Shuttle).

Source Quantity ATP per Unit Total ATP
Direct ATP (Glycolysis) 2 ATP 1 +2
Direct GTP (TCA Cycle) 2 GTP 1 +2
Glycolysis NADH (via Malate-Aspartate Shuttle) 2 NADH 2.5 +5
PDC NADH 2 NADH 2.5 +5
TCA Cycle NADH 6 NADH 2.5 +15
TCA Cycle FADH₂ 2 FADH₂ 1.5 +3
TOTAL (Theoretical Max) ≈ 32 ATP

Step 6: State the net reaction and yield.

  • C₆H₁₂O₆ + 6 O₂ → 6 CO₂ + 6 H₂O
  • ΔG°’ = -2,840 kJ/mol (Energy released)
  • ~32 ATP synthesized (Energy captured)
  • Efficiency = (32 ATP * ~30.5 kJ/mol) / (2,840 kJ/mol) ≈ 34% (Highly efficient compared to man-made engines).

C. Applying the Logic to Other Fuels (e.g., Palmitate, a C₁₆ saturated fatty acid)

  1. Activation: -2 ATP (to form Palmitoyl-CoA).
  2. β-Oxidation Rounds: (16/2) – 1 = 7 rounds. Each round produces: 1 NADH, 1 FADH₂, and 1 Acetyl-CoA.
  3. Acetyl-CoA Oxidation: 8 Acetyl-CoA enter TCA, producing per acetyl-CoA: 3 NADH, 1 FADH₂, 1 GTP.
  4. Sum the total NADH, FADH₂, and SLP from β-oxidation and TCA.
  5. Convert all reducing equivalents to ATP using P/O ratios.
  6. Subtract activation cost to get Net ATP yield (~106 ATP for Palmitate).

Summary & Key Takeaway

  • Metabolism is the organized network of catabolic (energy-releasing) and anabolic (energy-consuming) pathways.
  • ATP is the universal energy currency, synthesized primarily via Substrate-Level Phosphorylation (in cytosol and matrix) and Oxidative Phosphorylation (in mitochondria).
  • NAD⁺, FAD, and CoA are essential coenzymes that act as recyclable carriers of electrons (NAD⁺/FAD) and acyl groups (CoA), linking different metabolic pathways.
  • ATP yield calculations require a systematic approach: track direct ATP/GTP, count reducing equivalents (NADH, FADH₂), apply the correct P/O ratios, and account for any energy investments (e.g., activation) or shuttle systems.

BCH-502 Nutritional Biochemistry 3(2-1)

 Nutrition Fundamentals: Food Selection, Planning, and Dietary Requirements

I. Concepts of Foodstuffs

A. Definition

Foodstuffs are any substances consumed to provide nutritional support for the body. They contain essential macronutrients (carbohydrates, proteins, fats) and micronutrients (vitamins, minerals) necessary for health, growth, and energy.

B. Classification of Foodstuffs

Category Primary Nutrients Functions Examples
Cereals & Grains Carbohydrates, B-vitamins, Fiber Energy, Digestive health Rice, wheat, oats, millets
Pulses & Legumes Protein, Fiber, B-vitamins, Iron Tissue building, Energy Lentils, beans, chickpeas
Milk & Products Protein, Calcium, Vitamin D, B12 Bone health, Growth Milk, yogurt, cheese
Meat & Alternatives Protein, Iron, B-vitamins, Zinc Tissue repair, Immunity Fish, poultry, eggs, tofu
Fruits & Vegetables Vitamins, Minerals, Fiber, Antioxidants Immunity, Disease prevention Citrus, leafy greens, berries
Fats & Oils Essential fatty acids, Fat-soluble vitamins Energy, Hormone synthesis Olive oil, ghee, nuts, seeds
Sugar & Sweets Simple carbohydrates Quick energy Honey, jaggery, sugar

II. Food Selection and Meal Planning for Healthy Individuals

A. Principles of Food Selection

  1. Nutritional Adequacy: Choose foods that provide all essential nutrients in proper proportions
  2. Variety: Include different foods from each food group daily
  3. Balance: Proportionate amounts of all nutrients
  4. Moderation: Avoid excessive intake of any single nutrient
  5. Safety: Ensure food is clean, fresh, and properly prepared
  6. Cultural Acceptance: Consider traditional food patterns and preferences
  7. Cost-Effectiveness: Balance nutrition with affordability

B. Meal Planning Guidelines

  1. Daily Distribution:
    • 3 main meals (breakfast, lunch, dinner)
    • 1-2 healthy snacks (mid-morning, evening)
    • Breakfast: 25-30% of daily calories
    • Lunch: 35-40% of daily calories
    • Dinner: 25-30% of daily calories
  2. Plate Method (Visual Guide): 
    ┌─────────────────────────┐
│     ½ Plate             │
│   Vegetables & Fruits   │
├──────────┬──────────────┤
│   ¼ Plate│   ¼ Plate    │
│  Protein │  Grains/     │
│          │  Starchy Veg │
└──────────┴──────────────┘
  3. Color Diversity: Aim for 5 colors daily in fruits/vegetables
    • Red: Tomatoes, strawberries (lycopene)
    • Green: Spinach, broccoli (folate, iron)
    • Yellow/Orange: Carrots, oranges (vitamin A)
    • Purple: Eggplant, blueberries (anthocyanins)
    • White: Onions, garlic (allicin)
  4. Timing Considerations:
    • Eat within 1 hour of waking
    • Space meals 3-4 hours apart
    • Finish dinner 2-3 hours before bedtime

III. Food Exchange Lists

A. Purpose

  • Tool for meal planning and portion control
  • Allows substitution within food groups while maintaining nutritional consistency
  • Particularly useful for diabetes management and weight control

B. Standard Exchange System (Approximate Values)

Food Group 1 Exchange Contains Calories Key Nutrients
Starch/Bread 15g carbohydrate<br>3g protein<br>0-1g fat 80 Fiber, B-vitamins
Fruit 15g carbohydrate 60 Vitamins, Fiber
Milk 12g carbohydrate<br>8g protein<br>0-8g fat 90-150 Calcium, Protein
Vegetables 5g carbohydrate<br>2g protein 25 Vitamins, Minerals
Meat/Protein 7g protein<br>3-8g fat 45-100 Protein, Iron
Fat 5g fat 45 Essential fatty acids

C. Sample Exchanges (1 Serving Each)

Starch Group (1 exchange = 80 cal):

  • 1 slice bread (30g)
  • ½ cup cooked rice/pasta (100g)
  • ½ medium potato (75g)
  • 3 cups popcorn (air-popped)

Protein Group (Lean = 45 cal, Medium-fat = 75 cal):

  • 30g cooked chicken/fish (lean)
  • 1 large egg (medium-fat)
  • ¼ cup cottage cheese (lean)
  • ½ cup cooked lentils (lean)

Vegetable Group (1 exchange = 25 cal):

  • 1 cup raw leafy vegetables
  • ½ cup cooked vegetables
  • ½ cup vegetable juice

Fruit Group (1 exchange = 60 cal):

  • 1 small apple/orange/pear
  • ½ banana
  • ½ cup fruit juice
  • 15 grapes

Milk Group (1 exchange = 90-150 cal):

  • 1 cup milk (fat-free = 90 cal)
  • 1 cup yogurt (plain, fat-free)
  • ⅓ cup powdered milk

Fat Group (1 exchange = 45 cal):

  • 1 tsp oil/butter
  • 1 tbsp salad dressing
  • ⅛ avocado
  • 5 olives

IV. Balanced Diet

A. Definition

A diet that contains all essential nutrients in appropriate quantities and proper proportions to maintain optimal health and prevent deficiency diseases.

B. Components of a Balanced Diet (ICMR Guidelines)

Nutrient Recommended % of Total Calories Functions
Carbohydrates 55-60% Primary energy source
Proteins 10-15% Tissue building and repair
Fats 20-30% Energy, hormone production
Vitamins Trace amounts Metabolic regulation
Minerals Trace amounts Structural components, enzyme cofactors
Water Adequate for hydration Transport, temperature regulation
Fiber 25-30g/day Digestive health

C. Sample Balanced Daily Diet (2000 kcal)

Breakfast (500 kcal):

  • 2 slices whole wheat bread (Starch: 2 exchanges)
  • 2 boiled eggs (Protein: 2 exchanges)
  • 1 cup milk (Milk: 1 exchange)
  • 1 apple (Fruit: 1 exchange)

Lunch (700 kcal):

  • 2 chapati (Starch: 2 exchanges)
  • 1 cup dal (Protein: 2 exchanges)
  • 1 cup mixed vegetables (Vegetable: 2 exchanges)
  • ½ cup curd (Milk: ½ exchange)
  • 1 tsp oil for cooking (Fat: 1 exchange)

Evening Snack (200 kcal):

  • 1 cup tea with milk
  • 2 biscuits (Starch: 1 exchange)

Dinner (600 kcal):

  • 1.5 cups rice (Starch: 3 exchanges)
  • 100g fish/chicken (Protein: 3 exchanges)
  • 1 cup vegetable curry (Vegetable: 2 exchanges)
  • Salad with 1 tsp dressing (Fat: 1 exchange)

V. Recommended Dietary Allowances (RDA)

A. Definition

The average daily dietary intake level sufficient to meet the nutrient requirements of nearly all (97-98%) healthy individuals in a particular life stage and gender group.

B. Factors Influencing RDA

  1. Age (infants, children, adults, elderly)
  2. Gender (different needs for males/females)
  3. Physiological State (pregnancy, lactation)
  4. Activity Level (sedentary, moderate, heavy work)
  5. Climate and Environment
  6. Body Size and Composition

C. ICMR (Indian) RDAs for Different Categories

1. Adult Men (Sedentary, 60kg)

  • Energy: 2320 kcal/day
  • Protein: 60g/day
  • Fat: 25-30g/day
  • Calcium: 600mg/day
  • Iron: 17mg/day

2. Adult Women (Sedentary, 55kg)

  • Energy: 1900 kcal/day
  • Protein: 55g/day
  • Fat: 20-25g/day
  • Calcium: 600mg/day
  • Iron: 21mg/day (pre-menopausal)

3. Pregnancy (Additional Requirements)

  • Energy: +350 kcal/day (2nd & 3rd trimester)
  • Protein: +23g/day
  • Iron: 35mg/day
  • Calcium: 1200mg/day
  • Folic Acid: 500μg/day

4. Lactation (0-6 months)

  • Energy: +600 kcal/day
  • Protein: +19g/day
  • Calcium: 1200mg/day
  • Vitamin A: 950μg/day

5. Children (1-3 years)

  • Energy: 1060 kcal/day
  • Protein: 16.7g/day
  • Calcium: 600mg/day
  • Iron: 9mg/day

6. Adolescents (13-15 years)

  • Boys: Energy: 2750 kcal, Protein: 70g
  • Girls: Energy: 2330 kcal, Protein: 65g
  • Calcium: 800mg/day
  • Iron: Boys: 21mg, Girls: 27mg

7. Elderly (60+ years)

  • Men: Energy: 1900 kcal, Protein: 60g
  • Women: Energy: 1500 kcal, Protein: 55g
  • Calcium: 800mg/day
  • Vitamin D: 600 IU/day

D. Special Considerations

Vegetarian Diets:

  • Combine cereals + pulses for complete protein
  • Include vitamin C-rich foods with iron sources
  • Consider B12 supplementation

Sports Nutrition:

  • Increased carbohydrate needs: 6-10g/kg body weight
  • Protein: 1.2-2.0g/kg body weight
  • Hydration: 500ml water 2 hours before exercise

Weight Management:

  • Create 500 kcal deficit daily for 0.5kg/week weight loss
  • Focus on nutrient density rather than just calories

VI. Practical Applications

A. Using Food Exchange Lists for Meal Planning

  1. Determine daily calorie needs based on age, gender, activity
  2. Allocate exchanges across food groups
  3. Distribute exchanges throughout the day
  4. Plan menus using exchange equivalents
  5. Monitor and adjust based on results

B. Common Dietary Patterns

Indian Thali System:

  • 40% cereals, 20% pulses, 25% vegetables, 15% others
  • Includes all six tastes: sweet, sour, salty, bitter, pungent, astringent

Mediterranean Pattern:

  • High in fruits, vegetables, whole grains, olive oil
  • Moderate fish, poultry, dairy
  • Low red meat, sweets

DASH Diet (Hypertension):

  • High potassium, calcium, magnesium
  • Low sodium, saturated fat
  • Rich in fruits, vegetables, low-fat dairy

C. Assessment Tools

  1. 24-Hour Dietary Recall: What was eaten in last 24 hours
  2. Food Frequency Questionnaire: How often specific foods are consumed
  3. Food Diary: Detailed record of all foods consumed
  4. Dietary Guidelines Index: Measures adherence to dietary recommendations

Key Takeaways

  1. Food selection should prioritize nutritional adequacy, variety, and balance
  2. Food exchange lists provide flexibility in meal planning while maintaining nutritional consistency
  3. A balanced diet provides all nutrients in proper proportions from diverse food sources
  4. RDAs vary significantly across life stages and physiological conditions
  5. Practical meal planning combines scientific principles with individual preferences and cultural practices

 

Energy Metabolism, Dietary Assessment, and Diet in Disease Management

I. Energy Metabolism Fundamentals

A. The Energy Balance Equation

Energy Balance = Energy Intake (Food) - Energy Expenditure
  • Positive Balance: Weight gain (intake > expenditure)
  • Negative Balance: Weight loss (intake < expenditure)
  • Neutral Balance: Weight maintenance

B. Energy Units

  1. Calorie (cal): Heat required to raise 1g water by 1°C
  2. Kilocalorie (kcal): 1000 calories = heat to raise 1kg water by 1°C
  3. Kilojoule (kJ): SI unit; 1 kcal = 4.184 kJ

II. Measurement of Food Energy

A. Direct Calorimetry

Principle: Measures heat produced by food/bomb calorimeter

Food + O₂ → CO₂ + H₂O + Heat
  • Bomb Calorimeter: Sealed chamber with oxygen; measures temperature rise
  • Atwater Factors (physiological energy values):
    • Carbohydrates: 4 kcal/g
    • Proteins: 4 kcal/g
    • Fats: 9 kcal/g
    • Alcohol: 7 kcal/g

B. Indirect Calorimetry

Principle: Measures O₂ consumption and CO₂ production to calculate energy expenditure

  1. Closed-Circuit Method: Subject breathes from sealed O₂ tank; measures O₂ depletion
  2. Open-Circuit Method (more common):
    • Measures composition of inhaled vs. exhaled air
    • Uses Douglas Bag or Metabolic Cart
    • Calculates energy from Respiratory Quotient (RQ)

C. Respiratory Quotient (RQ)

RQ = CO₂ produced ÷ O₂ consumed

RQ Values for Different Nutrients:

  • Carbohydrates: RQ = 1.0 (C₆H₁₂O₆ + 6O₂ → 6CO₂ + 6H₂O)
  • Fats: RQ = 0.7 (Palmitic acid: C₁₆H₃₂O₂ + 23O₂ → 16CO₂ + 16H₂O)
  • Proteins: RQ = 0.8 (average)
  • Mixed Diet: RQ = 0.85 (typical)
  • Alcohol: RQ = 0.67

Clinical Significance of RQ:

  • RQ > 1.0: Lipogenesis (carbohydrate → fat conversion)
  • RQ = 0.7: Pure fat oxidation (during starvation)
  • RQ Monitoring: Assesses substrate utilization in metabolic studies

III. Energy Expenditure Components

Total Energy Expenditure (TEE) = BMR + TEF + PA

A. Basal Metabolic Rate (BMR)

Definition: Energy expended for vital functions at complete rest, 12-18 hours postprandial, in thermoneutral environment

Factors Affecting BMR:

Factor Effect on BMR Reason/Mechanism
Body Size ↑ with ↑ surface area Larger body = more cells = higher metabolism
Lean Body Mass Directly proportional Muscle tissue is metabolically more active than fat
Age ↓ with age Decreased muscle mass, decreased cellular activity
Gender Men > Women (~10%) Higher lean body mass in men
Climate ↑ in cold climates Increased heat production for thermoregulation
Hormonal Status ↑ with hyperthyroidism, ↓ with hypothyroidism Thyroid hormones regulate metabolic rate
Pregnancy ↑ by 15-25% Increased metabolic demands of fetus and maternal tissues
Nutritional Status ↓ in starvation/malnutrition Adaptive thermogenesis to conserve energy
Sleep ↓ by 10% Reduced muscle tone, CNS activity
Genetics Varies 5-10% Inherited metabolic efficiency

BMR Calculation (Harris-Benedict Equation):

  • Men: BMR = 88.362 + (13.397 × weight kg) + (4.799 × height cm) – (5.677 × age years)
  • Women: BMR = 447.593 + (9.247 × weight kg) + (3.098 × height cm) – (4.330 × age years)

B. Physical Activity (PA)

Activity Multipliers:

  • Sedentary: BMR × 1.2
  • Lightly active: BMR × 1.375
  • Moderately active: BMR × 1.55
  • Very active: BMR × 1.725
  • Extremely active: BMR × 1.9

C. Thermic Effect of Food (TEF)

Energy required for digestion, absorption, transport, and storage of nutrients

  • Carbohydrates: 5-10% of energy content
  • Fats: 0-3% of energy content
  • Proteins: 20-30% of energy content
  • Mixed Diet: ~10% of total intake

IV. Energy Requirements of Individuals

A. Determination Methods

  1. Factorial Method: TEE = BMR × Physical Activity Level (PAL)
  2. Doubly Labeled Water: Gold standard; measures CO₂ production using stable isotopes
  3. Heart Rate Monitoring: Correlates heart rate with energy expenditure
  4. Accelerometry: Measures body movement to estimate PA

B. Factors Influencing Energy Requirements

  1. Age and Growth Phase
    • Infants: 100-120 kcal/kg
    • Children: Decreases per kg with age
    • Adults: Stable
    • Elderly: Decreases by 5-10% per decade
  2. Body Composition and Weight
    • More lean mass = higher requirements
    • Weight gain/loss goals adjust requirements
  3. Physiological State
    • Pregnancy: +300 kcal/day (2nd/3rd trimester)
    • Lactation: +500 kcal/day
  4. Health Status
    • Fever: +13% per °C above normal
    • Burns/trauma/surgery: Increased requirements
    • Chronic illness: Variable effects

ICMR Energy Requirements (Indian Guidelines):

Category Age (years) Weight (kg) Energy (kcal/day)
Men 18-29 60 2720 (Sedentary)
30-59 60 2330 (Sedentary)
60+ 60 1900 (Sedentary)
Women 18-29 55 2230 (Sedentary)
30-59 55 1900 (Sedentary)
60+ 55 1500 (Sedentary)
Pregnancy – – +350 (2nd/3rd trim)
Lactation – – +600 (0-6 months)

V. Diet and Disease: Nutritional Disorders

A. Food Borne Diseases

Type Cause Examples Prevention
Infections Pathogens multiply in host Salmonella, E. coli, Listeria Proper cooking, hygiene
Intoxications Pre-formed toxins Botulism, Staphylococcal Proper storage, handling
Toxin-mediated Toxins produced in host Clostridium perfringens Temperature control

B. Primary Nutritional Diseases

1. Protein-Energy Malnutrition (PEM)

  • Marasmus: Chronic energy deficiency
    • Diet: High energy, gradual protein increase, frequent small meals
  • Kwashiorkor: Acute protein deficiency
    • Diet: High protein, adequate energy, micronutrient supplementation

2. Vitamin Deficiencies

  • Vitamin A: Xerophthalmia → Diet: Orange/yellow fruits, leafy greens
  • Vitamin D: Rickets/Osteomalacia → Diet: Fortified dairy, sunlight exposure
  • B Vitamins: Beriberi, Pellagra → Diet: Whole grains, legumes, meat

3. Mineral Deficiencies

  • Iron: Anemia → Diet: Red meat, leafy greens + vitamin C
  • Iodine: Endemic Goiter → Diet: Iodized salt, seafood
  • Calcium: Osteoporosis → Diet: Dairy, fortified foods

C. Endemic Goiter

Pathophysiology: Iodine deficiency → decreased thyroid hormones → TSH stimulation → thyroid hyperplasia

Dietetic Management:

  1. Iodine Supplementation: Iodized salt (15-30 ppm iodine)
  2. Food Sources: Seaweed, fish, dairy
  3. Goitrogen Avoidance: Limit raw cruciferous vegetables (cabbage, cauliflower) in deficient areas

D. Eating Disorders

1. Anorexia Nervosa

  • Characteristics: Self-starvation, fear of weight gain, distorted body image
  • Nutritional Therapy:
    • Start: 1000-1200 kcal/day, increase gradually
    • Small, frequent meals (6-8/day)
    • Liquid supplements if oral intake inadequate
    • Monitor for refeeding syndrome (electrolyte imbalances)

2. Obesity

  • Definition: BMI ≥ 30 kg/m² or body fat >25% (men), >32% (women)
  • Dietetic Treatment:
    • Calorie deficit: 500-1000 kcal/day
    • Macronutrient distribution: 55% carbs, 15-20% protein, 25-30% fat
    • High fiber: 25-30g/day
    • Behavior modification: Self-monitoring, stimulus control
    • Physical activity: Gradually increase to 150-300 min/week

E. Diabetes Mellitus

Nutritional Goals:

  1. Maintain near-normal blood glucose
  2. Achieve optimal lipid profile
  3. Provide adequate energy for weight management
  4. Prevent complications

Dietetic Principles:

  • Carbohydrate Counting: 45-60g per meal
  • Glycemic Index: Emphasize low-GI foods
  • Fiber: 25-50g/day
  • Protein: 0.8-1.0g/kg (normal renal function)
  • Fat: <30% total calories, <7% saturated fat
  • Meal Timing: Consistent carbohydrate distribution

Sample Diabetic Diet (1500 kcal):

  • Breakfast: 2 chapatis, 1 cup vegetables, 1 cup milk
  • Lunch: 2 chapatis, 1 cup dal, 1 cup vegetables, salad
  • Dinner: 1.5 cups rice, 100g chicken/fish, 1 cup vegetables
  • Snacks: 1 fruit, ½ cup yogurt

F. Cardiovascular Diseases

Dietary Management for Hypertension:

  • DASH Diet: Rich in fruits, vegetables, low-fat dairy
  • Sodium: <1500-2300 mg/day
  • Potassium: 4700 mg/day (fruits, vegetables)
  • Calcium: 1200 mg/day
  • Magnesium: 500 mg/day

Diet for Hyperlipidemia:

  • Reduce saturated fat to <7% calories
  • Increase omega-3 fatty acids (fish, flaxseeds)
  • Soluble fiber: 10-25g/day (oats, legumes)
  • Plant sterols/stanols: 2g/day
  • Limit trans fats completely

G. Gastrointestinal Disorders

1. Peptic Ulcer Disease:

  • Avoid: Spicy foods, caffeine, alcohol, large meals
  • Include: Bland diet, frequent small meals
  • No evidence for milk-based diets (may increase acid secretion)

2. Inflammatory Bowel Disease:

  • Crohn’s: High protein, low residue during flare-ups
  • Ulcerative Colitis: Low lactose if intolerant, omega-3 supplements
  • Elemental diets for acute exacerbations

3. Liver Disease:

  • Cirrhosis: High energy (35-40 kcal/kg), moderate protein (1.0-1.5g/kg)
  • Hepatic Encephalopathy: Protein restriction (0.5-0.7g/kg), then gradual increase
  • Branched-chain amino acid supplements

H. Food Intolerances and Allergies

Condition Mechanism Common Triggers Management
Lactose Intolerance Lactase deficiency Milk, dairy products Lactase enzymes, lactose-free products
Gluten Sensitivity Non-celiac immune response Wheat, barley, rye Gluten-free diet
Celiac Disease Autoimmune reaction to gluten Gluten-containing grains Strict gluten-free diet for life
Food Allergy (IgE-mediated) Immune reaction to food proteins Peanuts, shellfish, eggs, milk Avoidance, epinephrine for anaphylaxis
Histamine Intolerance DAO enzyme deficiency Fermented foods, aged cheese, wine Low-histamine diet

I. Cancer and Nutrition

Nutritional Issues in Cancer:

  1. Cachexia: Muscle wasting, weight loss, anorexia
  2. Treatment Side Effects: Mucositis, taste changes, nausea, diarrhea
  3. Metabolic Alterations: Increased energy needs, insulin resistance

Dietetic Management:

  • Energy: 25-35 kcal/kg (may need 1.5× BMR)
  • Protein: 1.2-2.0g/kg (preserve lean mass)
  • During Treatment: Small, frequent meals; nutrient-dense foods
  • Tube Feeding/Parenteral Nutrition: When oral intake <60% needs for >10 days

Cancer Prevention Dietary Guidelines:

  • Fruits/vegetables: 5+ servings/day
  • Whole grains: 3+ servings/day
  • Limit processed/red meat
  • Maintain healthy weight
  • Limit alcohol

J. Nutrition and Infection

Bidirectional Relationship:

  1. Malnutrition → Immunodeficiency:
    • Protein-energy malnutrition impairs cell-mediated immunity
    • Micronutrient deficiencies (Zn, Se, Vit A, C, E) reduce immune function
  2. Infection → Malnutrition:
    • Increased metabolic demands
    • Reduced intake (anorexia)
    • Nutrient losses (diarrhea, vomiting)
    • Altered metabolism

Nutritional Support During Infection:

  • Increased energy: 1.3-1.5× BMR
  • Increased protein: 1.5-2.0g/kg
  • Micronutrient supplementation as needed
  • Hydration: 30-35 ml/kg + losses

VI. Starvation: Metabolic Adaptation

A. Phases of Starvation

Phase Duration Metabolic Changes Energy Sources
Postabsorptive 4-24 hours Glycogen depletion, gluconeogenesis Liver glycogen (75%), gluconeogenesis (25%)
Early Starvation 1-3 days Increased lipolysis, ketogenesis Adipose tissue triglycerides (80%), muscle protein (20%)
Adapted Starvation 3 days-3 weeks Ketone bodies become major fuel, protein sparing Adipose tissue (85%), ketones (10%), protein (5%)
Late Starvation Weeks-months Severe protein conservation, metabolic rate ↓ 30% Adipose tissue (90%), ketones (8%), protein (2%)

B. Refeeding Syndrome

Risk: After prolonged starvation (>10 days with <50% intake)
Pathophysiology: Rapid feeding → insulin surge → intracellular shifts of phosphate, potassium, magnesium → hypophosphatemia, hypokalemia, hypomagnesemia
Prevention:

  • Start feeding at 10-20 kcal/kg (50% of goal)
  • Increase slowly over 4-7 days
  • Provide thiamine before feeding
  • Monitor electrolytes closely

VII. Clinical Nutrition Assessment

A. Components of Nutritional Assessment

  1. Anthropometry: Weight, height, BMI, waist circumference, skinfold thickness
  2. Biochemical Tests: Albumin, prealbumin, transferrin, CRP
  3. Clinical Examination: Signs of deficiency, muscle wasting, edema
  4. Dietary Assessment: 24-hour recall, food frequency, food diary

B. Nutritional Support Indications

  • Oral Diet: When patient can eat and absorb normally
  • Enteral Nutrition: Functional GI tract but inadequate oral intake
  • Parenteral Nutrition: Non-functional GI tract

Key Clinical Applications

  1. Calculate Energy Needs: Use appropriate equations considering disease state
  2. Design Therapeutic Diets: Modify consistency, composition, timing based on condition
  3. Monitor Nutritional Status: Regular assessment during treatment
  4. Educate Patients: Practical dietary modifications for disease management
  5. Prevent Complications: Anticipate and address nutritional risks

Micronutrients: Vitamins and Minerals

I. Introduction to Micronutrients

A. Definition and Characteristics

Micronutrients are essential dietary components required in small quantities (mg or μg/day) that are crucial for physiological functions but do not provide energy directly.

Characteristic Vitamins Minerals
Chemical Nature Organic compounds Inorganic elements
Stability Destroyed by heat, light, oxidation Generally stable
Absorption Often require carriers/fat Variable mechanisms
Storage Limited (water-soluble) or extensive (fat-soluble) Bones, tissues
Excretion Urine (water-soluble), limited (fat-soluble) Urine, feces, sweat

B. Classification of Vitamins

1. Based on Solubility

VITAMINS
├── WATER-SOLUBLE
│   ├── B-Complex Vitamins
│   │   ├── B1 (Thiamine)
│   │   ├── B2 (Riboflavin)
│   │   ├── B3 (Niacin)
│   │   ├── B5 (Pantothenic Acid)
│   │   ├── B6 (Pyridoxine)
│   │   ├── B7 (Biotin)
│   │   ├── B9 (Folic Acid)
│   │   └── B12 (Cobalamin)
│   └── Vitamin C (Ascorbic Acid)
└── FAT-SOLUBLE
    ├── Vitamin A (Retinoids)
    ├── Vitamin D (Calciferols)
    ├── Vitamin E (Tocopherols)
    └── Vitamin K (Phylloquinone, Menaquinone)

2. Based on Function

  • Coenzymes: B vitamins (energy metabolism)
  • Antioxidants: Vitamins C, E, beta-carotene
  • Gene Expression Regulators: Vitamins A, D
  • Blood Coagulation: Vitamin K
  • Collagen Synthesis: Vitamin C

II. WATER-SOLUBLE VITAMINS

A. B-COMPLEX VITAMINS

1. Vitamin B1 (Thiamine)

Chemistry:

  • Thiazole + pyrimidine ring
  • Active form: Thiamine pyrophosphate (TPP)
  • Heat labile (destroyed in alkaline pH)

Functions:

  1. Coenzyme in carbohydrate metabolism:
    • Pyruvate dehydrogenase (glycolysis → TCA cycle)
    • α-ketoglutarate dehydrogenase (TCA cycle)
    • Transketolase (Pentose phosphate pathway)
  2. Nerve conduction: Maintains myelin sheath
  3. Appetite regulation: Through hypothalamic centers

Sources:

  • Whole grains, legumes, nuts, pork, yeast
  • Polished rice: Poor source (lost during milling)

Daily Allowance:

  • Adult men: 1.2 mg/day
  • Adult women: 1.1 mg/day
  • Pregnancy/lactation: +0.3 mg

Deficiency Diseases:

  • Beriberi:
    • Dry beriberi: Peripheral neuropathy, muscle wasting
    • Wet beriberi: Cardiovascular symptoms (edema, cardiomegaly)
    • Infantile beriberi: In breastfed infants of deficient mothers
  • Wernicke-Korsakoff syndrome: Alcoholics (ataxia, confusion, ophthalmoplegia)

Toxicity: Rare; excess excreted in urine

2. Vitamin B2 (Riboflavin)

Chemistry:

  • Isoalloxazine ring + ribitol side chain
  • Active forms: FMN (Flavin Mononucleotide) & FAD (Flavin Adenine Dinucleotide)
  • Light sensitive (destroyed by UV light)

Functions:

  1. Electron transport: FAD/FMN in respiratory chain
  2. Antioxidant: Regeneration of glutathione
  3. Metabolism: Fatty acid oxidation, amino acid catabolism

Sources:

  • Milk, eggs, liver, green leafy vegetables
  • Fortified cereals

Daily Allowance:

  • Adult men: 1.3 mg/day
  • Adult women: 1.1 mg/day

Deficiency Manifestations:

  • Cheilosis (cracks at mouth corners)
  • Glossitis (magenta tongue)
  • Angular stomatitis
  • Seborrheic dermatitis
  • Photophobia, corneal vascularization

Toxicity: None known (excess excreted, yellow urine)

3. Vitamin B3 (Niacin)

Chemistry:

  • Nicotinic acid & nicotinamide
  • Active forms: NAD⁺ & NADP⁺
  • Can be synthesized from tryptophan (60 mg tryptophan = 1 mg niacin)

Functions:

  1. Coenzyme in redox reactions: Over 200 enzymes
  2. DNA repair: PARP enzymes
  3. Cholesterol metabolism: High doses lower LDL, raise HDL

Sources:

  • Meat, fish, poultry, whole grains
  • Legumes, nuts
  • Synthesis from tryptophan

Daily Allowance:

  • Expressed as Niacin Equivalents (NE)
  • Adult men: 16 mg NE/day
  • Adult women: 14 mg NE/day

Deficiency Disease: Pellagra (“3 Ds”)

  • Dermatitis: Photosensitive rash (Casal’s necklace)
  • Diarrhea: GI inflammation
  • Dementia: Confusion, disorientation
  • Death (if untreated)

Toxicity (from supplements):

  • Flushing, itching (prostaglandin mediated)
  • Hepatotoxicity (high doses)
  • Glucose intolerance

4. Vitamin B5 (Pantothenic Acid)

Chemistry:

  • β-alanine + pantoic acid
  • Active form: Coenzyme A (CoA)

Functions:

  1. Acyl group carrier: Fatty acid synthesis/oxidation
  2. Cholesterol synthesis
  3. Acetylcholine synthesis

Sources: Ubiquitous (pantos = everywhere)

  • Meat, eggs, legumes, whole grains

Daily Allowance: AI = 5 mg/day

Deficiency: Rare; causes:

  • Burning feet syndrome
  • Fatigue, insomnia
  • GI disturbances

5. Vitamin B6 (Pyridoxine)

Chemistry:

  • Pyridine derivatives
  • Active form: Pyridoxal phosphate (PLP)

Functions:

  1. Amino acid metabolism: Transamination, decarboxylation
  2. Neurotransmitter synthesis: Serotonin, GABA, dopamine
  3. Heme synthesis
  4. Glycogen phosphorylase cofactor

Sources:

  • Meat, fish, poultry
  • Bananas, potatoes, chickpeas
  • Fortified cereals

Daily Allowance:

  • Adults: 1.3-1.7 mg/day
  • Pregnancy: 1.9 mg/day

Deficiency:

  • Microcytic hypochromic anemia
  • Neurological symptoms (depression, confusion)
  • Dermatitis, glossitis
  • Drug-induced: Isoniazid, penicillamine

Toxicity (from supplements):

  • Sensory neuropathy
  • Photosensitivity
  • UL: 100 mg/day

6. Vitamin B7 (Biotin)

Chemistry:

  • Ureido ring + thiophene ring
  • Covalently bound to enzymes

Functions:

  1. Carboxylation reactions:
    • Acetyl-CoA carboxylase (fatty acid synthesis)
    • Pyruvate carboxylase (gluconeogenesis)
    • Propionyl-CoA carboxylase
  2. Gene expression regulation
  3. Cell signaling

Sources:

  • Egg yolk (avidin binds biotin – destroyed by cooking)
  • Liver, nuts, legumes
  • Gut bacteria synthesis

Daily Allowance: AI = 30 μg/day

Deficiency: Rare; causes:

  • Alopecia (hair loss)
  • Dermatitis (scaly red rash)
  • Neurological symptoms (depression, lethargy)
  • Raw egg white consumption (avidin)

7. Vitamin B9 (Folic Acid)

Chemistry:

  • Pteridine + PABA + glutamate
  • Active form: Tetrahydrofolate (THF)

Functions:

  1. One-carbon metabolism:
    • DNA synthesis (purines, thymidylate)
    • Amino acid metabolism (methionine, histidine)
  2. Neural tube development (embryonic)

Sources:

  • Leafy green vegetables (foliage)
  • Legumes, citrus fruits
  • Fortified grains

Daily Allowance:

  • Adults: 400 μg/day
  • Pregnancy: 600 μg/day
  • Lactation: 500 μg/day

Deficiency:

  • Megaloblastic anemia (large immature RBCs)
  • Neural tube defects (spina bifida, anencephaly)
  • Homocysteinemia (cardiovascular risk)
  • Glossitis, diarrhea

Toxicity: Masks B12 deficiency (neurological damage)

8. Vitamin B12 (Cobalamin)

Chemistry:

  • Corrin ring with cobalt
  • Requires intrinsic factor for absorption
  • Active forms: Methylcobalamin, Adenosylcobalamin

Functions:

  1. Methionine synthesis: Homocysteine → methionine
  2. Methylmalonyl-CoA mutase: Odd-chain fatty acid metabolism
  3. DNA synthesis

Sources:

  • Animal products only: Meat, fish, eggs, dairy
  • Fortified foods for vegetarians

Daily Allowance: 2.4 μg/day

Absorption:

  1. Stomach: R-protein binds B12
  2. Duodenum: Pancreatic proteases release B12
  3. Ileum: Intrinsic factor-B12 complex absorbed
  4. Blood: Transcobalamin transports

Deficiency:

  • Pernicious anemia (autoimmune destruction of parietal cells)
  • Megaloblastic anemia (with neurological symptoms)
  • Neurological: Peripheral neuropathy, dementia
  • Schilling test: Diagnostic for malabsorption

B. VITAMIN C (Ascorbic Acid)

Chemistry:

  • Enediol-lactone structure
  • Strong reducing agent
  • Heat and light sensitive

Functions:

  1. Collagen synthesis: Hydroxylation of proline/lysine
  2. Antioxidant: Regenerates vitamin E
  3. Iron absorption: Reduces Fe³⁺ to Fe²⁺
  4. Neurotransmitter synthesis: Norepinephrine, serotonin
  5. Carnitine synthesis
  6. Immune function: Leukocyte activity

Sources:

  • Citrus fruits, berries, kiwi
  • Bell peppers, broccoli, tomatoes
  • Destroyed by cooking, storage

Daily Allowance:

  • Adults: 75-90 mg/day
  • Smokers: +35 mg/day
  • Pregnancy/lactation: 85-120 mg/day

Deficiency Disease: Scurvy

  • Early: Fatigue, weakness
  • Gingival bleeding, loose teeth
  • Perifollicular hemorrhages
  • Poor wound healing
  • Anemia
  • Corkscrew hairs

Toxicity (high doses >2000 mg/day):

  • Diarrhea, GI discomfort
  • Kidney stones (oxalate)
  • Iron overload in susceptible individuals

III. FAT-SOLUBLE VITAMINS

A. VITAMIN A (Retinoids)

Chemistry:

  • Preformed: Retinol, retinal, retinoic acid
  • Provitamin: Carotenoids (β-carotene)
  • Stored in liver (90%)

Functions:

  1. Vision: Rhodopsin synthesis (retinal + opsin)
  2. Gene expression: Retinoic acid receptors
  3. Immune function: Mucosal integrity
  4. Growth and development: Embryogenesis
  5. Reproduction: Spermatogenesis

Sources:

  • Preformed: Liver, fish oils, dairy, eggs
  • Provitamin: Carrots, sweet potatoes, spinach

Daily Allowance:

  • Expressed as Retinol Activity Equivalents (RAE)
  • Adult men: 900 μg RAE/day
  • Adult women: 700 μg RAE/day
  • 1 RAE = 1 μg retinol = 12 μg β-carotene

Deficiency Diseases:

  • Night blindness (nyctalopia) – earliest sign
  • Xerophthalmia:
    • Conjunctival xerosis (dryness)
    • Bitot’s spots (foamy patches)
    • Corneal xerosis, ulceration, keratomalacia
  • Follicular hyperkeratosis (gooseflesh skin)
  • Increased infection susceptibility

Toxicity (Hypervitaminosis A):

  • Acute: Nausea, headache, vertigo
  • Chronic: Alopecia, hepatotoxicity, bone pain
  • Teratogenic: Birth defects in pregnancy

B. VITAMIN D (Calciferol)

Chemistry:

  • D2 (Ergocalciferol): Plant/fungal source
  • D3 (Cholecalciferol): Animal source/skin synthesis
  • Active form: 1,25-dihydroxyvitamin D [Calcitriol]

Synthesis:

7-Dehydrocholesterol (skin) → UVB → Previtamin D3 → Vitamin D3 → Liver → 25-OH-D3 → Kidney → 1,25-(OH)2-D3

Functions:

  1. Calcium homeostasis: Increases intestinal Ca²⁺ absorption
  2. Bone mineralization: Works with PTH, calcitonin
  3. Cell differentiation/proliferation
  4. Immune modulation

Sources:

  • Sunlight (10-15 min/day, arms/face)
  • Fatty fish, cod liver oil, egg yolk
  • Fortified milk, cereals

Daily Allowance:

  • Adults <70: 600 IU (15 μg)/day
  • Adults >70: 800 IU (20 μg)/day
  • Status measured: Serum 25-OH-D (optimal >30 ng/mL)

Deficiency Diseases:

  • Children: Rickets
    • Bone deformities (bow legs, knock knees)
    • Craniotabes (soft skull)
    • Rachitic rosary (costochondral swelling)
    • Harrison’s sulcus
  • Adults: Osteomalacia
    • Bone pain, muscle weakness
    • Fractures

Toxicity (Hypervitaminosis D):

  • Hypercalcemia (nausea, vomiting, confusion)
  • Nephrocalcinosis, kidney stones
  • Soft tissue calcification

C. VITAMIN E (Tocopherols)

Chemistry:

  • α-tocopherol: Most biologically active
  • 8 isomers (α, β, γ, δ tocopherols & tocotrienols)
  • Major lipid-soluble antioxidant

Functions:

  1. Antioxidant: Protects PUFAs from peroxidation
  2. Immune function: Enhances cell-mediated immunity
  3. Gene expression regulation
  4. Platelet aggregation inhibition

Sources:

  • Vegetable oils (wheat germ, sunflower, safflower)
  • Nuts, seeds
  • Green leafy vegetables

Daily Allowance:

  • Adults: 15 mg α-tocopherol/day
  • Pregnancy/lactation: 15-19 mg/day

Deficiency:

  • Rare in humans (stored in adipose tissue)
  • Hemolytic anemia in premature infants
  • Peripheral neuropathy (abetalipoproteinemia)
  • Ataxia (genetic disorders)

Toxicity: Least toxic fat-soluble vitamin

  • High doses may interfere with vitamin K action
  • UL: 1000 mg/day

D. VITAMIN K

Chemistry:

  • K1 (Phylloquinone): Plant sources
  • K2 (Menaquinone): Bacterial synthesis (gut)
  • K3 (Menadione): Synthetic (water-soluble)

Functions:

  1. Blood coagulation: Carboxylation of glutamic acid residues
    • Prothrombin (Factor II), Factors VII, IX, X
    • Proteins C, S, Z
  2. Bone metabolism: Osteocalcin carboxylation
  3. Vascular calcification prevention

Sources:

  • Green leafy vegetables (K1)
  • Gut bacteria synthesis (K2)
  • Meat, cheese (K2)

Daily Allowance:

  • Adult men: 120 μg/day
  • Adult women: 90 μg/day

Deficiency:

  • Hemorrhagic disease of newborn (no gut flora, poor placental transfer)
  • Prolonged clotting time (PT/INR increased)
  • Risk factors: Malabsorption, antibiotics, liver disease

Toxicity: Rare (natural forms)

  • Synthetic K3 can cause hemolytic anemia, kernicterus in infants

IV. MINERALS

A. Classification of Minerals

Category Requirement Examples
Macrominerals >100 mg/day Ca, P, Mg, Na, K, Cl, S
Microminerals (Trace) <100 mg/day Fe, Zn, Cu, I, Se, Mn, F, Cr, Mo, Co
Ultratrace μg/day B, Si, Ni, V, As

B. Biological Importance

1. Calcium (Ca)

  • Distribution: 99% bones/teeth, 1% extracellular fluid
  • Functions: Bone structure, muscle contraction, nerve transmission, blood clotting, enzyme cofactor
  • Absorption: Enhanced by vitamin D, lactose, acidic pH; Inhibited by phytates, oxalates, excess phosphorus
  • Daily Allowance: 1000-1300 mg/day
  • Deficiency: Rickets, osteomalacia, osteoporosis, tetany
  • Sources: Dairy, leafy greens, fortified foods

2. Phosphorus (P)

  • Distribution: 85% bones/teeth, 15% soft tissues
  • Functions: Bone mineralization, ATP, DNA/RNA, phospholipids, pH buffer
  • Daily Allowance: 700 mg/day
  • Deficiency: Rare; bone pain, weakness
  • Sources: Meat, dairy, nuts, legumes

3. Magnesium (Mg)

  • Distribution: 60% bones, 40% intracellular
  • Functions: 300+ enzyme cofactor, nerve/muscle function, protein synthesis
  • Daily Allowance: 310-420 mg/day
  • Deficiency: Muscle cramps, arrhythmias, hypertension
  • Sources: Nuts, seeds, whole grains, green vegetables

4. Sodium (Na) & Potassium (K)

  • Na Functions: Fluid balance, nerve impulse, muscle contraction
  • K Functions: Intracellular cation, nerve function, cardiac rhythm
  • Na/K Balance: Critical for membrane potential
  • Deficiency: Hyponatremia (confusion, seizures); Hypokalemia (weakness, arrhythmias)
  • Recommendations: Na <2300 mg/day; K 3400-4700 mg/day

C. TRACE MINERALS (Selected)

1. Iron (Fe)

  • Forms: Heme iron (Fe²⁺, better absorbed) and Non-heme iron (Fe³⁺)
  • Distribution: 70% hemoglobin, 10% myoglobin, 20% storage (ferritin, hemosiderin)
  • Absorption: Enhanced by vitamin C, meat factor; Inhibited by phytates, tannins, calcium
  • Transport: Transferrin
  • Storage: Ferritin (soluble), Hemosiderin (insoluble)
  • Daily Allowance: Men: 8 mg, Women: 18 mg (premenopausal)
  • Deficiency: Iron deficiency anemia (microcytic hypochromic)
  • Toxicity: Hemochromatosis (liver damage, diabetes, bronze skin)
  • Sources: Red meat, liver, legumes, fortified cereals

2. Zinc (Zn)

  • Functions: 100+ enzyme cofactor, immune function, wound healing, taste/smell
  • Absorption: Inhibited by phytates, fiber, iron/copper supplements
  • Daily Allowance: Men: 11 mg, Women: 8 mg
  • Deficiency: Growth retardation, hypogonadism, impaired immunity, diarrhea, dermatitis (acrodermatitis enteropathica)
  • Toxicity: Nausea, copper deficiency, impaired immunity
  • Sources: Meat, shellfish, legumes, nuts

3. Iodine (I)

  • Function: Thyroid hormone synthesis (T3, T4)
  • Daily Allowance: 150 μg/day
  • Deficiency: Goiter, hypothyroidism, cretinism (mental retardation in children)
  • Sources: Iodized salt, seafood, dairy

4. Selenium (Se)

  • Function: Glutathione peroxidase cofactor (antioxidant), thyroid hormone metabolism
  • Daily Allowance: 55 μg/day
  • Deficiency: Keshan disease (cardiomyopathy), Kashin-Beck disease (osteoarthritis)
  • Toxicity: Selenosis (hair loss, nail brittleness, neurological symptoms)
  • Sources: Brazil nuts, seafood, meat

5. Copper (Cu)

  • Functions: Cytochrome oxidase, superoxide dismutase, melanin synthesis, iron metabolism
  • Daily Allowance: 900 μg/day
  • Deficiency: Anemia, neutropenia, bone abnormalities (Menkes disease – genetic)
  • Toxicity: Wilson’s disease (genetic), liver damage, neurological symptoms
  • Sources: Shellfish, nuts, seeds, organ meats

6. Fluoride (F)

  • Function: Strengthens tooth enamel, prevents dental caries
  • Daily Allowance: 3-4 mg/day
  • Deficiency: Dental caries
  • Toxicity: Dental fluorosis (mottled teeth), skeletal fluorosis
  • Sources: Fluoridated water, tea, seafood

V. METABOLISM OF INORGANIC IONS

A. Regulation of Mineral Homeostasis

1. Calcium-Phosphate Regulation

Three hormones maintain Ca²⁺/PO₄³⁻ balance:

  • Parathyroid Hormone (PTH): ↑ Ca²⁺, ↓ PO₄³⁻
    • Bone: Stimulates osteoclasts
    • Kidney: ↑ Ca²⁺ reabsorption, ↑ PO₄³⁻ excretion
    • Intestine: Indirect via ↑ vitamin D activation
  • Vitamin D: ↑ Ca²⁺ and PO₄³⁻ absorption
  • Calcitonin: ↓ Ca²⁺ (opposes PTH)

2. Sodium-Potassium Balance

  • Aldosterone: ↑ Na⁺ reabsorption, ↑ K⁺ excretion
  • ANP/BNP: ↑ Na⁺ excretion
  • Renin-Angiotensin System: Regulates blood pressure/volume

B. Interrelationships Between Minerals

  • Zn-Cu antagonism: High Zn → Cu deficiency
  • Fe-Cu synergy: Cu required for Fe mobilization
  • Ca-Mg balance: Both compete for absorption
  • Na-K pump: ATP-dependent exchange (3Na⁺ out, 2K⁺ in)

C. Mineral Bioavailability Factors

Enhancers Inhibitors
Vitamin C (Fe) Phytates (Ca, Fe, Zn)
Meat factor (Fe) Oxalates (Ca)
Vitamin D (Ca) Tannins (Fe)
Acidic pH Fiber (multiple minerals)
Lactose (Ca) Excess competing minerals

VI. DEFICIENCY DISEASES SUMMARY TABLE

Nutrient Deficiency Disease Key Features
Thiamine Beriberi Neuropathy, edema, cardiomegaly
Riboflavin Ariboflavinosis Cheilosis, glossitis, dermatitis
Niacin Pellagra 3 Ds: Dermatitis, Diarrhea, Dementia
Vitamin C Scurvy Bleeding gums, poor wound healing
Vitamin A Xerophthalmia Night blindness, corneal ulcers
Vitamin D Rickets/Osteomalacia Bone deformities, fractures
Vitamin K Hemorrhagic disease Prolonged clotting, bleeding
Iron Anemia Fatigue, pallor, weakness
Iodine Goiter, Cretinism Thyroid enlargement, mental retardation
Zinc Growth retardation Delayed growth, impaired immunity

VII. CLINICAL APPLICATIONS

A. Laboratory Assessment

  • Vitamins: Serum/plasma levels, functional tests
  • Minerals: Serum levels (not always reflective of stores), RBC levels, hair/nail analysis

B. Supplementation Guidelines

  1. Targeted supplementation: Based on deficiency
  2. Prophylactic supplementation:
    • Folic acid in pregnancy
    • Vitamin D in limited sun exposure
    • Iron in menstruating women
  3. Therapeutic doses: Higher than RDA for treatment

C. Special Populations

  • Elderly: Vitamin D, B12, calcium
  • Pregnant: Folic acid, iron, calcium
  • Vegetarians: B12, iron, zinc, calcium
  • Alcoholics: Thiamine, folate, B6

Key Learning Points

  1. Vitamins are organic, required in small amounts, classified by solubility
  2. B vitamins function primarily as coenzymes in energy metabolism
  3. Vitamin C is crucial for collagen synthesis and as an antioxidant
  4. Fat-soluble vitamins require dietary fat for absorption and are stored
  5. Minerals are inorganic, classified by daily requirement
  6. Calcium, phosphorus, magnesium are major bone minerals
  7. Iron deficiency is the most common nutritional deficiency worldwide
  8. Iodine deficiency causes preventable mental retardation
  9. Mineral interactions significantly affect absorption and function
  10. Deficiency diseases have characteristic clinical presentations

BCH-504 Industrial Biochemistry 3(2-1)

Food Processing and Manufacturing

I. EXTRACTION AND PROCESSING OF EDIBLE OILS

A. Oilseed Composition and Types

Oilseed Oil Content (%) Protein Content (%) Major Fatty Acids
Soybean 18-20 38-40 Linoleic (51%), Oleic (23%)
Groundnut 45-50 25-28 Oleic (46%), Linoleic (32%)
Sunflower 40-50 20-25 Linoleic (68%), Oleic (21%)
Mustard/Rapeseed 40-45 20-25 Erucic (40-50%), Oleic (25%)
Cottonseed 18-20 20-22 Linoleic (54%), Palmitic (24%)
Sesame 50-55 18-20 Oleic (40%), Linoleic (43%)
Coconut 65-68 7-8 Lauric (48%), Myristic (18%)
Palm 45-50 9-10 Palmitic (44%), Oleic (39%)

B. Oil Extraction Methods

1. Mechanical Extraction

A. Traditional Methods

  • Ghani (Kolhu): Wooden/mortar-pestle, 65-70% extraction
  • Expeller Press: Screw press, 85-90% efficiency 
    Seeds → Cleaning → Cracking → Flaking → Cooking → Pressing → Crude Oil

B. Modern Mechanical Pressing

  • Cold Pressing: <50°C, retains flavor/nutrients, lower yield
  • Hot Pressing: 80-110°C, higher yield, more impurities
  • Solvent-Assisted Mechanical Extraction: Combination method

2. Solvent Extraction

Process Flow:

Seeds → Cleaning → Dehulling → Flaking → Cooking → Solvent Extraction → Miscella → Desolventization → Crude Oil
  • Solvents used: Hexane (most common), ethanol, isopropanol
  • Extraction efficiency: 98-99%
  • Advantages: High yield, continuous process
  • Disadvantages: Solvent residue, explosion risk

3. Supercritical Fluid Extraction (SFE)

  • CO₂ as solvent (supercritical at 31°C, 73 atm)
  • Advantages: No solvent residue, selective extraction, low temperature
  • Disadvantages: High cost, low throughput
  • Used for: High-value oils (evening primrose, borage)

C. Oil Purification and Refining

Purpose: Remove impurities while preserving oil quality

1. Crude Oil Composition

CRUDE OIL
├── TRIGLYCERIDES (95-98%)
├── NON-GLYCERIDES (2-5%)
│   ├── Phospholipids (1-3%)
│   ├── Free fatty acids (0.5-5%)
│   ├── Sterols (0.1-0.5%)
│   ├── Tocopherols (0.05-0.1%)
│   ├── Pigments (0.01-0.05%)
│   ├── Hydrocarbons, waxes
│   └── Trace metals, moisture
└── OXIDATION PRODUCTS (variable)

2. Refining Process Steps

Step 1: Degumming

  • Purpose: Remove phospholipids (gums)
  • Methods:
    • Water degumming: Add 2-3% water, hydrate gums, centrifuge
    • Acid degumming: Phosphoric/citric acid for non-hydratable gums
    • Enzymatic degumming: Phospholipase enzymes
  • Byproduct: Lecithin (commercial value)

Step 2: Neutralization (Alkali Refining)

  • Purpose: Remove free fatty acids (FFAs)
  • Reaction: FFA + NaOH → Soap + H₂O
  • Process: 
    Crude Oil + NaOH → Mixing → Centrifugation → Washed Oil → Drying
  • Conditions: 80-90°C, 0.1-0.15% excess NaOH
  • Byproduct: Soapstock (used for acid oils, animal feed)

Step 3: Bleaching

  • Purpose: Remove pigments, oxidation products, trace metals
  • Adsorbents: Activated earth (0.5-2%), activated carbon
  • Process: 90-110°C under vacuum, 15-30 minutes
  • Spent bleach contains adsorbed impurities

Step 4: Deodorization

  • Purpose: Remove volatile compounds (aldehydes, ketones), FFAs
  • Process: Steam distillation at 200-250°C under vacuum (3-6 mmHg)
  • Conditions: 15-120 minutes, 1-3% stripping steam
  • Removes: Odors, flavors, pesticides, oxidation products

Step 5: Winterization (Optional)

  • Purpose: Remove waxes, high-melting triglycerides
  • Process: Cool to 5-10°C, hold 4-24 hours, filter
  • For oils: Sunflower, rice bran, cottonseed

3. Physical Refining

  • Alternative to alkali refining
  • Process: Degumming → Bleaching → Steam refining
  • Advantages: No soapstock, higher yield, less pollution
  • Limitations: Only for low-phosphatide oils (palm, lauric oils)

D. Oil Quality Parameters

Parameter Acceptable Range Test Method
FFA <0.1% Titration
Peroxide Value <10 meq/kg Iodometric
Anisidine Value <4 Spectrophotometric
Phosphorus <10 ppm Colorimetric
Moisture <0.1% Karl Fischer
Color Depends on oil type Lovibond

II. SOAPS AND DETERGENTS

A. SOAPS

1. Chemistry of Soaps

Definition: Sodium or potassium salts of long-chain fatty acids
General Formula: R-COONa⁺ (sodium soap) or R-COOK⁺ (potassium soap)

Classification:

  • Hard soap: Sodium salts, hard texture
  • Soft soap: Potassium salts, soft/liquid
  • Medicated soap: Antimicrobial additives
  • Transparent soap: Glycerol content >10%
  • Toilet soap: High-grade, perfumed

2. Manufacturing Methods

A. Boiling Process (Kettle Process)

Fats/Oils + NaOH → Boiling → Salting Out → Settling → Soap Curds → Purification → Finishing

Reactions:

1. Saponification: Fat + NaOH → Soap + Glycerol
2. Salting Out: Soap + NaCl → Soap + Glycerol

B. Cold Process

  • Mixing at 27-32°C, no external heating
  • Advantages: Lower energy, retains glycerin
  • Disadvantages: Long curing time (4-6 weeks)

C. Continuous Process

  • Saponification: 98% completion in 30 minutes
  • Neutralization: With fatty acids
  • Advantages: Continuous, automated, consistent quality

3. Chemical Reactions in Soap Making

A. Saponification

Fat (Triglyceride) + NaOH → Soap + Glycerol

Example:

C₁₇H₃₅COO-C₁₇H₃₅
C₁₇H₃₅COO-C₁₇H₃₅ + 3NaOH → 3C₁₇H₃₅COONa + Glycerol
C₁₇H₃₅COO-C₁₇H₃₅

B. Neutralization of Fatty Acids

Fatty acid + NaOH → Soap + Water

Example:

C₁₇H₃₅COOH + NaOH → C₁₇H₃₅COONa⁺ + H₂O

B. EFFECTS ON SOAPS

1. Effect of Acidic Species

Soap + Acid → Fatty acid + Salt

Example:

Stearate (Soap) + HCl → Stearic acid + NaCl

Effects:

  • Decreased lathering: Fatty acids precipitate
  • Reduced cleaning efficiency: Loss of surfactant properties
  • Rancidity: Release of fatty acids

2. Effect of Hard Water

Hard Water Composition:

  • Temporary hardness: Ca²⁺/Mg²⁺ + bicarbonate → CaCO₃/MgCO₃
  • Permanent hardness: Ca²⁺/Mg²⁺ + chloride/sulfate

Reactions:

2R-COONa⁺ + Ca²⁺ → (R-COO)₂Ca + 2Na⁺
2R-COONa⁺ + Mg²⁺ → (R-COO)₂Mg + 2Na⁺

Effects:

  1. Decreased lathering: Insoluble calcium/magnesium soaps
  2. Reduced cleaning efficiency: Formation of scum
  3. Wastage: More soap needed for cleaning
  4. Formation of scum: White precipitate on clothes/surfaces

Chemical Reactions:

2C₁₇H₃₅COONa⁺ + Ca²⁺ → (C₁₇H₃₅COO)₂Ca + 2Na⁺

Solutions:

  1. Boiling: Removes temporary hardness
  2. Clark’s process: Lime softening
  3. Permutit process: Zeolite softening
  4. Ion exchange resins: Modern softening

C. DETERGENTS

Definition: Synthetic surfactants that clean better than soaps

Classification:

  1. Based on charge:
    • Anionic: Sodium lauryl sulfate
    • Cationic: Quaternary ammonium salts
    • Nonionic: Ethoxylated fatty alcohols
    • Amphoteric: Betaines
  2. Based on structure:
    • Linear: Better biodegradability
    • Branched: Lower biodegradability

Advantages over Soaps:

  1. Better cleaning in hard water: No scum formation
  2. Better solubility: No calcium/magnesium salts formed
  3. Better performance in acidic conditions: Not affected by acids
  4. Better biodegradability: Linear structure
  5. Better cleaning efficiency: Lower surface tension

Examples:

  1. Anionic: Sodium lauryl sulfate (SLS)
  2. Cationic: Quaternary ammonium salts
  3. Nonionic: Ethoxylated fatty alcohols
  4. Amphoteric: Betaines

Comparison Table:

Parameter Soaps Detergents
Hard water Precipitates No precipitation
Acidic conditions Decomposes Stable
Biodegradability High Variable
Cleaning efficiency Good Excellent
Cost Low High
Environmental impact Low High

III. SUGAR MANUFACTURING

A. Sugar Sources and Types

Source Sugar Content (%) Main Sugar Type
Sugar Cane 15-20 Sucrose
Sugar Beet 15-20 Sucrose
Maple 2-5 Sucrose
Corn 70-80 Glucose
Honey 80-85 Glucose, Fructose
Fruit 5-20 Glucose, Fructose

B. Sugar Cane Processing

1. Sugar Cane Processing Flow

A. Extraction of Juice

Sugar Cane → Crushing → Juice (65% extraction)
  • Crushing: Rollers extract 65% of juice
  • Bagasse: Remaining solid (35% extraction)
  • Bagasse: Used as fuel, paper, cardboard

BCH-506 Genetics 3(3-0)

Study Notes: Fundamentals of Genetics

1. Classification of Genetics

Genetics can be broadly classified into several major sub-disciplines:

  • Classical (Mendelian) Genetics: Studies the patterns of inheritance of traits from parents to offspring, based on Mendel’s principles.
  • Molecular Genetics: Focuses on the structure, function, and replication of DNA and RNA at the molecular level.
  • Population Genetics: Examines genetic variation within and between populations and how allele frequencies change over time (evolution).
  • Quantitative Genetics: Deals with the inheritance of complex traits influenced by multiple genes and the environment (e.g., height, yield).
  • Cytogenetics: Studies chromosomes, their structure, abnormalities, and behavior during cell division.
  • Genomics: The study of the entire genome (all the DNA) of an organism, including gene mapping and sequencing.
  • Epigenetics: Studies heritable changes in gene expression that do not involve changes to the underlying DNA sequence.

2. The Nature of Genetic Material

  • DNA (Deoxyribonucleic Acid) is the universal genetic material for all cellular life forms.
  • Structure (Watson & Crick Model): A double helix composed of two antiparallel strands. Each strand is a polymer of nucleotides.
  • A Nucleotide consists of:
    • A Deoxyribose sugar
    • A Phosphate group
    • A Nitrogenous Base: Adenine (A), Thymine (T), Guanine (G), Cytosine (C)
  • Base Pairing Rule: A pairs with T (via 2 hydrogen bonds), G pairs with C (via 3 hydrogen bonds). This ensures complementary strands and accurate replication.
  • Key Properties:
    1. Stability: Its chemical structure and double-stranded nature provide stability for long-term storage of information.
    2. Replication: It can make identical copies of itself (semi-conservative replication).
    3. Information Storage: The sequence of bases encodes all genetic instructions.
    4. Variability/Mutation: Changes in the base sequence (mutations) provide the raw material for evolution.
  • RNA (Ribonucleic Acid) acts as the genetic material in some viruses (e.g., HIV, Influenza) and is crucial as a messenger (mRNA), transfer (tRNA), and ribosomal (rRNA) molecule in protein synthesis.

3. Scope and Brief History of Genetics

  • Scope: Genetics is central to biology, with applications in:
    • Medicine: Diagnosis and treatment of genetic disorders, gene therapy, pharmacogenomics.
    • Agriculture: Development of high-yield, pest-resistant crops (GM crops).
    • Forensics: DNA fingerprinting for identification.
    • Evolutionary Biology: Understanding ancestry and speciation.
    • Biotechnology: Production of insulin, vaccines, etc.
  • Brief History:
    • Pre-Mendelian: Blending theory of inheritance was prevalent.
    • 1866: Gregor Mendel published “Experiments on Plant Hybridization,” establishing the fundamental laws of inheritance. His work was largely ignored for 34 years.
    • 1900: Rediscovery of Mendel’s work by Correns, de Vries, and Tschermak.
    • 1902-1903: Sutton and Boveri proposed the Chromosomal Theory of Inheritance, linking Mendel’s “factors” to chromosomes.
    • 1944: Avery, MacLeod, and McCarty demonstrated that DNA is the transforming principle (genetic material).
    • 1952: Hershey-Chase Experiment confirmed DNA as the genetic material in bacteriophages.
    • 1953: Watson, Crick, Franklin, and Wilkins elucidated the double-helix structure of DNA.
    • 2003: Completion of the Human Genome Project.

Study Notes: Mendelian Inheritance

Core Concepts & Laws (Based on Mendel’s Pea Plant Experiments)

  • Gene: The unit of heredity; a segment of DNA coding for a protein/trait.
  • Allele: Alternative forms of a gene (e.g., allele for tallness ‘T’ vs. allele for dwarfness ‘t’).
  • Genotype: The genetic constitution of an organism (e.g., TT, Tt, tt).
  • Phenotype: The observable physical or biochemical characteristic (e.g., Tall, Dwarf).
  • Homozygous: Having two identical alleles for a gene (TT or tt).
  • Heterozygous: Having two different alleles for a gene (Tt).
  • Dominant Allele: Expresses itself in both homozygous and heterozygous conditions (T).
  • Recessive Allele: Expresses itself only in homozygous condition (t).

Mendel’s Three Laws

1. Law of Dominance

  • In a cross between two pure-breeding (homozygous) parents for contrasting traits, only one trait (the dominant one) appears in the F1 generation. The recessive trait is masked.
  • Example: Pure Tall (TT) × Pure Dwarf (tt) → All F1 progeny are Tall (Tt).

2. Law of Segregation (The First Law)

  • During gamete formation, the two alleles for a trait separate (segregate) from each other so that each gamete carries only one allele for each gene.
  • A heterozygous (Tt) individual produces two types of gametes in equal proportion: 50% with ‘T’ and 50% with ‘t’.
  • This explains the 3:1 phenotypic ratio in the F2 generation of a monohybrid cross.

3. Law of Independent Assortment (The Second Law)

  • Applies to genes located on different chromosomes (non-linked genes).
  • During gamete formation, the segregation of alleles for one gene occurs independently of the segregation of alleles for another gene.
  • This explains the 9:3:3:1 phenotypic ratio in the F2 generation of a dihybrid cross.

The Punnett Square

  • A graphical tool (checkerboard) devised by Reginald Punnett to predict the genotypes and phenotypes of offspring from a genetic cross.
  • Steps:
    1. Write the genotypes of the parents.
    2. Determine the possible gametes each parent can produce.
    3. Arrange the gametes of one parent on the top and the other on the side.
    4. Fill in the squares by combining the alleles from each gamete.

Types of Crosses

1. Monohybrid Cross

  • A cross between two individuals differing in one character (e.g., Tall vs. Dwarf).
  • Parental (P) Cross: TT × tt
  • F1 Generation: All Tt (Tall)
  • F2 Generation (F1 selfing): Tt × Tt → Genotype Ratio: 1 TT : 2 Tt : 1 tt. Phenotype Ratio: 3 Tall : 1 Dwarf.

2. Dihybrid Cross

  • A cross between two individuals differing in two characters (e.g., Seed shape: Round/R, Wrinkled/r & Seed color: Yellow/Y, Green/y).
  • Parental Cross: RRYY (Round Yellow) × rryy (Wrinkled Green)
  • F1 Generation: All RrYy (Round Yellow)
  • F2 Generation (F1 selfing): RrYy × RrYy
    • Phenotype Ratio: 9 Round Yellow : 3 Round Green : 3 Wrinkled Yellow : 1 Wrinkled Green.
    • Demonstrates Independent Assortment.

3. Back Cross

  • Crossing an offspring (F1 or later generation) back with one of its parents.
  • Purpose: To recover or reinforce the desirable traits of the parent.
  • Example: F1 hybrid (Tt) × Pure Tall Parent (TT).

4. Test Cross (Crucial Tool)

  • Crossing an individual of unknown genotype (showing dominant phenotype) with a homozygous recessive individual.
  • Purpose: To determine the unknown genotype (homozygous dominant or heterozygous).
  • Logic:
    • If the unknown is Homozygous Dominant (TT) × Recessive (tt): All offspring (100%) will show the dominant trait.
    • If the unknown is Heterozygous (Tt) × Recessive (tt): Offspring ratio will be 1 Dominant : 1 Recessive (50% each).
  • The appearance of even one recessive offspring proves the unknown parent was heterozygous.

Study Notes: Non-Mendelian Inheritance & Advanced Genetic Concepts

I. Non-Mendelian Inheritance

Inheritance patterns that do not follow Mendel’s laws of dominance, segregation, and independent assortment.

1. The Cytoplasm in Heredity

  • Genetic information is not confined to the nucleus. Cytoplasmic organelles (mitochondria and chloroplasts) contain their own DNA.
  • This DNA is circular, lacks histones, and is maternally inherited in most animals and plants.
  • Implication: Traits encoded by organelle DNA do not follow Mendelian (nuclear) inheritance patterns.

2. The Maternal Effect

  • The phenotype of the offspring is determined by the genotype of the mother, not its own genotype.
  • Occurs due to the deposition of mRNA or proteins in the egg cytoplasm by the mother, which directs early embryonic development.
  • Classic Example: Limnaea snail coiling. The direction of shell coiling (dextral vs. sinistral) is determined by a single maternal-effect gene. A mother homozygous for the recessive allele will produce all left-coiling offspring, regardless of the offspring’s own genotype.

3. Extranuclear (Cytoplasmic) Inheritance

  • The inheritance of traits controlled by genes located in mitochondria (mtDNA) or chloroplasts (cpDNA).
  • Key Characteristics:
    • Uniparental (Maternal) Inheritance: In sexual reproduction, organelles (and their DNA) are typically inherited only from the mother via the egg’s cytoplasm.
    • Non-Mendelian Segregation: Progeny do not show Mendelian ratios.
    • Vegetative Segregation: During cell division, organelles are randomly partitioned into daughter cells, leading to variation.
  • Examples:
    • Mitochondrial: Human mitochondrial diseases (e.g., Leber’s Hereditary Optic Neuropathy – LHON). These disorders are passed from mother to all her children.
    • Chloroplast: Variegation in plants like Mirabilis jalapa (four o’clock plant). Green, white, or variegated leaf color depends solely on the chloroplasts inherited from the maternal parent.

4. Incomplete Dominance

  • The heterozygous phenotype is a BLEND or intermediate of the two homozygous phenotypes.
  • Neither allele is completely dominant over the other.
  • Example: Flower color in snapdragons (Antirrhinum).
    • RR (Red) × rr (White) → All F1 are Rr (Pink).
    • F1 cross (Pink × Pink) → F2 Phenotype Ratio: 1 Red : 2 Pink : 1 White (Genotype ratio remains 1:2:1).

5. Codominance

  • Both alleles are fully and separately expressed in the heterozygous condition.
  • The heterozygote shows the phenotypes of both homozygotes simultaneously.
  • Example: Human ABO blood group (see below) and Roan coat color in cattle.
    • CRCR (Red) × CWCW (White) → All F1 are CRCW (Roan), a coat with a mixture of distinct red and white hairs.

II. Gene Interaction

When two or more genes influence the expression of a single phenotypic character. The expected Mendelian dihybrid ratios (9:3:3:1) are modified.

Epistasis

  • A form of gene interaction where one gene masks or modifies the expression of another gene at a different locus.
  • The gene that does the masking is the epistatic gene. The gene whose effect is masked is the hypostatic gene.
  • Types with Modified Dihybrid Ratios:
    1. Recessive Epistasis (9:3:4 Ratio): The homozygous recessive genotype at one locus (e.g., aa) masks the expression of alleles at the second locus.
      • Example: Coat color in Labrador Retrievers. Gene B (Black/Brown) is masked if the dog is ee (recessive at the E locus for pigment deposition), resulting in a yellow lab.
    2. Dominant Epistasis (12:3:1 Ratio): A single dominant allele at the epistatic locus (e.g., I-) masks the expression of another gene.
      • Example: Fruit color in summer squash. Dominant I (Inhibitor) produces white fruit, masking the color gene (Y/y).
    3. Duplicate Recessive Epistasis (9:7 Ratio): A dominant allele at either locus is required for a trait to be expressed. The homozygous recessive condition at both loci produces a different phenotype.
      • Example: Flower color in sweet peas. Genes C and P are both needed for purple pigment. cc or pp results in white flowers.
    4. Complementary Gene Action (9:7): Similar to duplicate recessive epistasis; two genes work together to produce a trait.

III. Multiple Alleles

  • The existence of more than two alleles for a single gene within a population. However, a diploid individual can only possess two of these alleles (one on each homologous chromosome).
  • Example 1: ABO Blood Groups in Humans
    • Gene: I (isoagglutinogen).
    • Three Alleles: IA, IB, i (or IO).
    • IA and IB are codominant to each other.
    • IA and IB are both completely dominant over the recessive i allele.
    • Genotypes & Phenotypes:
      • Type A: IAIA or IAi
      • Type B: IBIB or IBi
      • Type AB: IAIB (Codominance)
      • Type O: ii
  • Example 2: Rh Factor in Humans
    • A major blood group system independent of ABO.
    • Governed by multiple genes, but simplified as a single gene with two common alleles: D and d.
    • Rh+ (Positive): Genotype DD or Dd. Possesses the Rh(D) antigen on red blood cells.
    • Rh- (Negative): Genotype dd. Lacks the Rh(D) antigen.
    • Medical Significance (Erythroblastosis Fetalis / Hemolytic Disease of the Newborn):
      • Can occur when an Rh- mother (dd) carries an Rh+ fetus (D-).
      • During the first pregnancy, the mother may become sensitized to the Rh+ antigen (usually at delivery).
      • In a subsequent pregnancy with another Rh+ fetus, the mother’s anti-Rh antibodies can cross the placenta and attack the fetal red blood cells.
      • Prevention: Administration of Rho(D) immune globulin (RhoGAM) to the Rh- mother soon after the first delivery (or after any sensitizing event). This prevents her immune system from forming its own permanent antibodies.

Study Notes: Chromosomes, Sex Linkage, & Population Genetics

I. Structure of Chromosomes

  • Chemical Composition: DNA (40%) + Histone Proteins (60%) = Chromatin.
  • Levels of Organization:
    1. Nucleosome: The fundamental unit. DNA wrapped around a core of 8 histone proteins (an octamer of H2A, H2B, H3, H4). Connected by linker DNA and histone H1.
    2. Solenoid (30 nm Fiber): Nucleosomes coil to form a thicker chromatin fiber.
    3. Chromatin Loops: The solenoid fiber forms loops anchored to a protein scaffold.
    4. Condensed Chromosome: Loops coil and fold further to form the highly condensed metaphase chromosome visible under a light microscope.
  • Chromosome Parts:
    • Centromere: Constricted region where spindle fibers attach. Divides chromosome into arms.
    • Telomeres: Protective caps at chromosome ends, preventing fusion and degradation.
    • Kinetochore: Protein complex on the centromere for microtubule attachment.
  • Types: Metacentric (centromere in middle), Submetacentric, Acrocentric, Telocentric (centromere at end).

II. Organization of Gene and Genome

  • Gene: A segment of DNA that codes for a functional product (polypeptide or RNA).
  • Structure of a Typical Eukaryotic Gene:
    • Promoter: Regulatory region where RNA polymerase binds (TATA box, etc.).
    • Exons: Coding sequences that are expressed and spliced together in mRNA.
    • Introns: Non-coding intervening sequences that are spliced out.
    • Terminator: Sequence signaling the end of transcription.
  • Genome: The complete set of genetic material (DNA) in an organism.
  • C-value Paradox: Lack of correlation between an organism’s genome size (C-value) and its biological complexity (e.g., some plants have larger genomes than humans).
  • Non-coding DNA: A large portion of eukaryotic genomes do not code for proteins. Includes introns, regulatory sequences, repetitive DNA (transposons, satellites), and pseudogenes.

III. Sex-Linked Inheritance & Sex Determination

1. Sex-Linked Inheritance

  • Inheritance of genes located on the sex chromosomes (X or Y).
  • X-linked Inheritance: Genes on the X chromosome. Shows a criss-cross pattern of inheritance (father to daughter to grandson).
    • Males are hemizygous for X-linked genes (XY) → express all X-linked alleles, whether dominant or recessive.
    • Females can be homozygous or heterozygous (XX).
  • Significant Features:
    • Higher incidence in males: X-linked recessive disorders (e.g., hemophilia, red-green color blindness) are much more common in males.
    • No male-to-male transmission: A father cannot pass his X chromosome to his sons.
    • Carrier females: Heterozygous females are typically unaffected (for recessive disorders) but can transmit the allele to offspring.
  • Y-linked Inheritance (Holandric): Genes on the Y chromosome (e.g., SRY gene, genes for male fertility). Passed exclusively from father to all sons.

2. Sex Determination

  • In Drosophila (Fruit Fly): X:A Ratio (Number of X chromosomes / Number of haploid sets of autosomes).
    • Ratio = 1.0 → Female (XX, XXY)
    • Ratio = 0.5 → Male (XY, XO)
    • Ratio > 1.0 → Metafemale
    • Ratio < 0.5 → Metamale
  • In Humans (and most mammals): XX-XY System.
    • Female: XX
    • Male: XY
    • The SRY gene (Sex-determining Region Y) on the Y chromosome triggers male development by initiating testis formation. Its absence leads to default female development.

IV. Linkage and Crossing Over

1. Definitions

  • Linkage: Genes located on the same chromosome tend to be inherited together because they are physically connected.
  • Crossing Over (Recombination): The reciprocal exchange of genetic material between non-sister chromatids of homologous chromosomes during Prophase I of meiosis. It produces new combinations of alleles (recombinants).

2. Linkage Groups

  • All genes located on a single chromosome constitute one linkage group.
  • The number of linkage groups equals the haploid chromosome number (n).

3. Detection of Linkage

  • Deviations from the expected Mendelian dihybrid ratios (9:3:3:1) in a test cross indicate linkage.
  • A test cross of a dihybrid (AaBb × aabb) with complete linkage would produce only parental phenotypes (1:1 ratio).
  • The appearance of recombinant phenotypes (in less than 50% frequency) demonstrates that linkage is incomplete due to crossing over.

4. Construction of Linkage Maps

  • Recombination Frequency (RF): The percentage of recombinant offspring in a cross.
    • RF = (Number of Recombinant Offspring / Total Offspring) × 100%
  • Genetic Map Unit (Centimorgan, cM): A unit of distance on a genetic map. 1% recombination frequency = 1 map unit (cM).
  • Three-Point Test Cross: Used to determine the order of three linked genes and the distances between them by analyzing the frequency of single and double crossover events.

V. Pedigree Analysis

  • A diagram representing the family history and inheritance pattern of a trait across generations.
  • Symbols: Squares (males), circles (females), shaded (affected), unshaded (unaffected), horizontal lines (mating), vertical lines (offspring).
  • Used to:
    • Determine if a trait is dominant or recessive.
    • Determine if a trait is autosomal or sex-linked.
    • Calculate the probability of an individual inheriting or transmitting a genetic disorder.

VI. Mutations

  • A permanent, heritable change in the nucleotide sequence of DNA.
  • Point Mutations (Gene Mutations):
    • Substitution: Replacement of one base pair. Can be silent, missense, or nonsense.
    • Insertion/Deletion (Indels): Addition or loss of base pairs, causing a frameshift if not in multiples of three.
  • Causes: Spontaneous errors or induced by mutagens (chemicals, radiation).

VII. Chromosomal Aberrations

1. Changes in Chromosome Number

  • Aneuploidy: Gain or loss of one or a few chromosomes from the normal diploid set.
    • Monosomy (2n-1): One missing chromosome (e.g., Turner syndrome, 45, X).
    • Trisomy (2n+1): One extra chromosome (e.g., Down syndrome, 47, +21; Klinefelter syndrome, 47, XXY).
  • Euploidy: Change in the number of complete sets of chromosomes.
    • Monoploidy (n) / Haploidy.
    • Polyploidy: Multiple complete sets (e.g., 3n = triploidy, 4n = tetraploidy). Common in plants.

2. Changes in Chromosome Structure

  • Deficiency/Deletion: Loss of a chromosomal segment. (e.g., Cri-du-chat syndrome, del 5p).
  • Duplication: Repetition of a chromosomal segment. Can be a source of new genetic material (e.g., Bar eye in Drosophila).
  • Inversion: A segment breaks, flips 180°, and reattaches. Paracentric (does not include centromere) vs. Pericentric (includes centromere). Suppresses crossing over.
  • Translocation: Movement of a segment from one chromosome to a non-homologous chromosome.
    • Reciprocal: Exchange of segments between two chromosomes.
    • Robertsonian: Fusion of two acrocentric chromosomes at the centromere (e.g., a cause of familial Down syndrome, t(14;21)).

VIII. Population Genetics: Hardy-Weinberg Equilibrium

  • Describes a theoretical, non-evolving population where allele and genotype frequencies remain constant from generation to generation.
  • Five Assumptions (Violations cause evolution):
    1. No mutations.
    2. Random mating (panmixia).
    3. No natural selection.
    4. Extremely large population size (no genetic drift).
    5. No gene flow (migration).
  • Hardy-Weinberg Equations:
    • For a gene with two alleles: p (frequency of dominant allele A) + q (frequency of recessive allele a) = 1.
    • Genotype frequencies: p² (AA) + 2pq (Aa) + q² (aa) = 1.
  • Applications:
    • Calculate carrier frequencies (2pq) for recessive genetic disorders.
    • Test if a population is evolving at a given locus.
    • Estimate allele frequencies when only phenotype frequencies are known.

BCH- 603 Biological Metabolism 4(4-0)

Study Notes: Carbohydrate Metabolism

I. Digestion and Absorption of Carbohydrates

1. Digestion

  • Mouth: Salivary α-amylase (ptyalin) hydrolyzes α-1,4 glycosidic bonds in starch, producing maltose, maltotriose, and α-limit dextrins.
  • Stomach: Acidic pH inactivates salivary amylase; minimal carbohydrate digestion.
  • Small Intestine:
    • Pancreatic α-amylase continues starch digestion.
    • Brush Border Enzymes (Disaccharidases) on intestinal epithelial cells complete digestion:
      • Maltase: Maltose → 2 Glucose
      • Sucrase: Sucrose → Glucose + Fructose
      • Lactase: Lactose → Glucose + Galactose
      • Isomaltase (α-dextrinase): α-limit dextrins → Glucose

2. Absorption

  • Monosaccharides (glucose, galactose, fructose) are absorbed in the duodenum and jejunum.
  • Mechanisms:
    • Secondary Active Transport (SGLT1): Glucose & Galactose are co-transported with Na⁺ into enterocytes. Driven by Na⁺/K⁺ ATPase creating a Na⁺ gradient.
    • Facilitated Diffusion (GLUT5): Fructose enters via GLUT5 transporter.
    • Exit to Blood (GLUT2): All monosaccharides exit the basolateral side into blood via GLUT2.

II. Central Pathways of Carbohydrate Metabolism

1. Glycolysis (Embden-Meyerhof Pathway)

  • Location: Cytosol of all cells.
  • Function: Oxidizes glucose (6C) to pyruvate (3C), generating ATP (net 2 ATP) and NADH (2 NADH).
  • Key Regulatory Enzymes (Irreversible):
    1. Hexokinase/Glucokinase (Step 1: Glucose → G-6-P)
    2. Phosphofructokinase-1 (PFK-1) (Step 3: F-6-P → F-1,6-BP) MAJOR REGULATORY STEP
    3. Pyruvate Kinase (Step 10: PEP → Pyruvate)
  • Fate of Pyruvate:
    • Aerobic: Pyruvate enters mitochondria → Acetyl-CoA (via Pyruvate Dehydrogenase Complex) → Citric Acid Cycle.
    • Anaerobic: Pyruvate → Lactate (via Lactate Dehydrogenase, LDH) to regenerate NAD⁺ for glycolysis.

2. Fermentation

  • Anaerobic regeneration of NAD⁺ from NADH when oxygen is absent.
  • Lactic Acid Fermentation: Pyruvate → Lactate (in muscles, RBCs).
  • Alcoholic Fermentation: Pyruvate → Acetaldehyde → Ethanol (in yeast).

3. Citric Acid Cycle (Krebs Cycle/TCA Cycle)

  • Location: Mitochondrial matrix.
  • Function: Complete oxidation of Acetyl-CoA (from pyruvate, fatty acids, amino acids) to CO₂, generating high-energy electrons (NADH, FADH₂) and 1 GTP (≈ATP) per cycle.
  • Key Points:
    • Acetyl-CoA (2C) + Oxaloacetate (4C) → Citrate (6C).
    • Two decarboxylation steps release 2 CO₂.
    • Energy Yield per Acetyl-CoA: 3 NADH, 1 FADH₂, 1 GTP.
    • Regulated by: ATP/ADP ratio, NADH/NAD⁺ ratio, Ca²⁺ levels.

III. Glucose Synthesis and Storage

1. Gluconeogenesis

  • Location: Liver (90%) and Kidney cortex (10%).
  • Function: Synthesis of new glucose from non-carbohydrate precursors (lactate, glycerol, glucogenic amino acids).
  • Precursors: Lactate (from Cori cycle), glycerol (from fat), alanine/glutamine (from proteins).
  • Key Enzymes (Bypassing irreversible steps of glycolysis):
    1. Pyruvate Carboxylase & PEP Carboxykinase (PEPCK): Bypass Pyruvate Kinase.
    2. Fructose-1,6-bisphosphatase (FBPase-1): Bypasses PFK-1.
    3. Glucose-6-phosphatase: Bypasses Glucokinase (Liver & Kidney ONLY).
  • Regulation: Opposes glycolysis. Stimulated by glucagon, cortisol; inhibited by insulin.

2. Cori Cycle

  • Cycle: Lactate produced in active muscles → transported to liver → converted back to glucose via gluconeogenesis → glucose returned to muscles.
  • Purpose: Prevents lactic acidosis, recycles carbon, but is energetically costly (6 ATP consumed in liver vs. 2 ATP produced in muscle per glucose round-trip).

3. Glycogenesis

  • Synthesis of glycogen from glucose for storage.
  • Location: Cytosol of liver and muscle.
  • Key Enzyme: Glycogen Synthase (rate-limiting). Activated by insulin (dephosphorylation).
  • Requires a primer: Glycogenin protein.

4. Glycogenolysis

  • Breakdown of glycogen to glucose-1-phosphate.
  • Location: Liver and muscle.
  • Key Enzyme: Glycogen Phosphorylase (rate-limiting). Activated by glucagon/epinephrine (phosphorylation).
  • Liver: Releases free glucose (has glucose-6-phosphatase) into blood to maintain blood glucose.
  • Muscle: Produces G-6-P for internal use only (lacks glucose-6-phosphatase).

IV. Alternative Pathways of Glucose Metabolism

1. Hexose Monophosphate (HMP) Shunt (Pentose Phosphate Pathway)

  • Location: Cytosol (liver, adipose, RBCs, adrenal cortex, lactating mammary gland).
  • Two Phases:
    • Oxidative Phase (Irreversible): Generates NADPH (for reductive biosynthesis & antioxidant defense) and ribose-5-phosphate (for nucleotide synthesis).
    • Non-oxidative Phase (Reversible): Interconverts various sugar phosphates; can feed back into glycolysis.
  • Key Enzyme: Glucose-6-phosphate Dehydrogenase (G6PD) – rate-limiting. Deficiency causes hemolytic anemia.

2. Uronic Acid Pathway

  • Location: Cytosol (liver).
  • Function:
    1. Synthesis of UDP-glucuronic acid for detoxification (conjugation of bilirubin, drugs) and synthesis of glycosaminoglycans (heparin, hyaluronic acid).
    2. Minor source of Vitamin C synthesis in most animals (not humans).
  • Key Enzyme: UDP-glucose dehydrogenase.

V. Integration of Fuel Metabolism

1. Hormonal Regulation (Key Players)

  • Insulin (Fed State): ↑ Glucose uptake (GLUT4), ↑ Glycolysis, ↑ Glycogenesis, ↓ Gluconeogenesis.
  • Glucagon (Fasting State): ↑ Glycogenolysis, ↑ Gluconeogenesis, ↑ Lipolysis.
  • Epinephrine (Stress/Fight-or-Flight): ↑ Glycogenolysis (liver & muscle), ↑ Lipolysis.
  • Cortisol (Stress/Fasting): ↑ Gluconeogenesis, ↑ Proteolysis (provides amino acids), ↓ Glucose utilization.

2. Metabolic States

  • Fed State (High Insulin):
    • Liver: Glycogenesis, glycolysis, fatty acid synthesis.
    • Muscle: Glucose uptake, glycogenesis.
    • Adipose: Glucose uptake, triglyceride synthesis.
  • Fasting State (High Glucagon):
    • Liver: Glycogenolysis (early), gluconeogenesis (later), ketogenesis (prolonged).
    • Muscle: Uses fatty acids, spares glucose.
    • Brain: Uses glucose (switches to ketones in prolonged starvation).
  • Prolonged Starvation:
    • Liver: Gluconeogenesis (from glycerol & alanine), ketone body production.
    • Brain: Adapts to use ketone bodies (acetoacetate, β-hydroxybutyrate).
    • Muscle: Proteolysis provides gluconeogenic precursors, uses fatty acids & ketones.

3. Tissue-Specialized Metabolism

  • Liver: Metabolic hub – maintains blood glucose, processes nutrients, detoxifies.
  • Brain: Obligate glucose consumer (except in starvation), high aerobic metabolism.
  • Muscle: Can use glucose, fatty acids, ketones. Stores glycogen for its own use. Produces lactate during intense exercise.
  • Adipose Tissue: Stores and releases fatty acids as triglycerides.
  • RBCs: Obligate glycolytic (no mitochondria), produce lactate. Dependent on HMP shunt for NADPH.
  • Heart: Prefers fatty acids as primary fuel. Aerobic metabolism only.

Protein Metabolism: Comprehensive Study Notes

I. Digestion and Absorption of Proteins

Goal: Break down dietary proteins into absorbable units (amino acids and small peptides).

  • Stomach:
    • HCl: Denatures proteins (unfolds tertiary structure), activates pepsinogen.
    • Pepsin (chief cells): An endopeptidase. Cleaves internal peptide bonds, especially those involving aromatic amino acids (Phe, Tyr, Trp). Produces large polypeptides.
  • Small Intestine (Primary Site):
    • Pancreatic Proteases (secreted as zymogens):
      • Endopeptidases: Trypsin, chymotrypsin, elastase. Cleave internal bonds.
      • Exopeptidases: Carboxypeptidases A & B. Cleave amino acids from the C-terminal end.
    • Brush Border Enzymes: Aminopeptidases (cleave from N-terminus) and di-/tri-peptidases.
  • Absorption:
    • Mainly as free amino acids via specific Na⁺-dependent symporters (multiple systems for different AA types: basic, acidic, neutral).
    • Di-/Tri-peptides absorbed via H⁺-coupled symporter (PEPT1), then hydrolyzed to free AAs inside enterocytes.
    • Free AAs enter portal circulation to liver.

II. General Reactions of Amino Acid Metabolism

These are key chemical transformations that AAs undergo.

  1. Deamination: Removal of the α-amino group (-NH₂) as ammonia (NH₃).
    • Oxidative Deamination (Liver): Primarily via Glutamate Dehydrogenase (GDH). Central reaction linking AA metabolism to the TCA cycle.
      • Glutamate + NAD⁺ + H₂O → α-Ketoglutarate + NADH + NH₄⁺
    • Non-Oxidative Deamination: e.g., Serine → Pyruvate + NH₃ (via serine dehydratase).
  2. Transamination: Transfer of an amino group from one AA to a keto acid. Crucial for AA synthesis & degradation.
    • Catalyzed by aminotransferases (transaminases). Require coenzyme Pyridoxal Phosphate (PLP, Vitamin B6).
    • Example (ALT): Alanine + α-Ketoglutarate ↔ Pyruvate + Glutamate
    • Key Point: Amino groups are funneled to α-ketoglutarate to form glutamate, which then undergoes oxidative deamination (via GDH) to release NH₃.
  3. Transmethylation: Transfer of a methyl group (-CH₃) from one molecule to another.
    • Primary Methyl Donor: S-adenosylmethionine (SAM). Synthesized from methionine and ATP.
    • Functions: Synthesis of creatine, phosphatidylcholine, epinephrine; methylation of DNA, RNA, proteins.
    • After donating methyl, SAM becomes S-adenosylhomocysteine (SAH), which is recycled back to methionine (requires folate and B12).
  4. Transpeptidation: Formation of peptide bonds. This is the core reaction of protein synthesis on ribosomes, driven by GTP hydrolysis. Not a major catabolic pathway.
  5. Decarboxylation: Removal of the α-carboxyl group (-COOH) as CO₂. Produces biogenic amines.
    • Requires PLP.
    • Examples:
      • Histidine → Histamine (allergic response, gastric acid secretion).
      • Glutamate → GABA (γ-aminobutyric acid) (major inhibitory neurotransmitter).
      • DOPA → Dopamine (neurotransmitter).

III. Metabolism of Ammonia: Urea Cycle

Ammonia is highly toxic, especially to the CNS. The Urea Cycle in the liver converts NH₃ and aspartate-derived nitrogen into urea for safe excretion.

  • Location: Liver (mitochondria & cytosol).
  • Key Inputs:
    1. NH₃ (from AA deamination, gut bacteria).
    2. HCO₃⁻ (from cellular respiration).
    3. Aspartate (provides the 2nd nitrogen atom).
  • Five Core Reactions:
    1. Formation of Carbamoyl Phosphate: (Mitochondria) NH₃ + HCO₃⁻ + 2ATP → Carbamoyl Phosphate. Rate-limiting step. Catalyzed by Carbamoyl Phosphate Synthetase I (CPS I), activated by N-acetylglutamate (NAG).
    2. Formation of Citrulline: (Mitochondria) Carbamoyl phosphate + Ornithine → Citrulline.
    3. Formation of Argininosuccinate: (Cytosol) Citrulline + Aspartate + ATP → Argininosuccinate.
    4. Cleavage to Arginine & Fumarate: (Cytosol) Argininosuccinate → Arginine + Fumarate (links to TCA cycle).
    5. Cleavage to Urea & Ornithine: (Cytosol) Arginine + H₂O → Urea + Ornithine. Ornithine returns to mitochondria.
  • Energetics: Consumes 4 high-energy phosphate bonds (2 ATP → 2 ADP + Pi for CPS I; 1 ATP → AMP + PPi for argininosuccinate synthase).
  • Regulation:
    • Short-term: Allosteric activation of CPS I by N-acetylglutamate (NAG). NAG synthesis is stimulated by arginine and high protein intake.
    • Long-term: Increased synthesis of all urea cycle enzymes during high-protein diet or starvation.

IV. Nitrogen Balance

A measure of the body’s protein turnover equilibrium.

  • Nitrogen In = Dietary protein nitrogen.
  • Nitrogen Out = Urinary urea nitrogen (major) + fecal nitrogen + minor losses.
  • States:
    • Positive Nitrogen Balance: Intake > Excretion. Seen in: Growth (children), pregnancy, recovery from illness, muscle building. Indicates net protein synthesis.
    • Negative Nitrogen Balance: Excretion > Intake. Seen in: Starvation, severe injury, burns, infection, uncontrolled diabetes. Indicates net protein breakdown.
    • Zero (Normal) Nitrogen Balance: Intake = Excretion. Healthy, non-growing adults on adequate protein.

V. Breakdown and Synthesis of Individual Amino Acids

AAs are categorized as glucogenic, ketogenic, or both based on their degradation products.

  • Glucogenic Amino Acids: Yield pyruvate or TCA cycle intermediates (α-KG, succinyl-CoA, fumarate, oxaloacetate) that can be used for gluconeogenesis.
    • Examples: Ala, Ser, Gly, Cys → Pyruvate. Gln, His, Pro → α-KG. Asp, Asn → OAA.
  • Ketogenic Amino Acids: Yield acetyl-CoA or acetoacetate, which can form ketone bodies but not glucose.
    • Pure Ketogenic: Leucine, Lysine.
  • Both Glucogenic & Ketogenic: Isoleucine, Phenylalanine, Tyrosine, Tryptophan, Threonine.
  • Special Pathways:
    • Branched-Chain Amino Acids (BCAAs: Leu, Ile, Val): Degraded primarily in muscle, not liver. Initial transamination occurs in muscle; the resulting keto acids are transported to liver for further oxidation.
    • Aromatic AAs (Phe, Tyr, Trp): Complex pathways. Phenylalanine hydroxylase converts Phe to Tyr (deficiency causes PKU). Tyrosine is precursor for dopamine, norepinephrine, epinephrine, and melanin.

VI. Biosynthesis and Degradation of Non-Essential Amino Acids

Non-essential AAs can be synthesized by the body. Essential AAs cannot and must be obtained from the diet.

  • From TCA Cycle Intermediates:
    • α-Ketoglutarate → Glutamate → Glutamine, Proline, Arginine.
    • Oxaloacetate → Aspartate → Asparagine, Methionine, Threonine, Lysine (in plants/microbes; essential for humans).
  • From Glycolytic Intermediates:
    • 3-Phosphoglycerate → Serine → Glycine, Cysteine.
    • Pyruvate → Alanine.
  • Degradation: Follows the general and specific pathways outlined in Section V.

VII. Integration and Regulation of Metabolism

Protein metabolism is not isolated; it is integrated with carbohydrate and lipid metabolism.

  • The Central Role of Glutamate & α-Ketoglutarate: Transamination reactions use α-KG as the primary amino group acceptor, forming glutamate. Glutamate is then deaminated by GDH, linking AA nitrogen to urea synthesis and carbon skeletons to the TCA cycle.
  • Hormonal Regulation:
    • Insulin (Fed State): Promotes protein synthesis, inhibits proteolysis. Increases AA uptake into cells. Anabolic for protein.
    • Glucagon & Cortisol (Fasting/Stress): Promote protein degradation in muscle, increase transamination & gluconeogenesis in liver. Catabolic for protein.
    • Growth Hormone: Stimulates protein synthesis and positive nitrogen balance.
  • Metabolic States:
    • Postprandial (Fed): Excess dietary AAs are deaminated; the carbon skeletons used for energy or stored as fat, nitrogen excreted as urea.
    • Fasting/Starvation: Muscle proteins break down to provide glucogenic AAs (especially Ala and Gln) for liver gluconeogenesis to maintain blood glucose.
    • Diabetes (Uncontrolled): Similar to starvation; lack of insulin causes muscle proteolysis and increased gluconeogenesis from AAs.

VIII. Protein Degradation (Proteolysis)

Cellular proteins are constantly turned over via two major pathways:

  1. Lysosomal Pathway (Autophagy):
    • Degrades extracellular proteins (endocytosed) and long-lived intracellular proteins and organelles.
    • Non-specific bulk degradation, especially active during starvation.
  2. Ubiquitin-Proteasome Pathway:
    • Major pathway for regulated degradation of specific intracellular proteins (short-lived, misfolded, regulatory proteins).
    • Mechanism:
      • Ubiquitination: Target protein is tagged with a polymer of ubiquitin (a small protein) via E1, E2, E3 enzymes.
      • Degradation: Polyubiquitinated protein is recognized and unfolded by the 26S proteasome, a large protease complex.
      • Products: Short peptides (further degraded) and reusable ubiquitin.
    • Key Roles: Cell cycle control, apoptosis, immune response, removal of damaged proteins.

Key Mnemonics & Summary

  • Essential AAs: PVT TIM HALL (Phe, Val, Thr, Trp, Ile, Met, His, Arg, Leu, Lys). Arg & His are conditionally essential.
  • Urea Cycle Intermediates: Ordinary Careless Crappers Are Also Frivolous About Urination (Ornithine, Carbamoyl Phosphate, Citrulline, Aspartate, Argininosuccinate, Fumarate, Arginine, Urea).
  • Pure Ketogenic AAs: Leu and Lys (“Let’s Ketogenate” or “Lose Lots”).
  • The Big Picture: Dietary Protein → AAs → (Transamination → Glutamate → GDH) → NH₃ (to Urea Cycle) + Carbon Skeletons (to Glucose/Fat/Energy).

Digestion and Absorption of Lipids

This is where it all begins. Dietary lipids (mostly triacylglycerols or TAGs, plus cholesterol and phospholipids) are hydrophobic, while our digestive system is aqueous.

  • Mouth & Stomach: Mechanical emulsification begins. Gastric lipase starts minimal digestion.
  • Small Intestine: The main event.
    • Bile salts (made from cholesterol in the liver) act as biological detergents, creating tiny micelles that solubilize fat droplets.
    • Pancreatic lipase breaks down TAGs into 2-monoacylglycerols and free fatty acids.
    • Cholesterol esters and phospholipids are also hydrolyzed by specific enzymes.
  • Absorption: These breakdown products (fatty acids, monoacylglycerols, cholesterol) are absorbed by intestinal cells (enterocytes). Inside, they are reassembled into TAGs and packaged with cholesterol, phospholipids, and a special protein called apolipoprotein B-48 into chylomicrons.

2. Transport of Lipids: Lipoproteins

Lipids are insoluble in blood. They are transported as complex particles called lipoproteins (a core of neutral lipids like TAGs and cholesterol esters, surrounded by a shell of phospholipids, free cholesterol, and specific apolipoproteins).

  • Chylomicrons: Carry dietary lipids from intestine to tissues (muscle for energy, adipose for storage). Lipoprotein lipase (LPL) on capillary walls hydrolyzes their TAGs to release fatty acids.
  • VLDL (Very Low-Density Lipoprotein): Produced by the liver, carries newly synthesized TAGs to tissues.
  • LDL (Low-Density Lipoprotein): The “remnant” of VLDL after TAG removal. It is cholesterol-rich and delivers cholesterol to peripheral tissues. High LDL is a major risk for atherosclerosis.
  • HDL (High-Density Lipoprotein): The “good cholesterol.” It scavenges excess cholesterol from tissues and arteries and returns it to the liver for excretion (reverse cholesterol transport).

3. Lipid Metabolism: The Two Sides of the Coin

A. Catabolism (Breaking Down for Energy)

  • Transport of Fatty Acids to Mitochondria: Fatty acids are activated in the cytosol (attached to CoA). They cannot cross the inner mitochondrial membrane. The carnitine shuttle (CPT-I & CPT-II) is essential for transport. CPT-I is the key regulatory enzyme of fatty acid oxidation.
  • β-Oxidation: Inside the mitochondrial matrix, fatty acyl-CoA is systematically broken down in a cycle of four reactions (oxidation, hydration, oxidation, thiolysis). Each cycle releases one acetyl-CoA (enters Krebs cycle) and shortens the fatty acid by two carbons. It is highly exergonic, producing vast ATP.
  • ω-Oxidation: A minor pathway in the endoplasmic reticulum that oxidizes the methyl end (ω-end) of fatty acids. It becomes more important for medium-chain fatty acids or in certain genetic disorders of β-oxidation.
  • Ketone Bodies (Synthesis & Role):
    • Synthesis (Ketogenesis): In the liver during prolonged fasting/starvation or uncontrolled diabetes, excess acetyl-CoA from massive β-oxidation is diverted to form the water-soluble ketone bodies (acetoacetate, β-hydroxybutyrate, acetone).
    • Role: They are an alternative fuel for the brain, heart, and muscle when glucose is scarce. In diabetes mellitus (type 1), severe insulin deficiency leads to extreme lipolysis and ketogenesis, causing diabetic ketoacidosis (DKA), a life-threatening acidosis.

B. Anabolism (Biosynthesis)

  • Biosynthesis of Fatty Acids: This occurs in the cytosol (opposite compartment to oxidation) and is not the reverse of β-oxidation. The key enzyme is fatty acid synthase (FAS). Using acetyl-CoA as a primer and malonyl-CoA as the 2-carbon donor, it builds palmitate (16:0) in a repeating condensation-reduction-dehydration-reduction cycle. Acetyl-CoA carboxylase (ACC) producing malonyl-CoA is the key regulatory step.
  • Triacylglycerol (TAG) Synthesis: The primary form of stored energy. Glycerol-3-phosphate is esterified with three fatty acyl-CoA molecules (from diet or synthesis) in the liver and adipose tissue.
  • Metabolism of Phospholipids & Glycolipids:
    • Phospholipids (e.g., phosphatidylcholine) are membrane components and signaling precursors. They are synthesized by attaching a head group (like choline) to diacylglycerol (DAG) or phosphatidic acid.
    • Glycolipids have carbohydrate head groups (e.g., cerebrosides, gangliosides) and are crucial for cell recognition and nervous system function.

4. Specialized Lipid Molecules

  • Eicosanoids (including Prostaglandins): Potent local signaling molecules (autocrines/paracrines) derived from arachidonic acid (a 20-carbon polyunsaturated fatty acid released from membrane phospholipids by phospholipase A₂). They mediate inflammation, fever, pain, blood clotting, and smooth muscle contraction. Aspirin/NSAIDs work by inhibiting their synthesis (cyclooxygenase enzyme).
  • Cholesterol, Steroids, and Isoprenoids:
    • Cholesterol: A vital membrane component and the precursor for all other steroids. Synthesized from acetyl-CoA via the mevalonate pathway (HMG-CoA reductase is the rate-limiting, drug-targeted enzyme).
    • Steroids: Hormones (e.g., cortisol, aldosterone, sex hormones) synthesized from cholesterol in adrenal glands and gonads.
    • Isoprenoids: A vast class built from isopentenyl pyrophosphate (an intermediate of the cholesterol pathway). Includes dolichol (protein glycosylation), ubiquinone (electron transport), and vitamin A.

Integrated Summary: The Big Picture

Lipid metabolism is a dynamic balance between storage and mobilization, dictated by hormonal signals (insulin vs. glucagon/epinephrine).

  • Fed State (High Insulin): Promotes fat storage. Fatty acid and TAG synthesis is active. Lipoprotein lipase is active, storing dietary fatty acids in adipose tissue.
  • Fasting/Starvation/Diabetes (Low Insulin, High Glucagon): Promotes fat breakdown. Hormone-sensitive lipase in adipose tissue releases fatty acids into the blood. These are β-oxidized in tissues for energy. The liver packages excess fatty acids into ketone bodies for export to the brain.

All these processes—digestion, transport via lipoproteins, oxidative breakdown (β-oxidation, ketogenesis), and complex biosynthesis (fatty acids, cholesterol, phospholipids, eicosanoids)—are interconnected, ensuring energy homeostasis, membrane integrity, and critical cellular signaling.

Nucleic Acid Metabolism: The Blueprint and Its Building Blocks

This comprehensive overview connects the digestion of nucleic acids to their synthesis, regulation, and ultimate function in genetic information flow.

1. Digestion and Absorption of Nucleic Acids

Dietary nucleic acids (DNA/RNA) are broken down into their components for absorption and reuse.

  • Mouth & Stomach: Minimal digestion; mechanical breakdown only.
  • Small Intestine: Pancreatic enzymes complete digestion:
    • Nucleases (DNases and RNases) hydrolyze phosphodiester bonds
    • Phosphodiesterases yield nucleotides
    • Nucleotidases remove phosphate groups → nucleosides
    • Nucleosidases and phosphorylases split nucleosides into:
      • Nitrogenous bases (purines: adenine, guanine; pyrimidines: cytosine, thymine, uracil)
      • Pentose sugars (ribose/deoxyribose)
      • Phosphate ions
  • Absorption: Bases and nucleosides are absorbed via specific transporters. Most purines are degraded (see below), while pyrimidines and their nucleosides can be reused more efficiently.

2. Nucleotide Biosynthesis: Two Pathways

Cells synthesize nucleotides via complementary strategies:

  • De Novo Pathways: Synthesis from simple precursors (amino acids, CO₂, formate, ribose-5-phosphate)
  • Salvage Pathways: Recycling of preformed bases/nucleosides (more energy-efficient)

3. Purine Metabolism

A. De Novo Synthesis of Purines (IMP as Core Intermediate)

  • Location: Cytosol (liver is primary site)
  • Precursors: Glycine, aspartate, glutamine, CO₂, formyl-THF, PRPP (phosphoribosyl pyrophosphate)
  • Key Features:
    • Built atom-by-atom on the ribose phosphate (PRPP) scaffold
    • First committed step: PRPP + glutamine → 5-phosphoribosylamine (catalyzed by PRPP amidotransferase, the rate-limiting enzyme)
    • After 10 steps, produces IMP (inosine monophosphate), the common precursor
    • IMP is converted to AMP and GMP
  • Regulation: Feedback inhibition by end products (AMP, GMP, IMP)

B. Salvage of Purines

  • Enzymes: HGPRT (hypoxanthine-guanine phosphoribosyltransferase) and APRT (adenine phosphoribosyltransferase)
  • Function: Recycles free bases by adding them to PRPP
  • Clinical: HGPRT deficiency → Lesch-Nyhan syndrome (neurological disorder, self-mutilation, gout)

C. Purine Degradation

  • Process: Dephosphorylation → deamination → conversion to uric acid
  • Key enzyme: Xanthine oxidase (produces uric acid)
  • Clinical relevance:
    • Gout: Excess uric acid crystallizes in joints
    • Treatment: Allopurinol inhibits xanthine oxidase
    • Severe combined immunodeficiency (SCID): Adenosine deaminase deficiency

4. Pyrimidine Metabolism

A. De Novo Synthesis

  • Location: Cytosol (with mitochondrial step for carbamoyl phosphate)
  • Key Differences from Purines:
    • Ring synthesized first (as orotate), then attached to PRPP
    • First committed step: Carbamoyl phosphate synthesis (by carbamoyl phosphate synthetase II, CPS-II, in cytosol)
    • Common intermediate: UMP (uridine monophosphate)
  • Regulation: Feedback inhibition by UTP (inhibits CPS-II)

B. Conversion Pathways:

  • UMP → UTP → CTP (cytidine triphosphate)
  • dUMP → dTMP (thymidylate) via thymidylate synthase (critical for DNA synthesis)

C. Pyrimidine Degradation

  • Reduced to simple, water-soluble products (β-amino acids, NH₃, CO₂)
  • Unlike purines, does not produce insoluble uric acid

5. Chemotherapy and Nucleotide Metabolism

Many anticancer drugs target nucleotide synthesis:

  • Antifolates (Methotrexate): Inhibits dihydrofolate reductase → depletes THF → blocks dTMP synthesis
  • 5-Fluorouracil (5-FU): Inhibits thymidylate synthase → blocks dTMP synthesis
  • 6-Mercaptopurine/6-Thioguanine: Purine analogs that inhibit de novo synthesis
  • Hydroxyurea: Inhibits ribonucleotide reductase → blocks DNA synthesis
  • Cytarabine (Ara-C): Pyrimidine analog that inhibits DNA polymerase

6. Central Dogma & Introduction to Replication, Transcription, Translation

Central Dogma: DNA → RNA → Protein (information flow)

A. DNA Replication

  • Semi-conservative: Each daughter DNA has one parental strand
  • Key Enzymes & Proteins:
    • Helicase: Unwinds DNA
    • SSB Proteins: Stabilize single strands
    • Primase: Synthesizes RNA primer
    • DNA Polymerase III: Main elongation enzyme (5’→3′ synthesis)
    • DNA Polymerase I: Removes RNA primers, fills gaps
    • DNA Ligase: Joins Okazaki fragments
    • Topoisomerases: Relieve supercoiling
  • Features: Bidirectional, semi-discontinuous (leading and lagging strands), high fidelity

B. Transcription (DNA → RNA)

  • Key Enzymes:
    • RNA Polymerase: Synthesizes RNA (prokaryotes: single enzyme; eukaryotes: Pol I, II, III)
  • Stages:
    1. Initiation: Promoter recognition, formation of transcription bubble
    2. Elongation: RNA synthesis 5’→3′
    3. Termination: Release of RNA transcript
  • Post-transcriptional Processing (Eukaryotes):
    • 5′ capping, 3′ polyadenylation, splicing (removal of introns)

C. Translation (RNA → Protein)

  • Components:
    • mRNA: Template with genetic code
    • tRNA: Adaptor molecules with anticodons, carry specific amino acids
    • Ribosomes: rRNA-protein complexes; catalytic sites (A, P, E)
  • Stages:
    1. Initiation: Ribosome assembles on start codon (AUG)
    2. Elongation: Aminoacyl-tRNAs enter A site; peptide bond formation; translocation
    3. Termination: Release factor recognizes stop codon
  • Genetic Code: Triplet, degenerate, unambiguous, universal (with minor exceptions)

Integration and Clinical Connections

Nucleotide metabolism sits at the crossroads of nutrition, genetics, and pharmacology:

  1. Digestion provides bases for salvage pathways
  2. De novo synthesis meets demands for cell division and nucleic acid synthesis
  3. Salvage pathways conserve energy and materials
  4. Degradation eliminates excess, with purine degradation having specific clinical implications (gout)
  5. Chemotherapeutic agents exploit rapid nucleotide synthesis in cancer cells
  6. Central dogma processes (replication, transcription, translation) depend entirely on proper nucleotide supply and regulation

Key Regulatory Points:

  • PRPP amidotransferase (purines)
  • CPS-II (pyrimidines)
  • Ribonucleotide reductase (conversion to deoxy forms)
  • Feedback inhibition maintains balance

Disease Connections:

  • Cancer: Targeted by nucleotide synthesis inhibitors
  • Gout: Purine degradation disorder
  • Immunodeficiency: ADA deficiency (SCID)
  • Genetic disorders: Lesch-Nyhan syndrome
  • Antiviral therapy: Many target viral polymerases (e.g., acyclovir, AZT)

This integrated system ensures cells have the necessary nucleotides for genetic information storage (DNA), expression (RNA), and protein synthesis, while allowing therapeutic intervention at multiple points in pathological conditions.

BCH-602 Immunochemistry 3(3-0

The Immune System: A Comprehensive Introduction

The immune system is a remarkably sophisticated defense network that protects the body from pathogens (bacteria, viruses, fungi, parasites), eliminates abnormal cells (like cancer), and removes cellular debris. Its function is based on distinguishing “self” from “non-self” and mounting an appropriate response.

1. Elements of Innate (Natural) Immunity

The first line of defense, rapid (minutes/hours), non-specific, and lacks memory.

A. Physical & Chemical Barriers:

  • Skin: Physical barrier, acidic pH, antimicrobial fatty acids.
  • Mucous Membranes: Trap microbes (respiratory, GI, GU tracts).
  • Chemical Secretions: Lysozyme (tears, saliva), stomach acid, antimicrobial peptides (defensins).

B. Cellular Components:

  • Phagocytes:
    • Neutrophils: Most abundant; first responders to bacterial infection.
    • Macrophages: Tissue-resident “big eaters”; also act as Antigen-Presenting Cells (APCs).
    • Dendritic Cells: The most professional APCs, bridge innate and adaptive immunity.
  • Innate Lymphoid Cells:
    • Natural Killer (NK) Cells: Recognize and kill virus-infected cells and tumor cells (no prior sensitization needed).
  • Granulocytes:
    • Eosinophils: Fight parasites; involved in allergies.
    • Basophils & Mast Cells: Release histamine in allergic/inflammatory responses.

C. Soluble Factors:

  • Complement System: A cascade of ~30 plasma proteins that can lyse pathogens directly (Membrane Attack Complex), opsonize them (tag for phagocytosis), and promote inflammation.
  • Cytokines: Signaling proteins (e.g., interferons – antiviral; interleukins – cell communication; TNF – inflammation).
  • Acute Phase Proteins: C-reactive protein (CRP), Mannose-Binding Lectin (MBL) – increase during infection.

D. Pattern Recognition:

  • Uses Pattern Recognition Receptors (PRRs) on immune cells to detect Pathogen-Associated Molecular Patterns (PAMPs) (e.g., bacterial LPS, viral dsRNA). This is the core of innate specificity.

2. Elements of Acquired (Adaptive) Immunity

The second line of defense, slow to initiate (days), highly specific, and possesses immunological memory.

A. Key Features:

  • Specificity: Targets unique molecular structures (epitopes) on antigens.
  • Diversity: Can recognize billions of different antigens via lymphocyte receptors.
  • Memory: Upon re-exposure, response is faster and stronger.
  • Self-Tolerance: Normally does not react against self-antigens.

B. Cellular Components:

  • Lymphocytes:
    • B Lymphocytes (B Cells): Mature in bone marrow. Responsible for humoral (antibody-mediated) immunity. Differentiate into Plasma Cells (antibody factories) and Memory B Cells.
    • T Lymphocytes (T Cells): Mature in the thymus. Responsible for cell-mediated immunity.
      • Helper T Cells (CD4+): Orchestrate immune responses by secreting cytokines. Activate B cells, macrophages, and cytotoxic T cells.
      • Cytotoxic T Cells (CD8+): Directly kill virus-infected cells, tumor cells, and foreign graft cells.
      • Regulatory T Cells (Tregs): Suppress immune responses to prevent autoimmunity.

C. Soluble Factor:

  • Antibodies (Immunoglobulins): The effector molecules of B cells.

3. Immunogens and Antigens

  • Immunogen: Any substance capable of inducing an immune response (must be foreign, large enough, chemically complex).
  • Antigen (Ag): Any substance that can be specifically bound by an antibody or T-cell receptor. All immunogens are antigens, but not all antigens are immunogens (e.g., a small molecule like penicillin is an antigen but not immunogenic unless it binds to a larger carrier protein, becoming a hapten-carrier complex).
  • Epitope (Antigenic Determinant): The specific, small region of an antigen that is recognized and bound by an antibody or T-cell receptor. A single antigen can have multiple different epitopes.

4. Antibody Structure and Function

A. Basic Structure (Prototype: IgG)
An antibody is a Y-shaped glycoprotein composed of four polypeptide chains:

  • Two identical Heavy (H) Chains (large)
  • Two identical Light (L) Chains (small)
  • Chains are held together by disulfide bonds.

B. Key Regions:

  1. Variable (V) Regions: Located at the tips of the “Y”. The antigen-binding site (Fab fragment). The amino acid sequence here is hypervariable, creating the unique paratope that binds to a specific epitope. This region determines specificity.
  2. Constant (C) Regions: Form the stem of the “Y” (Fc fragment). Determines the antibody class (IgG, IgA, etc.) and its biological function (e.g., complement activation, binding to phagocytes).

C. Antibody Classes (Isotypes) & Functions

Class Structure Key Functions & Location
IgG Monomer Most abundant in blood/lymph/tissue. Crosses placenta (passive immunity to fetus). Neutralizes toxins/viruses, opsonizes, activates complement.
IgM Pentamer (5 units) First antibody produced in primary response. Excellent at complement activation. Expressed on naive B cell surface (BCR).
IgA Dimer (2 units) Major antibody in secretions (mucus, saliva, tears, breast milk). Protects mucosal surfaces.
IgE Monomer Bound to mast cells/basophils. Triggers allergic reactions (histamine release). Defends against parasitic worms.
IgD Monomer Primarily found as a receptor on the surface of naive B cells (BCR); role in B cell activation.

D. Functions of Antibodies (Effector Mechanisms):

  1. Neutralization: Blocks toxins/viruses from binding to host cells.
  2. Opsonization: Coats pathogens, marking them for phagocytosis (via Fc receptors on phagocytes).
  3. Complement Activation: IgM and IgG trigger the classical complement pathway.
  4. Antibody-Dependent Cellular Cytotoxicity (ADCC): NK cells use their Fc receptors to recognize and kill antibody-coated target cells (e.g., virus-infected cells).
  5. Agglutination: Clumps pathogens together (more effective with IgM due to its valence).

Integration: How It All Works Together

  1. A pathogen breaches physical barriers.
  2. Innate immunity responds immediately: Macrophages/dendritic cells phagocytose the pathogen, release inflammatory cytokines, and present processed antigen fragments on their surface using MHC molecules.
  3. Adaptive immunity is activated: The dendritic cell (an APC) migrates to a lymph node and presents the antigen to naive T cells. The correct Helper T cell is activated.
  4. Clonal expansion and differentiation: The activated Helper T cell proliferates and helps activate the correct B cell (which recognized the same antigen via its BCR).
  5. Effector phase: Activated B cells differentiate into plasma cells that secrete massive amounts of specific antibodies. Antibodies travel to the site of infection and execute their functions (neutralize, opsonize, etc.). Cytotoxic T cells are also activated to kill infected cells.
  6. Resolution and Memory: Most effector cells die after the pathogen is cleared. Memory B and T cells persist, providing long-lasting protection for future encounters with the same pathogen.

Antigen-Antibody Interactions, Lymphocyte Biology, and Immune Activation

I. ANTIGEN-ANTIBODY INTERACTIONS

A. Nature of the Bond

  • Non-covalent interactions: Hydrogen bonds, ionic bonds, van der Waals forces, hydrophobic interactions
  • Reversible binding: Follows law of mass action
  • High specificity: “Lock and key” fit between paratope (antibody binding site) and epitope (antigenic determinant)

B. Affinity vs Avidity

  • Affinity: Strength of interaction between single antigen-binding site and single epitope
    • Measured by association constant (Kₐ)
    • Higher affinity = stronger binding
  • Avidity: Overall strength of multiple interactions between antibody and antigen
    • IgM (10 binding sites) has low affinity but high avidity
    • IgG (2 binding sites) has high affinity but lower avidity than IgM

C. Cross-Reactivity

  • Antibody specific for one antigen may bind to similar epitope on different antigen
  • Examples:
    • ABO blood group antigens
    • Rheumatic fever (streptococcal M protein vs heart tissue)
    • Diagnostic tests (syphilis – VDRL uses cardiolipin)

D. Forces Involved

  1. Hydrophobic interactions: Most significant (40-50%)
  2. Hydrogen bonds: Provide specificity
  3. Electrostatic interactions: Salt bridges
  4. Van der Waals forces: Weak but numerous

II. GENETIC BASIS OF ANTIBODY STRUCTURE

A. The Antibody Diversity Problem

How can limited genes (~20,000) generate billions of different antibodies?

B. Gene Rearrangement (Somatic Recombination)

  • Germline configuration: Antibody genes exist as separate gene segments
  • Somatic recombination: Random rearrangement during B cell development

C. Gene Segments for Antibody Chains

1. Heavy Chain (Chromosome 14):

  • V segments (~40): Variable region
  • D segments (~25): Diversity region
  • J segments (~6): Joining region
  • C segments (9): Constant region (determines isotype: μ, δ, γ, ε, α)

2. Light Chain:

  • κ chain (Chromosome 2): ~40 V, 5 J, 1 C
  • λ chain (Chromosome 22): ~30 V, 4 J, 4 C

D. Mechanisms Generating Diversity

  1. Combinatorial V-(D)-J joining: Random selection and joining
    • Heavy chain: V × D × J = 40 × 25 × 6 = 6,000
    • Light chain: κ: 40 × 5 = 200; λ: 30 × 4 = 120
    • Combined: 6,000 × 320 = ~1.9 million
  2. Junctional diversity:
    • P-nucleotide addition: Palindromic sequences
    • N-nucleotide addition: Random nucleotides by TdT enzyme
    • Imprecise joining: Exonuclease trimming
  3. Combinatorial association: Heavy + light chain pairing
    • 1.9 million heavy × 1.9 million light = ~3.6 × 10¹² possibilities
  4. Somatic hypermutation: After antigen exposure, point mutations in V regions
  5. Class switching: Changes constant region (isotype) without changing specificity

E. Order of Rearrangement

  1. Heavy chain: D-J → V-DJ → complete VDJ
  2. Light chain: κ chain first; if fails, λ chain
  3. If productive rearrangement → surface IgM expressed → B cell selection

III. MONOCLONAL ANTIBODIES

A. Definition

Antibodies derived from a single B cell clone, all identical and specific for a single epitope.

B. Hybridoma Technology (Köhler & Milstein, 1975)

  1. Immunize mouse with antigen
  2. Isolate spleen B cells (antibody producers)
  3. Fuse with myeloma cells (immortal, HGPRT⁻)
  4. Select in HAT medium:
    • Only hybrids survive (B cell provides HGPRT, myeloma provides immortality)
  5. Screen for specific antibody production
  6. Clone positive hybrids

C. Types of Monoclonal Antibodies

  1. Murine: Mouse origin (suffix: –omab)
  2. Chimeric: Mouse variable + human constant (suffix: –ximab)
  3. Humanized: Mouse CDRs + human framework (suffix: –zumab)
  4. Fully human: Phage display or transgenic mice (suffix: –umab)

D. Clinical Applications

  • Cancer therapy: Rituximab (CD20), Trastuzumab (Her2/neu)
  • Autoimmune diseases: Infliximab (TNF-α), Adalimumab (TNF-α)
  • Transplantation: Basiliximab (IL-2R)
  • Diagnostics: ELISA, immunohistochemistry, flow cytometry
  • Drug delivery: Antibody-drug conjugates (ADC)

IV. BIOLOGY OF B LYMPHOCYTES

A. Development

  • Site: Bone marrow (mammals), Bursa of Fabricius (birds)
  • Stages:
    1. Pro-B cell: D-J rearrangement
    2. Pre-B cell: V-DJ rearrangement, μ heavy chain expressed with surrogate light chain
    3. Immature B cell: Light chain rearrangement, surface IgM expressed
    4. Selection: Negative selection against self-reactive cells (clonal deletion, anergy, receptor editing)
    5. Mature naïve B cell: Co-expresses IgM and IgD, exits to periphery

B. B Cell Receptor (BCR) Complex

  • Membrane-bound antibody (IgM or IgD)
  • Igα/Igβ heterodimer: Signaling molecules (ITAM motifs)

C. B Cell Subsets

  1. B-1 cells: CD5⁺, innate-like, produce natural antibodies (T-independent responses)
  2. B-2 cells: Conventional B cells (follicular B cells)
  3. Marginal zone B cells: Rapid response to blood-borne pathogens
  4. Regulatory B cells (Bregs): Produce IL-10, suppress immune responses

V. BIOLOGY OF T LYMPHOCYTES

A. Development

  • Site: Thymus
  • Stages:
    1. Double negative (DN): CD4⁻CD8⁻, TCR gene rearrangement
    2. Double positive (DP): CD4⁺CD8⁺, positive selection (MHC restriction)
    3. Single positive (SP): CD4⁺ or CD8⁺, negative selection (self-tolerance)
    4. Mature naïve T cell: Exit to periphery

B. T Cell Receptor (TCR) Complex

  • αβ TCR (95%) or γδ TCR (5%)
  • CD3 complex: Signaling molecules (ζ chain, ε, δ, γ)
  • Co-receptors: CD4 (MHC II) or CD8 (MHC I)

C. T Cell Subsets

  1. Helper T cells (Th): CD4⁺
    • Th1: IFN-γ → cell-mediated immunity (macrophages)
    • Th2: IL-4, IL-5, IL-13 → humoral immunity (eosinophils, B cells)
    • Th17: IL-17 → neutrophil recruitment, mucosal defense
    • Tfh: CXCR5⁺ → B cell help in germinal centers
    • Treg: CD25⁺FoxP3⁺ → immunosuppression
  2. Cytotoxic T cells (CTL): CD8⁺ → kill infected/cancer cells
  3. Memory T cells: Central (Tcm) and effector (Tem) memory
  4. γδ T cells: Epithelial surveillance, stress response

VI. ACTIVATION AND FUNCTION OF T AND B CELLS

A. B Cell Activation

1. T-independent (TI) Antigens:

  • Type 1 (TI-1): LPS, polyclonal B cell activators
  • Type 2 (TI-2): Polysaccharides with repeating epitopes (pneumococcal capsule)
  • Response: Mainly IgM, no memory, no affinity maturation

2. T-dependent (TD) Antigens:

  • Require T cell help
  • Process:
    a) B cell internalizes antigen via BCR, processes, presents on MHC II
    b) Cognate interaction with activated Th cell (CD40L-CD40, cytokines)
    c) Germinal center reactions:

    • Somatic hypermutation: Affinity maturation
    • Class switch recombination: IgM → IgG/IgA/IgE
    • Differentiation: Plasma cells (antibody factories) and memory B cells

B. T Cell Activation

Three Signals Required:

  1. Signal 1: TCR recognition of peptide-MHC + co-receptor (CD4/CD8)
  2. Signal 2: Co-stimulation (B7 on APC → CD28 on T cell)
    • Without Signal 2 → anergy (tolerance)
  3. Signal 3: Cytokines → differentiation into effector subsets

Immunological Synapse:

  • Organized interface between T cell and APC
  • Central: TCR-MHC-peptide
  • Peripheral: Adhesion molecules (LFA-1-ICAM-1)

C. Effector Functions

1. Helper T cells (CD4⁺):

  • Th1: Activate macrophages (IFN-γ), promote IgG2a
  • Th2: Promote IgE, eosinophilia, alternative macrophage activation
  • Th17: Recruit neutrophils, defend against fungi/extracellular bacteria
  • Tfh: B cell help in germinal centers

2. Cytotoxic T cells (CD8⁺):

  • Killing mechanisms:
    • Perforin/granzyme: Induce apoptosis
    • Fas-FasL pathway: Death receptor-mediated apoptosis
    • Cytokines: IFN-γ, TNF-α

3. Regulatory T cells (Tregs):

  • Mechanisms: IL-10, TGF-β, CTLA-4, direct cytotoxicity
  • Prevent autoimmunity, maintain tolerance

VII. THE ROLE OF MHC IN IMMUNE RECOGNITION

A. MHC Structure

  • MHC Class I: Present endogenous peptides (viral, tumor) to CD8⁺ T cells
    • α chain (heavy) + β₂-microglobulin
    • Expressed on all nucleated cells
  • MHC Class II: Present exogenous peptides to CD4⁺ T cells
    • α chain + β chain
    • Expressed on APCs (DCs, macrophages, B cells)

B. Antigen Processing Pathways

  1. Endogenous pathway (MHC I):
    • Cytosolic proteins → proteasome → TAP transporter → ER → MHC I
  2. Exogenous pathway (MHC II):
    • Endocytosed antigens → lysosomal degradation → MHC II
  3. Cross-presentation: Exogenous antigens presented on MHC I (DCs only)

C. MHC Polymorphism

  • Most polymorphic genes in genome
  • Ensures population survival against pathogens
  • Basis for transplant rejection

VIII. IMMUNE MEMORY

A. Characteristics

  • Faster response (hours vs days)
  • Greater magnitude (higher antibody titers, more effector cells)
  • Higher affinity antibodies (affinity maturation)
  • Different quality (class-switched antibodies, different cytokine profiles)

B. Memory Cell Types

  1. Central memory (Tcm): Lymph node homing, better proliferative capacity
  2. Effector memory (Tem): Tissue homing, immediate effector function
  3. Resident memory (Trm): Tissue-resident, rapid local response
  4. Memory B cells: Express IgG/IgA/IgE, rapid plasma cell differentiation

C. Vaccination Principles

  • Primary response: Slow, low affinity IgM → IgG
  • Secondary response: Rapid, high affinity IgG
  • Adjuvants: Enhance immunogenicity (alum, MF59, AS01B)

IX. CLINICAL CORRELATIONS

A. Immunodeficiencies

  • X-linked agammaglobulinemia: Bruton’s tyrosine kinase defect → no B cells
  • Hyper-IgM syndrome: CD40L defect → no class switching
  • SCID: Various defects (ADA deficiency, γc chain defect)

B. Autoimmunity

  • Mechanisms: Molecular mimicry, epitope spreading, bystander activation
  • Examples: Rheumatoid arthritis, SLE, Type 1 diabetes

C. Cancer Immunotherapy

  • Immune checkpoint inhibitors: Anti-PD-1, anti-CTLA-4
  • CAR-T cells: Genetically engineered T cells with chimeric antigen receptors
  • Bi-specific antibodies: Blinatumomab (CD19-CD3)

D. Transplantation

  • HLA matching: Critical for graft survival
  • Immunosuppression: Calcineurin inhibitors (cyclosporine, tacrolimus), mTOR inhibitors

X. KEY REGULATORY MOLECULES

Molecule Expression Ligand Function
CD28 T cells B7 (CD80/86) Co-stimulation (Signal 2)
CTLA-4 Activated T cells, Tregs B7 Negative regulation
PD-1 Exhausted T cells PD-L1/PD-L2 Inhibition, peripheral tolerance
CD40L Activated T cells CD40 (B cells, APCs) B cell activation, class switching
ICOS Activated T cells ICOS-L T cell help, germinal center formation
4-1BB Activated T cells 4-1BBL Co-stimulation, survival signal

This integrated system allows for specific recognition, appropriate response amplification, precise targeting of pathogens, and establishment of protective memory while maintaining self-tolerance.

 

Leave a Comment